Compound ID,Uniprot ID,Compound Name,Standard inchi key,Max Phase,Target Pref Name,Gene Names,Target Class,Wild type or mutant,Mutation information,PubMed ID,End Point Standard Type,End Point Standard Relation,End Point Standard Value,End Point Standard Units,Endpoint Mode of Action,Assay Format,Assay Type,Assay Sub Type,Inhibitor Type,Detection Technology,Compound concentration value,Compound concentration value units,Substrate type,Substrate Type Standard Relation,Substrate Type Standard Value,Substrate Type Standard Units,Assay cell line,Assay Description,Activity Comments,Title,Journal,Year,Volume,Issue,Authors,Annotation Comments,Assay ID,DTC Tid,DTC Activity ID,DTC Molregno,Record ID,DTC Document ID
CHEMBL100100,P08254,,ZRDGYJAMDSHROJ-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1453247,DTCC00264536,982314,3373
CHEMBL100100,P08254,,ZRDGYJAMDSHROJ-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,7.08,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258356,DTCC00264536,972938,24803
CHEMBL100273,P08254,,CVJMAXDBGIRLPL-MNOVXSKESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,,,,,,,,,,,,,,,,,"Inhibition of Stromelysin-1, MMP-3 (Not determined)",Not Determined,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101946,DTCT0024060,1478677,DTCC00264430,885728,3373
CHEMBL100584,P08254,,IFHBUYGFCSEHIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11212095,IC50,=,4.3,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104720,DTCT0024060,628943,DTCC00269547,161928,4635
CHEMBL100805,P08254,,XYVVUCAHUUIYFV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11212095,IC50,=,69,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104720,DTCT0024060,637872,DTCC00269559,582958,4635
CHEMBL101121,P08254,,VVZTYGQJDUUATC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11212095,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104720,DTCT0024060,619916,DTCC00269629,2001205,4635
CHEMBL10180,P08254,,MOVLHCHTKCWLQE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,22100,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,939251,DTCC00138525,1016783,16645
CHEMBL10193,P08254,,QIKCPSHYSFYKBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,956224,DTCC00138519,272574,16645
CHEMBL102260,P08254,,YGKWWBDJTLTOFW-MNOVXSKESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,2700,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,24,,,101944,DTCT0024060,1314928,DTCC00272271,76353,1465
CHEMBL102415,P08254,,RNMJVOBQCWORLK-GFOWMXPYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543676,IC50,=,6.7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,104730,DTCT0024060,1202333,DTCC00273885,226190,16385
CHEMBL102438,P08254,,BSGLIFPGYIIUAJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,0.9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1389495,DTCC00273957,885822,16392
CHEMBL102441,P08254,,AGLYKFTUNLOGBT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,705,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1379267,DTCC00273131,465265,16392
CHEMBL102459,P08254,,YMFBAKCSKQKFMX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11212095,IC50,=,62,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104720,DTCT0024060,650232,DTCC00269592,1326752,4635
CHEMBL102504,P08254,,MEVLEABHOAUFQW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,20,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1371786,DTCC00273508,1661708,16392
CHEMBL10257,P08254,,ZOSFRKHRZHSICA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,4360,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,969086,DTCC00138526,110709,16645
CHEMBL10266,P08254,,DPDQSBRVGYFIHD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,2340,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,956061,DTCC00138497,919742,16645
CHEMBL102698,P08254,,WYWVSRVZNIIISU-BPGUCPLFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543676,IC50,=,6.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,104730,DTCT0024060,1194614,DTCC00273956,97110,16385
CHEMBL102785,P08254,,PECNGMJVFOGIBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,1.6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1398097,DTCC00273055,723954,16392
CHEMBL102798,P08254,,MAOGHLYYLNCNCI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,1.6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1399290,DTCC00273086,2077525,16392
CHEMBL102839,P08254,,YZESNXPVWTXSOW-NEPJUHHUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,20400,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,24,,,101944,DTCT0024060,1285976,DTCC00272270,1338693,1465
CHEMBL102941,P08254,,IWWYEUSBHSDVOX-KVMCETHSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,24,,,101944,DTCT0024060,1291044,DTCC00272244,141035,1465
CHEMBL10296,P08254,,AWDSUFIHUSMPAR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,17400,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,956232,DTCC00138702,726065,16645
CHEMBL10335,P08254,,XZFOATQBCODVSR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,5060,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,965339,DTCC00138703,822790,16645
CHEMBL103442,P08254,,KFTWEWMQNRZZNL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11212095,IC50,=,23,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104720,DTCT0024060,621140,DTCC00269617,1003168,4635
CHEMBL103589,P08254,,JMNSYQVLGRFSQE-MNOVXSKESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,810,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,24,,,101944,DTCT0024060,1293340,DTCC00272233,1468001,1465
CHEMBL104021,P08254,,NKRKWSFHPLAZOP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,10.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1381856,DTCC00106784,1240704,16392
CHEMBL104022,P08254,,TWQZYQBXMVVVCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,0.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1385694,DTCC00273200,433728,16392
CHEMBL104022,P08254,,TWQZYQBXMVVVCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16392792,IC50,=,0.7,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.,J. Med. Chem.,2006,49,1,"Pirard B, Matter H",,329821,DTCT0024060,1880217,DTCC00273200,423989,20214
CHEMBL10431,P08254,,SBPZKNUSQCPAAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,6600,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,954776,DTCC00138456,2015345,16645
CHEMBL104446,P08254,,BMPCLJPYXFVWKY-ARLHGKGLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543676,IC50,=,293,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,104730,DTCT0024060,1194609,DTCC00273526,1228796,16385
CHEMBL10454,P08254,,UXURFMZZZWZYFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,2280,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,936725,DTCC00138391,693756,16645
CHEMBL10454,P08254,,UXURFMZZZWZYFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,2280,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1321637,DTCC00138391,578578,16328
CHEMBL104599,P08254,,XOOXBIFEOHDRHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,4.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1398102,DTCC00273602,1564726,16392
CHEMBL10469,P08254,,TZGXQAYCVFGRLH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,8900,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,936721,DTCC00138421,1695954,16645
CHEMBL104722,P08254,,CQIQKDQFHVTTKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,29,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1385698,DTCC00273620,659487,16392
CHEMBL10492,P08254,,YUOAPDQYFOIVNS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,964048,DTCC00138706,1695957,16645
CHEMBL105142,P08254,,FCYBWLNLMVDLRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,45,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1401770,DTCC00273509,1207889,16392
CHEMBL105279,P08254,,ACXYSVKNGLLDLY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,5.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1369048,DTCC00273107,1500350,16392
CHEMBL105311,P08254,,SWRNCXLTVBBIMK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,1.1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1402983,DTCC00274052,205240,16392
CHEMBL105422,P08254,,AXBFSSCCVFPFFC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,195,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1371782,DTCC00273155,1079676,16392
CHEMBL105535,P08254,,SSFOEYVZLXDDTG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,6.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1384507,DTCC00273105,659486,16392
CHEMBL105705,P08254,,IEHZWPSZVCILAW-SNVBAGLBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,9670,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,24,,,101944,DTCT0024060,1288604,DTCC00272246,562491,1465
CHEMBL10590,P08254,,ZSZSGGNFCMWYDF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,10100,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,950661,DTCC00138558,403686,16645
CHEMBL105962,P08254,,ZPNXAVJYHSAOKF-SJBAFXMYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543676,IC50,=,18.7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,104730,DTCT0024060,1200050,DTCC00273570,389552,16385
CHEMBL106016,P08254,,MMOBDSFVSOBMOV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,2.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1389490,DTCC00273742,335997,16392
CHEMBL10646,P08254,,PTRUGAYWWQMKAT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,956228,DTCC00138654,822791,16645
CHEMBL10655,P08254,,KMBQQDDLWIEVKL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,3520,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,947004,DTCC00138617,1949640,16645
CHEMBL10671,P08254,,UMBHCIONUFCHIP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,3400,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,952150,DTCC00138613,403685,16645
CHEMBL10672,P08254,,HSFOMBDSDMOJCP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,1320,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,957553,DTCC00138695,34638,16645
CHEMBL10673,P08254,,ZCJYXMGAZICHPN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,3570,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,953641,DTCC00138696,1695956,16645
CHEMBL10674,P08254,,AXDNELHYOHIRLD-MIHMCVIASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,5100,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,952154,DTCC00138552,822792,16645
CHEMBL10760,P08254,,XHIUPZBXQZTGTG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,4560,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,975194,DTCC00138621,34636,16645
CHEMBL10761,P08254,,FFHXMPKAWWFPSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,8620,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,964044,DTCC00138622,564527,16645
CHEMBL1077203,P08254,,CNUCYIDHDPTDOD-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20172725,KI,>,40000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery and SAR of hydantoin TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,6,"Yu W, Guo Z, Orth P, Madison V, Chen L, Dai C, Feltz RJ, Girijavallabhan VM, Kim SH, Kozlowski JA, Lavey BJ, Li D, Lundell D, Niu X, Piwinski JJ, Popovici-Muller J, Rizvi R, Rosner KE, Shankar BB, Shih NY, Siddiqui MA, Sun J, Tong L, Umland S, Wong MK, Yang DY, Zhou G",,615265,DTCT0024060,3227035,DTCC00631173,1104573,38167
CHEMBL1078281,P08254,,GRSFKJZRDUZQPW-ONUMYQOESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21417219,IC50,=,68,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743611,DTCT0024060,5927580,DTCC00632907,1007708,44276
CHEMBL1078396,P08254,,PIEMRKVLYXWKFP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20172725,KI,=,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery and SAR of hydantoin TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,6,"Yu W, Guo Z, Orth P, Madison V, Chen L, Dai C, Feltz RJ, Girijavallabhan VM, Kim SH, Kozlowski JA, Lavey BJ, Li D, Lundell D, Niu X, Piwinski JJ, Popovici-Muller J, Rizvi R, Rosner KE, Shankar BB, Shih NY, Siddiqui MA, Sun J, Tong L, Umland S, Wong MK, Yang DY, Zhou G",,615265,DTCT0024060,3227034,DTCC00631942,1232705,38167
CHEMBL10792,P08254,,LQLNFJVHRIWFTO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,14600,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,939390,DTCC00138714,1308274,16645
CHEMBL10806,P08254,,DPNFTGXQMOIHKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,10700,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,961570,DTCC00138724,1081840,16645
CHEMBL10809,P08254,,GCCFOYRWIAVTCA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,3330,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,962733,DTCC00138658,1755790,16645
CHEMBL10822,P08254,,HCOFTHTVAIHKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,4560,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,936717,DTCC00138431,467502,16645
CHEMBL1082317,P08254,,QOWJHUFMPPFELP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20529685,IC50,=,160,NM,,,,,,,,,,,,,,Inhibition of MMP3,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634121,DTCT0024060,3346212,DTCC00647799,780673,35540
CHEMBL1082318,P08254,,HWZVYNMATDDRGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20529685,IC50,=,550,NM,,,,,,,,,,,,,,Inhibition of MMP3,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634121,DTCT0024060,3346213,DTCC00647800,2038151,35540
CHEMBL1082381,P08254,SC-276,WXNWNNKHEJMQOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16220987,KI,=,13,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14742624,DTCC00031197,2108114,69259
CHEMBL1082381,P08254,SC-276,WXNWNNKHEJMQOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20529684,IC50,=,13,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634111,DTCT0024060,3346117,DTCC00031197,792376,35532
CHEMBL1082381,P08254,SC-276,WXNWNNKHEJMQOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,13,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005902,DTCC00031197,781480,45214
CHEMBL108275,P08254,,FUWKALSZHXSYKK-DGPALRBDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,540,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3),,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102081,DTCT0024060,1020728,DTCC00283583,237806,1950
CHEMBL108412,P08254,,OYZQESBTDIZNIE-HKBOAZHASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10560745,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease (MMP-3),,Selective inhibition of low affinity IgE receptor (CD23) processing: P1' bicyclomethyl substituents.,Bioorg. Med. Chem. Lett.,1999,9,21,"Bailey S, Bolognese B, Faller A, Louis-Flamberg P, MacPherson DT, Mayer RJ, Marshall LA, Milner PH, Mistry J, Smith DG, Ward JG",,105818,DTCT0024060,1412071,DTCC00278610,1850573,3450
CHEMBL1084238,P08254,,UFKFLDDRYBWLPH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20529684,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634111,DTCT0024060,3346114,DTCC00647546,80529,35532
CHEMBL1084509,P08254,,VCKIKUWRRCAZBI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20529684,IC50,=,130,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634111,DTCT0024060,3346115,DTCC00647547,1601315,35532
CHEMBL1084510,P08254,,HMVRHAWMVBUIKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20529684,IC50,=,24.5,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634111,DTCT0024060,3346116,DTCC00647548,1375495,35532
CHEMBL10848,P08254,,QFUKIOJKDCKUGI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,9000,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,960227,DTCC00138628,1081839,16645
CHEMBL10851,P08254,,GVUFJCREUUFMPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,936783,DTCC00138737,1146775,16645
CHEMBL1085257,P08254,,WVNVANHURONWTG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20529685,IC50,=,370,NM,,,,,,,,,,,,,,Inhibition of MMP3,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634121,DTCT0024060,3346223,DTCC00647802,262531,35540
CHEMBL10881,P08254,,WYTXTYOLYMMDCW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,5440,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,939394,DTCC00138674,403684,16645
CHEMBL10885,P08254,,WUKUJFFVJZRRNH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,943130,DTCC00138648,34637,16645
CHEMBL109074,P08254,4-PHENYLPYRIDINE,JVZRCNQLWOELDU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,=,170000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in the presence of acetohydroxamic acid,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205632,DTCT0024060,1274892,DTCC01742144,1080479,17092
CHEMBL109074,P08254,4-PHENYLPYRIDINE,JVZRCNQLWOELDU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,=,900000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in the presence of 1-Napthohydroxamate,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205631,DTCT0024060,1274891,DTCC01742144,1080479,17092
CHEMBL10908,P08254,,GLFZNNLEMNMSQE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,2850,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,957558,DTCC00138721,1373409,16645
CHEMBL109239,P08254,,IKIPPVJMYSOQOD-GVAUOCQISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,9.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1377685,DTCC00282987,291843,2897
CHEMBL109246,P08254,,IZXYSBTXZXSNBA-MZKRTTBSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,54,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1398773,DTCC00282967,226309,2897
CHEMBL10935,P08254,,XFLXFAKGEAQTOI-MIHMCVIASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,3700,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,949519,DTCC00138543,1242881,16645
CHEMBL109358,P08254,,WRARKZOMOGNDCB-VWNXMTODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,520,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1030625,DTCC00283663,1818474,1950
CHEMBL109438,P08254,,HXMCVMJQARWQIU-ZUKKLESISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,2.3,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1028258,DTCC00284144,336105,1950
CHEMBL10952,P08254,,MWPVYUMZDJJEOU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,1810,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,936779,DTCC00138640,1949638,16645
CHEMBL10953,P08254,,PMHIYNQSFXKIMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,777,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,941797,DTCC00138641,855708,16645
CHEMBL109596,P08254,,YLXVWRCBKXEQFD-BDTNDASRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,10,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1382742,DTCC00282942,193946,2897
CHEMBL109670,P08254,,LCBDMDPQRIZWHQ-RSXGOPAZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,130,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1020725,DTCC00284035,820715,1950
CHEMBL109671,P08254,,XPMZVZSLPMEDJA-VEEOACQBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,170,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1018145,DTCC00283582,401605,1950
CHEMBL109706,P08254,,YLQBSSFZOXXRNR-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,82,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1397639,DTCC00282928,1456432,2897
CHEMBL109829,P08254,,PWMJELWPVMQEPL-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,17,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1047959,DTCC00283940,141139,1950
CHEMBL109910,P08254,,PPRCMDPOMBHOSF-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,16,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1036515,DTCC00284158,1175856,1950
CHEMBL11005,P08254,,ILNPRELUGQHUMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,941801,DTCC00138731,1631580,16645
CHEMBL110075,P08254,,VXEAQOOPZOMMSG-UHSQPCAPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,470,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1047962,DTCC00283616,982501,1950
CHEMBL110153,P08254,,GCGWPKSFLVGEQR-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,360,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease 3 (MMP3),,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102122,DTCT0024060,1380018,DTCC00282990,1871220,2897
CHEMBL110253,P08254,,BZHYFMBTEMWGNH-MVSFAKPFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,70,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1049334,DTCC00283939,1079791,1950
CHEMBL110312,P08254,,WQLAEVNCLSNAFK-ACHIHNKUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,260,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101939,DTCT0024060,1031811,DTCC00107036,1144730,1950
CHEMBL110527,P08254,,DOECLBQWTWHNID-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,16,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1375229,DTCC00106999,193948,2897
CHEMBL110696,P08254,,SGQBRJNZCHCINW-ARNLJNQMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,36,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1398769,DTCC00282953,583127,2897
CHEMBL110991,P08254,,DTQSORRPTAWCFK-VXMNRCMCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,24,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1015645,DTCC00283637,1014852,1950
CHEMBL110997,P08254,,QQIBFLKIYAKNQM-BHYZAODMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,670,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1036518,DTCC00283545,1144731,1950
CHEMBL111017,P08254,,CVNQIEKSHLAVBX-NHKHRBQYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,33,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,578050,DTCC00285102,1935563,1951
CHEMBL111104,P08254,,AALOSJKQIIRSAO-ZRBLBEILSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,4.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1380022,DTCC00282940,1228896,2897
CHEMBL111601,P08254,,PPRNBKQKXZPFHI-JOMNFKBKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,440,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1016972,DTCC00283604,1723494,1950
CHEMBL111736,P08254,,VYGKNAIULXUTGK-GVAUOCQISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,2.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1401314,DTCC00282980,744763,2897
CHEMBL111798,P08254,,AAPPTEGQHHRRCP-NJNPRVFISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,1.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1387584,DTCC00282748,809145,2897
CHEMBL111856,P08254,,ZBRHTUMWSDPCMI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15177439,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,104896,DTCT0024060,1496219,DTCC00287961,76527,6475
CHEMBL11188,P08254,,NDCGWDYXJPEWRR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,>,9999,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,945723,DTCC00138717,1146774,16645
CHEMBL111975,P08254,,DEQRLFQPZJLTBQ-LMERMFHRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,62,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1043100,DTCC00283937,1371398,1950
CHEMBL112100,P08254,,ARJINTGTQBBVFK-YPKYBTACSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,120,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,576094,DTCC00285128,357053,1951
CHEMBL112147,P08254,,XCJPWKHINIJNBZ-QAXCHELISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,557441,DTCC00285793,938755,1951
CHEMBL112180,P08254,,MTAVQVITWBDOLI-YPKYBTACSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,552777,DTCC00285522,1164282,1951
CHEMBL112180,P08254,,MTAVQVITWBDOLI-YPKYBTACSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,8,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,7,,,102093,DTCT0024060,583436,DTCC00285522,1165199,2023
CHEMBL112508,P08254,,OLFNQERWBAAFKD-DSPMFFIESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,47,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,546661,DTCC00285691,1618288,1951
CHEMBL112724,P08254,,GBAPWUJOZAJNDZ-IRPSRAIASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,410,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1039250,DTCC00283900,498278,1950
CHEMBL112803,P08254,,RDCAEKWUGPXPHR-JBOQNHBVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,140,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,552774,DTCC00285368,162108,1951
CHEMBL112864,P08254,,NHZFPZSJJGPCJS-NHKHRBQYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,120,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,578053,DTCC00285373,1068101,1951
CHEMBL11306,P08254,,MOPRTFSMCQNUCT-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,79,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,507672,DTCC00139917,356636,13104
CHEMBL11306,P08254,,MOPRTFSMCQNUCT-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,79.43,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258523,DTCC00139917,359207,24803
CHEMBL11306,P08254,,MOPRTFSMCQNUCT-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17719700,IC50,=,43,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510905,DTCT0024060,2438450,DTCC00139917,359575,30977
CHEMBL11306,P08254,,MOPRTFSMCQNUCT-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,79,NM,,,,,,,,,,,,,,Inhibitory concentration of compound against human neutrophil collagenase (HNC) was determined,,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102099,DTCT0024060,585745,DTCC00139917,368856,1496
CHEMBL11306,P08254,,MOPRTFSMCQNUCT-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,89,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102092,DTCT0024060,832562,DTCC00139917,368874,1497
CHEMBL113234,P08254,,DEQRLFQPZJLTBQ-WEAWZCMZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,26,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1049337,DTCC00284348,433823,1950
CHEMBL113322,P08254,,DGFULAROBOKMBD-YPKYBTACSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,564678,DTCC00285573,583161,1951
CHEMBL113362,P08254,,DVZGEDWEZGPRNW-ZUKKLESISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,2.5,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1049331,DTCC00284347,885924,1950
CHEMBL113460,P08254,,SXKYEZPKHTUHRD-UTBBQBIJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,180,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,565722,DTCC00285374,162107,1951
CHEMBL113500,P08254,,QDCHHVZSTNDDIC-KYJUHHDHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,>,200000,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101939,DTCT0024060,1025584,DTCC00284078,1306152,1950
CHEMBL114116,P08254,,PPHAWIZVVUURJO-OXQOHEQNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10052961,KI,=,500,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3 (MMP-3), stromelysin-1",,Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.,J. Med. Chem.,1999,42,4,"Groneberg RD, Burns CJ, Morrissette MM, Ullrich JW, Morris RL, Darnbrough S, Djuric SW, Condon SM, McGeehan GM, Labaudiniere R, Neuenschwander K, Scotese AC, Kline JA",,104735,DTCT0024060,874375,DTCC00288870,1113109,15577
CHEMBL114116,P08254,,PPHAWIZVVUURJO-OXQOHEQNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669559,KI,=,500,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104750,DTCT0024060,1084493,DTCC00288870,1100953,16063
CHEMBL114272,P08254,,SUEBJDNLBVTIQP-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19942433,KD,=,43,NM,,,,,,,,,,,,,,Binding affinity to stromelysin-1 catalytic domain expressed in Escherichia coli BL21 (DE3) by isothermal titration colorimetry,,A single step purification for autolytic zinc proteinases.,Bioorg. Med. Chem. Lett.,2010,20,1,"Wilfong EM, Locklear U, Toone EJ",,603252,DTCT0024060,3177042,DTCC00288482,566245,36833
CHEMBL114272,P08254,,SUEBJDNLBVTIQP-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19942433,KD,=,113,NM,,,,,,,,,,,,,,Binding affinity to stromelysin-1 catalytic domain,,A single step purification for autolytic zinc proteinases.,Bioorg. Med. Chem. Lett.,2010,20,1,"Wilfong EM, Locklear U, Toone EJ",,603251,DTCT0024060,3177038,DTCC00288482,566245,36833
CHEMBL114523,P08254,,ZRMIETZFPZGBEB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,<,50000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in the presence of 1-Napthohydroxamate,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205631,DTCT0024060,1257567,DTCC00290455,141832,17092
CHEMBL114523,P08254,,ZRMIETZFPZGBEB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,<,50000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in the presence of acetohydroxamic acid,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205632,DTCT0024060,1257568,DTCC00290455,141832,17092
CHEMBL114523,P08254,,ZRMIETZFPZGBEB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,=,20000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in place of acetohydroxamic acid.,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205633,DTCT0024060,1249394,DTCC00290455,141833,17092
CHEMBL114523,P08254,,ZRMIETZFPZGBEB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15214773,KD,=,20000,NM,,,,,,,,,,,,,,Dissociation constant for Matrix Metalloprotease-3 (MMP-3),,Fragment-based drug discovery.,J. Med. Chem.,2004,47,14,"Erlanson DA, McDowell RS, O'Brien T",,104900,DTCT0024060,366771,DTCC00290455,141231,17883
CHEMBL114673,P08254,,HZAXNPDJVFUGDS-SCSAIBSYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669559,KI,=,18,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104750,DTCT0024060,1075031,DTCC00288871,1489116,16063
CHEMBL114815,P08254,,SQQHSADBIVCBBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944582,DTCT0024060,11835355,DTCC00288372,1612260,53820
CHEMBL114878,P08254,,LCWWOMJWYGNKJF-IARZGTGTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11585440,KI,>,2000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104869,DTCT0024060,1322674,DTCC00286952,724080,16439
CHEMBL114944,P08254,,WNJWSNXIZOSCTK-BVRKHOPBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669559,KI,=,30,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104750,DTCT0024060,1072602,DTCC00288872,453373,16063
CHEMBL115189,P08254,,OCSMOTCMPXTDND-JKIOLJMWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669559,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104719,DTCT0024060,1072593,DTCC00289405,1035817,16063
CHEMBL115263,P08254,,SOPDPCOBVSOXIM-ZDXQCDESSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11585440,KI,>,2000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104869,DTCT0024060,1309691,DTCC00287904,433861,16439
CHEMBL115460,P08254,,FOOIUOKCYUZPDW-YCLCTBJKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12877590,IC50,=,23,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3 (MMP-3),,"A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.",J. Med. Chem.,2003,46,16,"Fray MJ, Dickinson RP, Huggins JP, Occleston NL",,104716,DTCT0024060,1548442,DTCC00293174,1871336,17445
CHEMBL115467,P08254,,JTVUPWROGYERPT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15214773,IC50,=,340,NM,,,,,,,,,,,,,,Inhibition of Matrix Metalloprotease-3 (MMP-3),,Fragment-based drug discovery.,J. Med. Chem.,2004,47,14,"Erlanson DA, McDowell RS, O'Brien T",,104898,DTCT0024060,628270,DTCC00291974,886023,17883
CHEMBL115468,P08254,NAPHTHALENE-1-CARBOXYLIC ACID HYDROXYAMIDE,JRZGPWOEHDOVMC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,IC50,=,50000,NM,,,,,,,,,,,,,,Inhibition of Stromelysin (MMP-3),,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205630,DTCT0024060,1263503,DTCC01742517,336854,17092
CHEMBL115468,P08254,NAPHTHALENE-1-CARBOXYLIC ACID HYDROXYAMIDE,JRZGPWOEHDOVMC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,=,50000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in place of acetohydroxamic acid.,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205633,DTCT0024060,1263502,DTCC01742517,336854,17092
CHEMBL115468,P08254,NAPHTHALENE-1-CARBOXYLIC ACID HYDROXYAMIDE,JRZGPWOEHDOVMC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15214773,KD,=,50000,NM,,,,,,,,,,,,,,Dissociation constant for Matrix Metalloprotease-3 (MMP-3),,Fragment-based drug discovery.,J. Med. Chem.,2004,47,14,"Erlanson DA, McDowell RS, O'Brien T",,104900,DTCT0024060,627210,DTCC01742517,336207,17883
CHEMBL115623,P08254,,IGABAYLGZIHXFO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15214773,IC50,=,62,NM,,,,,,,,,,,,,,Inhibition of Matrix Metalloprotease-3 (MMP-3),,Fragment-based drug discovery.,J. Med. Chem.,2004,47,14,"Erlanson DA, McDowell RS, O'Brien T",,104898,DTCT0024060,648302,DTCC00292029,1532945,17883
CHEMBL115653,P08254,CIPEMASTAT,GFUITADOEPNRML-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669559,KI,=,527,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104750,DTCT0024060,1065649,DTCC00288838,1839322,16063
CHEMBL115653,P08254,CIPEMASTAT,GFUITADOEPNRML-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,527,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,527937,DTCC00288838,1850867,13726
CHEMBL115653,P08254,CIPEMASTAT,GFUITADOEPNRML-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16516469,KI,=,56,NM,,,,,,,,,,,,,,Binding affinity to recombinant MMP3,,A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,10,"Janser P, Neumann U, Miltz W, Feifel R, Buhl T",,354052,DTCT0024060,1926039,DTCC00288838,1852176,20779
CHEMBL115653,P08254,CIPEMASTAT,GFUITADOEPNRML-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19422229,IC50,=,87,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500583,DTCT0024060,2824175,DTCC00288838,1841984,33635
CHEMBL115727,P08254,,MCSWSPNUKWMZHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9733482,IC50,=,18.4,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,"Discovery of potent, achiral matrix metalloproteinase inhibitors.",J. Med. Chem.,1998,41,19,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Rydel T, Dunaway CM, Gu F, Mieling GE",,104724,DTCT0024060,1542945,DTCC00288787,1585709,14767
CHEMBL115727,P08254,,MCSWSPNUKWMZHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669559,KI,=,18,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104750,DTCT0024060,1080946,DTCC00288787,1585632,16063
CHEMBL115727,P08254,,MCSWSPNUKWMZHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,=,28.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535406,DTCC00288787,1591034,48665
CHEMBL115727,P08254,,MCSWSPNUKWMZHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827441,DTCT0024060,10535509,DTCC00288787,1591034,48665
CHEMBL1160559,P08254,QUINALDIC ACID,LOAUVZALPPNFOQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,73,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103874,DTCC00648701,183412,43205
CHEMBL1160566,P08254,,HYOIXDQZRRYZMK-MCSJAMFESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1997,7,20,,,102100,DTCT0024060,528459,DTCC00648708,1773963,2305
CHEMBL1160569,P08254,,JTDLQABYTLWHGW-QCVPMONFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,800,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1997,7,20,,,102100,DTCT0024060,530274,DTCC00648711,808776,2305
CHEMBL1160570,P08254,,NFDGDKSWNHBFPY-MCSJAMFESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,900,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1997,7,20,,,102100,DTCT0024060,526461,DTCC00648712,1035378,2305
CHEMBL1160574,P08254,,XRNHYCWNCWJTCZ-KYYDNFDVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,900,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1997,7,20,,,102100,DTCT0024060,533131,DTCC00648716,1456048,2305
CHEMBL1160575,P08254,,IJSCISRMHJAJIZ-CNFXVBRLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,900,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1997,7,20,,,102100,DTCT0024060,526462,DTCC00648717,486362,2305
CHEMBL1160685,P08254,CYCLOHEXANAMINIUM HYDROGEN (ISOBUTYLAMINO)CARBONYLPHOSPHONATE,JAOQWUBVSCNFML-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1301425,DTCC00648810,401328,17838
CHEMBL1160686,P08254,,SPZJLPXBRLFGFY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1302614,DTCC00648811,1273344,17838
CHEMBL1161012,P08254,,DLGBEGBHXSAQOC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,76,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103332,DTCC00649095,1057326,43205
CHEMBL116318,P08254,,UICDMTYNXJBPNZ-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,11,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102092,DTCT0024060,839746,DTCC00293444,1723601,1497
CHEMBL116756,P08254,,WCEYHKKUIBHLOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15214773,IC50,=,15,NM,,,,,,,,,,,,,,Inhibition of Matrix Metalloprotease-3 (MMP-3),,Fragment-based drug discovery.,J. Med. Chem.,2004,47,14,"Erlanson DA, McDowell RS, O'Brien T",,104898,DTCT0024060,653963,DTCC00292007,1500555,17883
CHEMBL1169,P08254,AMINOSALICYLIC ACID,WUBBRNOQWQTFEX-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,4,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103210,DTCC00290367,669653,43205
CHEMBL117225,P08254,UK-356618,JJHRUUKMPWUYIB-HVOSOHGQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229774,IC50,=,5.9,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-3 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,104580,DTCT0024060,573962,DTCC01742560,174043,4692
CHEMBL117225,P08254,UK-356618,JJHRUUKMPWUYIB-HVOSOHGQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12877590,IC50,=,5.9,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3 (MMP-3),,"A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.",J. Med. Chem.,2003,46,16,"Fray MJ, Dickinson RP, Huggins JP, Occleston NL",,104716,DTCT0024060,1551207,DTCC01742560,162203,17445
CHEMBL117225,P08254,UK-356618,JJHRUUKMPWUYIB-HVOSOHGQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,5.89,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258554,DTCC01742560,164163,24803
CHEMBL117225,P08254,UK-356618,JJHRUUKMPWUYIB-HVOSOHGQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,IC50,=,5.9,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457462,DTCC01742560,176034,32556
CHEMBL1172417,P08254,,NJNBOILPWXEYGR-GDNBJRDFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,14200,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) using Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate after 3 mins by fluorimetric assay,,Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures,MedChemComm,2015,6,5,"Panico A, Maccari R, Cardile V, Avondo S, Crasci L, Ottana R",,1541339,DTCT0024060,11377,DTCC00655418,27470,65440
CHEMBL117296,P08254,,MCDVAZDSWVFMGC-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,3500,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102092,DTCT0024060,828560,DTCC00293413,1338924,1497
CHEMBL117720,P08254,,XJLATMLVMSFZBN-BZEOVNSFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,1700,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102092,DTCT0024060,817081,DTCC00293037,76595,1497
CHEMBL118512,P08254,,XIDVVJBXNORWKN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15214773,KD,=,20000,NM,,,,,,,,,,,,,,Dissociation constant for Matrix Metalloprotease-3 (MMP-3),,Fragment-based drug discovery.,J. Med. Chem.,2004,47,14,"Erlanson DA, McDowell RS, O'Brien T",,104900,DTCT0024060,638249,DTCC00292303,1947613,17883
CHEMBL118740,P08254,,USRUKOUPEOXKSQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15214773,IC50,=,310,NM,,,,,,,,,,,,,,Inhibition of Matrix Metalloprotease-3 (MMP-3),,Fragment-based drug discovery.,J. Med. Chem.,2004,47,14,"Erlanson DA, McDowell RS, O'Brien T",,104898,DTCT0024060,646088,DTCC00292302,1882872,17883
CHEMBL118744,P08254,,CMBPIMDJJHAVBX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9733482,IC50,=,41,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,"Discovery of potent, achiral matrix metalloproteinase inhibitors.",J. Med. Chem.,1998,41,19,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Rydel T, Dunaway CM, Gu F, Mieling GE",,104724,DTCT0024060,1535790,DTCC00294723,744900,14767
CHEMBL118848,P08254,,XWGUPBCCRWJAMM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9733482,IC50,=,19.5,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,"Discovery of potent, achiral matrix metalloproteinase inhibitors.",J. Med. Chem.,1998,41,19,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Rydel T, Dunaway CM, Gu F, Mieling GE",,104724,DTCT0024060,1553918,DTCC00295131,1327053,14767
CHEMBL119083,P08254,,IQXWFHDFTAZGNB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,29,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103355,DTCC00298384,701897,43205
CHEMBL11945,P08254,,AJKVQEKCUACUMD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,>,25000000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in place of acetohydroxamic acid.,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205633,DTCT0024060,1278385,DTCC00140491,1724192,17092
CHEMBL119647,P08254,,UFVLIVCXTIGACT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,87,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103953,DTCC00292472,540481,43205
CHEMBL120305,P08254,,URZNSEWPQRLLLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9733482,IC50,=,1290,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,"Discovery of potent, achiral matrix metalloproteinase inhibitors.",J. Med. Chem.,1998,41,19,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Rydel T, Dunaway CM, Gu F, Mieling GE",,104724,DTCT0024060,1528764,DTCC00295327,258700,14767
CHEMBL1204013,P08254,,RUFCUNSVBIYRLT-CPLNNKCJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19635666,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP-3,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598557,DTCT0024060,3101257,DTCC00681531,910637,36106
CHEMBL121188,P08254,TROPOLONE,MDYOLVRUBBJPFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,95,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103936,DTCC00298736,183415,43205
CHEMBL121557,P08254,E637,YIKYNHJUKRTCJL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,38,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103108,DTCC00298041,1445791,43205
CHEMBL1222867,P08254,,XMSHNXONZBWQTA-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20663669,INH,=,3.61,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Biaryl substituted hydantoin compounds as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,17,"Yu W, Tong L, Kim SH, Wong MK, Chen L, Yang DY, Shankar BB, Lavey BJ, Zhou G, Kosinski A, Rizvi R, Li D, Feltz RJ, Piwinski JJ, Rosner KE, Shih NY, Siddiqui MA, Guo Z, Orth P, Shah H, Sun J, Umland S, Lundell DJ, Niu X, Kozlowski JA",,651598,DTCT0024060,3456518,DTCC00691619,307666,40340
CHEMBL1223007,P08254,,JHADKVOWWKZBNS-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20663669,INH,=,430,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Biaryl substituted hydantoin compounds as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,17,"Yu W, Tong L, Kim SH, Wong MK, Chen L, Yang DY, Shankar BB, Lavey BJ, Zhou G, Kosinski A, Rizvi R, Li D, Feltz RJ, Piwinski JJ, Rosner KE, Shih NY, Siddiqui MA, Guo Z, Orth P, Shah H, Sun J, Umland S, Lundell DJ, Niu X, Kozlowski JA",,651598,DTCT0024060,3456544,DTCC00691756,1310511,40340
CHEMBL1223075,P08254,,HGPPYGXNQCWPLJ-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20663669,INH,=,434,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Biaryl substituted hydantoin compounds as TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,17,"Yu W, Tong L, Kim SH, Wong MK, Chen L, Yang DY, Shankar BB, Lavey BJ, Zhou G, Kosinski A, Rizvi R, Li D, Feltz RJ, Piwinski JJ, Rosner KE, Shih NY, Siddiqui MA, Guo Z, Orth P, Shah H, Sun J, Umland S, Lundell DJ, Niu X, Kozlowski JA",,651598,DTCT0024060,3456561,DTCC00691820,922026,40340
CHEMBL1229868,P08254,SC-77774,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,22,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005924,DTCC00032045,781475,45214
CHEMBL1231240,P08254,,IPBPOBHSNJFRFT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25265401,IC50,=,30000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),,"Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.",J. Med. Chem.,2014,57,24,"Fabre B, Ramos A, de Pascual-Teresa B",,1433219,DTCT0024060,13993808,DTCC00694031,1204120,60040
CHEMBL12318,P08254,CLODRONIC ACID,ACSIXWWBWUQEHA-UHFFFAOYSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17583333,IC50,=,300000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 after 1 hr,,"Platinum complexes can inhibit matrix metalloproteinase activity: platinum-diethyl[(methylsulfinyl)methyl]phosphonate complexes as inhibitors of matrix metalloproteinases 2, 3, 9, and 12.",J. Med. Chem.,2007,50,15,"Sasanelli R, Boccarelli A, Giordano D, Laforgia M, Arnesano F, Natile G, Cardellicchio C, Capozzi MA, Coluccia M",,439904,DTCT0024060,2112260,DTCC00140920,1523158,23003
CHEMBL1232487,P08254,,KOVQMCGGWATESY-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,62,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247465,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,170285,DTCC00694177,1422152,64498
CHEMBL1232489,P08254,,LIIRZRQVACDFBI-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247476,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,161623,DTCC00694178,484290,64498
CHEMBL1232492,P08254,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247556,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,175547,DTCC00694179,1680179,64498
CHEMBL1232492,P08254,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247557,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,175744,DTCC00694179,1680179,64498
CHEMBL123320,P08254,,CAPSVCHNNRHIDK-LOACHALJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,60,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1704453,DTCC00302421,1035964,16065
CHEMBL123320,P08254,,CAPSVCHNNRHIDK-LOACHALJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,60.01,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,500203,DTCC00302421,1047501,16483
CHEMBL1234326,P08254,3-HYDROXYPICOLINIC ACID,BRARRAHGNDUELT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,56,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103973,DTCC00032094,1607385,43205
CHEMBL1234370,P08254,,CYYCSKFJEOSZTF-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,>,10000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1371837,DTCC00694384,1883251,15412
CHEMBL123499,P08254,,JCCRVIZMNYULMQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,4.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1688098,DTCC00303217,486972,16065
CHEMBL123499,P08254,,JCCRVIZMNYULMQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,4.3,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,495479,DTCC00303217,498525,16483
CHEMBL123503,P08254,,DZFFLJXATZFATL-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,60,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,515824,DTCC00304831,1371678,13726
CHEMBL1235568,P08254,,XYEPUTZVZYUENX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,64,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103284,DTCC00694512,1283744,43205
CHEMBL123563,P08254,,XVZWTHXPJUVJAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,3.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1711245,DTCC00302702,874710,16065
CHEMBL123563,P08254,,XVZWTHXPJUVJAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,3.2,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,487967,DTCC00302702,886182,16483
CHEMBL123615,P08254,,IAENNQHKVZEBQT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,39,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1709796,DTCC00302858,1682780,16065
CHEMBL123615,P08254,,IAENNQHKVZEBQT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,39,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,493060,DTCC00302858,1694206,16483
CHEMBL123627,P08254,,INSQINPAEQOIQL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,7.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1704458,DTCC00302808,744987,16065
CHEMBL123627,P08254,,INSQINPAEQOIQL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,7.5,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,482212,DTCC00302808,756424,16483
CHEMBL123858,P08254,,QSTJVEYCHWTPDX-CHQNGUEUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,550,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,101940,DTCT0024060,1518459,DTCC00304375,562828,1959
CHEMBL123967,P08254,,RYRSPABEKSPRKC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,3.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1700451,DTCC00302821,777059,16065
CHEMBL123967,P08254,,RYRSPABEKSPRKC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,3.5,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,507761,DTCC00302821,788631,16483
CHEMBL124026,P08254,,GOLRDGXHDIYHCN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,75,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1681644,DTCC00302820,1585795,16065
CHEMBL124026,P08254,,GOLRDGXHDIYHCN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,74.99,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,489202,DTCC00302820,1597559,16483
CHEMBL124100,P08254,,ZFYWVXBCKVCYOL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,28,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1691926,DTCC00303263,1164479,16065
CHEMBL124100,P08254,,ZFYWVXBCKVCYOL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,28,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,497800,DTCC00303263,1176123,16483
CHEMBL1241348,P08254,FALDAPREVIR,LLGDPTDZOVKFDU-XUHJSTDZSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20823284,INHIBITION,=,11,%,,,,,,,,,,,,,,Inhibition of human MMP-3 at 10 uM,,"Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease.",Antimicrob. Agents Chemother.,2010,54,11,"White PW, Llinàs-Brunet M, Amad M, Bethell RC, Bolger G, Cordingley MG, Duan J, Garneau M, Lagacé L, Thibeault D, Kukolj G",,724362,DTCT0024060,5125912,DTCC00126282,118904,43507
CHEMBL124265,P08254,,YWZUYEWFBPKKSJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,71,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1712475,DTCC00303495,1521506,16065
CHEMBL124265,P08254,,YWZUYEWFBPKKSJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,71.01,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,499057,DTCC00303495,1533088,16483
CHEMBL124514,P08254,,QMHSEIOSCQWTPQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,175,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1680208,DTCC00303304,97463,16065
CHEMBL124514,P08254,,QMHSEIOSCQWTPQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,174.98,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,500204,DTCC00303304,108961,16483
CHEMBL124558,P08254,,VUANPBMJTLCNSC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,13,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1707026,DTCC00302325,1262121,16065
CHEMBL124558,P08254,,VUANPBMJTLCNSC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,13,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,490480,DTCC00302325,1273798,16483
CHEMBL124598,P08254,,ZAJDMTLZCCTTNJ-DTXPUJKBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,50,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,101940,DTCT0024060,1496388,DTCC00304376,401838,1959
CHEMBL124680,P08254,,NDGWYSJFTMSGNY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,48,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1379337,DTCC00303465,1662307,15412
CHEMBL124680,P08254,,NDGWYSJFTMSGNY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,48,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1703158,DTCC00303465,1650647,16065
CHEMBL124680,P08254,,NDGWYSJFTMSGNY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,48,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,485710,DTCC00303465,1662069,16483
CHEMBL124681,P08254,,GTRBSPVJGOLISO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,269,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1696746,DTCC00303466,1585794,16065
CHEMBL124681,P08254,,GTRBSPVJGOLISO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,269.15,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,497799,DTCC00303466,1597557,16483
CHEMBL125068,P08254,,KEWGKOQZKWDXBX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,20,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1712480,DTCC00303279,1489255,16065
CHEMBL125068,P08254,,KEWGKOQZKWDXBX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,20,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,490481,DTCC00303279,1500716,16483
CHEMBL125104,P08254,,BHBDAWJEKOCFGP-TUSQITKMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,3,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,541127,DTCC00304856,627570,13726
CHEMBL125138,P08254,,UROHLDAMBMAOKL-DPSWKAHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,8,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,514821,DTCC00304556,1468365,13726
CHEMBL125281,P08254,,FGCFPKFVQOUMFJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,184,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1720789,DTCC00302814,2001625,16065
CHEMBL125281,P08254,,FGCFPKFVQOUMFJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,184.08,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,478882,DTCC00302814,2013541,16483
CHEMBL125302,P08254,,KZZHUKUOPGQIRQ-YSSFQJQWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,514818,DTCC00304565,917876,13726
CHEMBL125384,P08254,,PQRKDBIFJONDMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,124,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1694285,DTCC00302906,519185,16065
CHEMBL125384,P08254,,PQRKDBIFJONDMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,123.88,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,493061,DTCC00302906,530613,16483
CHEMBL1255934,P08254,,SWELIMKTDYHAOY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,14,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103062,DTCC00699570,1672007,43205
CHEMBL125598,P08254,,KXZZWRQJKQVMKR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,23,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1689340,DTCC00303280,777060,16065
CHEMBL125598,P08254,,KXZZWRQJKQVMKR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,23,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,476484,DTCC00303280,788632,16483
CHEMBL125601,P08254,,FKPCCEUCLYUJQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,385,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1703168,DTCC00302219,1164478,16065
CHEMBL125601,P08254,,FKPCCEUCLYUJQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,385.48,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,478883,DTCC00302219,1176122,16483
CHEMBL125672,P08254,,PNVLBMRGQMDPBJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,65,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1713849,DTCC00302951,258782,16065
CHEMBL125672,P08254,,PNVLBMRGQMDPBJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,65.01,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,487969,DTCC00302951,270761,16483
CHEMBL125755,P08254,,DYVJPNSKJGHBKT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,27,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1688103,DTCC00302953,680411,16065
CHEMBL125755,P08254,,DYVJPNSKJGHBKT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,27,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,485712,DTCC00302953,692005,16483
CHEMBL125901,P08254,,LAXIFXUCVNKYRQ-TZYHBYERSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,513863,DTCC00304596,270760,13726
CHEMBL126004,P08254,,SJJAJPMVTRAZSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,38,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1716500,DTCC00302594,809381,16065
CHEMBL126004,P08254,,SJJAJPMVTRAZSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,38,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,483369,DTCC00302594,820980,16483
CHEMBL126044,P08254,,HWRVCRDVLWYPOY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,2.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1713839,DTCC00302324,1262120,16065
CHEMBL126044,P08254,,HWRVCRDVLWYPOY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,2.5,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,499058,DTCC00302324,1273797,16483
CHEMBL126307,P08254,,LXCTYQRQUPZROK-DTXPUJKBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,50,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,101940,DTCT0024060,1501829,DTCC00304150,1112716,1959
CHEMBL126380,P08254,,QKYPFBUZQDJQHX-NWVWQQAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,3.3,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,518978,DTCC00304598,853892,13726
CHEMBL126380,P08254,,QKYPFBUZQDJQHX-NWVWQQAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,98,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,541122,DTCC00304598,853893,13726
CHEMBL126380,P08254,,QKYPFBUZQDJQHX-NWVWQQAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,235,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,536420,DTCC00304598,853891,13726
CHEMBL126388,P08254,,DEZZFUOGAFLCST-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,41,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1700461,DTCC00302969,583382,16065
CHEMBL126388,P08254,,DEZZFUOGAFLCST-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,41,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,485711,DTCC00302969,595070,16483
CHEMBL126461,P08254,,NOCFVGZKPITVEY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,10,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,533623,DTCC00304599,108960,13726
CHEMBL126467,P08254,,HHSRPGRTUBHMGF-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,101940,DTCT0024060,1507237,DTCC00304300,401837,1959
CHEMBL126711,P08254,,BOXAYSWQFMJSDX-OEOAZWSVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,474,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,514826,DTCC00304242,1500715,13726
CHEMBL126712,P08254,,DRINIAFHXKEERM-VDGAXYAQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,9.4,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,516919,DTCC00304243,205585,13726
CHEMBL126923,P08254,,UVAFSUYDCCCUTO-HRNNMHKYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,26,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,530745,DTCC00304832,820979,13726
CHEMBL126977,P08254,,CXRYZROMBCZZFO-IGKWTDBASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,278,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,537436,DTCC00304833,1241046,13726
CHEMBL1269994,P08254,,RCTYLDJWEDNGIO-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22342144,KI,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 using OmniMMP as substrate,,Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.,Bioorg. Med. Chem. Lett.,2012,22,6,"Jiao GS, Kim S, Moayeri M, Crown D, Thai A, Cregar-Hernandez L, McKasson L, Sankaran B, Lehrer A, Wong T, Johns L, Margosiak SA, Leppla SH, Johnson AT",,811338,DTCT0024060,10427392,DTCC00703250,1719078,47718
CHEMBL127035,P08254,,IHWAKJKUYYZNCF-NDXORKPFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,216,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,517913,DTCC00304827,595069,13726
CHEMBL127093,P08254,,DOIKBNWTWCOTKR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,17,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1700456,DTCC00302970,2066273,16065
CHEMBL127093,P08254,,DOIKBNWTWCOTKR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,16.98,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,476485,DTCC00302970,2077863,16483
CHEMBL127138,P08254,,XJZZRJAENCZOAK-APTRMMRNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,18,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,530750,DTCC00304826,1047499,13726
CHEMBL127168,P08254,,GQVFUZHQNCWOMM-SSPYTLHUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,103,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,538391,DTCC00304825,1565048,13726
CHEMBL127279,P08254,,QRQFMTYAJVQMHW-SDHOMARFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,1900,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,101940,DTCT0024060,1505064,DTCC00304403,2077859,1959
CHEMBL127364,P08254,,SYDKUXARUOQYRZ-CHQNGUEUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,510,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,101940,DTCT0024060,1503893,DTCC00304404,1306375,1959
CHEMBL127559,P08254,,AKWUAHDLDRSRDC-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,64,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,522122,DTCC00304754,724286,13726
CHEMBL127715,P08254,,YSBAYUBRRQWYNR-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,101940,DTCT0024060,1499749,DTCC00304339,1662066,1959
CHEMBL127747,P08254,,YVARQPGBOLUGDV-KCHLEUMXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,120,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,101940,DTCT0024060,1512795,DTCC00304499,853885,1959
CHEMBL127787,P08254,,IYWLZQLIFMUDCK-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,253,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,521081,DTCC00304726,498524,13726
CHEMBL127812,P08254,,NXXWRUUYGMBTAG-SVBPBHIXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,18000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,101940,DTCT0024060,1490538,DTCC00304237,1371676,1959
CHEMBL127867,P08254,,SPHCUXPEUQITEV-HARLFGEKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,184,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,539254,DTCC00304547,530612,13726
CHEMBL127927,P08254,,APIRPAHYNXCYPW-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,101940,DTCT0024060,1502895,DTCC00304264,724282,1959
CHEMBL1287851,P08254,,FYZPCUXRTDXRBF-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21106451,IC50,=,5800,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Novel TNF-a converting enzyme (TACE) inhibitors as potential treatment for inflammatory diseases.,Bioorg. Med. Chem. Lett.,2010,20,24,"Girijavallabhan VM, Chen L, Dai C, Feltz RJ, Firmansjah L, Li D, Kim SH, Kozlowski JA, Lavey BJ, Kosinski A, Piwinski JJ, Popovici-Muller J, Rizvi R, Rosner KE, Shankar BB, Shih NY, Siddiqui MA, Tong L, Wong MK, Yang DY, Yang L, Yu W, Zhou G, Guo Z, Orth P, Madison V, Bian H, Lundell D, Niu X, Shah H, Sun J, Umland S",,686066,DTCT0024060,3618670,DTCC00707887,40801,42108
CHEMBL132762,P08254,,BMRADOMTKGXKQT-KMDXXIMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205501,DTCT0024060,1262043,DTCC00318518,31521,12304
CHEMBL132816,P08254,,QZPAQYPSRXIPQS-WHBJXLRSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,IC50,=,47000,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205501,DTCT0024060,1274564,DTCC00318493,2078017,12304
CHEMBL1330588,P08254,METHYLTHIOURACIL,HWGBHCRJGXAGEU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,37,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103292,DTCC00739824,896233,43205
CHEMBL133199,P08254,,XFPUHEASCSXICK-SQNIBIBYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,IC50,~,100000,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205501,DTCT0024060,1259578,DTCC00318277,1915387,12304
CHEMBL133303,P08254,,CLEOQVDSXZQLLG-DSITVLBTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,IC50,=,10800,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205501,DTCT0024060,1281387,DTCC00318351,109125,12304
CHEMBL133314,P08254,,VUYBRUBUOZYSQS-FSSWDIPSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,218,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1258562,DTCC00317457,357423,16522
CHEMBL133369,P08254,,JERYKMOBMXUTFQ-AABGKKOBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,84,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1268068,DTCC00317456,583574,16522
CHEMBL134849,P08254,,JLPMPXKOGZSSRK-SQNIBIBYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,214,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1262173,DTCC00317832,1774765,16522
CHEMBL135034,P08254,,MQLHBSAEUUVJRX-BDXSIMOUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,49,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1280318,DTCC00317167,842336,16522
CHEMBL135075,P08254,,JEFVBTZAXMPPTH-SQNIBIBYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,79,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1281520,DTCC00317266,551473,16522
CHEMBL135216,P08254,,ARACCHZGYNRRSQ-DKLXNKCPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,IC50,=,28000,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205501,DTCT0024060,1267956,DTCC00318519,1818902,12304
CHEMBL135251,P08254,,VNCIHKLPBWTDIP-PBDJWPIDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,76,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1250395,DTCC00317233,551474,16522
CHEMBL135448,P08254,,NODRUMNZQLWMFX-LEOXJPRUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,KI,=,230,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205627,DTCT0024060,1269076,DTCC00318421,141535,12304
CHEMBL135590,P08254,,HUBNMJYLBBXLHV-BARDWOONSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,273,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1274751,DTCC00317635,874877,16522
CHEMBL135640,P08254,,YLFRNDPMRQUKDD-OIBXWCBGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,KI,=,1600,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205627,DTCT0024060,1279219,DTCC00318281,336562,12304
CHEMBL135641,P08254,,XVGNAZNOVPHPDB-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,KI,=,640,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205627,DTCT0024060,1269073,DTCC00318282,465784,12304
CHEMBL135783,P08254,,QUEIBYWBRFSDLX-QXSJWSMHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,169,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1273687,DTCC00317321,1903974,16522
CHEMBL135857,P08254,,PHONOBBRKWZBQB-SEPFQZFQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,IC50,=,27000,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205501,DTCT0024060,1282577,DTCC00318492,918052,12304
CHEMBL135886,P08254,,YBQLENDMILTZBB-IKGGRYGDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,62,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1252551,DTCC00317762,1164665,16522
CHEMBL135931,P08254,,HZRAYMWLJLWNAA-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,1490,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1265784,DTCC00317627,712874,16522
CHEMBL135983,P08254,,UBBKFTZMBAKVDC-OSBIAPMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,115,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1281526,DTCC00317483,1294774,16522
CHEMBL1368601,P08254,,UHBIKXOBLZWFKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,94,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103858,DTCC00775206,734154,43205
CHEMBL1371684,P08254,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22018790,ACTIVITY,=,100,%,,,,,,,,,,,,,,Inhibition of MMP3 expressed in Escherichia coli assessed as residual activity using Knight SSP as substrate at 100 uM after 1.5 to 4 hrs by spectrofluorometric analysis relative to control,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799331,DTCT0024060,7596131,DTCC00778134,283182,47025
CHEMBL1371684,P08254,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25330343,INHIBITION,>,10,%,,,,,,,,,,,,,,Inhibition of recombinant human MMP-3 using GRIGFL substrate up to 20 uM,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435006,DTCT0024060,14018303,DTCC00778134,266421,60192
CHEMBL137468,P08254,,OARVSZIEJWIMBW-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205627,DTCT0024060,1272412,DTCC00318921,205761,12304
CHEMBL13766,P08254,GUAIACOL,LHGVFZTZFXWLCP-UHFFFAOYSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,-4,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5104050,DTCC00143437,798492,43205
CHEMBL137835,P08254,,RNWNGVUCFRPGIO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1048555,DTCC00324330,1586062,15462
CHEMBL137900,P08254,,LERSXUYNVGTZOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,400,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1037000,DTCC00324998,1743004,15462
CHEMBL137929,P08254,,VOORVZQGMACJHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1017371,DTCC00324853,939175,15462
CHEMBL137966,P08254,,BMKJAROLBFYRMM-RSXQAXDFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1046074,DTCC00324328,1521758,15462
CHEMBL138181,P08254,,YXXPZIJDDIJKDH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1020052,DTCC00324497,453845,15462
CHEMBL138264,P08254,,SRXJKOWUSBFUNU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1034594,DTCC00324800,5683,15462
CHEMBL138273,P08254,,CLKXWRSURRSEKP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,800,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1029861,DTCC00324622,1003829,15462
CHEMBL138338,P08254,,MYZZCJKXPLJTGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,50,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1047278,DTCC00324060,1306658,15462
CHEMBL138400,P08254,,FNUQESAUEFWUCJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1016240,DTCC00324799,939174,15462
CHEMBL138535,P08254,,AGYRDWGTLLSXLW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1042539,DTCC00324315,1325127,15462
CHEMBL138613,P08254,,PNICWAPKRSLYIU-ZDGMYTEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1028721,DTCC00324253,1807302,15462
CHEMBL138643,P08254,,BXZZUNDHINECCH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,30,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1024934,DTCC00324039,1164745,15462
CHEMBL138656,P08254,,DHXMAFQQCCOWGL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1017368,DTCC00324418,1871729,15462
CHEMBL138696,P08254,,HYNBRLICGGQMNU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,500,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1034591,DTCC00324548,745254,15462
CHEMBL138814,P08254,,LTRQYQYXWUQKJZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,10,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1044759,DTCC00324040,292337,15462
CHEMBL138858,P08254,,ZQJORJBIVFLYIE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,100,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1017359,DTCC00324358,1424988,15462
CHEMBL138953,P08254,,PBJWRLBRUGJQMR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1036994,DTCC00323939,1489532,15462
CHEMBL139542,P08254,,ROVRDWIOAVCKAV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,10,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1053590,DTCC00324305,5684,15462
CHEMBL139609,P08254,,FRNDBEYBKGOTNX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,258,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1381925,DTCC00325286,1176353,15412
CHEMBL139884,P08254,,JGHZXBJPZQXVAB-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,6.6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1384562,DTCC00325370,1176354,15412
CHEMBL139884,P08254,,JGHZXBJPZQXVAB-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,6.61,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258577,DTCC00325370,1166447,24803
CHEMBL139886,P08254,,YTCCTPYUECNUFO-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,88,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1371832,DTCC00325371,821219,15412
CHEMBL139886,P08254,,YTCCTPYUECNUFO-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,87.1,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258578,DTCC00325371,811348,24803
CHEMBL140004,P08254,,GAQJSKIBXSLAJK-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,6.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1385762,DTCC00325534,1145228,15412
CHEMBL140152,P08254,,TVNINFNNQVBJHI-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,3.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1390646,DTCC00326357,1080274,15412
CHEMBL140305,P08254,,QESMDPOTHYLJHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,700,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1024931,DTCC00323986,1774849,15462
CHEMBL140335,P08254,,GIKKFOVDJPQBSW-ZHACJKMWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1020055,DTCC00324431,357519,15462
CHEMBL140368,P08254,,WVDBZKCLVKPIHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1042542,DTCC00324430,1489530,15462
CHEMBL140426,P08254,,YOFBHXUFTFPQDW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1042536,DTCC00324309,1774847,15462
CHEMBL140439,P08254,,NKTGQIQCKMXEOS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,200,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1020043,DTCC00324854,712958,15462
CHEMBL140454,P08254,,DOLJQSYCTYZCTL-ZHACJKMWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,700,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1049772,DTCC00324513,1969327,15462
CHEMBL140511,P08254,,XSWDEIOVOAQSMZ-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,10,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1383310,DTCC00325504,76971,15412
CHEMBL140511,P08254,,XSWDEIOVOAQSMZ-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258580,DTCC00325504,67157,24803
CHEMBL140543,P08254,,FDELEKDMYZLVHP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,100,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1033393,DTCC00324342,1294866,15462
CHEMBL140568,P08254,,MRZSOAZZNSUPLS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,4.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1403036,DTCC00325326,1851096,15412
CHEMBL140569,P08254,,PZPOCZWOYXDPDG-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,11,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1381932,DTCC00325327,31638,15412
CHEMBL140569,P08254,,PZPOCZWOYXDPDG-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,10.96,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258572,DTCC00325327,8957,24803
CHEMBL140575,P08254,,WFVYENBQHIIIQE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,14,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1393170,DTCC00325288,563042,15412
CHEMBL140602,P08254,,OGWVESDVKZYNCK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1031125,DTCC00324652,2034772,15462
CHEMBL140720,P08254,,BPNDGQNQHSBNOE-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,46,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1378202,DTCC00325470,563043,15412
CHEMBL140720,P08254,,BPNDGQNQHSBNOE-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,45.71,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258575,DTCC00325470,553252,24803
CHEMBL140788,P08254,,HXAROWWJPCDNRW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1394374,DTCC00326245,1786423,15412
CHEMBL140863,P08254,,MKTUSESWUSYVIL-RSXQAXDFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,30,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1020037,DTCC00324308,487229,15462
CHEMBL140888,P08254,,CVMQTPIUJOGYIP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,600,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1024937,DTCC00324522,712959,15462
CHEMBL140970,P08254,,CYYCSKFJEOSZTF-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,0.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1385754,DTCC00325595,692228,15412
CHEMBL140970,P08254,,CYYCSKFJEOSZTF-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,0.708,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258571,DTCC00325595,682319,24803
CHEMBL141004,P08254,,UKBWLBZDMUKXSY-MBMZGMDYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,40,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1024939,DTCC00324341,1618735,15462
CHEMBL141038,P08254,,DTFUJQWTCDBNIX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,300,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1034597,DTCC00325158,907520,15462
CHEMBL141080,P08254,,ULILDPSFFUSXJH-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,0.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1401845,DTCC00108095,821220,15412
CHEMBL141098,P08254,,MSWCSYXARJOPRA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,300,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1022549,DTCC00324370,2001891,15462
CHEMBL141283,P08254,,LKNQKZXVRWZYQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,200,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1020049,DTCC00324512,487228,15462
CHEMBL141339,P08254,,SDOLDYMSRUFDDY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1041223,DTCC00324545,357521,15462
CHEMBL141340,P08254,,WYWULSIANADMTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1049762,DTCC00324313,390163,15462
CHEMBL141359,P08254,,CCOMNSWISYQLEX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,80,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1038490,DTCC00325190,1586063,15462
CHEMBL141451,P08254,,GFDLNQRSUGRRNQ-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,31,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1386978,DTCC00325427,173833,15412
CHEMBL141470,P08254,,LKFQHLGPHTXZAW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,600,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1029864,DTCC00324511,971249,15462
CHEMBL141471,P08254,,RDHFQPOQGDBVBN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,400,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1029858,DTCC00324424,1774850,15462
CHEMBL141475,P08254,,WVJHDQDLYDFIKS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,100,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1048552,DTCC00324153,1489534,15462
CHEMBL141504,P08254,,KGEKBYNTOIYJHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1043544,DTCC00324423,712961,15462
CHEMBL141534,P08254,,YJKSIUVAMOZWEF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1032284,DTCC00324400,809611,15462
CHEMBL141560,P08254,,IGRVUOPMHNISAV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,100,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1017374,DTCC00325113,357520,15462
CHEMBL141589,P08254,,ZKKQCCSHBYRQHR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1036997,DTCC00324320,519434,15462
CHEMBL141672,P08254,,ULQUQVTVRZFECE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1043549,DTCC00324377,1807301,15462
CHEMBL141673,P08254,,GSLSWNSJTMLFSO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1033390,DTCC00324378,390165,15462
CHEMBL141674,P08254,,PZNZBFBEAZCEQK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,200,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1021177,DTCC00324650,390164,15462
CHEMBL141675,P08254,,ALUHGPANWKZMAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,300,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1031122,DTCC00324399,5685,15462
CHEMBL141835,P08254,,DNFKKMGBEKWECE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,300,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1021180,DTCC00324761,1360202,15462
CHEMBL142071,P08254,,YNCNUFDRUOIACX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,500,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1035835,DTCC00324316,1489531,15462
CHEMBL142095,P08254,,UJACCCBUXXMATQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,500,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1020040,DTCC00324855,1229458,15462
CHEMBL142134,P08254,,BYJSIHNQXBCYBX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1017377,DTCC00324514,2034771,15462
CHEMBL1427477,P08254,QUINOLINE-8-CARBOXYLIC ACID,QRDZFPUVLYEQTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,77,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103965,DTCC00032919,86518,43205
CHEMBL1432,P08254,"2,3-DIHYDROXYBENZOIC ACID",GLDQAMYCGOIJDV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,-1,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103835,DTCC00442073,540482,43205
CHEMBL1433,P08254,DOXYCYCLINE,JBIWCJUYHHGXTC-AKNGSSGZSA-N,4,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17267227,IC50,=,25000,NM,,,,,,,,,,,,,,Inhibition of human MMP3,,Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.,Bioorg. Med. Chem.,2007,15,6,"Vidal A, Sabatini M, Rolland-Valognes G, Renard P, Madelmont JC, Mounetou E",,441979,DTCT0024060,2144972,DTCC00443319,370710,23207
CHEMBL1440,P08254,TETRACYCLINE,OFVLGDICTFRJMM-WESIUVDSSA-N,4,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17267227,IC50,=,140000,NM,,,,,,,,,,,,,,Inhibition of human MMP3,,Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.,Bioorg. Med. Chem.,2007,15,6,"Vidal A, Sabatini M, Rolland-Valognes G, Renard P, Madelmont JC, Mounetou E",,441979,DTCT0024060,2144968,DTCC00445351,34477,23207
CHEMBL144176,P08254,,HPIJZAVGIHKGTA-MAUKXSAKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,12,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1635520,DTCC00332983,1586176,16049
CHEMBL144313,P08254,,IIDUBAKXXSWORH-OXJNMPFZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1599911,DTCC00333379,130092,16049
CHEMBL144430,P08254,,KUEURUPTKRCKAQ-QFBILLFUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,57,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1624031,DTCC00333938,616106,16049
CHEMBL145175,P08254,,ZZEIPXVXVCUKGA-XJKSGUPXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,48,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1607509,DTCC00333707,2034901,16049
CHEMBL145641,P08254,,VXVNMUQIRGITQV-WMLDXEAASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,13,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1625356,DTCC00333647,875086,16049
CHEMBL145930,P08254,,ZEDSMYWEJHIELA-JOYOIKCWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,42,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1606312,DTCC00333806,1257134,16049
CHEMBL145999,P08254,,CHCOTWNQXXEITG-SWLSCSKDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,14,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1616297,DTCC00333248,1133620,16049
CHEMBL1461,P08254,GENTISIC ACID,WXTMDXOMEHJXQO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,-3,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103762,DTCC00460344,1731965,43205
CHEMBL146256,P08254,,OQWMKRBWGAJEGE-PKOBYXMFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,12,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1610037,DTCC00333074,1262490,16049
CHEMBL146725,P08254,,HCQXIXVRBXTURQ-NZQKXSOJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,400,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1627965,DTCC00333751,971367,16049
CHEMBL146951,P08254,,NACPMNMCCDZXLH-AJAMINHISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,42,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1621635,DTCC00333084,1553949,16049
CHEMBL147004,P08254,,VBPVZEMPZISXMF-WMLDXEAASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1636628,DTCC00333211,1936150,16049
CHEMBL147005,P08254,,JRJPXBUCHQFJHU-MAUKXSAKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,10,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1611279,DTCC00333055,1425118,16049
CHEMBL147107,P08254,,SESDSMKBCYCQSU-WMLDXEAASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1612506,DTCC00333406,1425117,16049
CHEMBL147261,P08254,,UJUNISWMIDZDSX-SWLSCSKDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,26,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1617735,DTCC00333100,2066648,16049
CHEMBL147489,P08254,,YVJXBWDNNWDVMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944582,DTCT0024060,11835667,DTCC00333722,900923,53820
CHEMBL147494,P08254,,HKQQBEWUPLWAAA-WMLDXEAASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,30,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1603814,DTCC00333020,325018,16049
CHEMBL147561,P08254,,RZDQDYGREGZPAT-SLEUVZQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1610033,DTCC00333933,97821,16049
CHEMBL147629,P08254,,CPBPQYOAJUZJNL-SWLSCSKDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,10,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1608700,DTCC00333768,1457038,16049
CHEMBL147738,P08254,,FMYMFUHWQBEETO-IPELMVKDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,10,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1629169,DTCC00333306,1586177,16049
CHEMBL147804,P08254,,PQPJWKCPMXIWMW-HEHGZKQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1603795,DTCC00333935,5899,16049
CHEMBL147844,P08254,,UHNNTTJWQVSHSC-GZMMTYOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,23,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1603789,DTCC00333455,809739,16049
CHEMBL147903,P08254,,JAKYATQFPKVBNE-XJKSGUPXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1626766,DTCC00333080,1714823,16049
CHEMBL147910,P08254,,LKSVLIAQUIGTTF-SCLBCKFNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,36,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1617729,DTCC00333782,1489664,16049
CHEMBL148081,P08254,,YCKAPRALLQTAKS-WMLDXEAASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,11,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1625362,DTCC00333857,1457037,16049
CHEMBL148120,P08254,,PTGMPWHDIULCAR-PMOQBDJRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,12,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1621630,DTCC00333934,1714821,16049
CHEMBL148136,P08254,,YNSHKUPPIHHCNP-MAUKXSAKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1605193,DTCC00333769,130093,16049
CHEMBL148169,P08254,IK-682,YDMIPBHQKFOFQW-NSYGIPOTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12408705,KI,=,141,NM,,,,,,,,,,,,,,Affinity for Matrix metalloprotease-3 (MMP-3),,"Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.",J. Med. Chem.,2002,45,23,"Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP",,104737,DTCT0024060,697258,DTCC01743557,205947,17028
CHEMBL148169,P08254,IK-682,YDMIPBHQKFOFQW-NSYGIPOTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17064892,IC50,=,141,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440762,DTCT0024060,2153847,DTCC01743557,195837,23077
CHEMBL148169,P08254,IK-682,YDMIPBHQKFOFQW-NSYGIPOTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17368021,KI,=,141,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438529,DTCT0024060,2101544,DTCC01743557,207226,22885
CHEMBL148169,P08254,IK-682,YDMIPBHQKFOFQW-NSYGIPOTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,KI,=,141,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457296,DTCC01743557,208203,32556
CHEMBL148178,P08254,,DZVJLUYVLJYLGY-BLLLJJGKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,22,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1624042,DTCC00333407,583792,16049
CHEMBL148212,P08254,,BGWGORXFGYPUAF-SWLSCSKDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,30,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1612501,DTCC00333583,1774954,16049
CHEMBL148213,P08254,,IWJCPVCPLCTWHT-XJKSGUPXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1636655,DTCC00333584,1425116,16049
CHEMBL149431,P08254,,DQXUWRWXYMJLHB-RIFZZMRRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1616293,DTCC00333949,162627,16049
CHEMBL149977,P08254,,OCZKLINSAMKTBK-PWDRBQJJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,504072,DTCC00340600,983146,15546
CHEMBL149983,P08254,,YUFOYANNKICWEX-XJKSGUPXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,14,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1627967,DTCC00333972,842533,16049
CHEMBL150027,P08254,,GPLRECXXBJTJRJ-FFAHCDIZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,489264,DTCC00340723,918308,15546
CHEMBL150077,P08254,,BKIYUSXBJJEODV-VQCBNXJZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,491834,DTCC00340146,1662509,15546
CHEMBL150242,P08254,,USIBDKCJHKIPNX-VJOZSWGJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,493101,DTCC00340535,1274218,15546
CHEMBL150342,P08254,,KUDBVBLUURDAMX-CTBJKRMSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,504077,DTCC00340719,692420,15546
CHEMBL150386,P08254,,WUAZNNQUKKZSIX-HJNYFJLDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,370,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,6,,,102085,DTCT0024060,997349,DTCC00340452,97895,1529
CHEMBL150483,P08254,,YVUNEHSVUBACDW-SDLDRHLBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,483438,DTCC00340471,1694649,15546
CHEMBL150628,P08254,,BVLFHPOFMVUZAF-GIVPXCGWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,1600,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,6,,,102085,DTCT0024060,992412,DTCC00340832,1586251,1529
CHEMBL150655,P08254,,SFESNYSPTLYJFZ-JYVXZMADSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,482257,DTCC00340890,1915624,15546
CHEMBL150745,P08254,,MKKSGKUWQUXKAQ-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,16,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,512679,DTCC00340182,304181,15546
CHEMBL151,P08254,LUTEOLIN,IQPNAANSBPBGFQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,=,16200,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535394,DTCC00171064,458853,48665
CHEMBL151,P08254,LUTEOLIN,IQPNAANSBPBGFQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827441,DTCT0024060,10535503,DTCC00171064,458853,48665
CHEMBL151024,P08254,,WGVFUINCAVSVGT-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,15,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,500253,DTCC00340793,1694648,15546
CHEMBL151047,P08254,,BJHMYZYTJBIHAQ-PUHATCMVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,240,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,6,,,102085,DTCT0024060,1003416,DTCC00340658,2002074,1529
CHEMBL151133,P08254,,FIAWLFURFKPROF-RHTHQAGFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,11,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,502894,DTCC00340745,466055,15546
CHEMBL151235,P08254,,JBWUJRFOXXRXHG-LRHAYUFXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,500259,DTCC00340774,1948200,15546
CHEMBL151249,P08254,,PPHAWIZVVUURJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10052961,KI,=,600,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3 (MMP-3), stromelysin-1",,Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.,J. Med. Chem.,1999,42,4,"Groneberg RD, Burns CJ, Morrissette MM, Ullrich JW, Morris RL, Darnbrough S, Djuric SW, Condon SM, McGeehan GM, Labaudiniere R, Neuenschwander K, Scotese AC, Kline JA",,104735,DTCT0024060,896422,DTCC00340767,1404525,15577
CHEMBL151331,P08254,,AWPBSKGASHYAHG-AFDUHFSSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,482261,DTCC00340688,206056,15546
CHEMBL151399,P08254,,CBDXJWSRGWXYPR-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,14,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,494245,DTCC00340248,1662510,15546
CHEMBL151539,P08254,,NVNGYUBMJMOHQL-RQNDZEIBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,475399,DTCC00340432,595467,15546
CHEMBL1515648,P08254,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22018790,ACTIVITY,=,100,%,,,,,,,,,,,,,,Inhibition of MMP3 expressed in Escherichia coli assessed as residual activity using Knight SSP as substrate at 100 uM after 1.5 to 4 hrs by spectrofluorometric analysis relative to control,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799331,DTCT0024060,7596132,DTCC00912100,185710,47025
CHEMBL1515648,P08254,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25330343,INHIBITION,>,10,%,,,,,,,,,,,,,,Inhibition of recombinant human MMP-3 using GRIGFL substrate up to 20 uM,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435006,DTCT0024060,13947381,DTCC00912100,169412,60192
CHEMBL151591,P08254,,OJLWCTMBGWSVFC-FFFFSGIJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,19,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,478972,DTCC00340536,271200,15546
CHEMBL151718,P08254,,WXUQPWYPRTYWIR-JVVDOCDTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,9,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,476524,DTCC00340145,692419,15546
CHEMBL151741,P08254,,FGDQQAHGMHOQDV-NGXZDTIWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,KI,=,93,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104739,DTCT0024060,1112971,DTCC00344136,789075,4691
CHEMBL151975,P08254,,QSYNMGQKALWUKE-HJNYFJLDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,570,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,6,,,102085,DTCT0024060,1008210,DTCC00340679,907736,1529
CHEMBL151996,P08254,,ZTJKUSGWPHJXES-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10052961,KI,=,1000,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3 (MMP-3), stromelysin-1",,Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.,J. Med. Chem.,1999,42,4,"Groneberg RD, Burns CJ, Morrissette MM, Ullrich JW, Morris RL, Darnbrough S, Djuric SW, Condon SM, McGeehan GM, Labaudiniere R, Neuenschwander K, Scotese AC, Kline JA",,104735,DTCT0024060,858889,DTCC00340768,174000,15577
CHEMBL152005,P08254,,QIVSFBKFALWRSY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,IC50,=,3700,NM,,,,,,,,,,,,,,Inhibition of Stromelysin (MMP-3),,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205630,DTCT0024060,1262319,DTCC00343227,1015496,17092
CHEMBL152104,P08254,,FGDQQAHGMHOQDV-WVQWTBLQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,KI,=,580,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104739,DTCT0024060,1131337,DTCC00343439,174039,4691
CHEMBL152105,P08254,,DBNIJXWUCKXPAO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,IC50,=,62,NM,,,,,,,,,,,,,,Inhibition of Stromelysin (MMP-3),,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205630,DTCT0024060,1277067,DTCC00343576,304210,17092
CHEMBL152111,P08254,,JQKWVICASNBZKT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of Stromelysin (MMP-3),,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205630,DTCT0024060,1249395,DTCC00343256,1786640,17092
CHEMBL152164,P08254,,OCJKUQIPRNZDTK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,>,25000000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in place of acetohydroxamic acid.,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205633,DTCT0024060,1261198,DTCC00343477,369458,17092
CHEMBL152267,P08254,,DJWZYQPRHLAHAP-VAVYLYDRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,570,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1110314,DTCC00343245,1436447,4691
CHEMBL152267,P08254,,DJWZYQPRHLAHAP-VAVYLYDRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,575.44,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258406,DTCC00343245,1426642,24803
CHEMBL152277,P08254,,NXBDTIZSKZYBRI-BCAKYAHRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229774,IC50,=,7.2,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-3 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,104580,DTCT0024060,570632,DTCC00344459,369477,4692
CHEMBL152277,P08254,,NXBDTIZSKZYBRI-BCAKYAHRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,7.24,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258558,DTCC00344459,359209,24803
CHEMBL152413,P08254,,NPSQITJPDIQOJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,IC50,=,670,NM,,,,,,,,,,,,,,Inhibition of Stromelysin (MMP-3),,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205630,DTCT0024060,1270513,DTCC00343608,174022,17092
CHEMBL152531,P08254,,LYTGQQFBDSMLSD-GIFXNVAJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,22,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1121178,DTCC00343401,1694700,4691
CHEMBL152531,P08254,,LYTGQQFBDSMLSD-GIFXNVAJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,21.88,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258410,DTCC00343401,1684867,24803
CHEMBL152559,P08254,,LULHALISEADZEE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of Stromelysin (MMP-3),,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205630,DTCT0024060,1264788,DTCC00343242,628016,17092
CHEMBL152592,P08254,,VHDLIHHMSRFRJB-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,21,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1124751,DTCC00343895,206091,4691
CHEMBL152592,P08254,,VHDLIHHMSRFRJB-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,20.89,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258415,DTCC00343895,196123,24803
CHEMBL152603,P08254,,GCZQHDFWKVMZOE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,=,150000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in place of acetohydroxamic acid.,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205633,DTCT0024060,1279479,DTCC00343380,1981211,17092
CHEMBL152625,P08254,,BZZVTPZKPMXERH-DENIHFKCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,475,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1118161,DTCC00343350,789076,4691
CHEMBL152625,P08254,,BZZVTPZKPMXERH-DENIHFKCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,478.63,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258404,DTCC00343350,778989,24803
CHEMBL152769,P08254,,WVUNKWULDOXHJH-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,3400,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1105005,DTCC00344238,1948249,4691
CHEMBL152769,P08254,,WVUNKWULDOXHJH-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,3388.44,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258402,DTCC00344238,1937749,24803
CHEMBL152805,P08254,,RPEMCHYEPZNXLW-NVXWUHKLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,410,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1106406,DTCC00343384,756889,4691
CHEMBL152805,P08254,,RPEMCHYEPZNXLW-NVXWUHKLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,407.38,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258405,DTCC00343384,746929,24803
CHEMBL152840,P08254,,PQUSXSDPIZDHLP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,IC50,=,1500,NM,,,,,,,,,,,,,,Inhibition of Stromelysin (MMP-3),,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205630,DTCT0024060,1261200,DTCC00343213,1883437,17092
CHEMBL152855,P08254,,XJTUBPYIIOWNPG-ZJSXRUAMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,73,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1102020,DTCC00343406,238524,4691
CHEMBL152855,P08254,,XJTUBPYIIOWNPG-ZJSXRUAMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,72.44,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258408,DTCC00343406,228497,24803
CHEMBL153081,P08254,ETHYL HYDROXYCARBAMATE,VGEWEGHHYWGXGG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,>,25000000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in place of acetohydroxamic acid.,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205633,DTCT0024060,1270512,DTCC00108469,1786641,17092
CHEMBL1532097,P08254,DIHYDRODAPHNODORIN B,YXPCHLHMGOFXRA-DHGPJANISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,=,25550,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535396,DTCC00927565,717882,48665
CHEMBL1532097,P08254,DIHYDRODAPHNODORIN B,YXPCHLHMGOFXRA-DHGPJANISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827441,DTCT0024060,10535505,DTCC00927565,717882,48665
CHEMBL153213,P08254,,JLOGHKGHXSRQGG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of Stromelysin (MMP-3),,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205630,DTCT0024060,1278384,DTCC00343214,1468810,17092
CHEMBL153446,P08254,,LYTGQQFBDSMLSD-VDKIKQQVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,25,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1119571,DTCC00343397,498975,4691
CHEMBL153446,P08254,,LYTGQQFBDSMLSD-VDKIKQQVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,25.12,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258409,DTCC00343397,488943,24803
CHEMBL153469,P08254,,AFJPLWPNTPTDED-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10052961,KI,=,300,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3 (MMP-3), stromelysin-1",,Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.,J. Med. Chem.,1999,42,4,"Groneberg RD, Burns CJ, Morrissette MM, Ullrich JW, Morris RL, Darnbrough S, Djuric SW, Condon SM, McGeehan GM, Labaudiniere R, Neuenschwander K, Scotese AC, Kline JA",,104735,DTCT0024060,870468,DTCC00340951,141810,15577
CHEMBL153882,P08254,,LOAUOKWVGGODSI-BCAKYAHRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229774,IC50,=,13,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-3 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,104580,DTCT0024060,579452,DTCC00344509,1754436,4692
CHEMBL153882,P08254,,LOAUOKWVGGODSI-BCAKYAHRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,12.88,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258555,DTCC00344509,1744657,24803
CHEMBL153914,P08254,,XAHWTAYXASVGFG-BPUDTRNYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,9,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1106403,DTCC00343865,109423,4691
CHEMBL153914,P08254,,XAHWTAYXASVGFG-BPUDTRNYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,39.81,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258413,DTCC00343865,99393,24803
CHEMBL154040,P08254,,NKFQHGPGJWLOIN-ZFJSRUIDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229774,IC50,=,120,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-3 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,104580,DTCT0024060,573958,DTCC00344341,1819216,4692
CHEMBL154040,P08254,,NKFQHGPGJWLOIN-ZFJSRUIDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,120.23,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258561,DTCC00344341,1808955,24803
CHEMBL154044,P08254,,FHLVTPHOAMUXFU-ZJSXRUAMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229774,IC50,=,0.5,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-3 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,104580,DTCT0024060,558828,DTCC00344483,918365,4692
CHEMBL154044,P08254,,FHLVTPHOAMUXFU-ZJSXRUAMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,0.501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258550,DTCC00344483,909285,24803
CHEMBL154169,P08254,,FCZUABNOVRUEJK-GSVBYQBUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229774,IC50,=,450,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-3 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,104580,DTCT0024060,550479,DTCC00344508,1598055,4692
CHEMBL154169,P08254,,FCZUABNOVRUEJK-GSVBYQBUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,446.68,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258553,DTCC00344508,1587771,24803
CHEMBL154215,P08254,,KMQAVDUVVBJBAN-DENIHFKCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,560,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1126151,DTCC00344111,304231,4691
CHEMBL154215,P08254,,KMQAVDUVVBJBAN-DENIHFKCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,562.34,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258401,DTCC00344111,294022,24803
CHEMBL154317,P08254,,JGLOGDIUSBZLOV-DENIHFKCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,13,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1107767,DTCC00343839,1436446,4691
CHEMBL154317,P08254,,JGLOGDIUSBZLOV-DENIHFKCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,12.88,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258419,DTCC00343839,1426641,24803
CHEMBL154438,P08254,,OATYFBJQDLKLNJ-SMWWQBHQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11844676,KI,>,650,NM,,,,,,,,,,,,,,Inhibitory constant against recombinant human stromelysin-1 (Matrix metalloprotease-3),,Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.,Bioorg. Med. Chem. Lett.,2002,12,4,"Sawa M, Kondo H, Nishimura S",,104879,DTCT0024060,1426943,DTCC00345360,1197504,5346
CHEMBL154440,P08254,,YWZDVYPIFZUSBG-FHPVIJFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229774,IC50,=,8.8,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-3 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,104580,DTCT0024060,550476,DTCC00344325,402322,4692
CHEMBL154440,P08254,,YWZDVYPIFZUSBG-FHPVIJFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,8.71,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258559,DTCC00344325,391952,24803
CHEMBL154551,P08254,,XAHWTAYXASVGFG-ZFJSRUIDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,40,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1131334,DTCC00344114,918356,4691
CHEMBL154551,P08254,,XAHWTAYXASVGFG-ZFJSRUIDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,RATIO,=,1.5,,,,,,,,,,,,,,,The selectivity ratio of the Matrix metalloprotease-3 selective compound,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,231362,DTCT0024060,1131336,DTCC00344114,918356,4691
CHEMBL154551,P08254,,XAHWTAYXASVGFG-ZFJSRUIDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229774,IC50,=,40,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-3 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,104580,DTCT0024060,576227,DTCC00344114,918363,4692
CHEMBL154551,P08254,,XAHWTAYXASVGFG-ZFJSRUIDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,8.91,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258414,DTCC00344114,909282,24803
CHEMBL154706,P08254,,KFUADVZPCULIED-WRHNGFHOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831905,KI,=,9.07,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugs.,J. Med. Chem.,2002,45,4,"Sawa M, Tsukamoto T, Kiyoi T, Kurokawa K, Nakajima F, Nakada Y, Yokota K, Inoue Y, Kondo H, Yoshino K",,104744,DTCT0024060,546172,DTCC00345406,109753,17148
CHEMBL154706,P08254,,KFUADVZPCULIED-WRHNGFHOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11844676,KI,=,9.07,NM,,,,,,,,,,,,,,Inhibitory constant against recombinant human stromelysin-1 (Matrix metalloprotease-3),,Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.,Bioorg. Med. Chem. Lett.,2002,12,4,"Sawa M, Kondo H, Nishimura S",,104879,DTCT0024060,1431903,DTCC00345406,97950,5346
CHEMBL154828,P08254,,SQYRXZTYDRVAMZ-ROTAYESASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11844676,KI,>,650,NM,,,,,,,,,,,,,,Inhibitory constant against recombinant human stromelysin-1 (Matrix metalloprotease-3),,Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.,Bioorg. Med. Chem. Lett.,2002,12,4,"Sawa M, Kondo H, Nishimura S",,104879,DTCT0024060,1415955,DTCC00345691,649011,5346
CHEMBL154999,P08254,,DZWVTHAIOWIVNT-BJLXPSRBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11844676,KI,=,617,NM,,,,,,,,,,,,,,Inhibitory constant against recombinant human stromelysin-1 (Matrix metalloprotease-3),,Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.,Bioorg. Med. Chem. Lett.,2002,12,4,"Sawa M, Kondo H, Nishimura S",,104879,DTCT0024060,1437185,DTCC00345359,97949,5346
CHEMBL155134,P08254,,ZJYCLDORACELQK-WHUARKNTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11844676,KI,=,29.4,NM,,,,,,,,,,,,,,Inhibitory constant against recombinant human stromelysin-1 (Matrix metalloprotease-3),,Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.,Bioorg. Med. Chem. Lett.,2002,12,4,"Sawa M, Kondo H, Nishimura S",,104879,DTCT0024060,1407588,DTCC00345301,194683,5346
CHEMBL155862,P08254,,KJUQRHGKOLRTFD-HMEKMZBJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11266157,IC50,=,2490,NM,,,,,,,,,,,,,,Inhibition of Stromelysin (Matrix metalloprotease-3),,Chemoenzymatic synthesis of functionalized cyclohexylglycines and alpha-methylcyclohexylglycines via Kazmaier-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,2001,11,5,"Hudlicky T, Oppong K, Duan C, Stanton C, Laufersweiler MJ, Natchus MG",,104728,DTCT0024060,640105,DTCC00349395,1489851,4704
CHEMBL155874,P08254,,FUXIPODKBLQFAK-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104905,DTCT0024060,621902,DTCC00350429,821520,15057
CHEMBL156614,P08254,,IHPHOLWJEHZAOF-VAVYLYDRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,>,10000,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1119577,DTCC00344237,1533557,4691
CHEMBL156663,P08254,,FYHSMVNHGKEDAV-GIFXNVAJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,8500,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1115355,DTCC00344079,1208724,4691
CHEMBL156663,P08254,,FYHSMVNHGKEDAV-GIFXNVAJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,8511.38,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258395,DTCC00344079,1198920,24803
CHEMBL156830,P08254,,FLMHRETZLINTLJ-PCFFTZKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229774,IC50,=,3.8,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-3 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,104580,DTCT0024060,562255,DTCC00344510,1883465,4692
CHEMBL156830,P08254,,FLMHRETZLINTLJ-PCFFTZKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,3.8,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258556,DTCC00344510,1873439,24803
CHEMBL157048,P08254,,SLWFEUITEJIEHH-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,10000,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1121181,DTCC00344073,174038,4691
CHEMBL157048,P08254,,SLWFEUITEJIEHH-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258400,DTCC00344073,164161,24803
CHEMBL157065,P08254,,AOHMLOLALRZWQK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,IC50,=,690,NM,,,,,,,,,,,,,,Inhibition of Stromelysin (MMP-3),,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205630,DTCT0024060,1264789,DTCC00343607,77164,17092
CHEMBL157112,P08254,,WTMNDZGXJUPIBE-DENIHFKCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,19,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1098393,DTCC00343840,1241523,4691
CHEMBL157112,P08254,,WTMNDZGXJUPIBE-DENIHFKCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,19.05,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258416,DTCC00343840,1231165,24803
CHEMBL157163,P08254,,URGYPDKRIKINRO-VDKIKQQVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,40,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1130011,DTCC00343869,174037,4691
CHEMBL157163,P08254,,URGYPDKRIKINRO-VDKIKQQVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,18.2,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258412,DTCC00343869,164160,24803
CHEMBL15763,P08254,,STFPAYMUYSBAKD-ANYOKISRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,88,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1536219,DTCC00146582,1340953,2559
CHEMBL15796,P08254,,UVHJPRIQTAISRK-KOENEWCDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,1500,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1533821,DTCC00146496,1788056,2559
CHEMBL158265,P08254,,ZXQRCQILIYTPOF-BEHPGTHXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11266157,IC50,=,3795,NM,,,,,,,,,,,,,,Inhibition of Stromelysin (Matrix metalloprotease-3),,Chemoenzymatic synthesis of functionalized cyclohexylglycines and alpha-methylcyclohexylglycines via Kazmaier-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,2001,11,5,"Hudlicky T, Oppong K, Duan C, Stanton C, Laufersweiler MJ, Natchus MG",,104728,DTCT0024060,623451,DTCC00349425,1229760,4704
CHEMBL158366,P08254,,XSZFUUHZPTXVJI-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,>,10000,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1427032,DTCC00352918,1080604,12880
CHEMBL158571,P08254,,UAZHKINNICKCCP-VTFDQJKESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,4705,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1423459,DTCC00108674,628130,12880
CHEMBL158622,P08254,,GSCAICSUTUHIKD-JZGSEIKYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,960,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1443441,DTCC00353256,1208819,12880
CHEMBL158622,P08254,,GSCAICSUTUHIKD-JZGSEIKYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,4084,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1414868,DTCC00353256,1208820,12880
CHEMBL158625,P08254,,LGAMBGLWTORDNW-ZRBLBEILSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,481,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1443458,DTCC00353340,886729,12880
CHEMBL158696,P08254,,WKFUXNDEVSIEGA-PKTNWEFCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,7877,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1414877,DTCC00353538,1754553,12880
CHEMBL158739,P08254,,QWIPRZJIZDEZJZ-ZNZIZOMTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,314,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1407678,DTCC00353336,660388,12880
CHEMBL159033,P08254,,YSOWDIROXDYGJM-FTJBHMTQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,>,10000,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1427023,DTCC00353589,1404663,12880
CHEMBL159141,P08254,,BDRKJDRHTIDJDK-DSITVLBTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,518,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1433413,DTCC00353503,1015638,12880
CHEMBL159159,P08254,,QQTWJGZZLJPVHO-OEBVTXOESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,2473,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1434758,DTCC00353284,660387,12880
CHEMBL15920,P08254,,IMJNDIHWKZAXJD-XLQDAESGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,>,2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1550577,DTCC00146385,887973,2559
CHEMBL15930,P08254,,DDSRTXCZNKYQPZ-GEVKEYJPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,210,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1553070,DTCC00146418,1275585,2559
CHEMBL15962,P08254,,UXIXVZBLORSHJF-KBWCOIMZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,5100,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1519656,DTCC00146495,790450,2559
CHEMBL15964,P08254,,HXRVPYPXJBAKAT-BBMPLOMVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,43,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1550580,DTCC00146331,952237,2559
CHEMBL159645,P08254,,CLDWFWQEHSJBDI-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,>,10000,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1443364,DTCC00353775,1981339,12880
CHEMBL160153,P08254,,CTGTUEAFFDISNJ-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104905,DTCT0024060,622991,DTCC00350890,1080568,15057
CHEMBL16087,P08254,,DIXLCLWTVQJIDG-FQNRMIAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,160,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1535057,DTCC00146398,435942,2559
CHEMBL16099,P08254,,VRGMRZYBJKCBRL-ZBCRRDGASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,4600,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1529100,DTCC00146618,1081902,2559
CHEMBL16114,P08254,,LXJCNSMDGYASPQ-GMONCZTGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,210,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1522246,DTCC00146362,1755857,2559
CHEMBL16115,P08254,,RBSCETUBICKNGC-CBNMVNINSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,26,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1521042,DTCC00146400,1884840,2559
CHEMBL16118,P08254,,BEWFNUZAYXMBNS-AWKYBWMHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,16,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1522249,DTCC00146346,78543,2559
CHEMBL161224,P08254,,DMYQQPUOQMOFJU-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,178,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1419517,DTCC00352681,1015636,12880
CHEMBL161536,P08254,,XRAGTWOVABKXJS-SGNDLWITSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,1303,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1408868,DTCC00352864,141957,12880
CHEMBL16154,P08254,,CISYKXQCUSYTKA-WLXPTCNVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,4100,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1553067,DTCC00146269,1308346,2559
CHEMBL161562,P08254,,ICYVDMBWMGFEMP-RPWUZVMVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,309,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1424563,DTCC00353371,1339664,12880
CHEMBL161572,P08254,,OVKVSVACJPYFHM-ULNSLHSMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,121,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1443454,DTCC00353335,563378,12880
CHEMBL161669,P08254,,SKRSSNZOVQMETG-UVTDQMKNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,17500,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) using Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate after 3 mins by fluorimetric assay,,Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures,MedChemComm,2015,6,5,"Panico A, Maccari R, Cardile V, Avondo S, Crasci L, Ottana R",,1541339,DTCT0024060,11381,DTCC00354612,786782,65440
CHEMBL16172,P08254,,ALGKSUNHOBFZJP-LZBANZJXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,120,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1550571,DTCC00146425,661592,2559
CHEMBL162072,P08254,,PCKJJBIMKAITOP-FTJBHMTQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,1159,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1430690,DTCC00353290,1981338,12880
CHEMBL162128,P08254,,RMLJJALZEPRGDU-PVHODMMVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,2340,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1428330,DTCC00353480,1436585,12880
CHEMBL16213,P08254,,HSAXQLHVOUBVRZ-JNLGVIEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,290,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1550574,DTCC00146315,790451,2559
CHEMBL16235,P08254,,NTKMAVFFDZGDKA-VNXZQDSDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,140,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1547972,DTCC00146379,1916979,2559
CHEMBL16258,P08254,,QTXQZEVSCFUJCN-YMAMQOFZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,120,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1527945,DTCC00146519,1373481,2559
CHEMBL1627009,P08254,LITHIUM ETHYL (CYCLOHEXYLAMINO)CARBONYLPHOSPHONATE,UNVAKRAJEPVVLT-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1288020,DTCC01014520,627063,17838
CHEMBL16300,P08254,BENZOHYDROXAMATE,VDEUYMSGMPQMIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,=,7000000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in place of acetohydroxamic acid.,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205633,DTCT0024060,1259914,DTCC00146677,1981212,17092
CHEMBL1630091,P08254,,UNOIUBNRWWBQDJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21078557,IC50,=,8700,NM,,,,,,,,,,,,,,Inhibition of human MMP3 in cell-free system by fluorescent spectroscopy,,Structure based optimization of chromen-based TNF-a converting enzyme (TACE) inhibitors on S1' pocket and their quantitative structure-activity relationship (QSAR) study.,Bioorg. Med. Chem.,2010,18,24,"Yang JS, Chun K, Park JE, Cho M, Seo J, Song D, Yoon H, Park CH, Joe BY, Choi JH, Kim MH, Han G",,697252,DTCT0024060,5021791,DTCC01015985,490921,42159
CHEMBL1630098,P08254,DPC-333,VINTZLVANMVXOH-ZEQKJWHPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21078557,IC50,=,3900,NM,,,,,,,,,,,,,,Inhibition of human MMP3 in cell-free system by fluorescent spectroscopy,,Structure based optimization of chromen-based TNF-a converting enzyme (TACE) inhibitors on S1' pocket and their quantitative structure-activity relationship (QSAR) study.,Bioorg. Med. Chem.,2010,18,24,"Yang JS, Chun K, Park JE, Cho M, Seo J, Song D, Yoon H, Park CH, Joe BY, Choi JH, Kim MH, Han G",,697252,DTCT0024060,5021790,DTCC00033248,716707,42159
CHEMBL16398,P08254,,AIYJHCBHVDDOHF-KEKNWZKVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,39,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1543265,DTCC00146306,1696030,2559
CHEMBL16402,P08254,,SURPMIPINKUUFC-KOENEWCDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,1300,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1522243,DTCC00146342,1405920,2559
CHEMBL1645387,P08254,,TXGWLQVCPVHGKO-GDNBJRDFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,8960,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) using Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate after 3 mins by fluorimetric assay,,Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures,MedChemComm,2015,6,5,"Panico A, Maccari R, Cardile V, Avondo S, Crasci L, Ottana R",,1541339,DTCT0024060,11376,DTCC01021953,1531249,65440
CHEMBL1645389,P08254,,DNXCXYIPCYQEBG-UVTDQMKNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,48400,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) using Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate after 3 mins by fluorimetric assay,,Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures,MedChemComm,2015,6,5,"Panico A, Maccari R, Cardile V, Avondo S, Crasci L, Ottana R",,1541339,DTCT0024060,11380,DTCC01021955,107074,65440
CHEMBL1645391,P08254,,LNPKMUHSBCXBNB-GDNBJRDFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,77430,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) using Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate after 3 mins by fluorimetric assay,,Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures,MedChemComm,2015,6,5,"Panico A, Maccari R, Cardile V, Avondo S, Crasci L, Ottana R",,1541339,DTCT0024060,11382,DTCC01021957,1945807,65440
CHEMBL16474,P08254,,WFNGARIUMCOWHM-KBWCOIMZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,28,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1525596,DTCC00146277,693820,2559
CHEMBL16487,P08254,,PNVAEBBFARFVNB-ANYOKISRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,130,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1529103,DTCC00146304,532480,2559
CHEMBL1649594,P08254,,PVQRWPNLEMQCSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,98,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103929,DTCC01022968,960351,43205
CHEMBL1650458,P08254,6-METHYLPICOLINIC ACID,LTUUGSGSUZRPRV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,48,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103052,DTCC00033455,604860,43205
CHEMBL16505,P08254,,UOLDAWOAHWACHY-JHJVBQTASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871728,IC50,=,3700,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, stromelysin-1",,The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,10,"Levin JI, DiJoseph JF, Killar LM, Sharr MA, Skotnicki JS, Patel DV, Xiao XY, Shi L, Navre M, Campbell DA",,104712,DTCT0024060,1021979,DTCC00147183,661596,2560
CHEMBL1650601,P08254,8-HYDROXYQUINOLINE 1-OXIDE,FJKUOCCQEBLPNX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,81,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103871,DTCC00033473,1024885,43205
CHEMBL1650602,P08254,6-HYDROXYPICOLINIC ACID,VRCWSYYXUCKEED-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103985,DTCC00033474,1731964,43205
CHEMBL1650603,P08254,6-BROMOPICOLINIC ACID,XURXQNUIGWHWHU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,18,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103257,DTCC00033475,442587,43205
CHEMBL1650604,P08254,,PHQBKLKZIXCRIX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,28,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103193,DTCC01022962,280902,43205
CHEMBL1650605,P08254,CLOPYRALID,HUBANNPOLNYSAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5102641,DTCC01022963,1990718,43205
CHEMBL1650606,P08254,ISOQUINOLINE-1-CARBOXYLIC ACID,XAAKCCMYRKZRAK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,67,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103227,DTCC00033476,798490,43205
CHEMBL1650607,P08254,PYRIMIDIN-2-OL,VTGOHKSTWXHQJK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,49,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103793,DTCC00033477,830994,43205
CHEMBL1650608,P08254,2-THIOURACIL,OVONXEQGWXGFJD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,95,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103937,DTCC00033478,1860584,43205
CHEMBL1650609,P08254,,RAFAYWADRVMWFA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,70,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103783,DTCC01022964,1024886,43205
CHEMBL1650610,P08254,,PZVLJGKJIMBYNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,10,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103116,DTCC01022965,346294,43205
CHEMBL1650611,P08254,,STUQITWXBMZUGY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,38,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103237,DTCC01022966,280898,43205
CHEMBL1650612,P08254,,BPSGVKFIQZZFNH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,22,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103111,DTCC00127529,572604,43205
CHEMBL1650613,P08254,,UQFHLJKWYIJISA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,6,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103159,DTCC00127530,1478226,43205
CHEMBL1650614,P08254,,SHVCSCWHWMSGTE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,7,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103068,DTCC01022967,1639739,43205
CHEMBL1650615,P08254,,GKLSXUGPECNEMX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,98,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5104026,DTCC01022969,1672008,43205
CHEMBL1650616,P08254,,KKEBDEYRNMMBPM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,59,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103724,DTCC01022970,1413986,43205
CHEMBL1650617,P08254,,NFPVFWUVBGEVHR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,80,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103710,DTCC01022971,378880,43205
CHEMBL1650618,P08254,,LIPRKYKMVQPYPG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,72,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103876,DTCC01022972,1574896,43205
CHEMBL1650619,P08254,,YBBJKCMMCRQZMA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5104006,DTCC01022973,572605,43205
CHEMBL1650620,P08254,,SVOBTPSWHFSTQO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,99,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5104022,DTCC01022974,896235,43205
CHEMBL1650621,P08254,,SQEXIHSVVCJZTQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,90,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5104038,DTCC01022975,798491,43205
CHEMBL1650622,P08254,,QJEZBSWVHDOAFS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,86,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103866,DTCC01022976,572606,43205
CHEMBL1650623,P08254,,HMXGIMVMTIFQHT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,99,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5104021,DTCC01022977,1763873,43205
CHEMBL1650624,P08254,,XTMONGQRZFRDAJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,99,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5104020,DTCC01022978,1381650,43205
CHEMBL1650625,P08254,4-METHYLSALICYLIC ACID,NJESAXZANHETJV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,-1,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103215,DTCC00033479,1892888,43205
CHEMBL1650626,P08254,,TTZOLDXHOCCNMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,-2,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5102650,DTCC01022979,766406,43205
CHEMBL1650627,P08254,,KXZQYLBVMZGIKC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,93,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103941,DTCC01022980,1185923,43205
CHEMBL1650628,P08254,"1,4,7-TRIAZONANE",ITWBWJFEJCHKSN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,48,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103346,DTCC00033480,1542780,43205
CHEMBL1650629,P08254,,RRXGRDMHWYLJSY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,96,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5104032,DTCC01022981,1122425,43205
CHEMBL1650630,P08254,,IQGMRVWUTCYCST-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,72,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103714,DTCC01022982,1445793,43205
CHEMBL1650631,P08254,,GHGZVWOTJDLREY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,4,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103984,DTCC01022983,1024888,43205
CHEMBL1650632,P08254,,MVVGSPCXHRFDDR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,4,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103209,DTCC01022984,1607386,43205
CHEMBL1650633,P08254,,GSOHKPVFCOWKPU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,-1,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103834,DTCC01022985,1763874,43205
CHEMBL1650634,P08254,,GUARKOVVHJSMRW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,6,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103206,DTCC01022986,1796211,43205
CHEMBL1650635,P08254,,VLRGXXKFHVJQOL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,-6,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103381,DTCC01022987,151277,43205
CHEMBL1651842,P08254,,IEHSRERHOYOHOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,575,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP3 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831071,DTCT0024060,10566520,DTCC01024067,543746,48923
CHEMBL1651842,P08254,,IEHSRERHOYOHOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,600,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702133,DTCT0024060,5066072,DTCC01024067,523282,42713
CHEMBL1651843,P08254,,KPYDTDKHTIUCAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,38,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 20 uM by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702138,DTCT0024060,5066099,DTCC01024068,328820,42713
CHEMBL1651844,P08254,,GODQVOUTCHZIOJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,22,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 20 uM by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702138,DTCT0024060,5066100,DTCC01024069,1364047,42713
CHEMBL1651845,P08254,,IQVPMSHPSMKSIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,5,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 20 uM by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702138,DTCT0024060,5066101,DTCC01024070,846384,42713
CHEMBL1651846,P08254,,LWHDLJDNHJFUSI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,29,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 200 uM by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702144,DTCT0024060,5066107,DTCC01024071,716794,42713
CHEMBL1651847,P08254,,BXWKQAHPQICDHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,62,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 200 uM by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702144,DTCT0024060,5066109,DTCC01024072,198194,42713
CHEMBL1651848,P08254,,FDPYTWXXVNVJLZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,58,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 200 uM by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702144,DTCT0024060,5066110,DTCC01024073,1137429,42713
CHEMBL1651849,P08254,,NMRGHYQXKHANMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,25,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 200 uM by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702144,DTCT0024060,5066111,DTCC01024074,198195,42713
CHEMBL16519,P08254,,PNKICJSNJYXQOE-OWCLPIDISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871728,IC50,=,9,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, stromelysin-1",,The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,10,"Levin JI, DiJoseph JF, Killar LM, Sharr MA, Skotnicki JS, Patel DV, Xiao XY, Shi L, Navre M, Campbell DA",,104712,DTCT0024060,1047974,DTCC00147199,758311,2560
CHEMBL16520,P08254,RO-319790,QRXOZHSEEGNRFC-ZYHUDNBSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871728,IC50,=,470,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, stromelysin-1",,The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,10,"Levin JI, DiJoseph JF, Killar LM, Sharr MA, Skotnicki JS, Patel DV, Xiao XY, Shi L, Navre M, Campbell DA",,104712,DTCT0024060,1039270,DTCC00147200,984592,2560
CHEMBL16520,P08254,RO-319790,QRXOZHSEEGNRFC-ZYHUDNBSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11514157,KI,=,310,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution.,Bioorg. Med. Chem. Lett.,2001,11,16,"Musso DL, Andersen MW, Andrews RC, Austin R, Beaudet EJ, Becherer JD, Bubacz DG, Bickett DM, Chan JH, Conway JG, Cowan DJ, Gaul MD, Glennon KC, Hedeen KM, Lambert MH, Leesnitzer MA, McDougald DL, Mitchell JL, Moss ML, Rabinowitz MH, Rizzolio MC, Schaller LT, Stanford JB, Tippin T, Warner JR, Whitesell LG, Wiethe RW",,104901,DTCT0024060,926823,DTCC00147200,981874,4390
CHEMBL16554,P08254,,ZWDYAHGBOJEURS-GDBMZVCRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871728,IC50,=,8,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, stromelysin-1",,The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,10,"Levin JI, DiJoseph JF, Killar LM, Sharr MA, Skotnicki JS, Patel DV, Xiao XY, Shi L, Navre M, Campbell DA",,104712,DTCT0024060,1050548,DTCC00147128,919813,2560
CHEMBL16595,P08254,,ITKSAJKSHOIQGV-FQXDTITESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871728,IC50,=,36,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, stromelysin-1",,The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,10,"Levin JI, DiJoseph JF, Killar LM, Sharr MA, Skotnicki JS, Patel DV, Xiao XY, Shi L, Navre M, Campbell DA",,104712,DTCT0024060,1040681,DTCC00147096,239873,2560
CHEMBL16630,P08254,,UOLDAWOAHWACHY-FRRDWIJNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871728,IC50,=,470,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, stromelysin-1",,The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,10,"Levin JI, DiJoseph JF, Killar LM, Sharr MA, Skotnicki JS, Patel DV, Xiao XY, Shi L, Navre M, Campbell DA",,104712,DTCT0024060,1030634,DTCC00147118,1631662,2560
CHEMBL16650,P08254,,PNKICJSNJYXQOE-BZUAXINKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871728,IC50,=,430,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, stromelysin-1",,The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,10,"Levin JI, DiJoseph JF, Killar LM, Sharr MA, Skotnicki JS, Patel DV, Xiao XY, Shi L, Navre M, Campbell DA",,104712,DTCT0024060,1041950,DTCC00147268,1852726,2560
CHEMBL166564,P08254,,JYIVEWZWGSXEIG-NPPFBWRTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871551,KI,=,24,NM,,,,,,,,,,,,,,Binding affinity against human matrix metalloprotease-3.,,Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,7,"Jacobson IC, Reddy PG, Wasserman ZR, Hardman KD, Covington MB, Arner EC, Copeland RA, Decicco CP, Magolda RL",,101949,DTCT0024060,501100,DTCC00365442,842894,3059
CHEMBL16664,P08254,,ORNRXHLQXJIHAY-XLQDAESGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,13,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1533824,DTCC00146389,1146850,2559
CHEMBL1668126,P08254,,GZVYRVDFHLLJPP-IDRUGXTQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21130662,ACTIVITY,,,,,,,,,,,,,,,,,Activity at MMP3,Not Active,Functional in vivo imaging of cysteine cathepsin activity in murine model of inflammation.,Bioorg. Med. Chem.,2011,19,3,"Caglic D, Globisch A, Kindermann M, Lim NH, Jeske V, Juretschke HP, Bartnik E, Weithmann KU, Nagase H, Turk B, Wendt KU",,717557,DTCT0024060,5112231,DTCC01024969,1122449,43232
CHEMBL167232,P08254,,QVZSRIQXJCGDLT-PSAQOYSPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871551,KI,=,168,NM,,,,,,,,,,,,,,Binding affinity against human matrix metalloprotease-3.,,Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,7,"Jacobson IC, Reddy PG, Wasserman ZR, Hardman KD, Covington MB, Arner EC, Copeland RA, Decicco CP, Magolda RL",,101949,DTCT0024060,486584,DTCC00365117,292807,3059
CHEMBL167233,P08254,,VZLQRHVGUTYXBQ-IBGGVINMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871551,KI,=,28,NM,,,,,,,,,,,,,,Binding affinity against human matrix metalloprotease-3.,,Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,7,"Jacobson IC, Reddy PG, Wasserman ZR, Hardman KD, Covington MB, Arner EC, Copeland RA, Decicco CP, Magolda RL",,101949,DTCT0024060,487672,DTCC00365118,2035237,3059
CHEMBL167278,P08254,,OSDJVSPJKNBXKV-MZLICYQSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871551,KI,=,25,NM,,,,,,,,,,,,,,Binding affinity against human matrix metalloprotease-3.,,Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,7,"Jacobson IC, Reddy PG, Wasserman ZR, Hardman KD, Covington MB, Arner EC, Copeland RA, Decicco CP, Magolda RL",,101949,DTCT0024060,478553,DTCC00364305,1101849,3059
CHEMBL167302,P08254,,HCRZKUHDDTVHQM-GMTSZFNJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,1.9,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,7,,,102093,DTCT0024060,608933,DTCC00362471,357955,2023
CHEMBL167705,P08254,,IEJUQNIPUKZOAL-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,3600,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,7,,,102093,DTCT0024060,459347,DTCC00362009,325341,2023
CHEMBL168150,P08254,,QAYDNEIOSCTECQ-QCNZEISBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,0.36,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,7,,,102093,DTCT0024060,598607,DTCC00362047,1036632,2023
CHEMBL168601,P08254,,IGWLPPHUCLZWTC-TWOQFEAHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871551,KI,=,103,NM,,,,,,,,,,,,,,Binding affinity against human matrix metalloprotease-3.,,Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,7,"Jacobson IC, Reddy PG, Wasserman ZR, Hardman KD, Covington MB, Arner EC, Copeland RA, Decicco CP, Magolda RL",,101949,DTCT0024060,504944,DTCC00364721,1619197,3059
CHEMBL168802,P08254,,JBYQQXSCANNDNP-STWLZBDKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871551,KI,=,3,NM,,,,,,,,,,,,,,Binding affinity against human matrix metalloprotease-3.,,Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,7,"Jacobson IC, Reddy PG, Wasserman ZR, Hardman KD, Covington MB, Arner EC, Copeland RA, Decicco CP, Magolda RL",,101949,DTCT0024060,487669,DTCC00364268,1101848,3059
CHEMBL169084,P08254,,RCJJPUINEATAJF-GCKMJXCFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871551,KI,=,13,NM,,,,,,,,,,,,,,Binding affinity against human matrix metalloprotease-3.,,Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,7,"Jacobson IC, Reddy PG, Wasserman ZR, Hardman KD, Covington MB, Arner EC, Copeland RA, Decicco CP, Magolda RL",,101949,DTCT0024060,475037,DTCC00364247,6546,3059
CHEMBL169235,P08254,,SRVJEHMEZKLIMK-FTRWYGJKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871551,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity against human matrix metalloprotease-3.,,Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,7,"Jacobson IC, Reddy PG, Wasserman ZR, Hardman KD, Covington MB, Arner EC, Copeland RA, Decicco CP, Magolda RL",,101949,DTCT0024060,509778,DTCC00365082,1327928,3059
CHEMBL16933,P08254,,SPVUAASKZWLIQS-DGCLKSJQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871728,IC50,=,480,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, stromelysin-1",,The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,10,"Levin JI, DiJoseph JF, Killar LM, Sharr MA, Skotnicki JS, Patel DV, Xiao XY, Shi L, Navre M, Campbell DA",,104712,DTCT0024060,1034092,DTCC00147150,2047616,2560
CHEMBL169996,P08254,,BIDYRGOZWOVNRZ-BCQCSXDESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871551,KI,=,100,NM,,,,,,,,,,,,,,Binding affinity against human matrix metalloprotease-3.,,Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,7,"Jacobson IC, Reddy PG, Wasserman ZR, Hardman KD, Covington MB, Arner EC, Copeland RA, Decicco CP, Magolda RL",,101949,DTCT0024060,478556,DTCC00108963,1165232,3059
CHEMBL170315,P08254,,RTKNMWBYPISZDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,2.95,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1418815,DTCC00370641,1948587,17147
CHEMBL170429,P08254,,FITSVZFOIGFQQI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,5.19,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1418820,DTCC00372567,1501478,17147
CHEMBL17082,P08254,,PAGLSWGGXPHWJN-DBSNRUDNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871728,IC50,=,39,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, stromelysin-1",,The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,10,"Levin JI, DiJoseph JF, Killar LM, Sharr MA, Skotnicki JS, Patel DV, Xiao XY, Shi L, Navre M, Campbell DA",,104712,DTCT0024060,1045542,DTCC00147253,500351,2560
CHEMBL171292,P08254,,NQUUIXIBNFFYTG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,82.4,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1405726,DTCC00370477,499303,17147
CHEMBL171962,P08254,,DPQCHTZYBRQXQC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,12.3,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1409277,DTCC00371624,1404889,17147
CHEMBL171986,P08254,,RLVHPDACJUGNSL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,190,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1416480,DTCC00371044,725093,17147
CHEMBL172181,P08254,,MDDQQIMYYBMNMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,527,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1440107,DTCC00371829,369785,17147
CHEMBL172249,P08254,,OHBFRMUALPHZIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,2.04,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1411441,DTCC00371713,757267,17147
CHEMBL172415,P08254,,KADFIIKJGHEHDF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,51.4,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1443812,DTCC00371652,1754773,17147
CHEMBL172548,P08254,,MXGYLPKHTGTZKG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,34.9,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1408025,DTCC00109174,466432,17147
CHEMBL172722,P08254,,IAZFWEJODMHVIO-OUKQBFOZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,29.7,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1418825,DTCC00372096,1113479,17147
CHEMBL172857,P08254,,FTSDPRIBDLXKCA-GZAIGYLVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9888835,IC50,=,700,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,104722,DTCT0024060,1136759,DTCC00372099,369793,15162
CHEMBL172885,P08254,,NQYWUYPYYFALAI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,64.4,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1409282,DTCC00372088,466433,17147
CHEMBL172886,P08254,,USYXNFCQBGQYRW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,72.9,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1417566,DTCC00372089,238852,17147
CHEMBL173027,P08254,,TZNUGSCRBFBAFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,6.41,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1426179,DTCC00372005,1981537,17147
CHEMBL173075,P08254,,LWBGXTORWSRDHX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327602,IC50,=,30000,NM,,,,,,,,,,,,,,"Inhibition of Stromelysin, matrix metalloprotease-3",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,205496,DTCT0024060,970222,DTCC00372720,174400,4784
CHEMBL173207,P08254,,RNNMDWQPJWMEIA-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9888835,IC50,=,10300,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,104722,DTCT0024060,1149648,DTCC00371340,466444,15162
CHEMBL173208,P08254,,OWBJNSLROHEGOK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9888835,IC50,=,1750,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,104722,DTCT0024060,1169431,DTCC00371341,109757,15162
CHEMBL173235,P08254,,LXKHXLQQHKRMFP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,14.9,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1433784,DTCC00372426,2014370,17147
CHEMBL173316,P08254,,CDUNTBSHRUTDFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,5.2,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1418810,DTCC00372427,1851654,17147
CHEMBL173326,P08254,,PIHNCDLSZQOOPU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,47.8,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1436533,DTCC00371345,1630613,17147
CHEMBL173686,P08254,,IBUXWZOBVVWCHD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,4.85,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1417581,DTCC00370729,918694,17147
CHEMBL173744,P08254,,XUDSOJRUANECGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,24.4,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1408020,DTCC00372566,692792,17147
CHEMBL173754,P08254,,PCAPSCAFNCUGDE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,12.8,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1443807,DTCC00370762,725092,17147
CHEMBL173846,P08254,,KMYAHTGTYRRWEK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,2.43,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1439001,DTCC00109119,983530,17147
CHEMBL174014,P08254,,RBLCSCFFNCADJO-XRHLQHRESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,>,650,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1424992,DTCC00371948,1695013,17147
CHEMBL174037,P08254,,FWLOHVJOTFKEGS-JLCFBVMHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9888835,IC50,=,1600,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,104722,DTCT0024060,1169428,DTCC00372015,1851665,15162
CHEMBL174315,P08254,,AIBDPCDNFOFGFS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,8.15,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1440112,DTCC00370676,1565857,17147
CHEMBL174641,P08254,,FYEUWTVOOOULEH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327602,IC50,,,,,,,,,,,,,,,,,"Inhibition of Stromelysin, matrix metalloprotease-3 (not determined)",Not Determined,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,205497,DTCT0024060,959834,DTCC00375021,1404933,4784
CHEMBL175164,P08254,,DWFUVVZGNJNHKO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,11.6,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1429941,DTCC00372915,271599,17147
CHEMBL175282,P08254,,KYTLMUVGULFASG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327602,IC50,,,,,,,,,,,,,,,,,"Inhibition of Stromelysin, matrix metalloprotease-3 (not determined)",Not Determined,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,205497,DTCT0024060,953312,DTCC00374234,32720,4784
CHEMBL1760318,P08254,,SZPWYHRMRFNOHH-GHTZIAJQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22342144,KI,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 using OmniMMP as substrate,,Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.,Bioorg. Med. Chem. Lett.,2012,22,6,"Jiao GS, Kim S, Moayeri M, Crown D, Thai A, Cregar-Hernandez L, McKasson L, Sankaran B, Lehrer A, Wong T, Johns L, Margosiak SA, Leppla SH, Johnson AT",,811338,DTCT0024060,10427386,DTCC01075303,1687706,47718
CHEMBL1760322,P08254,,DUBRLRRJAJGWMU-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22342144,KI,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 using OmniMMP as substrate,,Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.,Bioorg. Med. Chem. Lett.,2012,22,6,"Jiao GS, Kim S, Moayeri M, Crown D, Thai A, Cregar-Hernandez L, McKasson L, Sankaran B, Lehrer A, Wong T, Johns L, Margosiak SA, Leppla SH, Johnson AT",,811338,DTCT0024060,10427388,DTCC01075307,1201801,47718
CHEMBL1760324,P08254,,PVPXSRWESCVIBD-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22342144,KI,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 using OmniMMP as substrate,,Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.,Bioorg. Med. Chem. Lett.,2012,22,6,"Jiao GS, Kim S, Moayeri M, Crown D, Thai A, Cregar-Hernandez L, McKasson L, Sankaran B, Lehrer A, Wong T, Johns L, Margosiak SA, Leppla SH, Johnson AT",,811338,DTCT0024060,10427390,DTCC01075309,976029,47718
CHEMBL176467,P08254,,RTBMLCLTYAPKIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327602,IC50,=,2000,NM,,,,,,,,,,,,,,"Inhibition of Stromelysin, matrix metalloprotease-3",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,205496,DTCT0024060,970227,DTCC00374112,1662912,4784
CHEMBL176602,P08254,,KGUVBHLPMGERAT-NIYFSFCBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9888835,IC50,=,24.4,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,104722,DTCT0024060,1151836,DTCC00373473,2078653,15162
CHEMBL1767014,P08254,,RDRCRROFSMSFED-KHIBUBOWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21417219,IC50,=,9600,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 after 60 mins by fluorescence plate reader,,"Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors.",J. Med. Chem.,2011,54,8,"Shiozaki M, Maeda K, Miura T, Kotoku M, Yamasaki T, Matsuda I, Aoki K, Yasue K, Imai H, Ubukata M, Suma A, Yokota M, Hotta T, Tanaka M, Hase Y, Haas J, Fryer AM, Laird ER, Littmann NM, Andrews SW, Josey JA, Mimura T, Shinozaki Y, Yoshiuchi H, Inaba T",,743611,DTCT0024060,5927581,DTCC01079536,2005992,44276
CHEMBL176832,P08254,,CQGUKDZSAPDCJL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327602,IC50,=,2000,NM,,,,,,,,,,,,,,"Inhibition of Stromelysin, matrix metalloprotease-3",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,205496,DTCT0024060,959839,DTCC00374111,1209081,4784
CHEMBL1770649,P08254,,PRUCBZGVKSTGBL-FPHUIIFBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21458257,KI,>,40000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors.",Bioorg. Med. Chem. Lett.,2011,21,10,"Dai C, Li D, Popovici-Muller J, Zhao L, Girijavallabhan VM, Rosner KE, Lavey BJ, Rizvi R, Shankar BB, Wong MK, Guo Z, Orth P, Strickland CO, Sun J, Niu X, Chen S, Kozlowski JA, Lundell DJ, Piwinski JJ, Shih NY, Siddiqui MA",,744261,DTCT0024060,5930514,DTCC01080402,1266399,44403
CHEMBL1770700,P08254,,MASDJPGVHCTFLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21507637,KI,=,900,NM,,,,,,,,,,,,,,Inhibition of human MMP-3,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744951,DTCT0024060,5937677,DTCC01080452,1040141,44430
CHEMBL177072,P08254,,JFMSSTVXWKCAJH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,10.7,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1414017,DTCC00373025,1372408,17147
CHEMBL177077,P08254,,UXMLHHOBOIXMAT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327602,IC50,=,1000,NM,,,,,,,,,,,,,,"Inhibition of Stromelysin, matrix metalloprotease-3",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,205496,DTCT0024060,937707,DTCC00372846,1404932,4784
CHEMBL1770826,P08254,,LOTUNSOIIWVNBG-JUJUEEDWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21458257,KI,>,40000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors.",Bioorg. Med. Chem. Lett.,2011,21,10,"Dai C, Li D, Popovici-Muller J, Zhao L, Girijavallabhan VM, Rosner KE, Lavey BJ, Rizvi R, Shankar BB, Wong MK, Guo Z, Orth P, Strickland CO, Sun J, Niu X, Chen S, Kozlowski JA, Lundell DJ, Piwinski JJ, Shih NY, Siddiqui MA",,744261,DTCT0024060,5930515,DTCC01080561,749314,44403
CHEMBL1771212,P08254,SD-2590,NXUHVWMBPOFLMA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,28.7,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005907,DTCC00033985,1557982,45214
CHEMBL1771212,P08254,SD-2590,NXUHVWMBPOFLMA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21507637,IC50,=,29,NM,,,,,,,,,,,,,,Inhibition of human MMP-3,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744951,DTCT0024060,5937675,DTCC00033985,1557806,44430
CHEMBL1771213,P08254,,QCRPOQONCVCBFI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21507637,IC50,=,90,NM,,,,,,,,,,,,,,Inhibition of human MMP-3,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744951,DTCT0024060,5937676,DTCC01080938,1040140,44430
CHEMBL1771214,P08254,,UIGGXLFLAQCMAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21507637,IC50,=,39,NM,,,,,,,,,,,,,,Inhibition of human MMP-3,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744951,DTCT0024060,5937678,DTCC01080939,134084,44430
CHEMBL1771215,P08254,,BNPWNBBKUMLEJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21507637,KI,=,28,NM,,,,,,,,,,,,,,Inhibition of human MMP-3,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744951,DTCT0024060,5937679,DTCC01080940,361645,44430
CHEMBL1771216,P08254,,MTRATHZFTCSGDT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21507637,KI,=,8.7,NM,,,,,,,,,,,,,,Inhibition of human MMP-3,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744951,DTCT0024060,5930545,DTCC01080941,1233526,44430
CHEMBL1771217,P08254,,MMCUCOOPEAHRPL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21507637,KI,=,44,NM,,,,,,,,,,,,,,Inhibition of human MMP-3,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744951,DTCT0024060,5930546,DTCC01080942,1040142,44430
CHEMBL1771218,P08254,,LIQFLIXIOKMDTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21507637,KI,=,3,NM,,,,,,,,,,,,,,Inhibition of human MMP-3,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744951,DTCT0024060,5930547,DTCC01080943,1908020,44430
CHEMBL1771219,P08254,,VCIBNYPUVKINDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21507637,KI,=,31,NM,,,,,,,,,,,,,,Inhibition of human MMP-3,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744951,DTCT0024060,5930548,DTCC01080944,975250,44430
CHEMBL1771220,P08254,,NVQGQIYFJRAZLX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21507637,KI,=,37,NM,,,,,,,,,,,,,,Inhibition of human MMP-3,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744951,DTCT0024060,5930549,DTCC01080945,1590129,44430
CHEMBL1771221,P08254,,JRPLACGAMSWTCU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21507637,KI,=,59,NM,,,,,,,,,,,,,,Inhibition of human MMP-3,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744951,DTCT0024060,5930550,DTCC01080946,230822,44430
CHEMBL1771222,P08254,,FVPQYGSYGOKFLW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21507637,KI,=,130,NM,,,,,,,,,,,,,,Inhibition of human MMP-3,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744951,DTCT0024060,5930551,DTCC01080947,1105335,44430
CHEMBL1771223,P08254,,UAFRGDNTZQMZFA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21507637,KI,=,9.9,NM,,,,,,,,,,,,,,Inhibition of human MMP-3,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744951,DTCT0024060,5930552,DTCC01080948,587727,44430
CHEMBL177740,P08254,,DDHOTWKNHXEMKO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327602,IC50,=,930,NM,,,,,,,,,,,,,,"Inhibition of Stromelysin, matrix metalloprotease-3",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,205496,DTCT0024060,961208,DTCC00374388,1404931,4784
CHEMBL1779630,P08254,,BXLWVAKSQMYQKF-HRUVVLKGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20638281,KI,=,19000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Structure and activity relationships of tartrate-based TACE inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,16,"Li D, Popovici-Muller J, Belanger DB, Caldwell J, Dai C, David M, Girijavallabhan VM, Lavey BJ, Lee JF, Liu Z, Mazzola R, Rizvi R, Rosner KE, Shankar B, Spitler J, Ting PC, Vaccaro H, Yu W, Zhou G, Zhu Z, Niu X, Sun J, Guo Z, Orth P, Chen S, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Shipps GW, Siddiqui MA, Strickland CO",,748389,DTCT0024060,5959054,DTCC01085211,1875737,44590
CHEMBL178163,P08254,,WKXRIMLOWDOHMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15686921,KI,=,110,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302480,DTCT0024060,1744905,DTCC00381624,130640,18787
CHEMBL178509,P08254,,TVKGACNFKXXAEF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15686921,KI,=,4500,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302480,DTCT0024060,1744345,DTCC00381771,227480,18787
CHEMBL179288,P08254,,DGZZVIWCMGVHGV-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15713379,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305734,DTCT0024060,1747881,DTCC00381940,1069270,18841
CHEMBL179288,P08254,,DGZZVIWCMGVHGV-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044909,DTCC00381940,1071500,35647
CHEMBL1795351,P08254,,YZKJTNXYLZWHHJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21514700,IC50,=,46,NM,,,,,,,,,,,,,,Inhibition of human MMP3 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753768,DTCT0024060,6000209,DTCC01091696,1893893,44948
CHEMBL1795857,P08254,,VZNWQFCLBMVARX-SSEXGKCCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21514700,IC50,=,180,NM,,,,,,,,,,,,,,Inhibition of human MMP3 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753768,DTCT0024060,6000216,DTCC01091697,1673074,44948
CHEMBL1795858,P08254,,ABUCHUKPMIVSQV-GDLZYMKVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21514700,IC50,=,84,NM,,,,,,,,,,,,,,Inhibition of human MMP3 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753768,DTCT0024060,6000223,DTCC01091698,638553,44948
CHEMBL1795859,P08254,,RSAGFYGPXOAVNX-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21514700,IC50,=,93,NM,,,,,,,,,,,,,,Inhibition of human MMP3 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753768,DTCT0024060,6000230,DTCC01091699,119860,44948
CHEMBL1795860,P08254,,YPLZYOZJLNQLST-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21514700,IC50,=,320,NM,,,,,,,,,,,,,,Inhibition of human MMP3 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753768,DTCT0024060,6000237,DTCC01091700,1640794,44948
CHEMBL1795861,P08254,,KGOHHLONXFWMRE-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21514700,IC50,=,38,NM,,,,,,,,,,,,,,Inhibition of human MMP3 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753768,DTCT0024060,6000244,DTCC01091701,1861595,44948
CHEMBL1795862,P08254,,OTEWYJZEFZRZKI-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21514700,IC50,=,11,NM,,,,,,,,,,,,,,Inhibition of human MMP3 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753768,DTCT0024060,6000251,DTCC01091702,767378,44948
CHEMBL179936,P08254,,YMPRSEQZGBKKAZ-HMTLIYDFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15780605,IC50,=,500,NM,,,,,,,,,,,,,,Binding affinity for human Matrix metalloprotease-3,,QSAR-by-NMR: quantitative insights into structural determinants for binding affinity by analysis of 1H/15N chemical shift differences in MMP-3 ligands.,Bioorg. Med. Chem. Lett.,2005,15,7,"Matter H, Schudok M, Elshorst B, Jacobs DM, Saxena K, Kogler H",,306088,DTCT0024060,1748659,DTCC00383350,174490,18912
CHEMBL1801044,P08254,,XQXSQQVRMVVPJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005930,DTCC01094745,1557976,45214
CHEMBL1801045,P08254,,KOPIIXVBCHXDHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,18.1,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005929,DTCC01094746,1747121,45214
CHEMBL1801046,P08254,,HBYRXCFAHCMHAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16220987,KI,=,18.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14743567,DTCC01094747,2108425,69259
CHEMBL1801046,P08254,,HBYRXCFAHCMHAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,18.1,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005928,DTCC01094747,1364426,45214
CHEMBL1801047,P08254,,RDFQXFRQTOWZEQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,35,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005927,DTCC01094748,1525962,45214
CHEMBL1801050,P08254,,SPEYRVQKGFNUCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005926,DTCC01094751,2070708,45214
CHEMBL1801051,P08254,,VFDSDRZNXLFCFF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,55.3,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005925,DTCC01094752,1811467,45214
CHEMBL1801052,P08254,,QLTNWLFWQKKDEO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,35,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005923,DTCC01094753,1105534,45214
CHEMBL1801054,P08254,,PGEMRSCSFPLCBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005922,DTCC01094755,1940371,45214
CHEMBL1801056,P08254,,GXZSIAVJNPWNMR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005921,DTCC01094757,1811468,45214
CHEMBL1801057,P08254,,QJNGNVJSSUXWBO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,20.6,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005920,DTCC01094758,1687244,45214
CHEMBL1801393,P08254,,JATUSZYMCBLDQS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,42.5,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005904,DTCC01095085,1622970,45214
CHEMBL1801396,P08254,,QDGVTWBFTFHWOG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,18.1,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005903,DTCC01095088,1072789,45214
CHEMBL1801413,P08254,,SIEIWCDBNIGNIG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,32.6,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005919,DTCC01095103,846766,45214
CHEMBL1801415,P08254,,SXSIQUOYBXOPSS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,22.5,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005918,DTCC01095105,1396864,45214
CHEMBL1801419,P08254,,SYYRIPAKWJBIOW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,35,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005917,DTCC01095109,1072790,45214
CHEMBL1801420,P08254,,LMIHEFSBOIGKDH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,18.1,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005916,DTCC01095110,879231,45214
CHEMBL1801421,P08254,,BDONYXHHXNTUSW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005915,DTCC01095111,1557981,45214
CHEMBL1801423,P08254,,XFBRPTYLOIFAQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,21.5,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005914,DTCC01095113,1429093,45214
CHEMBL1801424,P08254,,AOPZFYOXZYZEAC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,76.8,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005913,DTCC01095114,101933,45214
CHEMBL1801425,P08254,,DZCGIZPIPKWUIX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,64.7,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005912,DTCC01095115,1779153,45214
CHEMBL1801426,P08254,,LTCNKRUYOJZZJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005911,DTCC01095117,1843781,45214
CHEMBL1801427,P08254,,JKRVXAWKSWVVCV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,36.9,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005910,DTCC01095118,1169008,45214
CHEMBL1801428,P08254,,ORSWNUGKUNQTLF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,23.9,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005909,DTCC01095119,1687248,45214
CHEMBL1801429,P08254,,LCYYUMHWMVOGPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,21.5,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005908,DTCC01095120,717206,45214
CHEMBL1801430,P08254,SC-77964,NBRBWZJMBITNBC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,22,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005906,DTCC00034383,620315,45214
CHEMBL1801431,P08254,,IXVDOEAUVAJHER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20726512,IC50,=,115,NM,,,,,,,,,,,,,,Inhibition of human MMP3 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754460,DTCT0024060,6005905,DTCC01095121,263383,45214
CHEMBL180275,P08254,,JGGFVHVZVBWBKF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15686921,KI,=,3200,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302480,DTCT0024060,1744899,DTCC00381599,1360845,18787
CHEMBL180616,P08254,,FKICHBNUXJBKPB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15686921,KI,=,430,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302480,DTCT0024060,1744363,DTCC00381808,713599,18787
CHEMBL180808,P08254,,HALKBQWLGHJJBL-VYRBHSGPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15780605,CONCENTRATION,=,800000,NM,,,,,,,,,,,,,,Binding affinity for human Matrix metalloprotease-3,,QSAR-by-NMR: quantitative insights into structural determinants for binding affinity by analysis of 1H/15N chemical shift differences in MMP-3 ligands.,Bioorg. Med. Chem. Lett.,2005,15,7,"Matter H, Schudok M, Elshorst B, Jacobs DM, Saxena K, Kogler H",,308392,DTCT0024060,1748662,DTCC00383373,1307370,18912
CHEMBL181244,P08254,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15713379,IC50,=,4500,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305734,DTCT0024060,1747763,DTCC00381891,1586743,18841
CHEMBL181244,P08254,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,IC50,=,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457476,DTCC00381891,1600108,32556
CHEMBL181244,P08254,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19606871,IC50,=,5900,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571083,DTCT0024060,2859446,DTCC00381891,1588877,34421
CHEMBL181244,P08254,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23287054,IC50,=,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944582,DTCT0024060,11835677,DTCC00381891,1612259,53820
CHEMBL181394,P08254,,LXQKWUKMJDUEEO-VYRBHSGPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15780605,CONCENTRATION,=,100,NM,,,,,,,,,,,,,,Binding affinity for human Matrix metalloprotease-3,,QSAR-by-NMR: quantitative insights into structural determinants for binding affinity by analysis of 1H/15N chemical shift differences in MMP-3 ligands.,Bioorg. Med. Chem. Lett.,2005,15,7,"Matter H, Schudok M, Elshorst B, Jacobs DM, Saxena K, Kogler H",,308392,DTCT0024060,1748665,DTCC00383302,1372522,18912
CHEMBL181682,P08254,,VWGKXDUPRHRCAO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16002291,IC50,>,101000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,16,"Dublanchet AC, Ducrot P, Andrianjara C, O'Gara M, Morales R, Compère D, Denis A, Blais S, Cluzeau P, Courté K, Hamon J, Moreau F, Prunet ML, Tertre A",,305120,DTCT0024060,1742480,DTCC00381375,142259,9478
CHEMBL181891,P08254,,JBZFTIBOGQVLLX-HMTLIYDFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15780605,CONCENTRATION,=,200,NM,,,,,,,,,,,,,,Binding affinity for human Matrix metalloprotease-3,,QSAR-by-NMR: quantitative insights into structural determinants for binding affinity by analysis of 1H/15N chemical shift differences in MMP-3 ligands.,Bioorg. Med. Chem. Lett.,2005,15,7,"Matter H, Schudok M, Elshorst B, Jacobs DM, Saxena K, Kogler H",,308392,DTCT0024060,1748661,DTCC00383367,1501613,18912
CHEMBL1834420,P08254,,OWKCGOUEJMBBRA-NNBQYGFHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21866961,KI,=,40500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain assessed as hydrolysis of MOCAcPLGLA2pr(Dnp)AR-NH2 by fluorescence spectrofluorometry ,,Selective water-soluble gelatinase inhibitor prodrugs.,J. Med. Chem.,2011,54,19,"Gooyit M, Lee M, Schroeder VA, Ikejiri M, Suckow MA, Mobashery S, Chang M",,771372,DTCT0024060,6116308,DTCC01109922,198681,46049
CHEMBL1834422,P08254,,AGULWCWMDMKUSF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21866961,KI,=,23400,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain assessed as hydrolysis of MOCAcPLGLA2pr(Dnp)AR-NH2 by fluorescence spectrofluorometry ,,Selective water-soluble gelatinase inhibitor prodrugs.,J. Med. Chem.,2011,54,19,"Gooyit M, Lee M, Schroeder VA, Ikejiri M, Suckow MA, Mobashery S, Chang M",,771372,DTCT0024060,6116309,DTCC01109924,1072947,46049
CHEMBL1834423,P08254,,FANDWSFYLCHFFT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21866961,INHIBITION,=,54,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain assessed as hydrolysis of MOCAcPLGLA2pr(Dnp)AR-NH2 at 300 uM fluorescence by spectrofluorometry ,,Selective water-soluble gelatinase inhibitor prodrugs.,J. Med. Chem.,2011,54,19,"Gooyit M, Lee M, Schroeder VA, Ikejiri M, Suckow MA, Mobashery S, Chang M",,771373,DTCT0024060,6116307,DTCC01109925,166772,46049
CHEMBL184768,P08254,,DHUZZZSRYGMFNN-YBEGLDIGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,4190,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) using Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate after 3 mins by fluorimetric assay,,Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures,MedChemComm,2015,6,5,"Panico A, Maccari R, Cardile V, Avondo S, Crasci L, Ottana R",,1541339,DTCT0024060,11379,DTCC00386608,301939,65440
CHEMBL185623,P08254,,KDHQPBOMSXIRRL-YBEGLDIGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,58500,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) using Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate after 3 mins by fluorimetric assay,,Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures,MedChemComm,2015,6,5,"Panico A, Maccari R, Cardile V, Avondo S, Crasci L, Ottana R",,1541339,DTCT0024060,11378,DTCC00386607,1271920,65440
CHEMBL186422,P08254,QUINOLIN-2-OL,LISFMEBWQUVKPJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,3,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103757,DTCC00000874,1763872,43205
CHEMBL187092,P08254,,LTVIJEFEZVFIST-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15953722,IC50,=,5,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-3,,Discovery of 3-OH-3-methylpipecolic hydroxamates: potent orally active inhibitors of aggrecanase and MMP-13.,Bioorg. Med. Chem. Lett.,2005,15,14,"Noe MC, Natarajan V, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Otterness I, Bliven MA, Carty TJ, Barberia JT, Sweeney FJ, Liras JL, Vaughn M",,304621,DTCT0024060,1774141,DTCC00390625,681417,18571
CHEMBL187092,P08254,,LTVIJEFEZVFIST-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25415648,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of human MMP3 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435762,DTCT0024060,14000068,DTCC00390625,708051,60298
CHEMBL187265,P08254,"1,3,6,7-TETRAHYDROXYXANTONE",ZHTQCPCDXKMMLU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535400,DTCC00000833,1779807,48665
CHEMBL188894,P08254,,HBBHNZHTEFSNGF-HUUCEWRRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15369398,INHIBITION,=,3,%,,,,,,,,,,,,,,Inhibition of MMP-3 (matrix metalloprotease) at 1 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307796,DTCT0024060,1790621,DTCC00392759,1936804,19089
CHEMBL188894,P08254,,HBBHNZHTEFSNGF-HUUCEWRRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15369398,INHIBITION,=,20,%,,,,,,,,,,,,,,Inhibition of MMP-3 (matrix metalloprotease) at 10 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307803,DTCT0024060,1790622,DTCC00392759,1936804,19089
CHEMBL1914702,P08254,,CRPIWCWIMAOUCX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21548582,IC50,=,12100,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes.",J. Med. Chem.,2011,54,13,"Neelarapu R, Holzle DL, Velaparthi S, Bai H, Brunsteiner M, Blond SY, Petukhov PA",,785747,DTCT0024060,7517245,DTCC01159563,153491,46348
CHEMBL1914702,P08254,,CRPIWCWIMAOUCX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21548582,RATIO IC50,=,1590,,,,,,,,,,,,,,,Selectivity ratio of compound IC50 to GM6001 IC50 for MMP3,,"Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes.",J. Med. Chem.,2011,54,13,"Neelarapu R, Holzle DL, Velaparthi S, Bai H, Brunsteiner M, Blond SY, Petukhov PA",,785739,DTCT0024060,7517257,DTCC01159563,153491,46348
CHEMBL1914708,P08254,,IGNPXOQRVRXSKJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21548582,ACTIVITY,>,70,%,,,,,,,,,,,,,,Inhibition of MMP3 assessed as activity remaining at 10 mM,,"Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes.",J. Med. Chem.,2011,54,13,"Neelarapu R, Holzle DL, Velaparthi S, Bai H, Brunsteiner M, Blond SY, Petukhov PA",,785743,DTCT0024060,7517252,DTCC01159569,185603,46348
CHEMBL1914708,P08254,,IGNPXOQRVRXSKJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21548582,RATIO IC50,,,,,,,,,,,,,,,,,Selectivity ratio of compound IC50 to GM6001 IC50 for MMP3,Not Determined,"Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes.",J. Med. Chem.,2011,54,13,"Neelarapu R, Holzle DL, Velaparthi S, Bai H, Brunsteiner M, Blond SY, Petukhov PA",,785739,DTCT0024060,7517258,DTCC01159569,185603,46348
CHEMBL1916050,P08254,,GETDIWSMCUZGCD-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21925881,IC50,=,86,NM,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain (amino acids 100 to 265) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787973,DTCT0024060,7525359,DTCC01160859,685161,46368
CHEMBL1916054,P08254,,XAOJSOMIBKILNZ-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21925881,IC50,=,39,NM,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain (amino acids 100 to 265) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787973,DTCT0024060,7525360,DTCC01160863,749845,46368
CHEMBL1916207,P08254,,AFHDVSQBDWGAQU-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21925881,IC50,=,493,NM,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain (amino acids 100 to 265) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787973,DTCT0024060,7525361,DTCC01161004,1397221,46368
CHEMBL1916210,P08254,,YBTXAIOMVIXCOD-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21925881,IC50,=,90,NM,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain (amino acids 100 to 265) using acetyl-Cys(Eu)-Pro-Leu-Gly-Leu-Lys-(QSY7)-Ala-Arg-amide as substrate preincubated for 1 hrs before substrate addition measured after 15 mins by fluorimetry,,Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.,Bioorg. Med. Chem. Lett.,2011,21,21,"Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV",,787973,DTCT0024060,7525362,DTCC01161007,1655475,46368
CHEMBL191625,P08254,"PENTANE-2,4-DIONE",YRKCREAYFQTBPV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,-4,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103839,DTCC00001048,1957906,43205
CHEMBL1927183,P08254,,URQNIKFTQMJDKH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22088955,IC50,=,110000,NM,,,,,,,,,,,,,,Inhibition of human MMP3 using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791980,DTCT0024060,7555525,DTCC01165287,2025754,46745
CHEMBL1927184,P08254,,MXDNHABTSLQECK-VEJZVKIUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22088955,IC50,=,110000,NM,,,,,,,,,,,,,,Inhibition of human MMP3 using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791980,DTCT0024060,7555526,DTCC01165288,1480457,46745
CHEMBL1927185,P08254,,KKYDQVAGMODEPF-VMPITWQZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22088955,IC50,=,77000,NM,,,,,,,,,,,,,,Inhibition of human MMP3 using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791980,DTCT0024060,7555527,DTCC01165289,671878,46745
CHEMBL1927186,P08254,,RMYNLYNJRHVJNU-RIYZIHGNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22088955,IC50,=,850000,NM,,,,,,,,,,,,,,Inhibition of human MMP3 using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791980,DTCT0024060,7555528,DTCC01165290,898397,46745
CHEMBL1927187,P08254,,UEOIUIPMEKCWHI-YJBIHYNGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22088955,IC50,=,230000,NM,,,,,,,,,,,,,,Inhibition of human MMP3 using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate pre-incubated for 4 hrs before substrate addition measured every 15 secs for 15 mins by fluorimetry,,Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.,Eur. J. Med. Chem.,2012,47,,"La Pietra V, Marinelli L, Cosconati S, Di Leva FS, Nuti E, Santamaria S, Pugliesi I, Morelli M, Casalini F, Rossello A, La Motta C, Taliani S, Visse R, Nagase H, da Settimo F, Novellino E",,791980,DTCT0024060,7555529,DTCC01165291,1351218,46745
CHEMBL1935291,P08254,,MUMVNZHARHFSLP-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22153340,IC50,=,2530,NM,,,,,,,,,,,,,,Inhibition of human MMP-3,,Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD).,Bioorg. Med. Chem. Lett.,2012,22,1,"Wu Y, Li J, Wu J, Morgan P, Xu X, Rancati F, Vallese S, Raveglia L, Hotchandani R, Fuller N, Bard J, Cunningham K, Fish S, Krykbaev R, Tam S, Goldman SJ, Williams C, Mansour TS, Saiah E, Sypek J, Li W",,796147,DTCT0024060,7576409,DTCC01169633,51895,46933
CHEMBL1939844,P08254,,FTRCUXMVUJZMHT-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22017477,IC50,=,3400,NM,,,,,,,,,,,,,,Inhibition of MMP3 using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 4 hrs measured every 15 secs for 20 mins by fluorescence analysis,,"Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.",J. Med. Chem.,2011,54,24,"Marques SM, Tuccinardi T, Nuti E, Santamaria S, André V, Rossello A, Martinelli A, Santos MA",,799077,DTCT0024060,7595868,DTCC01171473,2071098,47023
CHEMBL1939845,P08254,,JVBFGGAYMSJQBZ-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22017477,IC50,=,3900,NM,,,,,,,,,,,,,,Inhibition of MMP3 using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 4 hrs measured every 15 secs for 20 mins by fluorescence analysis,,"Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.",J. Med. Chem.,2011,54,24,"Marques SM, Tuccinardi T, Nuti E, Santamaria S, André V, Rossello A, Martinelli A, Santos MA",,799077,DTCT0024060,7595867,DTCC01171474,1811871,47023
CHEMBL1939846,P08254,,RQCBSNJRFVZHOS-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22017477,IC50,=,220,NM,,,,,,,,,,,,,,Inhibition of MMP3 using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 4 hrs measured every 15 secs for 20 mins by fluorescence analysis,,"Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.",J. Med. Chem.,2011,54,24,"Marques SM, Tuccinardi T, Nuti E, Santamaria S, André V, Rossello A, Martinelli A, Santos MA",,799077,DTCT0024060,7595869,DTCC01171475,1461560,47023
CHEMBL1939876,P08254,,MMJPVSDTLGFIQW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22017539,IC50,>,22000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799151,DTCT0024060,7596037,DTCC01171504,1734238,47024
CHEMBL1940308,P08254,,RMPYEISUTHEMLW-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,797392,DTCT0024060,7601235,DTCC01171923,574793,47049
CHEMBL1940315,P08254,,IOEYWFCDGXVEFG-JVHFYALYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22153941,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis,,Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2.,Bioorg. Med. Chem. Lett.,2012,22,1,"De Savi C, Morley AD, Nash I, Karoutchi G, Page K, Ting A, Gerhardt S",,797392,DTCT0024060,7601236,DTCC01171930,1734240,47049
CHEMBL194377,P08254,,LRMGKWDRORXPRE-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16153831,IC50,=,561,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-3,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321186,DTCT0024060,1860393,DTCC00407675,110120,19837
CHEMBL194430,P08254,,FXZROVPZUUATHR-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16153831,IC50,=,1090,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-3,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321186,DTCT0024060,1860441,DTCC00407681,596206,19837
CHEMBL1956115,P08254,,GDYIQUFNICPYHF-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22175825,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP3,,Potent inhibitors of LpxC for the treatment of Gram-negative infections.,J. Med. Chem.,2012,55,2,"Brown MF, Reilly U, Abramite JA, Arcari JT, Oliver R, Barham RA, Che Y, Chen JM, Collantes EM, Chung SW, Desbonnet C, Doty J, Doroski M, Engtrakul JJ, Harris TM, Huband M, Knafels JD, Leach KL, Liu S, Marfat A, Marra A, McElroy E, Melnick M, Menard CA, Montgomery JI, Mullins L, Noe MC, O'Donnell J, Penzien J, Plummer MS, Price LM, Shanmugasundaram V, Thoma C, Uccello DP, Warmus JS, Wishka DG",,806640,DTCT0024060,7652737,DTCC01177834,866270,47510
CHEMBL1957601,P08254,,CYFUZHPFHKFWQX-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22386984,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,Not Determined,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805644,DTCT0024060,7640535,DTCC01179286,1642107,47642
CHEMBL1957602,P08254,,UCAJNLLYTGJPBY-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22386984,IC50,=,160,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805644,DTCT0024060,7640536,DTCC01179287,1798652,47642
CHEMBL1957603,P08254,,WIOGWLUNCZARAP-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22386984,IC50,=,700,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805644,DTCT0024060,7640537,DTCC01179288,1027325,47642
CHEMBL1957604,P08254,,FYFJMQCWKQDEQR-FZADBTJQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22386984,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805644,DTCT0024060,7640538,DTCC01179289,1609806,47642
CHEMBL1957605,P08254,,VVEIZVKRPYJCPP-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22386984,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805644,DTCT0024060,7640539,DTCC01179290,1862951,47642
CHEMBL1957606,P08254,,LXQUQEBAZBLBEJ-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22386984,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,Not Determined,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805644,DTCT0024060,7640540,DTCC01179291,1513073,47642
CHEMBL19611,P08254,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9548812,IC50,=,1.9,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-3 (MMP-3).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,104576,DTCT0024060,997037,DTCC00151638,1884891,15116
CHEMBL19611,P08254,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,KI,=,26,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104739,DTCT0024060,1102023,DTCC00151638,1883456,4691
CHEMBL19611,P08254,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,14611841,IC50,=,0.191,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,MMPs inhibitors: new succinylhydroxamates with selective inhibition of MMP-2 over MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,17,"Marcq V, Mirand C, Decarme M, Emonard H, Hornebeck W",,104721,DTCT0024060,859747,DTCC00151638,1870949,5741
CHEMBL19611,P08254,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17512742,IC50,=,1.9,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447906,DTCT0024060,2176035,DTCC00151638,1873251,23716
CHEMBL19611,P08254,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17623656,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507873,DTCT0024060,2388622,DTCC00151638,1885151,29282
CHEMBL19611,P08254,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18782669,IC50,=,26,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557957,DTCT0024060,2791189,DTCC00151638,1873635,31586
CHEMBL19611,P08254,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21548582,IC50,=,7.62,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes.",J. Med. Chem.,2011,54,13,"Neelarapu R, Holzle DL, Velaparthi S, Bai H, Brunsteiner M, Blond SY, Petukhov PA",,785747,DTCT0024060,7517246,DTCC00151638,1895024,46348
CHEMBL19611,P08254,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,28,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-3 (Stromelysin) at 100 uM,,,Bioorg. Med. Chem. Lett.,1995,5,15,,,205495,DTCT0024060,681892,DTCC00151638,1870076,1239
CHEMBL19611,P08254,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-3 (Stromelysin) at 10 uM,,,Bioorg. Med. Chem. Lett.,1995,5,15,,,205622,DTCT0024060,681889,DTCC00151638,1870076,1239
CHEMBL19611,P08254,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,46,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102092,DTCT0024060,842077,DTCC00151638,1882893,1497
CHEMBL19623,P08254,,KEPYRBFIGNMAQF-MJGOQNOKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9548812,IC50,=,17,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-3 (MMP-3).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,104576,DTCT0024060,982754,DTCC00151639,1917024,15116
CHEMBL197921,P08254,,XQTQPJFARUOTCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16242329,IC50,>,380000,NM,,,,,,,,,,,,,,Inhibitory activity against MMP3,,N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.,Bioorg. Med. Chem. Lett.,2006,16,1,"Campestre C, Agamennone M, Tortorella P, Preziuso S, Biasone A, Gavuzzo E, Pochetti G, Mazza F, Hiller O, Tschesche H, Consalvi V, Gallina C",,327979,DTCT0024060,1875150,DTCC00410753,1937031,20151
CHEMBL198039,P08254,,IRPQGYYABIPNQJ-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16153831,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against MMP-3; - = not available,Not Determined,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321291,DTCT0024060,1860349,DTCC00407671,1048682,19837
CHEMBL198262,P08254,,HHHAELOQIYTSIY-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16153831,IC50,=,144,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-3,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321186,DTCT0024060,1860303,DTCC00407624,1405256,19837
CHEMBL19827,P08254,,UZIPWLFVCPPGDS-ZFCXOUTPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,340,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,786453,DTCC00152143,1292885,772
CHEMBL198389,P08254,,HAWUDCIVXQTNAF-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16153831,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against MMP-3; - = not available,Not Determined,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321291,DTCT0024060,1860360,DTCC00407672,304937,19837
CHEMBL19843,P08254,,OFCWIPGKPUJTDP-CFVMTHIKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9548812,IC50,=,1.9,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-3 (MMP-3).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,104576,DTCT0024060,1012778,DTCC00151473,305658,15116
CHEMBL19855,P08254,,RUZDCFCMYATJSO-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11354379,IC50,=,940,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,104897,DTCT0024060,711886,DTCC00151144,581757,4814
CHEMBL199018,P08254,,XTRLBSLKNQZDBD-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16153831,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against MMP-3; - = not available,Not Determined,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321291,DTCT0024060,1860404,DTCC00407676,822181,19837
CHEMBL199241,P08254,,LSKSBHBGNRQEFN-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16153831,IC50,=,1060,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-3,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321186,DTCT0024060,1860338,DTCC00407670,1787390,19837
CHEMBL199917,P08254,,GJITXIQQHBXCIH-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16392792,IC50,>,1000,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.,J. Med. Chem.,2006,49,1,"Pirard B, Matter H",,329821,DTCT0024060,1880231,DTCC00412005,1743962,20214
CHEMBL200274,P08254,,JGRIYRSQHHLUHI-BSOSBYQFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16392792,IC50,=,500,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.,J. Med. Chem.,2006,49,1,"Pirard B, Matter H",,329821,DTCT0024060,1880232,DTCC00411964,1004812,20214
CHEMBL200385,P08254,,DBVIHPVOZIIXAL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16242329,IC50,=,380000,NM,,,,,,,,,,,,,,Inhibitory activity against MMP3,,N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.,Bioorg. Med. Chem. Lett.,2006,16,1,"Campestre C, Agamennone M, Tortorella P, Preziuso S, Biasone A, Gavuzzo E, Pochetti G, Mazza F, Hiller O, Tschesche H, Consalvi V, Gallina C",,327979,DTCT0024060,1875149,DTCC00410754,1970289,20151
CHEMBL200435,P08254,,GVMUNGGWXRKCEU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16242329,IC50,=,200000,NM,,,,,,,,,,,,,,Inhibitory activity against MMP3,,N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.,Bioorg. Med. Chem. Lett.,2006,16,1,"Campestre C, Agamennone M, Tortorella P, Preziuso S, Biasone A, Gavuzzo E, Pochetti G, Mazza F, Hiller O, Tschesche H, Consalvi V, Gallina C",,327979,DTCT0024060,1875151,DTCC00410823,1425968,20151
CHEMBL2010824,P08254,,RKZDOJQKLCPUQZ-AIBWNMTMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22342144,KI,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 using OmniMMP as substrate,,Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.,Bioorg. Med. Chem. Lett.,2012,22,6,"Jiao GS, Kim S, Moayeri M, Crown D, Thai A, Cregar-Hernandez L, McKasson L, Sankaran B, Lehrer A, Wong T, Johns L, Margosiak SA, Leppla SH, Johnson AT",,811338,DTCT0024060,10427389,DTCC01227244,1811993,47718
CHEMBL2011681,P08254,,QBZTYOLLKGGCEG-UZLBHIALSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22276851,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP3 by signal transduction fluorometric assay,Not Active,Caspase-1 and -3 inhibiting drimane sesquiterpenoids from the extremophilic fungus Penicillium solitum.,J. Nat. Prod.,2012,75,2,"Stierle DB, Stierle AA, Girtsman T, McIntyre K, Nichols J",,811622,DTCT0024060,10433481,DTCC01226117,781991,42027
CHEMBL2011682,P08254,,WYGDLENLCOFIFH-BEFAXECRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22276851,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP3 by signal transduction fluorometric assay,Not Active,Caspase-1 and -3 inhibiting drimane sesquiterpenoids from the extremophilic fungus Penicillium solitum.,J. Nat. Prod.,2012,75,2,"Stierle DB, Stierle AA, Girtsman T, McIntyre K, Nichols J",,811622,DTCT0024060,10433482,DTCC01226118,781992,42027
CHEMBL2011683,P08254,,PYMFODJLNHATSF-UZLBHIALSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22276851,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP3 by signal transduction fluorometric assay,Not Active,Caspase-1 and -3 inhibiting drimane sesquiterpenoids from the extremophilic fungus Penicillium solitum.,J. Nat. Prod.,2012,75,2,"Stierle DB, Stierle AA, Girtsman T, McIntyre K, Nichols J",,811622,DTCT0024060,10433483,DTCC01226119,588449,42027
CHEMBL2012836,P08254,,QKBHUOCFQAXIBG-BPGUCPLFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22342144,KI,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 using OmniMMP as substrate,,Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.,Bioorg. Med. Chem. Lett.,2012,22,6,"Jiao GS, Kim S, Moayeri M, Crown D, Thai A, Cregar-Hernandez L, McKasson L, Sankaran B, Lehrer A, Wong T, Johns L, Margosiak SA, Leppla SH, Johnson AT",,811338,DTCT0024060,10427391,DTCC01227243,653282,47718
CHEMBL2012837,P08254,,AWFIZJRPXRHSEA-BPGUCPLFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22342144,KI,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 using OmniMMP as substrate,,Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.,Bioorg. Med. Chem. Lett.,2012,22,6,"Jiao GS, Kim S, Moayeri M, Crown D, Thai A, Cregar-Hernandez L, McKasson L, Sankaran B, Lehrer A, Wong T, Johns L, Margosiak SA, Leppla SH, Johnson AT",,811338,DTCT0024060,10427387,DTCC01227245,2071212,47718
CHEMBL2012838,P08254,,BPGDVHWVHMDFBK-IQWVOLIVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22342144,KI,=,31000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 using OmniMMP as substrate,,Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.,Bioorg. Med. Chem. Lett.,2012,22,6,"Jiao GS, Kim S, Moayeri M, Crown D, Thai A, Cregar-Hernandez L, McKasson L, Sankaran B, Lehrer A, Wong T, Johns L, Margosiak SA, Leppla SH, Johnson AT",,811338,DTCT0024060,10427393,DTCC01227246,814410,47718
CHEMBL20154,P08254,,LPZWIAVKYXCHGC-NVXWUHKLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,48,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1132703,DTCC00151563,918357,4691
CHEMBL20154,P08254,,LPZWIAVKYXCHGC-NVXWUHKLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229774,IC50,=,48,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-3 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,104580,DTCT0024060,580581,DTCC00151563,918364,4692
CHEMBL20154,P08254,,LPZWIAVKYXCHGC-NVXWUHKLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,47.86,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258420,DTCC00151563,909281,24803
CHEMBL20256,P08254,,SQDPMXOFVRWYMR-DJHFWHLDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,330,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,788844,DTCC00152881,1772892,772
CHEMBL202932,P08254,,BZVYQWLRCHLAGK-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16451058,KI,=,40,NM,,,,,,,,,,,,,,Inhibitory activity against MMP3,,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330546,DTCT0024060,1887657,DTCC00413183,1274996,20245
CHEMBL202932,P08254,,BZVYQWLRCHLAGK-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17088065,IC50,=,52,NM,,,,,,,,,,,,,,Inhibition of MMP3,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432504,DTCT0024060,2061764,DTCC00413183,1263648,22402
CHEMBL204543,P08254,"NAPHTHALENE-1,2-DIOL",NXPPAOGUKPJVDI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,89,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103862,DTCC00001534,1892886,43205
CHEMBL204593,P08254,,LUCFRFDOOYLALP-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16338135,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibition of MMP3,,The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infection.,Bioorg. Med. Chem. Lett.,2006,16,4,"Xiong Y, Wiltsie J, Woods A, Guo J, Pivnichny JV, Tang W, Bansal A, Cummings RT, Cunningham BR, Friedlander AM, Douglas CM, Salowe SP, Zaller DM, Scolnick EM, Schmatz DM, Bartizal K, Hermes JD, MacCoss M, Chapman KT",,334085,DTCT0024060,1895865,DTCC00415249,1598833,20352
CHEMBL20471,P08254,,IHYFGNZPSNQXSD-MMNWNWMFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,4600,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,807265,DTCC00152812,1487612,772
CHEMBL2047536,P08254,,DACARRUBIAXSBX-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22175799,IC50,=,8200,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 using MCAArg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(DNP)-NH2 as substrate preincubated for 10 mins measured by fluorescence analysis,,"Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis.",J. Med. Chem.,2012,55,2,"Gege C, Bao B, Bluhm H, Boer J, Gallagher BM, Korniski B, Powers TS, Steeneck C, Taveras AG, Baragi VM",,827022,DTCT0024060,10526934,DTCC01242723,653432,48586
CHEMBL2047537,P08254,,CZRLAOXITNZAJA-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22175799,IC50,=,15000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 using MCAArg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(DNP)-NH2 as substrate preincubated for 10 mins measured by fluorescence analysis,,"Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis.",J. Med. Chem.,2012,55,2,"Gege C, Bao B, Bluhm H, Boer J, Gallagher BM, Korniski B, Powers TS, Steeneck C, Taveras AG, Baragi VM",,827022,DTCT0024060,10526932,DTCC01242724,1655819,48586
CHEMBL2048502,P08254,MACRATHOIN F,VEBNYMXKXIIGFX-KBXRYBNXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,=,10360,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535387,DTCC01243472,1844458,48665
CHEMBL2048502,P08254,MACRATHOIN F,VEBNYMXKXIIGFX-KBXRYBNXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827441,DTCT0024060,10535497,DTCC01243472,1844458,48665
CHEMBL2048503,P08254,,MZNIJRAPCCELQX-HWKANZROSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,=,58810,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535388,DTCC01243473,492092,48665
CHEMBL2048503,P08254,,MZNIJRAPCCELQX-HWKANZROSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827441,DTCT0024060,10535498,DTCC01243473,492092,48665
CHEMBL2048504,P08254,,FLOHNUCSNZDDJO-DUXPYHPUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535389,DTCC01243474,427800,48665
CHEMBL2048505,P08254,DIMETHYL LITHOSPERMATE,YAXTXMBBIHBGPZ-ZBBBDWFHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,=,8150,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535390,DTCC01243475,1494333,48665
CHEMBL2048505,P08254,DIMETHYL LITHOSPERMATE,YAXTXMBBIHBGPZ-ZBBBDWFHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827441,DTCT0024060,10535499,DTCC01243475,1494333,48665
CHEMBL2048506,P08254,,QWHMMEKTFNJGTI-GNBMGSNXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,=,14810,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535391,DTCC01243476,1041021,48665
CHEMBL2048506,P08254,,QWHMMEKTFNJGTI-GNBMGSNXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827441,DTCT0024060,10535500,DTCC01243476,1041021,48665
CHEMBL2048507,P08254,DAPHNODORIN F,KVPJDVHJFGPPAB-XOHQIPOJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,=,22300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535395,DTCC01243477,2071373,48665
CHEMBL2048507,P08254,DAPHNODORIN F,KVPJDVHJFGPPAB-XOHQIPOJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827441,DTCT0024060,10535504,DTCC01243477,2071373,48665
CHEMBL2048508,P08254,"(2R,3S)-DIHYDROMYRICETIN",KJXSIXMJHKAJOD-HUUCEWRRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,=,20270,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535397,DTCC00042059,362498,48665
CHEMBL2048508,P08254,"(2R,3S)-DIHYDROMYRICETIN",KJXSIXMJHKAJOD-HUUCEWRRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827441,DTCT0024060,10535506,DTCC00042059,362498,48665
CHEMBL2048509,P08254,,FYEZJIXULOZDRT-ARJAWSKDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535402,DTCC01243478,717883,48665
CHEMBL2048510,P08254,,DXXGHDAWCPTRPU-XOSAIJSUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535403,DTCC01243479,556512,48665
CHEMBL2048511,P08254,ALPHA-ISOVALEROXYISOVALERIC ACID,SOJFCTIYHPWXGZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,=,38150,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535405,DTCC00042060,264062,48665
CHEMBL2048511,P08254,ALPHA-ISOVALEROXYISOVALERIC ACID,SOJFCTIYHPWXGZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827441,DTCT0024060,10535508,DTCC00042060,264062,48665
CHEMBL2048512,P08254,,FQRZOEBSTPAQBJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535407,DTCC01243480,1812174,48665
CHEMBL2063270,P08254,,CXKWJJJVWDMSAG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,50,%,,,,,,,,,,,,,,Competitive inhibition of human MMP3 using fluorogenic substrate at 20 uM by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831072,DTCT0024060,10566521,DTCC01247512,186720,48923
CHEMBL2063271,P08254,,LEBLJISYPUWAJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,27000,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP3 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831071,DTCT0024060,10566515,DTCC01247513,2090921,48923
CHEMBL2063272,P08254,,KUWJZFVZZLSOHK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,18,%,,,,,,,,,,,,,,Competitive inhibition of human MMP3 using fluorogenic substrate at 60 uM by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831073,DTCT0024060,10566523,DTCC01247514,1896167,48923
CHEMBL2063273,P08254,,BGRGANYQQMRQLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,4100,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP3 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831071,DTCT0024060,10566516,DTCC01247515,316901,48923
CHEMBL2063274,P08254,,AHDPJKYOQXMDIX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,2200,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP3 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831071,DTCT0024060,10566517,DTCC01247516,834451,48923
CHEMBL2063275,P08254,,GPZUWAHQDYJABE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,17000,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP3 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831071,DTCT0024060,10566518,DTCC01247517,1546082,48923
CHEMBL2063276,P08254,,STSMSPOAFPZOFC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,12000,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP3 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831071,DTCT0024060,10566519,DTCC01247518,349672,48923
CHEMBL2063277,P08254,,RMRUTHBBMQENKJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,14,%,,,,,,,,,,,,,,Competitive inhibition of human MMP3 using fluorogenic substrate at 20 uM by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831072,DTCT0024060,10566522,DTCC01247519,543747,48923
CHEMBL206815,P08254,APRATASTAT,MAVDNGWEBZTACC-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,=,10,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14966647,DTCC00417680,2113997,70044
CHEMBL206815,P08254,APRATASTAT,MAVDNGWEBZTACC-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,=,10,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14966648,DTCC00417680,2113997,70044
CHEMBL206875,P08254,,ZFXFRRPQPVEFAM-LSDHHAIUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16516469,KI,=,300,NM,,,,,,,,,,,,,,Binding affinity to recombinant MMP3,,A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,10,"Janser P, Neumann U, Miltz W, Feifel R, Buhl T",,354052,DTCT0024060,1926036,DTCC00422586,2047092,20779
CHEMBL20696,P08254,,VRBYANBVEXRZTB-ACEFPKFPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,940,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,780770,DTCC00152882,775434,772
CHEMBL207305,P08254,,NUVSGXIVCJBRBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16516466,KI,=,82,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354469,DTCT0024060,1926602,DTCC00421580,552632,20786
CHEMBL207305,P08254,,NUVSGXIVCJBRBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,KI,=,82,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457280,DTCC00421580,565360,32556
CHEMBL207756,P08254,,ZQORGANDVNQVJF-YESZJQIVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16516469,KI,=,11,NM,,,,,,,,,,,,,,Binding affinity to recombinant MMP3,,A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,10,"Janser P, Neumann U, Miltz W, Feifel R, Buhl T",,354052,DTCT0024060,1926034,DTCC00422639,919235,20779
CHEMBL208009,P08254,,BODLESUVCQEUII-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16516466,KI,=,91,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354469,DTCT0024060,1926601,DTCC00421655,1037257,20786
CHEMBL208181,P08254,,MWYSQPGMUZLIHV-RCCFBDPRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16516469,KI,=,12,NM,,,,,,,,,,,,,,Binding affinity to recombinant MMP3,,A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,10,"Janser P, Neumann U, Miltz W, Feifel R, Buhl T",,354052,DTCT0024060,1926038,DTCC00422272,1695509,20779
CHEMBL2093894,P08254,,ZVYIZSNCEAHMCF-LMOVPXPDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,1300,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1286947,DTCC01256611,1326439,14264
CHEMBL210441,P08254,,LOZYBBRAEOAORI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16632358,IC50,=,34,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361729,DTCT0024060,1937050,DTCC00423321,778415,20885
CHEMBL210517,P08254,,OIBWGGKYJHWGPB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16632358,IC50,=,28,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,12,"Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P",,361729,DTCT0024060,1937051,DTCC00422956,1872825,20885
CHEMBL2111573,P08254,,IHERVMJHCHNTKO-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,14611841,IC50,=,910,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,MMPs inhibitors: new succinylhydroxamates with selective inhibition of MMP-2 over MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,17,"Marcq V, Mirand C, Decarme M, Emonard H, Hornebeck W",,104721,DTCT0024060,886784,DTCC01263970,808904,5741
CHEMBL2111687,P08254,,XJXBTXINGWHTHD-VSYOVCOZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10560745,INHIBITION,=,83,%,,,,,,,,,,,,,,Inhibition of matrix metalloprotease (MMP-3) at 10 uM,,Selective inhibition of low affinity IgE receptor (CD23) processing: P1' bicyclomethyl substituents.,Bioorg. Med. Chem. Lett.,1999,9,21,"Bailey S, Bolognese B, Faller A, Louis-Flamberg P, MacPherson DT, Mayer RJ, Marshall LA, Milner PH, Mistry J, Smith DG, Ward JG",,105819,DTCT0024060,1412067,DTCC01264077,2077567,3450
CHEMBL2111961,P08254,,ZOJMJLMSZDGBHC-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1047281,DTCC01264339,1839737,15462
CHEMBL2111965,P08254,,KMLOBHZAEFITDB-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,26,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1366555,DTCC01264342,1208504,15412
CHEMBL2112477,P08254,,XJXBTXINGWHTHD-RJCAOGMDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10560745,IC50,=,230,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease (MMP-3),,Selective inhibition of low affinity IgE receptor (CD23) processing: P1' bicyclomethyl substituents.,Bioorg. Med. Chem. Lett.,1999,9,21,"Bailey S, Bolognese B, Faller A, Louis-Flamberg P, MacPherson DT, Mayer RJ, Marshall LA, Milner PH, Mistry J, Smith DG, Ward JG",,105818,DTCT0024060,1423220,DTCC01264814,1144688,3450
CHEMBL2112796,P08254,,KMLOBHZAEFITDB-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,33,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1401852,DTCC01265121,1241293,15412
CHEMBL21137,P08254,,PNLPEFDGBQPKAF-TXDWVUBVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,1400,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,794757,DTCC00152615,969382,772
CHEMBL21141,P08254,,FDWJCEDPTNPQLJ-GPPFSWFQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,6.1,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,801695,DTCC00152858,1001917,772
CHEMBL2115165,P08254,ABT-518,IVPPTWCRAFCOFJ-RTBURBONSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11754593,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3) in fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104893,DTCT0024060,1572601,DTCC00045007,550427,16699
CHEMBL21198,P08254,,YESRVWYRSOICAY-QWYZADMVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,15,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,793443,DTCC00152613,1099470,772
CHEMBL215074,P08254,"3,2'-DIGUANIDINONEAMINE",SOBOASBOKGPTNI-HKEUSBCWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16870442,KI,>,300000,NM,,,,,,,,,,,,,,Activity at MMP3,,Selectively guanidinylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease.,Bioorg. Med. Chem. Lett.,2006,16,19,"Jiao GS, Simo O, Nagata M, O'Malley S, Hemscheidt T, Cregar L, Millis SZ, Goldman ME, Tang C",,393599,DTCT0024060,1981413,DTCC00001986,1852268,21299
CHEMBL215269,P08254,"1,3,2',6'-TETRAGUANIDINONEAMINE",BNWODYWXZNMCKX-HKEUSBCWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16870442,KI,>,300000,NM,,,,,,,,,,,,,,Activity at MMP3,,Selectively guanidinylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease.,Bioorg. Med. Chem. Lett.,2006,16,19,"Jiao GS, Simo O, Nagata M, O'Malley S, Hemscheidt T, Cregar L, Millis SZ, Goldman ME, Tang C",,393599,DTCT0024060,1981414,DTCC00001992,1437410,21299
CHEMBL215715,P08254,,DDPWNYDFUBXVGQ-MLFNNEOSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16870442,KI,>,300000,NM,,,,,,,,,,,,,,Activity at MMP3,,Selectively guanidinylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease.,Bioorg. Med. Chem. Lett.,2006,16,19,"Jiao GS, Simo O, Nagata M, O'Malley S, Hemscheidt T, Cregar L, Millis SZ, Goldman ME, Tang C",,393599,DTCT0024060,1981405,DTCC00433950,1469832,21299
CHEMBL218586,P08254,,KALKLNBLKRHXMI-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17256836,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425540,DTCT0024060,2019777,DTCC00438882,1081562,21880
CHEMBL219104,P08254,,MITLEGOYVUMBJH-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17256836,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425540,DTCT0024060,2019778,DTCC00438881,661246,21880
CHEMBL219104,P08254,,MITLEGOYVUMBJH-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,>,5000,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276522,DTCC00438881,650433,25086
CHEMBL219105,P08254,,YCCUTKPNUYYNML-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17256836,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425540,DTCT0024060,2019769,DTCC00438922,1916656,21880
CHEMBL220501,P08254,,SMNLJWDKCNVQNU-RDJZCZTQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17256836,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425540,DTCT0024060,2019776,DTCC00438889,1852360,21880
CHEMBL220975,P08254,,AXVVLBQLURTOIQ-DVRYWGNFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17256836,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425540,DTCT0024060,2019714,DTCC00438857,110435,21880
CHEMBL221120,P08254,,IWNGNUDBGMCFNB-RDJZCZTQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17256836,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425540,DTCT0024060,2019775,DTCC00438890,110436,21880
CHEMBL221698,P08254,,XKPUKZQRNSFQLM-JYJNAYRXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17256836,IC50,>,3000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425540,DTCT0024060,2019772,DTCC00438914,532136,21880
CHEMBL221857,P08254,,GGYBWFRTPPVUAZ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17256836,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425540,DTCT0024060,2019720,DTCC00438873,1340603,21880
CHEMBL221857,P08254,,GGYBWFRTPPVUAZ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,>,5000,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276420,DTCC00438873,1329203,25086
CHEMBL221857,P08254,,GGYBWFRTPPVUAZ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19457660,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of human MMP3,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523766,DTCT0024060,2828350,DTCC00438873,1329994,33677
CHEMBL225164,P08254,CLOXYQUIN,CTQMJYWDVABFRZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,45,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103798,DTCC00445307,1828598,43205
CHEMBL226345,P08254,ADENINE,GFFGJBXGBJISGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,10,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103030,DTCC00449510,86517,43205
CHEMBL226439,P08254,,ICISPHGVMHWYTI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944582,DTCT0024060,11835676,DTCC00449741,447228,53820
CHEMBL226630,P08254,UK-383367,ARJCBSRIPGJMAD-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17591762,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440139,DTCT0024060,2113791,DTCC00002834,1523163,23023
CHEMBL226630,P08254,UK-383367,ARJCBSRIPGJMAD-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP3 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440145,DTCT0024060,2113819,DTCC00002834,1523163,23023
CHEMBL226630,P08254,UK-383367,ARJCBSRIPGJMAD-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP3 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440151,DTCT0024060,2113847,DTCC00002834,1523163,23023
CHEMBL226630,P08254,UK-383367,ARJCBSRIPGJMAD-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP3 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440157,DTCT0024060,2113876,DTCC00002834,1523163,23023
CHEMBL226630,P08254,UK-383367,ARJCBSRIPGJMAD-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18945617,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP3 by fluorescence assay,,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518964,DTCT0024060,2690023,DTCC00002834,1535490,32223
CHEMBL226686,P08254,,FRASWKFJOBLAQF-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18945617,IC50,=,28000,NM,,,,,,,,,,,,,,Inhibition of human MMP3 by fluorescence assay,,"Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.",Bioorg. Med. Chem. Lett.,2008,18,24,"Bailey S, Fish PV, Billotte S, Bordner J, Greiling D, James K, McElroy A, Mills JE, Reed C, Webster R",,518964,DTCT0024060,2690033,DTCC00452728,1726167,32223
CHEMBL226852,P08254,,SWOIHXOGQYPPNC-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17591762,IC50,=,78000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440139,DTCT0024060,2113794,DTCC00452681,1361615,23023
CHEMBL226852,P08254,,SWOIHXOGQYPPNC-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP3 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440145,DTCT0024060,2113822,DTCC00452681,1361615,23023
CHEMBL226852,P08254,,SWOIHXOGQYPPNC-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP3 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440151,DTCT0024060,2113850,DTCC00452681,1361615,23023
CHEMBL226852,P08254,,SWOIHXOGQYPPNC-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP3 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440157,DTCT0024060,2113879,DTCC00452681,1361615,23023
CHEMBL227484,P08254,,CJTUBZULFXKTAT-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17088065,IC50,=,45,NM,,,,,,,,,,,,,,Inhibition of MMP3,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432504,DTCT0024060,2061768,DTCC00447716,326283,22402
CHEMBL227484,P08254,,CJTUBZULFXKTAT-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17088065,IC50,=,45,NM,,,,,,,,,,,,,,Inhibition of MMP3,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432504,DTCT0024060,2061998,DTCC00447716,326284,22402
CHEMBL227501,P08254,,WNLZTTHHHYZJMB-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17088065,IC50,=,230,NM,,,,,,,,,,,,,,Inhibition of MMP3,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432504,DTCT0024060,2061765,DTCC00447830,1426294,22402
CHEMBL227553,P08254,,FHZGYMLWCVBBPM-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17088065,INHIBITION,=,34,%,,,,,,,,,,,,,,Inhibition of MMP3 at 100 uM,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432511,DTCT0024060,2061774,DTCC00447831,1166105,22402
CHEMBL227598,P08254,,VKFNDAOTTJONML-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17088065,IC50,=,36,NM,,,,,,,,,,,,,,Inhibition of MMP3,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432504,DTCT0024060,2061771,DTCC00447803,972589,22402
CHEMBL227824,P08254,,RVKPGECPCLBLDB-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17088065,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP3,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432504,DTCT0024060,2061772,DTCC00447798,940549,22402
CHEMBL228141,P08254,,AGSXHHFUSDGSSO-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17088065,INHIBITION,=,31,%,,,,,,,,,,,,,,Inhibition of MMP3 at 100 uM,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432511,DTCT0024060,2061775,DTCC00447839,520801,22402
CHEMBL228187,P08254,,NZKKRYAESABOSS-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17088065,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of MMP3,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432504,DTCT0024060,2061767,DTCC00447819,1684493,22402
CHEMBL228188,P08254,,BGBWSADVPWNBME-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17088065,IC50,=,440,NM,,,,,,,,,,,,,,Inhibition of MMP3,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432504,DTCT0024060,2061766,DTCC00447820,1102691,22402
CHEMBL228268,P08254,,GQLPTZZPKXZFQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17368021,KI,=,567,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438529,DTCT0024060,2101568,DTCC00455487,143032,22885
CHEMBL228318,P08254,,BSAORORNNRENRI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17368021,KI,>,4501,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438529,DTCT0024060,2101567,DTCC00455489,1884640,22885
CHEMBL228319,P08254,,CLYVYZOSMYXOBC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17368021,KI,>,4501,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438529,DTCT0024060,2101566,DTCC00455490,984390,22885
CHEMBL228320,P08254,,HVVGLHPJPUUJHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17368021,KI,>,4501,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438529,DTCT0024060,2101565,DTCC00455491,467364,22885
CHEMBL228320,P08254,,HVVGLHPJPUUJHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2456513,DTCC00455491,468361,32556
CHEMBL229072,P08254,,IKRKDUGQVRSGJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17368021,KI,>,4501,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2007,17,10,"Sheppeck JE, Gilmore JL, Tebben A, Xue CB, Liu RQ, Decicco CP, Duan JJ",,438529,DTCT0024060,2101569,DTCC00455483,1373275,22885
CHEMBL229239,P08254,5-FLUOROSALICYLIC ACID,JWPRICQKUNODPZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,-2,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103836,DTCC00002746,183414,43205
CHEMBL22996,P08254,,WPBCXLCJWLNDPV-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,500000,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205500,DTCT0024060,731981,DTCC00155882,161335,12439
CHEMBL2316256,P08254,,RXBMEHOLQJITJI-LEOXJPRUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23343195,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP3 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by spectrophotometry,Active,Molecular determinants of a selective matrix metalloprotease-12 inhibitor: insights from crystallography and thermodynamic studies.,J. Med. Chem.,2013,56,3,"Czarny B, Stura EA, Devel L, Vera L, Cassar-Lajeunesse E, Beau F, Calderone V, Fragai M, Luchinat C, Dive V",,935214,DTCT0024060,11751208,DTCC01339596,71045,53441
CHEMBL2316257,P08254,,LIUMDGLYGBIKBM-SFYKDHMMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23343195,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP3 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by spectrophotometry,Not Active,Molecular determinants of a selective matrix metalloprotease-12 inhibitor: insights from crystallography and thermodynamic studies.,J. Med. Chem.,2013,56,3,"Czarny B, Stura EA, Devel L, Vera L, Cassar-Lajeunesse E, Beau F, Calderone V, Fragai M, Luchinat C, Dive V",,935214,DTCT0024060,11751207,DTCC01339597,589403,53441
CHEMBL2316258,P08254,,HXHLWPVBBLIGJV-XYJFISCASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23343195,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP3 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by spectrophotometry,Active,Molecular determinants of a selective matrix metalloprotease-12 inhibitor: insights from crystallography and thermodynamic studies.,J. Med. Chem.,2013,56,3,"Czarny B, Stura EA, Devel L, Vera L, Cassar-Lajeunesse E, Beau F, Calderone V, Fragai M, Luchinat C, Dive V",,935214,DTCT0024060,11751206,DTCC01339598,199757,53441
CHEMBL2326363,P08254,,UIVFNXLDHQCJRY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23458498,IC50,=,7100,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys-(Dnp)-NH2 as substrate after 4 hrs by fluorometric assay,,Synthesis and preliminary evaluation in tumor bearing mice of new (18)f-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography.,J. Med. Chem.,2013,56,6,"Casalini F, Fugazza L, Esposito G, Cabella C, Brioschi C, Cordaro A, D'Angeli L, Bartoli A, Filannino AM, Gringeri CV, Longo DL, Muzio V, Nuti E, Orlandini E, Figlia G, Quattrini A, Tei L, Digilio G, Rossello A, Maiocchi A",,940802,DTCT0024060,11795565,DTCC01344669,199799,53669
CHEMBL2326364,P08254,,XXBXRJDBCMCGGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23458498,IC50,=,67000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys-(Dnp)-NH2 as substrate after 4 hrs by fluorometric assay,,Synthesis and preliminary evaluation in tumor bearing mice of new (18)f-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography.,J. Med. Chem.,2013,56,6,"Casalini F, Fugazza L, Esposito G, Cabella C, Brioschi C, Cordaro A, D'Angeli L, Bartoli A, Filannino AM, Gringeri CV, Longo DL, Muzio V, Nuti E, Orlandini E, Figlia G, Quattrini A, Tei L, Digilio G, Rossello A, Maiocchi A",,940802,DTCT0024060,11795564,DTCC01344670,2040368,53669
CHEMBL2326365,P08254,,CREFCFAJHQSGNR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23458498,IC50,=,6800,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys-(Dnp)-NH2 as substrate after 4 hrs by fluorometric assay,,Synthesis and preliminary evaluation in tumor bearing mice of new (18)f-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography.,J. Med. Chem.,2013,56,6,"Casalini F, Fugazza L, Esposito G, Cabella C, Brioschi C, Cordaro A, D'Angeli L, Bartoli A, Filannino AM, Gringeri CV, Longo DL, Muzio V, Nuti E, Orlandini E, Figlia G, Quattrini A, Tei L, Digilio G, Rossello A, Maiocchi A",,940802,DTCT0024060,11795563,DTCC01344671,913412,53669
CHEMBL2333287,P08254,,HTYCVVAAKRVDGM-LKCJCFKCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23353736,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),,Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1).,Eur. J. Med. Chem.,2013,62,,"Yuan H, Lu W, Wang L, Shan L, Li H, Huang J, Sun Q, Zhang W",,946629,DTCT0024060,11806938,DTCC01346826,868646,53896
CHEMBL2333288,P08254,,HTYCVVAAKRVDGM-IPXXLZSSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23353736,IC50,=,3400,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),,Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1).,Eur. J. Med. Chem.,2013,62,,"Yuan H, Lu W, Wang L, Shan L, Li H, Huang J, Sun Q, Zhang W",,946629,DTCT0024060,11806937,DTCC01346827,447178,53896
CHEMBL2337130,P08254,,BEZJPBNIFWANDL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944582,DTCT0024060,11835668,DTCC01350532,56348,53820
CHEMBL2337131,P08254,,AJAHTKZXCRUIAR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944582,DTCT0024060,11835666,DTCC01350533,1061928,53820
CHEMBL2338554,P08254,SYMPLOSTATIN 5,KPKJQINJXGFAPS-NBGICTFWSA-M,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23350733,ACTIVITY,=,100,%,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) using (5-FAM/QXLTM) FRET peptide substrate assessed as residual activity at 10 uM incubated for 15 mins prior to substrate addition measured for 2 hrs,,Potent elastase inhibitors from cyanobacteria: structural basis and mechanisms mediating cytoprotective and anti-inflammatory effects in bronchial epithelial cells.,J. Med. Chem.,2013,56,3,"Salvador LA, Taori K, Biggs JS, Jakoncic J, Ostrov DA, Paul VJ, Luesch H",,944688,DTCT0024060,11803599,DTCC01351885,686495,53882
CHEMBL234034,P08254,,NMHJSIJTDAPUMQ-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17276676,IC50,=,1800,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447084,DTCT0024060,2169398,DTCC00464775,876465,23623
CHEMBL234350,P08254,,PUHDBKGWNNZTBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16220987,KI,=,42.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14759280,DTCC00461900,2111482,69259
CHEMBL234350,P08254,,PUHDBKGWNNZTBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16220987,KI,=,42.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14759929,DTCC00461900,2111482,69259
CHEMBL234350,P08254,,PUHDBKGWNNZTBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17064892,IC50,=,42.5,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440762,DTCT0024060,2153849,DTCC00461900,650170,23077
CHEMBL2347847,P08254,,JFYUPKXGFNQNTK-KPKJPENVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23453070,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) by FRET method,,A series of thiazole derivatives bearing thiazolidin-4-one as non-competitive ADAMTS-5 (aggrecanase-2) inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Ishiguro N, Sogame S, Suenaga Y, Kawanishi M, Suzuki H, Jinno N, Tanaka E, Miyoshi S",,953677,DTCT0024060,11856628,DTCC01353178,156183,54221
CHEMBL2348091,P08254,,FXCKSJPZDBQRLO-KPKJPENVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23453070,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) by FRET method,,A series of thiazole derivatives bearing thiazolidin-4-one as non-competitive ADAMTS-5 (aggrecanase-2) inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Ishiguro N, Sogame S, Suenaga Y, Kawanishi M, Suzuki H, Jinno N, Tanaka E, Miyoshi S",,953677,DTCT0024060,11856627,DTCC01353415,868718,54221
CHEMBL2348091,P08254,,FXCKSJPZDBQRLO-KPKJPENVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24316668,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-3 using Mca-ArgProLysProValGlu-Nval-TrpArgLys(Dnp)-NH2 as substrate after 45 mins by fluorescence plate reader analysis,,Discovery of a benzimidazole series of ADAMTS-5 (aggrecanase-2) inhibitors by scaffold hopping.,Eur. J. Med. Chem.,2014,71,,"Sogame S, Suenaga Y, Atobe M, Kawanishi M, Tanaka E, Miyoshi S",,1283987,DTCT0024060,12983852,DTCC01353415,848823,56872
CHEMBL2348094,P08254,,IBACCBWOEGUMMV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953883,DTCT0024060,11856707,DTCC01353418,1559615,54223
CHEMBL2348100,P08254,,MTZSGZVRTUPRNT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23453072,INH,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953883,DTCT0024060,11856708,DTCC01353424,1009477,54223
CHEMBL2348113,P08254,,WVVARRFLFPIQLC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23453072,INH,=,1200,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953883,DTCT0024060,11856709,DTCC01353437,557370,54223
CHEMBL2348114,P08254,,LUCYEPUXPXFUTP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23453072,INH,=,20000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953883,DTCT0024060,11856710,DTCC01353438,1300729,54223
CHEMBL2348115,P08254,,MCCUBPXKRMEWLF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23453072,INH,=,5100,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953883,DTCT0024060,11856712,DTCC01353439,330809,54223
CHEMBL2348116,P08254,,FIWXKDPCZMMNRI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23453072,INH,=,12000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953883,DTCT0024060,11856711,DTCC01353440,1333389,54223
CHEMBL236446,P08254,,QROXNPLBULDOSL-QGRTWZNFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17512742,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447906,DTCT0024060,2176039,DTCC00468601,163984,23716
CHEMBL237078,P08254,,BBUFBPSZYHVWGA-RSKCKNFOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17512742,IC50,=,8610,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447906,DTCT0024060,2176037,DTCC00468626,972772,23716
CHEMBL2370817,P08254,,CDMKWESEIDQQND-QMMLZNLJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,KI,=,1300,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205627,DTCT0024060,1259580,DTCC01367461,1468510,12304
CHEMBL2370819,P08254,,JJVBVWAKWZHHLG-QDSKXPNFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,KI,=,540,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205627,DTCT0024060,1259583,DTCC01367463,1694363,12304
CHEMBL2370820,P08254,,LISPGQPSYLENBK-UXPWSPDFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,IC50,=,19000,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205501,DTCT0024060,1249074,DTCC01367464,1915388,12304
CHEMBL2370820,P08254,,LISPGQPSYLENBK-UXPWSPDFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,KI,=,34000,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205627,DTCT0024060,1249075,DTCC01367464,1915388,12304
CHEMBL2370821,P08254,,GGFSYPJCMRNMQX-MNEFBYGVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205627,DTCT0024060,1251400,DTCC01367465,950610,12304
CHEMBL2370822,P08254,,YCFIKRHPDITMJW-OIBXWCBGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,KI,=,1600,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205627,DTCT0024060,1276781,DTCC01367466,1851029,12304
CHEMBL2370824,P08254,,DCBNANBTMSJGTO-UXPWSPDFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,KI,=,5300,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205627,DTCT0024060,1250196,DTCC01367468,1176277,12304
CHEMBL23725,P08254,,SXCBCJFEHSPGNX-KSZLIROESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10340614,KI,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (human fibroblast stromelysin),,Macrocyclic hydroxamate inhibitors of matrix metalloproteinases and TNF-alpha production.,Bioorg. Med. Chem. Lett.,1999,9,9,"Cherney RJ, Wang L, Meyer DT, Xue CB, Arner EC, Copeland RA, Covington MB, Hardman KD, Wasserman ZR, Jaffee BD, Decicco CP",,102086,DTCT0024060,928984,DTCC00158057,822976,3648
CHEMBL23725,P08254,,SXCBCJFEHSPGNX-KSZLIROESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669559,KI,<,1,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104750,DTCT0024060,1057253,DTCC00158057,809227,16063
CHEMBL23725,P08254,,SXCBCJFEHSPGNX-KSZLIROESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472217,KI,=,3,NM,,,,,,,,,,,,,,Inhibition of human MMP-3.,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104875,DTCT0024060,1676544,DTCC00158057,808788,16346
CHEMBL2380314,P08254,,ZXVWNUSVQOQAIY-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,=,37,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429943,DTCC01373961,1256045,54589
CHEMBL2380387,P08254,,WSFQQGCWUCOARG-NMLBUPMWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,=,990,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429959,DTCC01373946,1865323,54589
CHEMBL2380388,P08254,,KJNZDUKNEQXTSO-LIONHTAISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,=,300,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429958,DTCC01373947,123665,54589
CHEMBL2380389,P08254,,QDPILJAKSNERSV-YAOOYPAMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,=,31,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429957,DTCC01373948,1062010,54589
CHEMBL2380390,P08254,,RYDPXGZLAKQPJB-AUAHOFGGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,=,1.9,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429956,DTCC01373949,577338,54589
CHEMBL2380391,P08254,,YTQYMJLEQVXIPD-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,>,200000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429954,DTCC01373950,1995521,54589
CHEMBL2380391,P08254,,YTQYMJLEQVXIPD-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,>,200000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429955,DTCC01373950,1995520,54589
CHEMBL2380393,P08254,,IVYZHWRIIPQLOI-QWRGUYRKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,>,200000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429953,DTCC01373952,1929712,54589
CHEMBL2380394,P08254,,XBPHJVRPJAQGKS-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,=,10000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429952,DTCC01373953,706586,54589
CHEMBL2380395,P08254,,YTQYMJLEQVXIPD-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,>,200000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429950,DTCC01373954,1962830,54589
CHEMBL2380395,P08254,,YTQYMJLEQVXIPD-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,>,200000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429951,DTCC01373954,1962829,54589
CHEMBL2380396,P08254,,YTQYMJLEQVXIPD-IAGOWNOFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,=,100000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429949,DTCC01373955,156243,54589
CHEMBL2380397,P08254,,GPFVSBBSRCFVPP-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,>,200000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429948,DTCC01373956,738899,54589
CHEMBL2380398,P08254,,WOUSJKQGCHWOAQ-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,>,200000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429947,DTCC01373957,480801,54589
CHEMBL2380399,P08254,,HMRLQVJTSOHCLV-MOGJOVFKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,=,2500,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429946,DTCC01373958,868763,54589
CHEMBL2380399,P08254,,HMRLQVJTSOHCLV-MOGJOVFKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,=,5900,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429939,DTCC01373958,868764,54589
CHEMBL2380400,P08254,,UJWXVGWYDPXCST-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,=,460,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429945,DTCC01373959,1579765,54589
CHEMBL2380401,P08254,,BTCYLUBBXQARQV-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,=,350,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429944,DTCC01373960,706587,54589
CHEMBL2380402,P08254,,MUWDEQLPHWVPPA-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,=,810,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429942,DTCC01373962,156244,54589
CHEMBL2380403,P08254,,FHORSTUZHMJGTR-GUTACTQSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,=,2000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429941,DTCC01373963,318346,54589
CHEMBL2380404,P08254,,NCMGDRDFDQYIHA-GUTACTQSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429940,DTCC01373964,1962831,54589
CHEMBL2380405,P08254,,HMRLQVJTSOHCLV-QNBGGDODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,=,1600,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429938,DTCC01373965,1736763,54589
CHEMBL2380406,P08254,,IZCZBRLGTKWIIZ-VWTOLEPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23631440,KI,=,4100,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using Mca-PLGLDpa-AR-NH2 as substrate preincubated for 30 mins by fluorescence assay,,Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.,J. Med. Chem.,2013,56,11,"Jin Y, Roycik MD, Bosco DB, Cao Q, Constantino MH, Schwartz MA, Sang QX",,959636,DTCT0024060,12429960,DTCC01373966,1515507,54589
CHEMBL240464,P08254,,OTYPWJTWIVTSCQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215367,DTCC00477164,1539491,24158
CHEMBL240465,P08254,,VDNQILFFXZGSAK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215350,DTCC00477187,1378237,24158
CHEMBL240648,P08254,,JAJGEGVZSPWXRV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215360,DTCC00477171,763015,24158
CHEMBL240652,P08254,,RKUJFFMHPNCFGS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215357,DTCC00477174,1571477,24158
CHEMBL240653,P08254,,NRIFANAMCHKQRL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215365,DTCC00477166,1728630,24158
CHEMBL240654,P08254,,NOXUFSHDRYQLKO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215363,DTCC00477168,827621,24158
CHEMBL240852,P08254,,WUUXXJBNJKDVJH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215362,DTCC00477169,1668635,24158
CHEMBL240854,P08254,,MXSTVAAIMVPNIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215354,DTCC00477177,1760416,24158
CHEMBL240855,P08254,,HLZGHZBDUQUWJL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215351,DTCC00477186,310263,24158
CHEMBL240963,P08254,LAWSONE,CSFWPUWCSPOLJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,84,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103957,DTCC00473933,1057327,43205
CHEMBL241048,P08254,,RYFSQVRNVFCETF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215316,DTCC00477159,83180,24158
CHEMBL241051,P08254,,NIJRSBKAMIDLFF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215353,DTCC00477179,1247789,24158
CHEMBL241405,P08254,METHYL ROSMARINATE,XHALVRQBZGZHFE-BBOMDTFKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,=,28260,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535386,DTCC00474227,1267308,48665
CHEMBL241405,P08254,METHYL ROSMARINATE,XHALVRQBZGZHFE-BBOMDTFKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827441,DTCT0024060,10535496,DTCC00474227,1267308,48665
CHEMBL242073,P08254,,HOAKXOLFZXBTCB-UEUJIKQLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17267227,IC50,=,150000,NM,,,,,,,,,,,,,,Inhibition of human MMP3,,Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.,Bioorg. Med. Chem.,2007,15,6,"Vidal A, Sabatini M, Rolland-Valognes G, Renard P, Madelmont JC, Mounetou E",,441979,DTCT0024060,2144971,DTCC00460316,2079532,23207
CHEMBL242074,P08254,,PAWMGXIJYPYCIU-WQMPYENHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17267227,IC50,=,81000,NM,,,,,,,,,,,,,,Inhibition of human MMP3,,Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.,Bioorg. Med. Chem.,2007,15,6,"Vidal A, Sabatini M, Rolland-Valognes G, Renard P, Madelmont JC, Mounetou E",,441979,DTCT0024060,2144970,DTCC00460317,661441,23207
CHEMBL24347,P08254,,OQHRPJHBPQDYML-HBMCJLEFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10340614,KI,=,99,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (human fibroblast stromelysin),,Macrocyclic hydroxamate inhibitors of matrix metalloproteinases and TNF-alpha production.,Bioorg. Med. Chem. Lett.,1999,9,9,"Cherney RJ, Wang L, Meyer DT, Xue CB, Arner EC, Copeland RA, Covington MB, Hardman KD, Wasserman ZR, Jaffee BD, Decicco CP",,102086,DTCT0024060,920575,DTCC00158087,2047698,3648
CHEMBL2437163,P08254,,JRAYHZWPXHIVJI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24044937,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP-3 using NFF-2 as substrate after 30 mins,,Aggrecanase-2 inhibitors based on the acylthiosemicarbazide zinc-binding group.,Eur. J. Med. Chem.,2013,69,,"Maingot L, Elbakali J, Dumont J, Bosc D, Cousaert N, Urban A, Deglane G, Villoutreix B, Nagase H, Sperandio O, Leroux F, Deprez B, Deprez-Poulain R",,986685,DTCT0024060,12607849,DTCC01400189,751355,56087
CHEMBL2437163,P08254,,JRAYHZWPXHIVJI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24044937,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of human MMP-3 using NFF-2 as substrate at 10 uM after 30 mins,,Aggrecanase-2 inhibitors based on the acylthiosemicarbazide zinc-binding group.,Eur. J. Med. Chem.,2013,69,,"Maingot L, Elbakali J, Dumont J, Bosc D, Cousaert N, Urban A, Deglane G, Villoutreix B, Nagase H, Sperandio O, Leroux F, Deprez B, Deprez-Poulain R",,986693,DTCT0024060,12607876,DTCC01400189,751355,56087
CHEMBL2442878,P08254,,KXYWMKRIKCLADT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24028490,INHIBITION,=,37,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-3 catalytic domain at 50 uM by fluorescence spectrophotometric analysis relative to control,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990998,DTCT0024060,12639864,DTCC01403249,188424,56235
CHEMBL2442879,P08254,,VFVIUYYQHAEKJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24028490,INHIBITION,=,38,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-3 catalytic domain at 50 uM by fluorescence spectrophotometric analysis relative to control,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990998,DTCT0024060,12639863,DTCC01403250,91625,56235
CHEMBL2442880,P08254,,SJWVELZZBPYZRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24028490,INHIBITION,=,3,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-3 catalytic domain at 50 uM by fluorescence spectrophotometric analysis relative to control,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990998,DTCT0024060,12639862,DTCC01403251,220656,56235
CHEMBL2442881,P08254,,NPWUBXHYMWVDKN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24028490,INHIBITION,=,21,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-3 catalytic domain at 50 uM by fluorescence spectrophotometric analysis relative to control,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990998,DTCT0024060,12639861,DTCC01403252,351448,56235
CHEMBL2442882,P08254,,XCRZYFVDWZHDQG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24028490,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP-3 catalytic domain at 50 uM by fluorescence spectrophotometric analysis relative to control,Not Active,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990998,DTCT0024060,12639860,DTCC01403253,1547821,56235
CHEMBL2442883,P08254,,IUYSNQXMHWEVJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24028490,INHIBITION,=,18,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-3 catalytic domain at 50 uM by fluorescence spectrophotometric analysis relative to control,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990998,DTCT0024060,12639859,DTCC01403254,252989,56235
CHEMBL2442884,P08254,,PXYTTWPKWBWEHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24028490,INHIBITION,=,4,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-3 catalytic domain at 50 uM by fluorescence spectrophotometric analysis relative to control,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990998,DTCT0024060,12639858,DTCC01403255,2092731,56235
CHEMBL2442885,P08254,,NKVKCTYTQNQNIH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24028490,INHIBITION,=,38,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-3 catalytic domain at 50 uM by fluorescence spectrophotometric analysis relative to control,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990998,DTCT0024060,12639857,DTCC01403256,1256330,56235
CHEMBL2442886,P08254,,LJRIZWAWUQHHTF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24028490,INHIBITION,=,37,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-3 catalytic domain at 50 uM by fluorescence spectrophotometric analysis relative to control,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990998,DTCT0024060,12639856,DTCC01403257,1354112,56235
CHEMBL2442887,P08254,,KDYJIWZXMZGJQG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24028490,INHIBITION,=,27,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-3 catalytic domain at 50 uM by fluorescence spectrophotometric analysis relative to control,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990998,DTCT0024060,12639855,DTCC01403258,2060629,56235
CHEMBL2442888,P08254,,FNTWGXGOCVTLKR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24028490,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP-3 catalytic domain at 50 uM by fluorescence spectrophotometric analysis relative to control,Not Active,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990998,DTCT0024060,12639854,DTCC01403259,1030030,56235
CHEMBL2442889,P08254,,MWMLZWBDIRKPMD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24028490,INHIBITION,=,31,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-3 catalytic domain at 30 uM by fluorescence spectrophotometric analysis relative to control,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990995,DTCT0024060,12639821,DTCC01403260,1450847,56235
CHEMBL2442890,P08254,,JOSPLESHDLLQSD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24028490,INHIBITION,=,39,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-3 catalytic domain at 50 uM by fluorescence spectrophotometric analysis relative to control,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990998,DTCT0024060,12639868,DTCC01403261,1062314,56235
CHEMBL2442891,P08254,,NDWDLJQCZNKAHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24028490,INHIBITION,=,29,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-3 catalytic domain at 50 uM by fluorescence spectrophotometric analysis relative to control,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990998,DTCT0024060,12639867,DTCC01403262,481047,56235
CHEMBL2442892,P08254,,FWECVAAARPJXSH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24028490,INHIBITION,=,9,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-3 catalytic domain at 50 uM by fluorescence spectrophotometric analysis relative to control,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990998,DTCT0024060,12639866,DTCC01403263,57219,56235
CHEMBL2442893,P08254,,LYYLWOIDTXRRLW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24028490,INHIBITION,=,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP-3 catalytic domain at 50 uM by fluorescence spectrophotometric analysis relative to control,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990998,DTCT0024060,12639865,DTCC01403264,1547822,56235
CHEMBL24447,P08254,PHENETHYLCARBAMOYLPHOSPHONIC ACID,GHFCXEYUGIXTHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,=,90000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1320460,DTCC00158289,2077403,17838
CHEMBL24510,P08254,FUSARIC ACID,DGMPVYSXXIOGJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,80,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5104055,DTCC00104041,2055567,43205
CHEMBL247140,P08254,,BYQIIKCYPGKHOY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,=,2105,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240640,DTCC00479011,1987234,24538
CHEMBL247141,P08254,,WUGZBWFREMAISJ-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240637,DTCC00479014,1442482,24538
CHEMBL247346,P08254,,CXRXRCFYUZTJSR-JTHBVZDNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240635,DTCC00479016,634208,24538
CHEMBL247347,P08254,,XZCDAPHMYWQDPY-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240633,DTCC00479018,439330,24538
CHEMBL247348,P08254,,MOMCZJRIDPUOBK-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240632,DTCC00479019,1954523,24538
CHEMBL247545,P08254,,IMAXZHZQJLQAFI-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240631,DTCC00479020,1280403,24538
CHEMBL247546,P08254,,DAUHEXDIKFZUFM-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240629,DTCC00479022,1313114,24538
CHEMBL24761,P08254,,HLOJKFSLAAGGSY-HBMCJLEFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10340614,KI,=,3.4,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (human fibroblast stromelysin),,Macrocyclic hydroxamate inhibitors of matrix metalloproteinases and TNF-alpha production.,Bioorg. Med. Chem. Lett.,1999,9,9,"Cherney RJ, Wang L, Meyer DT, Xue CB, Arner EC, Copeland RA, Covington MB, Hardman KD, Wasserman ZR, Jaffee BD, Decicco CP",,102086,DTCT0024060,932673,DTCC00158058,919947,3648
CHEMBL24761,P08254,,HLOJKFSLAAGGSY-HBMCJLEFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472217,KI,=,3.4,NM,,,,,,,,,,,,,,Inhibition of human MMP-3.,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104875,DTCT0024060,1640387,DTCC00158058,906593,16346
CHEMBL247742,P08254,,HUKXOIMLTBNTPV-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240628,DTCC00479023,1280404,24538
CHEMBL247743,P08254,,QOMQSCJPJZHYPI-JTHBVZDNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240627,DTCC00479024,892829,24538
CHEMBL247946,P08254,,NBEQYTSXQZAREJ-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240625,DTCC00479026,1442483,24538
CHEMBL247947,P08254,,GQPOMTPZRNEORO-UKILVPOCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240624,DTCC00479027,1507443,24538
CHEMBL247966,P08254,,QNXKVQKPSNZLGB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215352,DTCC00477185,1539492,24158
CHEMBL247967,P08254,,YYHXOYNNTNFXCS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,,,,,,,,,,,,,,,,,Inhibition of MMP3,Not Determined,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215347,DTCC00477190,634148,24158
CHEMBL248148,P08254,,DXSANODVHPAKSB-UFHPHHKVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240623,DTCC00479028,698565,24538
CHEMBL248172,P08254,,CNPXAHGTJQERBN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215346,DTCC00477191,244564,24158
CHEMBL248173,P08254,,VXTLHKJGOCNUSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215345,DTCC00477192,1086718,24158
CHEMBL248323,P08254,,MEWQGNPVNKWBSS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240643,DTCC00479008,1119298,24538
CHEMBL248523,P08254,,AZDMTLYFRFXZGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240642,DTCC00479009,634207,24538
CHEMBL248524,P08254,,FRIRYAGACGIOFP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240641,DTCC00479010,342991,24538
CHEMBL24871,P08254,,DEQRLFQPZJLTBQ-HQMADOEBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10021913,KI,=,62,NM,,,,,,,,,,,,,,Inhibition of recombinant matrix metalloprotease-3 (MMP-3),,Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.,Bioorg. Med. Chem. Lett.,1999,9,2,"Reiter LA, Rizzi JP, Pandit J, Lasut MJ, McGahee SM, Parikh VD, Blake JF, Danley DE, Laird ER, Lopez-Anaya A, Lopresti-Morrow LL, Mansour MN, Martinelli GJ, Mitchell PG, Owens BS, Pauly TA, Reeves LM, Schulte GK, Yocum SA",,102095,DTCT0024060,685768,DTCC00160972,969472,3377
CHEMBL249449,P08254,,FIJLFZRLPPVBHV-YNJKOYDBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,36.31,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258528,DTCC00487070,909284,24803
CHEMBL249449,P08254,,FIJLFZRLPPVBHV-YNJKOYDBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,36,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,843367,DTCC00487070,906446,1379
CHEMBL249847,P08254,PNU-107859,RKWXKADYTDWZIJ-VIFPVBQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,710,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,882042,DTCC00003876,2000200,15677
CHEMBL249847,P08254,PNU-107859,RKWXKADYTDWZIJ-VIFPVBQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15163188,KI,=,710,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (MMP-3),,A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized born molecular dynamics simulations.,J. Med. Chem.,2004,47,12,"Rizzo RC, Toba S, Kuntz ID",,104749,DTCT0024060,1540254,DTCC00003876,2013186,17850
CHEMBL249847,P08254,PNU-107859,RKWXKADYTDWZIJ-VIFPVBQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,707.95,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258570,DTCC00003876,2003621,24803
CHEMBL249848,P08254,,VPPMHCSMXMERNR-LURJTMIESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,17000,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,875655,DTCC00487077,1034565,15677
CHEMBL249848,P08254,,VPPMHCSMXMERNR-LURJTMIESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,16982.44,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258567,DTCC00487077,1037847,24803
CHEMBL250266,P08254,UK-370106,NSMABJUGSNPHMN-BHYWQNONSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,23,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266847,DTCC00003798,779009,24951
CHEMBL250266,P08254,UK-370106,NSMABJUGSNPHMN-BHYWQNONSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,IC50,=,23,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457457,DTCC00003798,791164,32556
CHEMBL251481,P08254,L-702842,HDGWGGCPTVXRNA-QMMLZNLJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,230,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,521280,DTCC00003873,646655,14548
CHEMBL251481,P08254,L-702842,HDGWGGCPTVXRNA-QMMLZNLJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,229.09,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258530,DTCC00003873,650401,24803
CHEMBL251481,P08254,L-702842,HDGWGGCPTVXRNA-QMMLZNLJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,230,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,855811,DTCC00003873,647788,1379
CHEMBL251482,P08254,,DUPLBHCXXUUWQN-YGOYIFOWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,33.11,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258529,DTCC00487068,2068203,24803
CHEMBL251482,P08254,,DUPLBHCXXUUWQN-YGOYIFOWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,33,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,844411,DTCC00487068,2065533,1379
CHEMBL251820,P08254,,ZKFYETVHOLUSNG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18068976,IC50,=,237,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461865,DTCT0024060,2278104,DTCC00489350,1808991,25102
CHEMBL251865,P08254,,GYKATPWJHDSXEC-FQECFTEESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,=,4000,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276513,DTCC00488431,1971035,25086
CHEMBL251884,P08254,,MHXODSYUSQLZGR-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,=,359,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276521,DTCC00488364,260755,25086
CHEMBL251901,P08254,,LONXPMRZFFZWDV-VKHMYHEASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,31000,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,888317,DTCC00487079,1741350,15677
CHEMBL251901,P08254,,LONXPMRZFFZWDV-VKHMYHEASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15163188,KI,=,31000,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (MMP-3),,A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized born molecular dynamics simulations.,J. Med. Chem.,2004,47,12,"Rizzo RC, Toba S, Kuntz ID",,104749,DTCT0024060,1537941,DTCC00487079,1753701,17850
CHEMBL251901,P08254,,LONXPMRZFFZWDV-VKHMYHEASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,30902.95,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258565,DTCC00487079,1744658,24803
CHEMBL251916,P08254,,JRIUEEGXFJPYTG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266859,DTCC00486120,1166464,24951
CHEMBL251917,P08254,,YVBOXQAMDNUBQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266857,DTCC00486122,1296611,24951
CHEMBL251917,P08254,,YVBOXQAMDNUBQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457467,DTCC00486122,1309117,32556
CHEMBL251918,P08254,,MIINGMFBCOVDAE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266856,DTCC00486123,260740,24951
CHEMBL252024,P08254,,AQXFSOLTNZQWIK-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18068976,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461865,DTCT0024060,2278097,DTCC00489425,972983,25102
CHEMBL252081,P08254,,CADNLTAFOMUWRR-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,=,4999,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276520,DTCC00488367,553293,25086
CHEMBL252117,P08254,,ULYBHGVRJILHNJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266854,DTCC00486125,196148,24951
CHEMBL252246,P08254,,XKPUKZQRNSFQLM-YVZMLIKISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,>,3000,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276506,DTCC00488482,1587813,25086
CHEMBL252246,P08254,,XKPUKZQRNSFQLM-YVZMLIKISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19457660,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of human MMP3,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523766,DTCT0024060,2828347,DTCC00488482,1588619,33677
CHEMBL252278,P08254,,OEHDRCQWQWUTCW-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,>,5000,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276519,DTCC00488369,1070310,25086
CHEMBL252442,P08254,,DAWQVDWNIUMYHC-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,>,5000,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276504,DTCC00488486,260756,25086
CHEMBL252627,P08254,,JWVKYLLQNXGDRB-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18068976,IC50,=,942,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461865,DTCT0024060,2278102,DTCC00489371,2003660,25102
CHEMBL252678,P08254,,XZAGAORJLXBQCC-VYCPFJESSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,=,1669,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276511,DTCC00488448,1103077,25086
CHEMBL252716,P08254,BERKELEYTRIONE,BNDPVNXDSQOTOY-OKCDOLPESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17970594,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP3,Active,"The berkeleyacetals, three meroterpenes from a deep water acid mine waste Penicillium.",J. Nat. Prod.,2007,70,11,"Stierle DB, Stierle AA, Patacini B",,459798,DTCT0024060,2265361,DTCC00486772,1198939,24916
CHEMBL252877,P08254,,ZOHXHAYMXURWLP-MNNMKWMVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,>,5000,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276510,DTCC00488452,1841474,25086
CHEMBL252893,P08254,,RHKVTWOHZUDRRL-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18032037,KI,<,100,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of beta-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitors.",Bioorg. Med. Chem. Lett.,2008,18,1,"Duan JJ, Chen L, Lu Z, Xue CB, Liu RQ, Covington MB, Qian M, Wasserman ZR, Vaddi K, Christ DD, Trzaskos JM, Newton RC, Decicco CP",,461591,DTCT0024060,2276212,DTCC00487847,1921734,25081
CHEMBL252920,P08254,BERKELEYACETAL A,XNTNCSKBTFROEZ-YAVZHVFSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17970594,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP3,Active,"The berkeleyacetals, three meroterpenes from a deep water acid mine waste Penicillium.",J. Nat. Prod.,2007,70,11,"Stierle DB, Stierle AA, Patacini B",,459798,DTCT0024060,2265360,DTCC00486773,131682,24916
CHEMBL252921,P08254,BERKELEYACETAL B,XZKVBCSVEVIEBX-YJCISAIBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17970594,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP3,Active,"The berkeleyacetals, three meroterpenes from a deep water acid mine waste Penicillium.",J. Nat. Prod.,2007,70,11,"Stierle DB, Stierle AA, Patacini B",,459798,DTCT0024060,2264297,DTCC00486774,677572,24916
CHEMBL253035,P08254,,OJSMIPQPXMBSTI-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18068976,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461865,DTCT0024060,2278101,DTCC00489379,1937788,25102
CHEMBL253256,P08254,,QWCJOBSHHHILCA-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,>,5000,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276515,DTCC00112461,521199,25086
CHEMBL253275,P08254,BMS-566394,PGVYYPZKXKGBLD-JKSUJKDBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18242982,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462365,DTCT0024060,2282463,DTCC00003908,392011,25163
CHEMBL253275,P08254,BMS-566394,PGVYYPZKXKGBLD-JKSUJKDBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457236,DTCC00003908,404569,32556
CHEMBL253460,P08254,,GNZQSAUOKCWSHO-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,>,5000,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276514,DTCC00112462,1716239,25086
CHEMBL253665,P08254,,IVYQYYDKKZBNTO-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18068976,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461865,DTCT0024060,2278100,DTCC00489390,67182,25102
CHEMBL253680,P08254,,LFOGEPKUSWRLCL-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,33.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1312040,DTCC00487204,1035283,16328
CHEMBL253920,P08254,,KRVYWSXTKLCPHD-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,>,5000,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276517,DTCC00488379,9050,25086
CHEMBL254191,P08254,,JRSWWKMJUIACDX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,378,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266853,DTCC00486099,488955,24951
CHEMBL254295,P08254,,REAAGXUAXYMPTM-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18068976,IC50,=,756,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461865,DTCT0024060,2278099,DTCC00489402,2003661,25102
CHEMBL254396,P08254,,KNVSINWKESKLHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,174,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266877,DTCC00486102,326668,24951
CHEMBL254397,P08254,,OAQPUVCDKMAGGE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,26,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266876,DTCC00486103,1652660,24951
CHEMBL254398,P08254,,GYHDAVSEPKRYGB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266875,DTCC00486104,876686,24951
CHEMBL254399,P08254,,IEIPDFGOQQPNGP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,161,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266874,DTCC00486105,1937774,24951
CHEMBL254510,P08254,,ANOPQMHOFNTJCB-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18068976,IC50,=,2157,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461865,DTCT0024060,2278098,DTCC00489406,940969,25102
CHEMBL254603,P08254,,RNRPMRLNLCZHAR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,84,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266873,DTCC00486106,876687,24951
CHEMBL254604,P08254,,QJRFEWMMQFRQAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266871,DTCC00486108,391972,24951
CHEMBL254605,P08254,,CAEWBIZXRBQXKA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,55,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266870,DTCC00486109,1652661,24951
CHEMBL254606,P08254,,OWAPDZZCMRGQHC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266869,DTCC00486110,1329185,24951
CHEMBL254816,P08254,,URSVZCYOMZVHJE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,960,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266867,DTCC00486112,164177,24951
CHEMBL254817,P08254,,AFLLOSXTZXYSAK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266865,DTCC00486114,940947,24951
CHEMBL254818,P08254,,LMSQNDZFBZDFQV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,31,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266864,DTCC00486115,1776515,24951
CHEMBL255029,P08254,,JYHCJUBSWRQINP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266863,DTCC00486116,1005477,24951
CHEMBL255030,P08254,,SKUFTRBSRXIMDB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266862,DTCC00486117,391973,24951
CHEMBL255160,P08254,,UWFRWYGMHWPIMQ-JKSUJKDBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18282708,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463862,DTCT0024060,2317242,DTCC00499834,1700709,25272
CHEMBL255374,P08254,,ZSZOBVLJWIXXND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17981034,INHIBITION,=,34,%,,,,,,,,,,,,,,Inhibition of MMP3 at 100 uM,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469436,DTCT0024060,2289278,DTCC00501413,1905900,25715
CHEMBL255374,P08254,,ZSZOBVLJWIXXND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,IC50,=,240,NM,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564427,DTCT0024060,2612864,DTCC00501413,1917961,33264
CHEMBL255374,P08254,,ZSZOBVLJWIXXND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21609408,IC50,=,240,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14717815,DTCC00501413,2101220,69102
CHEMBL255418,P08254,,UCBHULDBBSNWOP-JTHBVZDNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18282708,KI,=,852,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463862,DTCT0024060,2317252,DTCC00500049,1442584,25272
CHEMBL255575,P08254,,NAYVOTYJJPROOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17981034,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP3,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469431,DTCT0024060,2289276,DTCC00501455,1038014,25715
CHEMBL255575,P08254,,NAYVOTYJJPROOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21609408,IC50,=,10,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14717124,DTCC00501455,2100874,69102
CHEMBL256157,P08254,,PRJCFROAJDAXAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16220987,KI,=,35,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14744863,DTCC00490063,2108850,69259
CHEMBL256157,P08254,,PRJCFROAJDAXAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18068976,IC50,<,1.5,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461865,DTCT0024060,2278125,DTCC00490063,2003662,25102
CHEMBL257088,P08254,,HAPYOOOJPQOLHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17981034,IC50,=,56.5,NM,,,,,,,,,,,,,,Inhibition of MMP3,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469431,DTCT0024060,2289320,DTCC00501372,2068358,25715
CHEMBL257480,P08254,,ISONEAYXNYSTJQ-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17980583,IC50,=,964,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469151,DTCT0024060,2289045,DTCC00501865,1873601,25686
CHEMBL258055,P08254,,AXERWECZRIZWCH-VQTJNVASSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18282708,KI,=,1123,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463862,DTCT0024060,2317249,DTCC00499963,2084595,25272
CHEMBL260125,P08254,,DHOGINMHWHECDJ-ZROIWOOFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25725607,IC50,=,10350,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463480,DTCT0024060,14035830,DTCC00495940,1464129,61492
CHEMBL260886,P08254,,MVMPYCDFQNONAY-DHDCSXOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25725607,IC50,=,3150,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463480,DTCT0024060,14035829,DTCC00495908,1431957,61492
CHEMBL261267,P08254,,JWLRMBKRMUREIB-ZROIWOOFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25725607,IC50,>=,100000,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463480,DTCT0024060,14035828,DTCC00495875,1171911,61492
CHEMBL261932,P08254,TANOMASTAT,JXAGDPXECXQWBC-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669559,KI,=,143,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104750,DTCT0024060,1077306,DTCC00288849,1035816,16063
CHEMBL261932,P08254,TANOMASTAT,JXAGDPXECXQWBC-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11754593,IC50,=,134,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3) in fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104893,DTCT0024060,1568635,DTCC00288849,1035158,16699
CHEMBL26317,P08254,,XGFZWXKDGNCTSR-QLFBSQMISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871766,ACTIVITY,=,50,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (Stromelysin-1),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,104574,DTCT0024060,630883,DTCC00163354,1227613,2586
CHEMBL263459,P08254,TCMDC-138171,ZLIOUDYFRDHHSM-IKGGRYGDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,122,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1280312,DTCC01743220,648695,16522
CHEMBL263717,P08254,,SPOYPAQQYPYRKF-TVZXLZGTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,62,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,518231,DTCC00135930,1772722,14548
CHEMBL263717,P08254,,SPOYPAQQYPYRKF-TVZXLZGTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,12,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,518229,DTCC00135930,1772722,14548
CHEMBL263909,P08254,,PUFLXTPEEIWEIM-ZROIWOOFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25725607,IC50,=,65000,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463480,DTCT0024060,14035831,DTCC00495838,1204202,61492
CHEMBL264053,P08254,,HRTBANZNKKWZHU-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,1000,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,897728,DTCC00178538,808034,15677
CHEMBL264164,P08254,,WFCYAEPJWPWCIM-ZROIWOOFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25725607,IC50,=,6190,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463480,DTCT0024060,14035825,DTCC00495840,1108532,61492
CHEMBL264455,P08254,,DTQSORRPTAWCFK-SMXONETASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,13,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1053125,DTCC00283638,594797,1950
CHEMBL264495,P08254,,SSNRGEULLFASJG-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,300,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,693238,DTCC00208605,647426,2288
CHEMBL264605,P08254,,ACEQKTCZFYDQCP-IXDOHACOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871766,ACTIVITY,=,500,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (Stromelysin-1),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,104574,DTCT0024060,628737,DTCC00164377,1902243,2586
CHEMBL264859,P08254,,YALGTTXMUHXKRY-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,1.73,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,573157,DTCC00231877,982005,16308
CHEMBL265075,P08254,,YPULLLFYLVWNFW-MVERNJQCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,87,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,536698,DTCC00136006,95662,14548
CHEMBL265075,P08254,,YPULLLFYLVWNFW-MVERNJQCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,11,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,536696,DTCC00136006,95662,14548
CHEMBL265216,P08254,,SJPBXYWXFIQQJH-XHNVNVPESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871551,KI,=,13,NM,,,,,,,,,,,,,,Binding affinity against human matrix metalloprotease-3.,,Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,7,"Jacobson IC, Reddy PG, Wasserman ZR, Hardman KD, Covington MB, Arner EC, Copeland RA, Decicco CP, Magolda RL",,101949,DTCT0024060,347985,DTCC00365441,649219,3059
CHEMBL265342,P08254,,WWRZCSYJKWXOGQ-CKIYMEHHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,61,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,533871,DTCC00135789,905269,14548
CHEMBL265342,P08254,,WWRZCSYJKWXOGQ-CKIYMEHHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,4,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,533869,DTCC00135789,905269,14548
CHEMBL265583,P08254,,PBTPMMOCCPQOJT-JNRZVTKQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,IC50,=,22000,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205501,DTCT0024060,1275653,DTCC00318455,918051,12304
CHEMBL265769,P08254,,SQEKFRREQBQUKS-VGSVOMNFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9191969,IC50,=,38000,NM,,,,,,,,,,,,,,The concentration required to achieve 50% inhibition against Matrix metalloprotease-3,,Dual inhibition of human leukocyte elastase and lipid peroxidation: in vitro and in vivo activities of azabicyclo[2.2.2]octane and perhydroindole derivatives.,J. Med. Chem.,1997,40,12,"Portevin B, Lonchampt M, Canet E, De Nanteuil G",,104906,DTCT0024060,1256582,DTCC00204634,1805941,14199
CHEMBL266133,P08254,,VVFWIKQAXZHMNQ-WWBASHGMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,21,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,534725,DTCC00135494,969197,14548
CHEMBL266133,P08254,,VVFWIKQAXZHMNQ-WWBASHGMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,52,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,534723,DTCC00135494,969197,14548
CHEMBL266271,P08254,,OOIUXDQSIJNJIF-FATZWSQISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,38,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,526207,DTCC00135803,1325238,14548
CHEMBL266292,P08254,,SUFSQYXUPYDFHG-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327577,IC50,=,180,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104725,DTCT0024060,1315160,DTCC00133589,1631533,4760
CHEMBL266294,P08254,,PLLLIPJQFJENRC-MVERNJQCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,9400,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,538671,DTCC00135942,2032739,14548
CHEMBL266367,P08254,,NBOQQJXCMRBQCH-HSALFYBXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,3800,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,455289,DTCC00136025,256865,14548
CHEMBL266579,P08254,,SIQAXTKFLDLSOX-AOHZBQACSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,70,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,532886,DTCC00135702,1195202,14548
CHEMBL266579,P08254,,SIQAXTKFLDLSOX-AOHZBQACSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,15,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,532884,DTCC00135702,1195202,14548
CHEMBL266764,P08254,,DTHLOBYXEMQYBV-CERRFVOPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,34,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,540342,DTCC00135671,1648847,14548
CHEMBL266764,P08254,,DTHLOBYXEMQYBV-CERRFVOPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,12,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,540340,DTCC00135671,1648847,14548
CHEMBL267452,P08254,,RQQIQUQRTVOJTM-FULLSBAXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,1200,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,518232,DTCC00135625,613900,14548
CHEMBL267503,P08254,,UIOBFFKNGCFAHB-UWPQIUOOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,519221,DTCC00135943,63200,14548
CHEMBL26753,P08254,,CRJIZTSRHKBTKG-HZSPNIEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871766,ACTIVITY,=,300,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (Stromelysin-1),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,104574,DTCT0024060,623310,DTCC00104118,128128,2586
CHEMBL267533,P08254,,ZDFWMZOVILGQKY-HRHHFINDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,72,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,529071,DTCC00135788,905268,14548
CHEMBL267533,P08254,,ZDFWMZOVILGQKY-HRHHFINDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,2,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,529069,DTCC00135788,905268,14548
CHEMBL267536,P08254,,MFDDFJXXVOMZLW-XFQWPLCWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,9.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,7,,,102093,DTCT0024060,610098,DTCC00362046,551991,2023
CHEMBL267722,P08254,,ODAJGMHJQWCVQY-OZNIXHKMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,17,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,542292,DTCC00135622,1772720,14548
CHEMBL267722,P08254,,ODAJGMHJQWCVQY-OZNIXHKMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,25,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,542290,DTCC00135622,1772720,14548
CHEMBL267939,P08254,,XDYZXHJJAIXYOR-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327577,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104725,DTCT0024060,1312863,DTCC00133464,1275453,4760
CHEMBL268050,P08254,,SBJYHMQPQSBUBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,938137,DTCC00138716,1177786,16645
CHEMBL268114,P08254,,CNDCCBOSTVCBMM-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327577,IC50,=,39.2,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104725,DTCT0024060,1315167,DTCC00133623,2015284,4760
CHEMBL268143,P08254,,WAQUJVIPPSYKJX-DYIKCSJPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,65,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,516071,DTCC00135994,1066391,14548
CHEMBL268143,P08254,,WAQUJVIPPSYKJX-DYIKCSJPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,120,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,516069,DTCC00135994,1066391,14548
CHEMBL268377,P08254,,SRBWJOFRJIEWKS-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327577,IC50,=,5.3,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104578,DTCT0024060,1322467,DTCC00133440,2015283,4760
CHEMBL268405,P08254,,ZFVODTPAFVMUMK-RMTZWNOUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,72,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,536695,DTCC00136037,63201,14548
CHEMBL268405,P08254,,ZFVODTPAFVMUMK-RMTZWNOUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,21,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,536693,DTCC00136037,63201,14548
CHEMBL268725,P08254,,KOWYVXBVZNCNSM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of Stromelysin (MMP-3),,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205630,DTCT0024060,1261199,DTCC00108475,789061,17092
CHEMBL268883,P08254,,PHPNJCKHSRLBDB-KWXIBIRDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,48,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,529077,DTCC00135899,1740944,14548
CHEMBL268883,P08254,,PHPNJCKHSRLBDB-KWXIBIRDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,95,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,529075,DTCC00135899,1740944,14548
CHEMBL268992,P08254,,VGFAMRABAXJUTN-GGXMVOPNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,625,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1122412,DTCC00344215,1241524,4691
CHEMBL268992,P08254,,VGFAMRABAXJUTN-GGXMVOPNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,630.96,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258393,DTCC00344215,1231166,24803
CHEMBL269019,P08254,,RCXJWFMVFQBLSC-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327577,IC50,=,3.5,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104578,DTCT0024060,1298434,DTCC00133541,1599275,4760
CHEMBL26913,P08254,,JHYKWSMPVGVBAN-STQMWFEESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457405,DTCC00104119,273427,32556
CHEMBL269334,P08254,,ZVCHAVSCMLWXRD-KWXIBIRDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,7,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,527195,DTCC00135721,1583956,14548
CHEMBL269334,P08254,,ZVCHAVSCMLWXRD-KWXIBIRDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,15,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,527193,DTCC00135721,1583956,14548
CHEMBL269613,P08254,,ZQJRBAHLNKPYFN-CMTIAEDTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,84,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,517200,DTCC00135528,1967124,14548
CHEMBL269613,P08254,,ZQJRBAHLNKPYFN-CMTIAEDTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,5,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,517198,DTCC00135528,1967124,14548
CHEMBL269834,P08254,,ZWPPXQSIUHCIOD-XXBNENTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18835710,KI,=,58000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496899,DTCT0024060,2456658,DTCC00505033,985373,31825
CHEMBL270050,P08254,,YOFJHCFIKFPSLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18251495,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain,Not Active,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465547,DTCT0024060,2311300,DTCC00503704,1636500,25409
CHEMBL270050,P08254,,YOFJHCFIKFPSLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP3,Not Active,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457324,DTCC00503704,1632393,32556
CHEMBL270083,P08254,CIS-2-AMINOCYCLOHEXYLCARBAMOYLPHOSPHONIC ACID,XHCXISPZIHYKQD-NTSWFWBYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18257543,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,"Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.",J. Med. Chem.,2008,51,5,"Hoffman A, Qadri B, Frant J, Katz Y, Bhusare SR, Breuer E, Hadar R, Reich R",,465796,DTCT0024060,2311838,DTCC00004596,2020286,25428
CHEMBL270083,P08254,CIS-2-AMINOCYCLOHEXYLCARBAMOYLPHOSPHONIC ACID,XHCXISPZIHYKQD-NTSWFWBYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457401,DTCC00004596,2016157,32556
CHEMBL270296,P08254,TRANS-2-AMINOCYCLOHEXYLCARBAMOYLPHOSPHONIC ACID,XHCXISPZIHYKQD-PHDIDXHHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18257543,IC50,=,25000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,"Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.",J. Med. Chem.,2008,51,5,"Hoffman A, Qadri B, Frant J, Katz Y, Bhusare SR, Breuer E, Hadar R, Reich R",,465796,DTCT0024060,2311846,DTCC00004597,1151799,25428
CHEMBL270515,P08254,DELANZOMIB,SJFBTAPEPRWNKH-CCKFTAQKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18247547,INHIBITION,=,-3,%,,,,,,,,,,,,,,Inhibition of human MMP3 at 10 uM,,"Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer.",J. Med. Chem.,2008,51,4,"Dorsey BD, Iqbal M, Chatterjee S, Menta E, Bernardini R, Bernareggi A, Cassarà PG, D'Arasmo G, Ferretti E, De Munari S, Oliva A, Pezzoni G, Allievi C, Strepponi I, Ruggeri B, Ator MA, Williams M, Mallamo JP",,464576,DTCT0024060,2308330,DTCC00504722,1442592,25324
CHEMBL270817,P08254,,KCBXQUWPZNVZIG-VQTJNVASSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18282708,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463862,DTCT0024060,2317239,DTCC00499794,472518,25272
CHEMBL271235,P08254,,SIICAQVADMFEDB-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18061445,KI,=,54,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463238,DTCT0024060,2296557,DTCC00502102,1776559,25233
CHEMBL271450,P08254,,FPQFSGNFLIZLQV-RBUKOAKNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18282708,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463862,DTCT0024060,2317243,DTCC00499874,989464,25272
CHEMBL271866,P08254,,CDYLCTGLLNQEQF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17980583,IC50,=,203,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469151,DTCT0024060,2289046,DTCC00502114,1103192,25686
CHEMBL271867,P08254,,WKRVNRRBAKSSCD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17980583,IC50,=,308,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF",,469151,DTCT0024060,2289050,DTCC00502115,1555685,25686
CHEMBL271938,P08254,,JRZMGNCXDSZZAF-LEWJYISDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18282708,KI,=,766,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463862,DTCT0024060,2317246,DTCC00499913,277689,25272
CHEMBL272102,P08254,,DOXOLOXDHNMGLW-PZJWPPBQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18282708,KI,=,3690,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463862,DTCT0024060,2317251,DTCC00500008,1539671,25272
CHEMBL272512,P08254,,VCNCKDLZUXUYIX-SIKLNZKXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18282708,KI,=,3060,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463862,DTCT0024060,2317250,DTCC00500007,1889728,25272
CHEMBL273762,P08254,,BKQXMGZHHHUCEX-KHEPKPQXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,140,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1539703,DTCC00146290,822861,2559
CHEMBL274174,P08254,,LFQCQDFQXKNBRD-OCOZRVBESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,16300,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,954772,DTCC00138502,952175,16645
CHEMBL274700,P08254,,CKOFSPSUQNKQAL-HTAVTVPLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,>,20,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1544573,DTCC00146617,1470264,2559
CHEMBL274881,P08254,,QJKGJGURDPRKGW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,4090,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,948298,DTCC00138736,855707,16645
CHEMBL274997,P08254,,PSKXAYSNQRZKIG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,965335,DTCC00138499,1949639,16645
CHEMBL275130,P08254,,NJHUORLPMNSFLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,2428,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,949523,DTCC00138690,305534,16645
CHEMBL275345,P08254,,LRNHIFFROICLCJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,975198,DTCC00138682,1502499,16645
CHEMBL275700,P08254,,ZZBMCFITYYSQSJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,3920,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,939399,DTCC00138634,1437792,16645
CHEMBL275754,P08254,,ZJBLIILJIFWDHP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,953645,DTCC00138683,596814,16645
CHEMBL27577,P08254,SALICYLAMIDE,SKZKKFZAGNVIMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,>,25000000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in place of acetohydroxamic acid.,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205633,DTCT0024060,1272641,DTCC00161342,174023,17092
CHEMBL27577,P08254,SALICYLAMIDE,SKZKKFZAGNVIMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,1,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103379,DTCC00161342,183413,43205
CHEMBL276016,P08254,,TYFXGYABSVUPRB-IDCGIGBZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,4270,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,969197,DTCC00138586,1437793,16645
CHEMBL276373,P08254,,NCWXRZLEODZYTE-YKILCQELSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,22,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,536692,DTCC00136043,1933918,14548
CHEMBL276373,P08254,,NCWXRZLEODZYTE-YKILCQELSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,39,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,536690,DTCC00136043,1933918,14548
CHEMBL27647,P08254,,ROFAQOFULLWONA-KEKNWZKVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10021913,IC50,=,2700,NM,,,,,,,,,,,,,,Inhibition of recombinant matrix metalloprotease-3 (MMP-3),,Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.,Bioorg. Med. Chem. Lett.,1999,9,2,"Reiter LA, Rizzi JP, Pandit J, Lasut MJ, McGahee SM, Parikh VD, Blake JF, Danley DE, Laird ER, Lopez-Anaya A, Lopresti-Morrow LL, Mansour MN, Martinelli GJ, Mitchell PG, Owens BS, Pauly TA, Reeves LM, Schulte GK, Yocum SA",,101942,DTCT0024060,656097,DTCC00160735,2000042,3377
CHEMBL276572,P08254,,PDPKCIVZWUPRKX-MMNWNWMFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,1300,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,796159,DTCC00152647,1423180,772
CHEMBL276588,P08254,,WMUOJNZCUBFVBY-LWMIZPGFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,22,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1538501,DTCC00146345,2047607,2559
CHEMBL276960,P08254,,GBAPWUJOZAJNDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,410,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,779209,DTCC00152827,1902130,772
CHEMBL277010,P08254,,OSIGCGJGUHPSSV-WKLVFNGESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,24,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,797484,DTCC00152859,1805460,772
CHEMBL277658,P08254,,KOLIYILUYWKKNC-ZRBLBEILSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10340614,KI,=,15,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (human fibroblast stromelysin),,Macrocyclic hydroxamate inhibitors of matrix metalloproteinases and TNF-alpha production.,Bioorg. Med. Chem. Lett.,1999,9,9,"Cherney RJ, Wang L, Meyer DT, Xue CB, Arner EC, Copeland RA, Covington MB, Hardman KD, Wasserman ZR, Jaffee BD, Decicco CP",,102086,DTCT0024060,924108,DTCC00158055,1243068,3648
CHEMBL277899,P08254,,KYWHPSLHEWPVNJ-OJDTUPNSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,370,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,779211,DTCC00152811,1099469,772
CHEMBL278050,P08254,,YVHCMRZCFTYSIV-BBMPLOMVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,88,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1535060,DTCC00146394,1599401,2559
CHEMBL278334,P08254,,SNARVSKRSPZKKQ-UUONJMKCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,42,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,787550,DTCC00153023,1681141,772
CHEMBL278452,P08254,,GDTJXNTYOVPWCL-KEKNWZKVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,98,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1521039,DTCC00146397,1114446,2559
CHEMBL278927,P08254,,UHMGUSIGEQSULM-HKHBYEJGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,110,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1542190,DTCC00146332,629430,2559
CHEMBL279078,P08254,,OBJBBLBMOOBABD-BEVDRBHNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9548812,IC50,=,0.6,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-3 (MMP-3).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,104576,DTCT0024060,982760,DTCC00151610,1308397,15116
CHEMBL279482,P08254,,TUIHSDQRXNNCLL-LSDHHAIUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10882354,IC50,=,703,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease -3,,Structure-based design and synthesis of a potent matrix metalloproteinase-13 inhibitor based on a pyrrolidinone scaffold.,J. Med. Chem.,2000,43,12,"Robinson RP, Laird ER, Blake JF, Bordner J, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Stam EJ, Yocum SA",,104891,DTCT0024060,1106732,DTCC00152021,140588,15747
CHEMBL279482,P08254,,TUIHSDQRXNNCLL-LSDHHAIUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11354379,IC50,=,700,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,104897,DTCT0024060,703844,DTCC00152021,128005,4814
CHEMBL279785,P08254,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9548812,IC50,=,4.4,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-3 (MMP-3).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,104576,DTCT0024060,980296,DTCC00151612,919877,15116
CHEMBL279785,P08254,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871766,ACTIVITY,=,200,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (Stromelysin-1),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,104574,DTCT0024060,643198,DTCC00151612,905592,2586
CHEMBL279785,P08254,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,10,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1397633,DTCC00151612,907004,2897
CHEMBL279785,P08254,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10397503,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101943,DTCT0024060,513407,DTCC00151612,905843,3181
CHEMBL279785,P08254,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1478660,DTCC00151612,917406,3373
CHEMBL279785,P08254,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11212095,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104720,DTCT0024060,627892,DTCC00151612,906831,4635
CHEMBL279785,P08254,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472217,KI,=,2.4,NM,,,,,,,,,,,,,,Inhibition of human MMP-3.,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104875,DTCT0024060,1669121,DTCC00151612,906592,16346
CHEMBL279785,P08254,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11754593,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3) in fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104893,DTCT0024060,1580591,DTCC00151612,906350,16699
CHEMBL279785,P08254,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12014967,KI,=,8.9,NM,,,,,,,,,,,,,,Inhibitory potency against Matrix metalloprotease-3 (MMP-3),,Beta-aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme.,J. Med. Chem.,2002,45,11,"Kottirsch G, Koch G, Feifel R, Neumann U",,104903,DTCT0024060,789591,DTCC00151612,917001,16740
CHEMBL279785,P08254,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12873504,KI,=,84,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,Structure--activity relationships of azasugar-based MMP/ADAM inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,16,"Moriyama H, Tsukida T, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104872,DTCT0024060,910434,DTCC00151612,917294,5719
CHEMBL279785,P08254,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12873505,KI,=,84,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,"Design, synthesis and evaluation of novel azasugar-based MMP/ADAM inhibitors.",Bioorg. Med. Chem. Lett.,2003,13,16,"Moriyama H, Tsukida T, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104873,DTCT0024060,968726,DTCC00151612,917300,5720
CHEMBL279785,P08254,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,25,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,516913,DTCC00151612,917874,13726
CHEMBL279785,P08254,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,73236,DTCC00151612,915925,65989
CHEMBL279785,P08254,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,200,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,691921,DTCC00151612,906079,2288
CHEMBL279786,P08254,BATIMASTAT,XFILPEOLDIKJHX-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9548812,IC50,=,0.65,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-3 (MMP-3).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,104576,DTCT0024060,1014095,DTCC00151611,984634,15116
CHEMBL279786,P08254,BATIMASTAT,XFILPEOLDIKJHX-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,0.75,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1372582,DTCC00151611,970785,2897
CHEMBL279786,P08254,BATIMASTAT,XFILPEOLDIKJHX-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,0.73,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1135161,DTCC00151611,983181,4691
CHEMBL279786,P08254,BATIMASTAT,XFILPEOLDIKJHX-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12877590,IC50,=,0.56,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3 (MMP-3),,"A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.",J. Med. Chem.,2003,46,16,"Fray MJ, Dickinson RP, Huggins JP, Occleston NL",,104716,DTCT0024060,1526046,DTCC00151611,970901,17445
CHEMBL279786,P08254,BATIMASTAT,XFILPEOLDIKJHX-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,20,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,665670,DTCC00151611,969961,2288
CHEMBL279964,P08254,,GTBJTISRJIZWKE-HIFRSBDPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9548812,IC50,=,4.4,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-3 (MMP-3).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,104576,DTCT0024060,999333,DTCC00151073,1114498,15116
CHEMBL280144,P08254,,SJEDBXQOLCNVJP-DCIMDAFDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,710,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,774935,DTCC00152141,1260526,772
CHEMBL280946,P08254,,UXXTUTFFBPWTOZ-ACEFPKFPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,280,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,814625,DTCC00152807,485340,772
CHEMBL280998,P08254,CATECHOL,YCIMNLLNPGFGHC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,1,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103163,DTCC00161195,517323,43205
CHEMBL281371,P08254,,YOZKFIDLBXLPFF-HIFRSBDPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9548812,IC50,=,2.3,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-3 (MMP-3).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,104576,DTCT0024060,1015394,DTCC00151650,1437901,15116
CHEMBL281409,P08254,,NQIXDTDBVQANSX-XZVIONEGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,20,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,808675,DTCC00152857,63386,772
CHEMBL281428,P08254,,HMQSTUIDQZFHHO-GRHQJALTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871766,ACTIVITY,=,20,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (Stromelysin-1),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,104574,DTCT0024060,637672,DTCC00164311,2033017,2586
CHEMBL281630,P08254,,MTAIFRNFDVAOAG-MMHUAGGKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,280,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,815947,DTCC00152140,1099468,772
CHEMBL281795,P08254,,GCBPAPVOMPJQHK-NQIIRXRSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,9,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,13,,,102094,DTCT0024060,1449486,DTCC00157778,1049545,1206
CHEMBL281850,P08254,,SYVJJGYFVAFQSH-AZNILEOFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,57,%,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1 at a concentration of 5 uM.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205641,DTCT0024060,776398,DTCC00152614,905454,772
CHEMBL282043,P08254,,NSVIJDMVTBZCRP-JDWSMFLASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,600,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,807263,DTCC00152813,905453,772
CHEMBL282146,P08254,,AKWKBACKRMYPRV-NQIIRXRSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,4500,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,13,,,102094,DTCT0024060,1470041,DTCC00168996,726366,1206
CHEMBL282446,P08254,,OBJVRBGDFWJQHI-SSMNMUGWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,2400,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,787548,DTCC00152880,711048,772
CHEMBL283066,P08254,,NWYFRVGJVQHAJF-DLFZDVPBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10021913,KI,=,1.4,NM,,,,,,,,,,,,,,Inhibition of recombinant matrix metalloprotease-3 (MMP-3),,Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.,Bioorg. Med. Chem. Lett.,1999,9,2,"Reiter LA, Rizzi JP, Pandit J, Lasut MJ, McGahee SM, Parikh VD, Blake JF, Danley DE, Laird ER, Lopez-Anaya A, Lopresti-Morrow LL, Mansour MN, Martinelli GJ, Mitchell PG, Owens BS, Pauly TA, Reeves LM, Schulte GK, Yocum SA",,102095,DTCT0024060,670651,DTCC00161074,451895,3377
CHEMBL283427,P08254,,JHUFDQZOUBDJHZ-KSZLIROESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10340614,KI,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (human fibroblast stromelysin),,Macrocyclic hydroxamate inhibitors of matrix metalloproteinases and TNF-alpha production.,Bioorg. Med. Chem. Lett.,1999,9,9,"Cherney RJ, Wang L, Meyer DT, Xue CB, Arner EC, Copeland RA, Covington MB, Hardman KD, Wasserman ZR, Jaffee BD, Decicco CP",,102086,DTCT0024060,909174,DTCC00158280,34981,3648
CHEMBL283429,P08254,,WBONEAZKRBRCNC-ZNMIVQPWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10340614,KI,=,118,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (human fibroblast stromelysin),,Macrocyclic hydroxamate inhibitors of matrix metalloproteinases and TNF-alpha production.,Bioorg. Med. Chem. Lett.,1999,9,9,"Cherney RJ, Wang L, Meyer DT, Xue CB, Arner EC, Copeland RA, Covington MB, Hardman KD, Wasserman ZR, Jaffee BD, Decicco CP",,102086,DTCT0024060,928980,DTCC00158053,2047699,3648
CHEMBL283526,P08254,,VITFWETUDKTLHA-NWENCFRDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,560,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,804453,DTCC00152142,1260527,772
CHEMBL283569,P08254,,RLSOYIYRBIXBNU-AGQABGQFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,210,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,786451,DTCC00152814,1805459,772
CHEMBL283580,P08254,,NBBPYGNNDFCNNP-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11354379,IC50,=,1380,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,9,"Robinson RP, Laird ER, Donahue KM, Lopresti-Morrow LL, Mitchell PG, Reese MR, Reeves LM, Rouch AI, Stam EJ, Yocum SA",,104897,DTCT0024060,696877,DTCC00151925,1066552,4814
CHEMBL28389,P08254,,UTSFQPTVPZNJJH-XIJSCUBXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10021913,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of recombinant matrix metalloprotease-3 (MMP-3),,Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.,Bioorg. Med. Chem. Lett.,1999,9,2,"Reiter LA, Rizzi JP, Pandit J, Lasut MJ, McGahee SM, Parikh VD, Blake JF, Danley DE, Laird ER, Lopez-Anaya A, Lopresti-Morrow LL, Mansour MN, Martinelli GJ, Mitchell PG, Owens BS, Pauly TA, Reeves LM, Schulte GK, Yocum SA",,101942,DTCT0024060,668162,DTCC00160701,2210,3377
CHEMBL284104,P08254,DIPICOLINIC ACID,WJJMNDUMQPNECX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,54,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103726,DTCC00159433,280901,43205
CHEMBL284465,P08254,,DFGIMYUXEBBKPA-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873367,IC50,=,2600,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104581,DTCT0024060,876454,DTCC00171529,1402575,2600
CHEMBL285112,P08254,,YKHOQKKUOWOUDP-CTNGQTDRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,800,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,13,,,102094,DTCT0024060,1476121,DTCC00168915,888195,1206
CHEMBL285418,P08254,,OONXADPQRATYFL-GCJKJVERSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,,,,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3 (not determined)",Not Determined,,Bioorg. Med. Chem. Lett.,1995,5,13,,,102091,DTCT0024060,1476118,DTCC00104294,35210,1206
CHEMBL286204,P08254,QUINOLINIC ACID,GJAWHXHKYYXBSV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,82,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103869,DTCC00158604,151276,43205
CHEMBL286290,P08254,,AGGJZKIOHQRDLH-HLAWJBBLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871766,ACTIVITY,=,20,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (Stromelysin-1),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,104574,DTCT0024060,647671,DTCC00164347,646950,2586
CHEMBL286295,P08254,,ITLCYVVIJXYTPH-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873367,IC50,=,170,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104581,DTCT0024060,881648,DTCC00170871,497070,2600
CHEMBL286698,P08254,,YFRJNXOLSKBGTP-QEMZJVQQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873367,IC50,=,160,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104581,DTCT0024060,879019,DTCC00170903,916301,2600
CHEMBL286718,P08254,,QJTVGYXBJXFBOD-YZGWKJHDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871766,ACTIVITY,=,20,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (Stromelysin-1),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,104574,DTCT0024060,364957,DTCC00163655,224926,2586
CHEMBL286718,P08254,,QJTVGYXBJXFBOD-YZGWKJHDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871766,ACTIVITY,=,50,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (Stromelysin-1),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,104574,DTCT0024060,638830,DTCC00163655,224925,2586
CHEMBL286788,P08254,,NWIDFBAHFQXVFF-QEMZJVQQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873367,IC50,=,15,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104581,DTCT0024060,885457,DTCC00171152,28545,2600
CHEMBL286904,P08254,,BQOKFWQTKSZIMZ-GCJKJVERSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,,,,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3 (not determined)",Not Determined,,Bioorg. Med. Chem. Lett.,1995,5,13,,,102091,DTCT0024060,1473754,DTCC00169030,856017,1206
CHEMBL287556,P08254,KOJIC ACID,BEJNERDRQOWKJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,62,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103335,DTCC00159276,1381648,43205
CHEMBL287899,P08254,"PYRIDINE-2,3-DIOL",GGOZGYRTNQBSSA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,-7,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103841,DTCC01739869,1316336,43205
CHEMBL287974,P08254,,FRFIXEYGXTUTBO-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,490,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,879448,DTCC00177986,388479,15677
CHEMBL288015,P08254,,KKYNARPBLCWYRS-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,380,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,888319,DTCC00177764,1358521,15677
CHEMBL288067,P08254,,MIXVCULNWAELJE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,9100,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1586512,DTCC00179777,464189,4273
CHEMBL288072,P08254,,NEQBRWOTAUTWCX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,708540,DTCC00184795,626230,3810
CHEMBL288099,P08254,,SMWGTYPHHCYQHB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11378378,IC50,=,350,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,104899,DTCT0024060,1033064,DTCC00173333,647042,4214
CHEMBL288510,P08254,,VKALTFMIUSHHED-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,35000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1564563,DTCC00179844,1239659,4273
CHEMBL288592,P08254,,XJIQVSMHQQCBEO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,27000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1558161,DTCC00180002,1499348,4273
CHEMBL288599,P08254,,QWHHWOMUBFYDRB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,IC50,=,97000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104727,DTCT0024060,896435,DTCC00178407,225076,15677
CHEMBL288649,P08254,,HOGIHVAAHRAULF-KDOFPFPSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,30,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1996,6,13,,,205490,DTCT0024060,1392738,DTCC00182771,1239701,1703
CHEMBL288664,P08254,,CFNLVCZTXBNJGL-QBPKDAKJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15006405,KI,=,29.6,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,Synthesis and biological activity of selective azasugar-based TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,6,"Tsukida T, Moriyama H, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104877,DTCT0024060,850603,DTCC00180253,1305040,6743
CHEMBL288701,P08254,,RLIATYHSAHYWGM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,37000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1581311,DTCC00179654,819627,4273
CHEMBL288843,P08254,,RFJSQAZBRWXDMS-QBPKDAKJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15006405,KI,=,58.05,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,Synthesis and biological activity of selective azasugar-based TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,6,"Tsukida T, Moriyama H, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104877,DTCT0024060,848170,DTCC00180252,107601,6743
CHEMBL288866,P08254,,KSBUMBLIXYZARX-QMMMGPOBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,3200,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,870473,DTCC00177714,1838095,15677
CHEMBL288896,P08254,RS-39066,CEEASCNCHQSPKF-AEFFLSMTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,0.8,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1996,6,13,,,205490,DTCT0024060,1375257,DTCC01739819,626205,1703
CHEMBL289003,P08254,,MVNUXJNXEWKALY-NPPFBWRTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873367,IC50,=,420,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104581,DTCT0024060,884190,DTCC00170896,334834,2600
CHEMBL289108,P08254,,QMVPXGOXZBWYSB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,180000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1560677,DTCC00179279,1046166,4273
CHEMBL289202,P08254,,RIKBZUAXWWQCJZ-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,660,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,875661,DTCC00178633,1773156,15677
CHEMBL289206,P08254,,LDKVMRNOUFHOST-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,IC50,>,2000000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104727,DTCT0024060,874385,DTCC00178652,128274,15677
CHEMBL289207,P08254,,CIRQLPIHICIABR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,IC50,=,23000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104727,DTCT0024060,869067,DTCC00178653,1391203,15677
CHEMBL289356,P08254,,BOJLJKMUGYYKCZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,IC50,=,190000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104727,DTCT0024060,867835,DTCC00178772,1552187,15677
CHEMBL289375,P08254,,RVFUBAXCKZOYOU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,IC50,=,29000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104727,DTCT0024060,892183,DTCC00178757,1681404,15677
CHEMBL289375,P08254,,RVFUBAXCKZOYOU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25553540,IC50,=,29000,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (unknown origin),,"1,3,4-Thiadiazoles: a potent multi targeted pharmacological scaffold.",Eur. J. Med. Chem.,2015,92,,"Haider S, Alam MS, Hamid H",,1468123,DTCT0024060,14081976,DTCC00178757,1690207,61763
CHEMBL289513,P08254,,QVXRAVFETVTALN-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1996,6,13,,,205490,DTCT0024060,1396279,DTCC00182518,400448,1703
CHEMBL289587,P08254,,MZMFSOYMXLYVMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,16000,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,861354,DTCC00178186,1293147,15677
CHEMBL289842,P08254,,NDOOKPHRXLOQEK-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,320,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1996,6,13,,,205490,DTCT0024060,1381341,DTCC00182284,334959,1703
CHEMBL289857,P08254,,CKVQEICURFVZKI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,723459,DTCC00184401,1628776,3810
CHEMBL290050,P08254,,WGDNBRDYDYVNIJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,IC50,=,318000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104727,DTCT0024060,876862,DTCC00178989,1520153,15677
CHEMBL290067,P08254,,JAFHGTXCEIJXQT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,>,10000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1570699,DTCC00179842,1946330,4273
CHEMBL290140,P08254,PNU-142372,HZAXNPDJVFUGDS-BYPYZUCNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,18,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,885899,DTCC01739728,1552186,15677
CHEMBL290140,P08254,PNU-142372,HZAXNPDJVFUGDS-BYPYZUCNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12217351,KI,=,18,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-3,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104742,DTCT0024060,1042215,DTCC01739728,1553007,5080
CHEMBL290140,P08254,PNU-142372,HZAXNPDJVFUGDS-BYPYZUCNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15163188,KI,=,18,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (MMP-3),,A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized born molecular dynamics simulations.,J. Med. Chem.,2004,47,12,"Rizzo RC, Toba S, Kuntz ID",,104749,DTCT0024060,1546259,DTCC01739728,1564727,17850
CHEMBL290377,P08254,,UTSFQPTVPZNJJH-YPJJGMIRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12824028,IC50,=,1600,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,104894,DTCT0024060,1488309,DTCC00181446,853101,5648
CHEMBL290457,P08254,,RNHVOKXLHUNLLK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,17000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1578728,DTCC00179878,819626,4273
CHEMBL290545,P08254,,CCTQEHDMZKCPPK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,IC50,=,47000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104727,DTCT0024060,870469,DTCC00178357,614383,15677
CHEMBL290600,P08254,,KDJQHAIUPWKKAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,7000,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,858890,DTCC00178824,485586,15677
CHEMBL290631,P08254,,CSLQYGQMUXSECS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,728349,DTCC00184264,1881772,3810
CHEMBL290704,P08254,,ZKPIBBFZVZLIIO-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,860,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,867841,DTCC00178601,1649264,15677
CHEMBL290857,P08254,,BTSWLXDOHMNQBM-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,520,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,866464,DTCC00178539,355852,15677
CHEMBL290892,P08254,,GLGBGXFJYXKPIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,IC50,=,125000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104727,DTCT0024060,857531,DTCC00177961,1870014,15677
CHEMBL290892,P08254,,GLGBGXFJYXKPIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,119000,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,857532,DTCC00177961,1870014,15677
CHEMBL291133,P08254,,UAFDRTNAZWZUDR-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,28,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,903634,DTCC00185834,1046252,15892
CHEMBL291264,P08254,,WZZROHGXDJBEMY-KLHDSHLOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15006405,KI,=,0.43,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,Synthesis and biological activity of selective azasugar-based TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,6,"Tsukida T, Moriyama H, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104878,DTCT0024060,850599,DTCC00180286,1434654,6743
CHEMBL291361,P08254,,KTCRMROJXXSPQJ-JRQMZCAUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12781187,INHIBITION,=,17,%,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-3 at 1000 nM,,Discovery of selective phosphonamide-based inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Sawa M, Kurokawa K, Inoue Y, Kondo H, Yoshino K",,104734,DTCT0024060,1075803,DTCC00212221,204534,5595
CHEMBL291387,P08254,,IPBVPRHDESNKFG-QIFAOCFZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12781187,INHIBITION,=,47,%,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-3 at 1000 nM,,Discovery of selective phosphonamide-based inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Sawa M, Kurokawa K, Inoue Y, Kondo H, Yoshino K",,104734,DTCT0024060,1060381,DTCC00211727,852897,5595
CHEMBL291603,P08254,,AHYFYYVVAXRMKB-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,2500,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,749747,DTCC00216039,1806053,12439
CHEMBL291603,P08254,,AHYFYYVVAXRMKB-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,7500,NM,,,,,,,,,,,,,,Inhibition of recombinant full length stromelysin (FLS).,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205498,DTCT0024060,749749,DTCC00216039,1806053,12439
CHEMBL291603,P08254,,AHYFYYVVAXRMKB-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,KI,=,2100,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205625,DTCT0024060,749748,DTCC00216039,1806053,12439
CHEMBL291603,P08254,,AHYFYYVVAXRMKB-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,KI,=,6300,NM,,,,,,,,,,,,,,Inhibition of recombinant full length stromelysin (FLS),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205624,DTCT0024060,749750,DTCC00216039,1806053,12439
CHEMBL291757,P08254,,OREVCDGKIGJEIW-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,60,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1020028,DTCC00204754,712956,15462
CHEMBL291758,P08254,,FKBDRAKAEJZJEQ-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1047272,DTCC00204755,1650909,15462
CHEMBL291829,P08254,,DZTHIGRZJZPRDV-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,500000,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205500,DTCT0024060,761311,DTCC00215397,518222,12439
CHEMBL291831,P08254,,CAHKINHBCWCHCF-SNVBAGLBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,>,500000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,756096,DTCC00215474,1196000,12439
CHEMBL291833,P08254,,MCRMUCXATQAAMN-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,22000,NM,,,,,,,,,,,,,,Inhibition of recombinant full length stromelysin (FLS).,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205498,DTCT0024060,743542,DTCC00216030,1358934,12439
CHEMBL291833,P08254,,MCRMUCXATQAAMN-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,24000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,743540,DTCC00216030,1358934,12439
CHEMBL291833,P08254,,MCRMUCXATQAAMN-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,KI,=,18000,NM,,,,,,,,,,,,,,Inhibition of recombinant full length stromelysin (FLS),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205624,DTCT0024060,743543,DTCC00216030,1358934,12439
CHEMBL291833,P08254,,MCRMUCXATQAAMN-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,KI,=,20000,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205625,DTCT0024060,743541,DTCC00216030,1358934,12439
CHEMBL291898,P08254,,PPELJLBDXLMTEW-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,7000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1054930,DTCC00204356,551562,15462
CHEMBL291994,P08254,,AMOCYMNNMVOHOG-IFMALSPDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,50,NM,,,,,,,,,,,,,,"Inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90641,DTCT0024060,669310,DTCC00208351,2000520,2288
CHEMBL292051,P08254,,MGHMWKZOLAAOTD-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,500000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,767702,DTCC00215475,647507,12439
CHEMBL292160,P08254,,IKZOIIFNGBJACQ-FYYLOGMGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,7000,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,684441,DTCC00208219,1002528,2288
CHEMBL292303,P08254,D-TRYPTOPHAN,QIVBCDIJIAJPQS-SECBINFHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,>,500000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,739933,DTCC00214991,1391597,12439
CHEMBL292313,P08254,,GWXMWHCYBJJJND-GDBMZVCRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,100,NM,,,,,,,,,,,,,,"Inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90641,DTCT0024060,671858,DTCC00208710,452427,2288
CHEMBL292545,P08254,,USDAGEMRRVCVKK-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873489,IC50,=,1040,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,Design and synthesis of conformationally-constrained MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,16,"Natchus MG, Cheng M, Wahl CT, Pikul S, Almstead NG, Bradley RS, Taiwo YO, Mieling GE, Dunaway CM, Snider CE, McIver JM, Barnett BL, McPhail SJ, Anastasio MB, De B",,101941,DTCT0024060,753036,DTCC00214483,140439,2711
CHEMBL292636,P08254,,FSKXYSMYBLXDDL-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1042533,DTCC00204204,1456926,15462
CHEMBL293003,P08254,,VCJOCQOXJUMEBE-HBMCJLEFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873491,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of fibroblast stromelysin (MMP-3),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101938,DTCT0024060,1658951,DTCC00215412,1596527,2712
CHEMBL293019,P08254,,NPZDPBHMFYXBRP-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,2150,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1528041,DTCC00209001,1046465,4358
CHEMBL293382,P08254,,NJCSEXFBNXQBFK-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,500,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,666935,DTCC00208627,2033485,2288
CHEMBL293411,P08254,,XXCBSIYZQACPFC-OBFZPWGMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,98,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1555877,DTCC00208643,497500,4358
CHEMBL294066,P08254,,SXFDETGXHVKYJE-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,450,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,659761,DTCC00208644,1067209,2288
CHEMBL294133,P08254,,YNYAHGDBURIHAM-FTJBHMTQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,0,%,,,,,,,,,,,,,,"Inhibition of human recombinant stromelysin (MMP-3, HFS) at 100000 nM",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90642,DTCT0024060,684437,DTCC00208774,1805982,2288
CHEMBL294167,P08254,,ZOJMJLMSZDGBHC-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,100,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1017365,DTCC00204330,1650910,15462
CHEMBL294337,P08254,,FDMDTOXXLRGLMS-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,1000,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,693230,DTCC00208602,1455607,2288
CHEMBL294405,P08254,,RUILUWMFIHGOHD-NKFKGCMQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,1250,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1529266,DTCC00208195,1046467,4358
CHEMBL294680,P08254,,PSFVLJSHQMPQKQ-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,300,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1044757,DTCC00204823,1294864,15462
CHEMBL294976,P08254,,DJNIILYGNAXATJ-SKNNYEEJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,38,%,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-3 (Stromelysin) at 10 uM,,,Bioorg. Med. Chem. Lett.,1995,5,15,,,205622,DTCT0024060,659635,DTCC00184497,1131920,1239
CHEMBL295058,P08254,,DFMJZEAMRUGHGU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,729505,DTCC00184292,1913831,3810
CHEMBL295191,P08254,FUTOENONE,SXHVHWXETMBKPP-KXXATPMCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,<,1000,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-3 (Stromelysin) at 10 uM,,,Bioorg. Med. Chem. Lett.,1995,5,15,,,205494,DTCT0024060,665626,DTCC00184952,1227814,1239
CHEMBL295191,P08254,FUTOENONE,SXHVHWXETMBKPP-KXXATPMCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,35,%,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-3 (Stromelysin) at 10 uM,,,Bioorg. Med. Chem. Lett.,1995,5,15,,,205622,DTCT0024060,679352,DTCC00184952,1227813,1239
CHEMBL295193,P08254,,ALKGLLLPQJKCRV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,723463,DTCC00184934,1628775,3810
CHEMBL295305,P08254,,DLSHWTXXGZXIQU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,711809,DTCC00183916,593730,3810
CHEMBL295526,P08254,,QFRQMCKTBBVNQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,707389,DTCC00184779,2044539,3810
CHEMBL295653,P08254,,YXSFWZAMZUKSOK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,724633,DTCC00184525,1628777,3810
CHEMBL295660,P08254,,OUYWTARRIITHBX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,KI,>,10000,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-3.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104880,DTCT0024060,724703,DTCC00185213,1143665,3810
CHEMBL295767,P08254,,PDDJIPBOFGXVEP-JBAPVGOWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,600,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-3 (Stromelysin) at 10 uM,,,Bioorg. Med. Chem. Lett.,1995,5,15,,,205494,DTCT0024060,689448,DTCC00184527,1195709,1239
CHEMBL295767,P08254,,PDDJIPBOFGXVEP-JBAPVGOWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,98,%,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-3 (Stromelysin) at 10 uM,,,Bioorg. Med. Chem. Lett.,1995,5,15,,,205622,DTCT0024060,689447,DTCC00184527,1195709,1239
CHEMBL295798,P08254,,OAXIYDWDKICQCU-PVHODMMVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,91,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1420822,DTCC00191774,434617,12880
CHEMBL295798,P08254,,OAXIYDWDKICQCU-PVHODMMVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,90,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,101940,DTCT0024060,1500830,DTCC00191774,434048,1959
CHEMBL295798,P08254,,OAXIYDWDKICQCU-PVHODMMVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease -3,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102083,DTCT0024060,570496,DTCC00191774,422440,1951
CHEMBL295818,P08254,,SNKXLTDCGDAPHC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,700487,DTCC00184369,1370314,3810
CHEMBL295871,P08254,,JUPHQCOZPHPYPF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,22,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,927043,DTCC00186639,1402750,15892
CHEMBL296196,P08254,,PTONAIKVYGVBIS-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,9,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,909625,DTCC00186419,236755,15892
CHEMBL296196,P08254,,PTONAIKVYGVBIS-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17088065,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP3,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432504,DTCT0024060,2061982,DTCC00186419,228138,22402
CHEMBL296368,P08254,,OZANAUCGDSBHQA-HZFRXHCASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,21,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 by MCA peptide assay,,,Bioorg. Med. Chem. Lett.,1997,7,13,,,104747,DTCT0024060,664645,DTCC00194354,1584534,2155
CHEMBL296487,P08254,,UBTDNVISINZMMM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,730609,DTCC00184259,1881771,3810
CHEMBL296761,P08254,,IQVPRIHMNPAIMY-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10397503,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101943,DTCT0024060,525492,DTCC00188542,1713326,3181
CHEMBL296874,P08254,,OCQHJTWHXNLSJE-PBHICJAKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,8,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1996,6,13,,,205490,DTCT0024060,1398815,DTCC00182488,1111392,1703
CHEMBL296911,P08254,,TWQZYQBXMVVVCY-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10397503,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101943,DTCT0024060,526385,DTCC00188240,2796,3181
CHEMBL29758,P08254,,JIJHAAWHZJGATL-ZCFHBRKKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871766,ACTIVITY,=,100,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (Stromelysin-1),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,104574,DTCT0024060,633213,DTCC00164378,873272,2586
CHEMBL297749,P08254,,GZQRNXJPJXICJZ-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,21,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,918812,DTCC00186610,658584,15892
CHEMBL297792,P08254,,YWCLDDLVLSQGSZ-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104905,DTCT0024060,620755,DTCC00192123,1436535,15057
CHEMBL297943,P08254,,OZXWOPIPFLIZIC-TUAOUCFPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 by MCA peptide assay,,,Bioorg. Med. Chem. Lett.,1997,7,13,,,104713,DTCT0024060,666995,DTCC00194336,840971,2155
CHEMBL298033,P08254,,TUXGRLPRNXNACO-OLZOCXBDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,320,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1996,6,13,,,205490,DTCT0024060,1390305,DTCC00182310,334958,1703
CHEMBL298167,P08254,,PMVTXYIJWIAFKQ-OKZBNKHCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9599226,KI,=,2900,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Macrocyclic amino carboxylates as selective MMP-8 inhibitors.,J. Med. Chem.,1998,41,11,"Cherney RJ, Wang L, Meyer DT, Xue CB, Wasserman ZR, Hardman KD, Welch PK, Covington MB, Copeland RA, Arner EC, DeGrado WF, Decicco CP",,104881,DTCT0024060,1357166,DTCC00193648,323312,14640
CHEMBL298258,P08254,,XHVNEGKHXFCMFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,723455,DTCC00184331,367692,3810
CHEMBL29897,P08254,,QAKAOVFKLDKHAW-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9632351,IC50,=,3800,NM,,,,,,,,,,,,,,Inhibition of Matrix Metalloprotease-3,,Rational design and combinatorial evaluation of enzyme inhibitor scaffolds: identification of novel inhibitors of matrix metalloproteinases.,J. Med. Chem.,1998,41,13,"Szardenings AK, Harris D, Lam S, Shi L, Tien D, Wang Y, Patel DV, Navre M, Campbell DA",,104888,DTCT0024060,818032,DTCC00163473,1002686,14688
CHEMBL29934,P08254,,PQOSFDCYBJNHGK-JALIKCBVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871766,ACTIVITY,=,40,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (Stromelysin-1),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,104574,DTCT0024060,626568,DTCC00163623,1649145,2586
CHEMBL29976,P08254,,QXLMMZHXXOWCDY-OWCLPIDISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871766,ACTIVITY,=,30,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (Stromelysin-1),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,104574,DTCT0024060,634407,DTCC00163718,905593,2586
CHEMBL29977,P08254,,PWLHPFHFBANNHA-KWXGJIJISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871766,ACTIVITY,=,40,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (Stromelysin-1),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,104574,DTCT0024060,639904,DTCC00163719,1681272,2586
CHEMBL30034,P08254,,KIGOGXGZNGEPBS-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9632351,IC50,=,4045,NM,,,,,,,,,,,,,,Inhibition of Matrix Metalloprotease-3,,Rational design and combinatorial evaluation of enzyme inhibitor scaffolds: identification of novel inhibitors of matrix metalloproteinases.,J. Med. Chem.,1998,41,13,"Szardenings AK, Harris D, Lam S, Shi L, Tien D, Wang Y, Patel DV, Navre M, Campbell DA",,104888,DTCT0024060,856678,DTCC00163758,1741864,14688
CHEMBL300375,P08254,,YHTDLXCRQOJRHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,210,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1538617,DTCC00209051,367960,4358
CHEMBL300613,P08254,,WLYMEGWHRCAYOJ-MNEFBYGVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,>,200000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 by MCA peptide assay,,,Bioorg. Med. Chem. Lett.,1997,7,13,,,104713,DTCT0024060,683358,DTCC00194268,356025,2155
CHEMBL300771,P08254,,BTZXQMHZPVTFBL-YITPRAEKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,26,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1526920,DTCC00209002,819930,4358
CHEMBL301108,P08254,,FRVONUPMTQJQGV-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,77,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 by MCA peptide assay,,,Bioorg. Med. Chem. Lett.,1997,7,13,,,104747,DTCT0024060,657277,DTCC00194321,517974,2155
CHEMBL301565,P08254,,CTVWOVYWOFCAMW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10230616,IC50,=,500,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,Discovery of a novel series of selective MMP inhibitors: identification of the gamma-sulfone-thiols.,Bioorg. Med. Chem. Lett.,1999,9,7,"Freskos JN, Mischke BV, DeCrescenzo GA, Heintz R, Getman DP, Howard SC, Kishore NN, McDonald JJ, Munie GE, Rangwala S, Swearingen CA, Voliva C, Welsch DJ",,102102,DTCT0024060,1696310,DTCC00194174,939779,3610
CHEMBL301626,P08254,,JNBNCWQZPZWAOV-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,400,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1046077,DTCC00204725,907522,15462
CHEMBL302227,P08254,,BJOZETKUSDMMAN-QRVBRYPASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873491,IC50,=,570,NM,,,,,,,,,,,,,,Inhibition of fibroblast stromelysin (MMP-3),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101938,DTCT0024060,1671241,DTCC00215866,433131,2712
CHEMBL302367,P08254,,CNBUSIJNWNXLQQ-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,>,500000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,760046,DTCC00216117,1838507,12439
CHEMBL302422,P08254,,PLMKYGHASWACNG-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,13000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,744800,DTCC00215443,2033561,12439
CHEMBL302422,P08254,,PLMKYGHASWACNG-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,KI,=,11000,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205625,DTCT0024060,744801,DTCC00215443,2033561,12439
CHEMBL302489,P08254,,KJWDSNDCRUJSLL-ZACQAIPSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873489,IC50,=,94,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,Design and synthesis of conformationally-constrained MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,16,"Natchus MG, Cheng M, Wahl CT, Pikul S, Almstead NG, Bradley RS, Taiwo YO, Mieling GE, Dunaway CM, Snider CE, McIver JM, Barnett BL, McPhail SJ, Anastasio MB, De B",,101941,DTCT0024060,742113,DTCC00214994,1564094,2711
CHEMBL302941,P08254,,NCKDXXIBASBEEV-MJBXVCDLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11514157,KI,=,120,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution.,Bioorg. Med. Chem. Lett.,2001,11,16,"Musso DL, Andersen MW, Andrews RC, Austin R, Beaudet EJ, Becherer JD, Bubacz DG, Bickett DM, Chan JH, Conway JG, Cowan DJ, Gaul MD, Glennon KC, Hedeen KM, Lambert MH, Leesnitzer MA, McDougald DL, Mitchell JL, Moss ML, Rabinowitz MH, Rizzolio MC, Schaller LT, Stanford JB, Tippin T, Warner JR, Whitesell LG, Wiethe RW",,104569,DTCT0024060,915126,DTCC00219780,108019,4390
CHEMBL303286,P08254,,ZYWQCDFNGKDOSB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,860,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1530486,DTCC00209007,529586,4358
CHEMBL303298,P08254,,HEPINVNDBLHRTM-BDTNDASRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873491,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of fibroblast stromelysin (MMP-3),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101938,DTCT0024060,1676101,DTCC00215881,1046551,2712
CHEMBL303352,P08254,2-(3-MERCAPTOPROPYL)PENTANEDIOIC ACID,FNLNSQHJKVQCBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12723961,SELECTIVITY,,,,,,,,,,,,,,,,,Selectivity for zinc metalloprotease over matrix metalloprotease 3(MMP-3) for >=50% inhibition,,Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor.,J. Med. Chem.,2003,46,10,"Majer P, Jackson PF, Delahanty G, Grella BS, Ko YS, Li W, Liu Q, Maclin KM, Poláková J, Shaffer KA, Stoermer D, Vitharana D, Wang EY, Zakrzewski A, Rojas C, Slusher BS, Wozniak KM, Burak E, Limsakun T, Tsukamoto T",,231457,DTCT0024060,926015,DTCC01740607,290990,17301
CHEMBL303352,P08254,2-(3-MERCAPTOPROPYL)PENTANEDIOIC ACID,FNLNSQHJKVQCBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12723961,SELECTIVITY,,,,,,,,,,,,,,,,,Selectivity for zinc metalloprotease over matrix metalloprotease 3(MMP-3) for >=50% stimulation,,Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor.,J. Med. Chem.,2003,46,10,"Majer P, Jackson PF, Delahanty G, Grella BS, Ko YS, Li W, Liu Q, Maclin KM, Poláková J, Shaffer KA, Stoermer D, Vitharana D, Wang EY, Zakrzewski A, Rojas C, Slusher BS, Wozniak KM, Burak E, Limsakun T, Tsukamoto T",,231458,DTCT0024060,926008,DTCC01740607,290990,17301
CHEMBL303756,P08254,,JPKRVTXRYYGNMK-TZIWHRDSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,60,NM,,,,,,,,,,,,,,"Inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90641,DTCT0024060,669306,DTCC00208704,323476,2288
CHEMBL303800,P08254,,MGHMWKZOLAAOTD-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,500000,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205500,DTCT0024060,748403,DTCC00215399,614791,12439
CHEMBL304221,P08254,,RTSLKKUJJKXEJT-ZCNNSNEGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873491,IC50,=,75,NM,,,,,,,,,,,,,,Inhibition of fibroblast stromelysin (MMP-3),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101938,DTCT0024060,1672489,DTCC00215898,237057,2712
CHEMBL304243,P08254,,CIQJGNDHWOIZCK-ZNZIZOMTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873491,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of fibroblast stromelysin (MMP-3),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101938,DTCT0024060,1662667,DTCC00216001,1144015,2712
CHEMBL304295,P08254,,BGNATPVKWHRROW-QLFBSQMISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11514157,KI,=,135,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP3),,N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution.,Bioorg. Med. Chem. Lett.,2001,11,16,"Musso DL, Andersen MW, Andrews RC, Austin R, Beaudet EJ, Becherer JD, Bubacz DG, Bickett DM, Chan JH, Conway JG, Cowan DJ, Gaul MD, Glennon KC, Hedeen KM, Lambert MH, Leesnitzer MA, McDougald DL, Mitchell JL, Moss ML, Rabinowitz MH, Rizzolio MC, Schaller LT, Stanford JB, Tippin T, Warner JR, Whitesell LG, Wiethe RW",,104570,DTCT0024060,910480,DTCC00220257,1370689,4390
CHEMBL305024,P08254,,AKXUEZCVUDYBQE-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9632351,IC50,=,3400,NM,,,,,,,,,,,,,,Inhibition of Matrix Metalloprotease-3,,Rational design and combinatorial evaluation of enzyme inhibitor scaffolds: identification of novel inhibitors of matrix metalloproteinases.,J. Med. Chem.,1998,41,13,"Szardenings AK, Harris D, Lam S, Shi L, Tien D, Wang Y, Patel DV, Navre M, Campbell DA",,104888,DTCT0024060,824278,DTCC00222867,291136,14688
CHEMBL305069,P08254,2-ACETYLCYCLOPENTANONE,OSWDNIFICGLKEE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,4,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103098,DTCC00223385,1283746,43205
CHEMBL305160,P08254,,CPDXTLZUFAYJLD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,560,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1524588,DTCC00208701,140369,4358
CHEMBL305478,P08254,,MCRMUCXATQAAMN-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,432000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,738572,DTCC00216116,1773594,12439
CHEMBL305478,P08254,,MCRMUCXATQAAMN-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,450000,NM,,,,,,,,,,,,,,Inhibition of recombinant full length stromelysin (FLS).,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205498,DTCT0024060,738574,DTCC00216116,1773594,12439
CHEMBL305478,P08254,,MCRMUCXATQAAMN-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,KI,=,356000,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205625,DTCT0024060,738573,DTCC00216116,1773594,12439
CHEMBL305478,P08254,,MCRMUCXATQAAMN-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,KI,=,377000,NM,,,,,,,,,,,,,,Inhibition of recombinant full length stromelysin (FLS),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205624,DTCT0024060,738575,DTCC00216116,1773594,12439
CHEMBL305729,P08254,,XNKSQYFVFJZMOA-HUUCEWRRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,2175,NM,,,,,,,,,,,,,,"Inhibition of human stromelysin-1, MMP-3",,,Bioorg. Med. Chem. Lett.,1997,7,17,,,205639,DTCT0024060,1073450,DTCC00230680,917003,2236
CHEMBL306033,P08254,,DGXRLXMZJHBYOU-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,6.26,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,575320,DTCC00232233,29797,16308
CHEMBL306090,P08254,PKF-241-466,KNCYWVRUUBOHGE-RRFJBIMHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12014967,KI,=,15.2,NM,,,,,,,,,,,,,,Inhibitory potency against Matrix metalloprotease-3 (MMP-3),,Beta-aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme.,J. Med. Chem.,2002,45,11,"Kottirsch G, Koch G, Feifel R, Neumann U",,104903,DTCT0024060,778401,DTCC01741052,497698,16740
CHEMBL306177,P08254,,KLIVJDFDIVVAGE-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,321,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,575314,DTCC00231343,1693401,16308
CHEMBL306177,P08254,,KLIVJDFDIVVAGE-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,321,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1687728,DTCC00231343,1693671,1013
CHEMBL306256,P08254,,LDNUXKXHGIVDIF-PXJZQJOASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,81.5,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,558998,DTCC00232234,1722974,16308
CHEMBL306412,P08254,RO-37-9790,QRXOZHSEEGNRFC-PWSUYJOCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,160,NM,,,,,,,,,,,,,,"Inhibition of human stromelysin-1, MMP-3",,,Bioorg. Med. Chem. Lett.,1997,7,17,,,205639,DTCT0024060,1055709,DTCC01741069,562037,2236
CHEMBL306608,P08254,,NGMNLVMLTVTIKU-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,1.38,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,567363,DTCC00232411,1532297,16308
CHEMBL306674,P08254,,NTWPNMLRTBRVIB-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9632351,IC50,=,2300,NM,,,,,,,,,,,,,,Inhibition of stromelysin (Matrix metalloprotease-3),,Rational design and combinatorial evaluation of enzyme inhibitor scaffolds: identification of novel inhibitors of matrix metalloproteinases.,J. Med. Chem.,1998,41,13,"Szardenings AK, Harris D, Lam S, Shi L, Tien D, Wang Y, Patel DV, Navre M, Campbell DA",,104577,DTCT0024060,832263,DTCC00223932,841295,14688
CHEMBL306674,P08254,,NTWPNMLRTBRVIB-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9632351,IC50,=,2910,NM,,,,,,,,,,,,,,Inhibition of Matrix Metalloprotease-3,,Rational design and combinatorial evaluation of enzyme inhibitor scaffolds: identification of novel inhibitors of matrix metalloproteinases.,J. Med. Chem.,1998,41,13,"Szardenings AK, Harris D, Lam S, Shi L, Tien D, Wang Y, Patel DV, Navre M, Campbell DA",,104904,DTCT0024060,832261,DTCC00223932,841295,14688
CHEMBL306724,P08254,,FBSRGDLMHOPCIT-ANYOKISRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,10,%,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3) at 50 uM,,,Bioorg. Med. Chem. Lett.,1997,7,18,,,104885,DTCT0024060,1560603,DTCC00232318,335548,2242
CHEMBL306779,P08254,,PENUYKDCGZXPRG-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,8400,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,573160,DTCC00232195,1785381,16308
CHEMBL306779,P08254,,PENUYKDCGZXPRG-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,8400,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1710782,DTCC00232195,1785645,1013
CHEMBL306947,P08254,,LHIMKPOFOYDWFM-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,2.75,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,575323,DTCC00231928,335551,16308
CHEMBL306985,P08254,,DJHMSJLOZQFJKZ-LYKKTTPLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,4100,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1997,7,18,,,104882,DTCT0024060,1577131,DTCC00232648,433292,2242
CHEMBL307027,P08254,,RGTVFBJQARSWHO-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,1600,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,550667,DTCC00231992,400996,16308
CHEMBL307027,P08254,,RGTVFBJQARSWHO-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,358,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1709255,DTCC00231992,401263,1013
CHEMBL307192,P08254,RO-32-3555,GFUITADOEPNRML-IAGOWNOFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,527,NM,,,,,,,,,,,,,,"Inhibition of human stromelysin-1, MMP-3",,,Bioorg. Med. Chem. Lett.,1997,7,17,,,205639,DTCT0024060,1087957,DTCC01741068,820155,2236
CHEMBL307207,P08254,,DAMUFYPHDRVCNP-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,3120,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,580742,DTCC00232255,1785380,16308
CHEMBL307207,P08254,,DAMUFYPHDRVCNP-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,3120,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1682591,DTCC00232255,1785644,1013
CHEMBL307211,P08254,,WFOYCJYFLJCILB-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,952,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,559001,DTCC00232825,1370823,16308
CHEMBL307211,P08254,,WFOYCJYFLJCILB-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,952,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1698784,DTCC00232825,1371102,1013
CHEMBL307365,P08254,,QQHGONNRQYLVKQ-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,472,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,574111,DTCC00232701,885379,16308
CHEMBL307365,P08254,,QQHGONNRQYLVKQ-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,472,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1720310,DTCC00232701,885636,1013
CHEMBL307773,P08254,,CVMOEYXHQALNTG-SOLBZPMBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11514157,KI,=,153,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP3),,N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution.,Bioorg. Med. Chem. Lett.,2001,11,16,"Musso DL, Andersen MW, Andrews RC, Austin R, Beaudet EJ, Becherer JD, Bubacz DG, Bickett DM, Chan JH, Conway JG, Cowan DJ, Gaul MD, Glennon KC, Hedeen KM, Lambert MH, Leesnitzer MA, McDougald DL, Mitchell JL, Moss ML, Rabinowitz MH, Rizzolio MC, Schaller LT, Stanford JB, Tippin T, Warner JR, Whitesell LG, Wiethe RW",,104570,DTCT0024060,920775,DTCC00219822,626590,4390
CHEMBL30782,P08254,,KSSHTSOSCFKFRS-VJBWXMMDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,25000,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,13,,,102094,DTCT0024060,1467651,DTCC00168888,436167,1206
CHEMBL30804,P08254,,UDNLRUDZHBXCON-OFSOJUDTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,806,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,13,,,102094,DTCT0024060,1455543,DTCC00168891,597107,1206
CHEMBL308277,P08254,,VGXYGECPCDQSNI-DINWUYGQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12824028,IC50,=,1600,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,104894,DTCT0024060,1510775,DTCC00232492,1532289,5648
CHEMBL308333,P08254,ACTINONIN,XJLATMLVMSFZBN-VYDXJSESSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11551755,IC50,=,6000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.,Bioorg. Med. Chem. Lett.,2001,11,19,"Pratt LM, Beckett RP, Davies SJ, Launchbury SB, Miller A, Spavold ZM, Todd RS, Whittaker M",,104889,DTCT0024060,1088119,DTCC00231518,1968387,4468
CHEMBL3084965,P08254,,FWZHHLOLYIUTJO-LBXVMSDZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11266157,IC50,=,1220,NM,,,,,,,,,,,,,,Inhibition of Stromelysin (Matrix metalloprotease-3),,Chemoenzymatic synthesis of functionalized cyclohexylglycines and alpha-methylcyclohexylglycines via Kazmaier-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,2001,11,5,"Hudlicky T, Oppong K, Duan C, Stanton C, Laufersweiler MJ, Natchus MG",,104728,DTCT0024060,646732,DTCC01407937,487523,4704
CHEMBL3084966,P08254,,RMJFXTVVOBTABN-RWWKDMOOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11266157,IC50,=,6150,NM,,,,,,,,,,,,,,Inhibition of Stromelysin (Matrix metalloprotease-3),,Chemoenzymatic synthesis of functionalized cyclohexylglycines and alpha-methylcyclohexylglycines via Kazmaier-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,2001,11,5,"Hudlicky T, Oppong K, Duan C, Stanton C, Laufersweiler MJ, Natchus MG",,104728,DTCT0024060,618642,DTCC01407938,1165043,4704
CHEMBL308511,P08254,,XQSIQJLWCRJICL-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,13.5,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,549320,DTCC00232151,497732,16308
CHEMBL308511,P08254,,XQSIQJLWCRJICL-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,13.5,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,1010698,DTCC00232151,486430,1012
CHEMBL308533,P08254,,ZAYGCPGBYLINSH-VWNXMTODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,0.96,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,555577,DTCC00232259,1979922,16308
CHEMBL308799,P08254,,WLKRWBCBYSPLIM-ZBFHGGJFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,29400,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1997,7,18,,,104882,DTCT0024060,1578662,DTCC00232649,1946971,2242
CHEMBL309067,P08254,,JWBVNSRNJDQUGY-NAKRPHOHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,1110,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,571956,DTCC00232218,1499897,16308
CHEMBL309067,P08254,,JWBVNSRNJDQUGY-NAKRPHOHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,1110,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1701367,DTCC00232218,1500150,1013
CHEMBL309247,P08254,,CZQAIUBHMIDFAY-QMMLZNLJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,1584.89,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258546,DTCC00238505,1620401,24803
CHEMBL309247,P08254,,CZQAIUBHMIDFAY-QMMLZNLJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,1600,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,840914,DTCC00238505,1617748,1379
CHEMBL309794,P08254,,IONSTZXMLPCJLY-LYKKTTPLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,19100,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1997,7,18,,,104882,DTCT0024060,1564490,DTCC00232570,497728,2242
CHEMBL30980,P08254,,IZYWROOEWSDARX-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,15,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,13,,,102094,DTCT0024060,1450650,DTCC00168927,338478,1206
CHEMBL310008,P08254,,QZURMXFXKAPVRT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944582,DTCT0024060,11835306,DTCC00241016,1736689,53820
CHEMBL310037,P08254,,AAMWPNSLYMJRGM-IAPPQJPRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,4.16,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,558995,DTCC00232110,2045038,16308
CHEMBL310037,P08254,,AAMWPNSLYMJRGM-IAPPQJPRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,4.16,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,1004551,DTCC00232110,2034010,1012
CHEMBL310118,P08254,,KCVCZNALVNWOCE-QDSKXPNFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,218.78,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258536,DTCC00238946,1491219,24803
CHEMBL310118,P08254,,KCVCZNALVNWOCE-QDSKXPNFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,220,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,853336,DTCC00238946,1488530,1379
CHEMBL310347,P08254,,SWNJNQBYQIREKX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,5350,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1302754,DTCC00243220,590828,14264
CHEMBL310347,P08254,,SWNJNQBYQIREKX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,5370.32,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458936,DTCT0024060,2258816,DTCC00243220,682318,24803
CHEMBL310422,P08254,,SVXJLDLOAQUWHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,1760,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1296635,DTCC00106203,1649967,14264
CHEMBL310422,P08254,,SVXJLDLOAQUWHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,1778.28,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458936,DTCT0024060,2258821,DTCC00106203,1652641,24803
CHEMBL310438,P08254,,PXKAFPXSNMQDMU-YGOYIFOWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,72.44,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258535,DTCC00239113,1555534,24803
CHEMBL310438,P08254,,PXKAFPXSNMQDMU-YGOYIFOWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,72,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,827234,DTCC00239113,1552857,1379
CHEMBL3104658,P08254,,VVXZPLQFCWCGBS-MDWZMJQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24316668,IC50,=,6400,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-3 using Mca-ArgProLysProValGlu-Nval-TrpArgLys(Dnp)-NH2 as substrate after 45 mins by fluorescence plate reader analysis,,Discovery of a benzimidazole series of ADAMTS-5 (aggrecanase-2) inhibitors by scaffold hopping.,Eur. J. Med. Chem.,2014,71,,"Sogame S, Suenaga Y, Atobe M, Kawanishi M, Tanaka E, Miyoshi S",,1283987,DTCT0024060,12983851,DTCC01417897,783634,56872
CHEMBL310520,P08254,,CYYNWRHSIGJVFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,3270,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1306519,DTCC00243450,64400,14264
CHEMBL310520,P08254,,CYYNWRHSIGJVFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,3235.94,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458936,DTCT0024060,2258822,DTCC00243450,67155,24803
CHEMBL310555,P08254,OXYQUINOLINE,MCJGNVYPOGVAJF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,83,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5104041,DTCC00239255,1090149,43205
CHEMBL310559,P08254,,PKVXVECJINENFT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,4400,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1295368,DTCC00243448,2033890,14264
CHEMBL310559,P08254,,PKVXVECJINENFT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,4365.16,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458936,DTCT0024060,2258819,DTCC00243448,2036411,24803
CHEMBL310587,P08254,,CAZNRDJXNQISBA-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,831.76,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258539,DTCC00238991,714624,24803
CHEMBL310587,P08254,,CAZNRDJXNQISBA-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,830,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,818388,DTCC00238991,711955,1379
CHEMBL310767,P08254,,WUSMUBXGTIYNCE-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,190.55,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258540,DTCC00238959,1555533,24803
CHEMBL310767,P08254,,WUSMUBXGTIYNCE-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,190,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,848435,DTCC00238959,1552858,1379
CHEMBL310823,P08254,,KDXMWIZHCFDNIO-OIBXWCBGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,218.78,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258538,DTCC00239467,359208,24803
CHEMBL310823,P08254,,KDXMWIZHCFDNIO-OIBXWCBGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,220,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,854579,DTCC00239467,356533,1379
CHEMBL310834,P08254,,ZKTSRBGPYOEYPS-OIBXWCBGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,109.65,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258537,DTCC00238972,650400,24803
CHEMBL310834,P08254,,ZKTSRBGPYOEYPS-OIBXWCBGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,110,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,838571,DTCC00238972,647789,1379
CHEMBL311004,P08254,,FNURWSLLBXZLRC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,40.6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1291618,DTCC00242427,582684,16328
CHEMBL3110281,P08254,,QQYCFXUASOHQCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24304348,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using omniMMP as fluorogenic substrate at 10 uM preincubated for 30 mins followed by substrate addition measured after 30 mins by fluorescence assay,Not Active,Synthesis and structure-activity relationship of 3-hydroxypyridine-2-thione-based histone deacetylase inhibitors.,J. Med. Chem.,2013,56,24,"Sodji QH, Patil V, Kornacki JR, Mrksich M, Oyelere AK",,1286650,DTCT0024060,12997869,DTCC01420618,1107623,57022
CHEMBL3110287,P08254,,YYRBBLSWPCHZTE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,24304348,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) using omniMMP as fluorogenic substrate at 10 uM preincubated for 30 mins followed by substrate addition measured after 30 mins by fluorescence assay,Not Active,Synthesis and structure-activity relationship of 3-hydroxypyridine-2-thione-based histone deacetylase inhibitors.,J. Med. Chem.,2013,56,24,"Sodji QH, Patil V, Kornacki JR, Mrksich M, Oyelere AK",,1286650,DTCT0024060,12997870,DTCC01420624,945416,57022
CHEMBL311097,P08254,,SBYCYYMPCYJMTP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,657,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1305049,DTCC00242342,193495,16328
CHEMBL311266,P08254,,YUWSFQQPCKKPJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,13.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1307402,DTCC00242099,744290,16328
CHEMBL311266,P08254,,YUWSFQQPCKKPJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,133,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1319105,DTCC00242099,744289,16328
CHEMBL311324,P08254,,MAOGCCYMZYSJDX-NYMACZPPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,1778.28,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258532,DTCC00239089,1587770,24803
CHEMBL311324,P08254,,MAOGCCYMZYSJDX-NYMACZPPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,1800,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,843365,DTCC00239089,1585027,1379
CHEMBL311336,P08254,,ZGSTVUAZFACDLH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,92,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1305431,DTCC00243756,808696,14264
CHEMBL311393,P08254,,ASDFSRLSQAJCEU-ZVAWYAOSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,10,%,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3) at 50 uM,,,Bioorg. Med. Chem. Lett.,1997,7,18,,,104885,DTCT0024060,1591646,DTCC00232297,1175294,2242
CHEMBL311397,P08254,,OHBYAEPYMITRJA-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,7.31,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,550670,DTCC00231917,204782,16308
CHEMBL311397,P08254,,OHBYAEPYMITRJA-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,7.31,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,978305,DTCC00231917,193641,1012
CHEMBL31164,P08254,,WATNMHGSJFUVDX-JOMNFKBKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,6575,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,13,,,102094,DTCT0024060,1467648,DTCC00168840,1725862,1206
CHEMBL311932,P08254,,JIRXORZYIXSWOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,133,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1302752,DTCC00243867,582697,14264
CHEMBL311932,P08254,,JIRXORZYIXSWOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,131.83,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458936,DTCT0024060,2258811,DTCC00243867,585410,24803
CHEMBL311932,P08254,,JIRXORZYIXSWOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23287054,IC50,=,6500,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944582,DTCT0024060,11835675,DTCC00243867,609579,53820
CHEMBL312076,P08254,,AHLWGTUBPHXANM-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,8.24,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,546996,DTCC00231894,1175299,16308
CHEMBL312076,P08254,,AHLWGTUBPHXANM-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,8.24,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,1014514,DTCC00231894,1163947,1012
CHEMBL312100,P08254,,IOANZCGEYMTXEK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,69.6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1301286,DTCC00242298,1773867,16328
CHEMBL312152,P08254,,SKWPMXDILDPKGU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,100,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1290712,DTCC00243599,874057,14264
CHEMBL312218,P08254,,HBPRCALADDGDIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,94,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1308951,DTCC00242814,1649966,14264
CHEMBL312649,P08254,,NDPOIVUWKQUMRL-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,331.13,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258544,DTCC00238529,294025,24803
CHEMBL312649,P08254,,NDPOIVUWKQUMRL-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,330,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,818385,DTCC00238529,291321,1379
CHEMBL312952,P08254,,MGKWVMCFDBSVCJ-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,48,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1291978,DTCC00243185,1035294,14264
CHEMBL313140,P08254,,KWXOWVYUSBDBIB-OXQOHEQNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,3,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,481141,DTCC00247344,1617842,13104
CHEMBL313207,P08254,,DUJYANRTHPGKCR-DYESRHJHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,16,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,511367,DTCC00246808,1552944,13104
CHEMBL313340,P08254,,IMQVPVWXNJYVAS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,418,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1297510,DTCC00242488,577853,16328
CHEMBL313356,P08254,,FPIZTGFSDBBQIE-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,700,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,499030,DTCC00246995,1391948,13104
CHEMBL313356,P08254,,FPIZTGFSDBBQIE-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,707.95,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258518,DTCC00246995,1394249,24803
CHEMBL313406,P08254,,KTTAUIWWFGTEIT-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,70,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1296641,DTCC00243585,938246,14264
CHEMBL313483,P08254,,MJERYQQJZATKQA-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,43,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,475316,DTCC00247651,841549,13104
CHEMBL313483,P08254,,MJERYQQJZATKQA-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,42.66,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258517,DTCC00247651,844216,24803
CHEMBL313483,P08254,,MJERYQQJZATKQA-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,<,100,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3 (potent inhibitor)",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102096,DTCT0024060,613718,DTCC00247651,853711,1496
CHEMBL313483,P08254,,MJERYQQJZATKQA-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,43,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102097,DTCT0024060,613717,DTCC00247651,853711,1496
CHEMBL313836,P08254,,QXKPLUFQYAQXMP-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,46,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1286946,DTCC00243991,518538,14264
CHEMBL314051,P08254,,JTNPIFRUAXRHGD-FZKQIMNGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,62,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,481139,DTCC00247209,1968375,13104
CHEMBL314059,P08254,,LJWJQJURYGEEAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,151,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1315833,DTCC00243550,1455984,14264
CHEMBL314064,P08254,,JRCGNOYYZQLNTH-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,36,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1290713,DTCC00243764,1935113,14264
CHEMBL314204,P08254,,JRCGNOYYZQLNTH-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,141,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1296638,DTCC00243845,1261491,14264
CHEMBL31422,P08254,MALTOL,XPCTZQVDEJYUGT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,34,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103142,DTCC00167287,604861,43205
CHEMBL314251,P08254,,HXFIFSALSXGAFS-VQIMIIECSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,17,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,478836,DTCC00246929,1424169,13104
CHEMBL314369,P08254,,PZGRHNUIXLWAPW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,107,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1316990,DTCC00243092,1196328,14264
CHEMBL314596,P08254,,YYCNZECYSJUTIY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,113,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1299195,DTCC00243872,2033888,14264
CHEMBL314918,P08254,,ACNMHGIRAHNELL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,61,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1314627,DTCC00243993,1326441,14264
CHEMBL315043,P08254,,LJXAVTUOWRDMBX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,71,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1286948,DTCC00243786,193513,14264
CHEMBL315114,P08254,,IIBGHLQTRXDEKI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,45.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1297517,DTCC00106157,1838801,16328
CHEMBL315493,P08254,,AKPXMDCVGKJBIP-CRAIPNDOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,6,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,490377,DTCC00246930,1968374,13104
CHEMBL315558,P08254,,UXDZMTSLDSZFSG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,90,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1313497,DTCC00244344,421972,14264
CHEMBL315688,P08254,,REPZHAUIJREHGP-HYBUGGRVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,<,2,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,477614,DTCC00247396,422016,13104
CHEMBL315905,P08254,,HBUCOYMWRVERSG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,336,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1323091,DTCC00243652,1067634,14264
CHEMBL315905,P08254,,HBUCOYMWRVERSG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,338.84,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458936,DTCT0024060,2258812,DTCC00243652,1070279,24803
CHEMBL315949,P08254,,BWTYNJYIHZVAOW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,192,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1316992,DTCC00243900,808697,14264
CHEMBL316169,P08254,,JRCGNOYYZQLNTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,86,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1312325,DTCC00243846,1713929,14264
CHEMBL316232,P08254,,VHYXHLISNBMNNB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,5000,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1302753,DTCC00243249,1359244,14264
CHEMBL316232,P08254,,VHYXHLISNBMNNB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,5011.87,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458936,DTCT0024060,2258817,DTCC00243249,1361902,24803
CHEMBL316332,P08254,,RSWUWSKXIDLCIR-PYNWJHIZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,82,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, MMP-3",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,101947,DTCT0024060,1316169,DTCC00257829,1196483,2323
CHEMBL316892,P08254,8-HYDROXY QUINALDINE,NBYLBWHHTUWMER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,71,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103781,DTCC00262976,508351,43205
CHEMBL316954,P08254,,OHZMUNMVWGUMMY-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,60,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1466336,DTCC00264378,1723295,3373
CHEMBL316954,P08254,,OHZMUNMVWGUMMY-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,60.26,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258360,DTCC00264378,1716220,24803
CHEMBL316978,P08254,,KCKFHONGIZWYTN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,15.1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1381866,DTCC00273603,530282,16392
CHEMBL316997,P08254,(CYCLOPENTYLAMINO)CARBONYLPHOSPHONIC ACID,CYCCYWRSDZSMIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1297664,DTCC00261231,303295,17838
CHEMBL317132,P08254,,VGAPHGIXAQRVAL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11212095,IC50,=,3.2,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104720,DTCT0024060,649003,DTCC00269579,1067913,4635
CHEMBL317307,P08254,,IISMJBOLNRKABL-JJXSEGSLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12873505,KI,=,50,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,"Design, synthesis and evaluation of novel azasugar-based MMP/ADAM inhibitors.",Bioorg. Med. Chem. Lett.,2003,13,16,"Moriyama H, Tsukida T, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104873,DTCT0024060,943920,DTCC00256256,1207711,5720
CHEMBL317508,P08254,,ITDDXQSXMTUIFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11212095,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104720,DTCT0024060,625725,DTCC00269558,1067912,4635
CHEMBL318023,P08254,,ARFFCGXUOISSHZ-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1464021,DTCC00264599,1371183,3373
CHEMBL318023,P08254,,ARFFCGXUOISSHZ-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258353,DTCC00264599,1361901,24803
CHEMBL318190,P08254,,MVEPSFJZKBVDHV-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1478672,DTCC00264484,949983,3373
CHEMBL318190,P08254,,MVEPSFJZKBVDHV-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,398.11,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258361,DTCC00264484,940926,24803
CHEMBL318252,P08254,,ODPDWLUYVWCNHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15125955,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104895,DTCT0024060,1378636,DTCC00265469,917418,6400
CHEMBL318252,P08254,,ODPDWLUYVWCNHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2456480,DTCC00265469,920644,32556
CHEMBL318455,P08254,,VWOQXPBXOWHZCH-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,7000,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1457853,DTCC00263986,1240611,3373
CHEMBL318455,P08254,,VWOQXPBXOWHZCH-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,6918.31,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258351,DTCC00263986,1231164,24803
CHEMBL318584,P08254,,UVWSNLIRCRFZEV-ZJUUUORDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,600,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,24,,,101944,DTCT0024060,1308036,DTCC00272269,1850515,1465
CHEMBL318664,P08254,PENTAN-3-YLCARBAMOYLPHOSPHONIC ACID,NBDIMGROXSSYHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1319236,DTCC01741840,723827,17838
CHEMBL318716,P08254,,LRVIJTRFTUQDKW-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,800,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1477305,DTCC00264594,335905,3373
CHEMBL318716,P08254,,LRVIJTRFTUQDKW-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,794.33,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258346,DTCC00264594,326644,24803
CHEMBL318795,P08254,,QYMKPTMAFMKKTC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11212095,IC50,=,313,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104720,DTCT0024060,633444,DTCC00269560,1871037,4635
CHEMBL318902,P08254,,CQDYUDMWSWIZOK-MXHVWWQHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,14611841,IC50,=,2340,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,MMPs inhibitors: new succinylhydroxamates with selective inhibition of MMP-2 over MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,17,"Marcq V, Mirand C, Decarme M, Emonard H, Hornebeck W",,104721,DTCT0024060,868729,DTCC00263292,291593,5741
CHEMBL319040,P08254,,MVTUAPMXVXQWFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,90,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1404225,DTCC00273183,1980402,16392
CHEMBL319782,P08254,,QBIHWFSRXVWUDN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15125955,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104895,DTCT0024060,1398530,DTCC00265485,1338612,6400
CHEMBL320045,P08254,,FXEYKJYOHRTUNG-VWPQPMDRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,7.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1375233,DTCC00282878,97233,2897
CHEMBL320402,P08254,,TWQZYQBXMVVVCY-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543676,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,104730,DTCT0024060,1182604,DTCC00273854,1521206,16385
CHEMBL320442,P08254,,NQHPVFGLBXTGFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,5.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1381861,DTCC00273104,627204,16392
CHEMBL320782,P08254,,DZVQTAQHEPKNSI-GCJKJVERSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,5.6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1391491,DTCC00283117,324379,2897
CHEMBL320968,P08254,,CIARJCUCRKNXEE-PPTMTGTBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,5.5,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1035340,DTCC00284042,659574,1950
CHEMBL321005,P08254,,SJVNLZPBUGMURM-VEEOACQBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,5.7,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1047956,DTCC00284069,1047272,1950
CHEMBL321006,P08254,,DYGUFLUIGDJMDE-VJGNERBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,530,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,559670,DTCC00285615,583160,1951
CHEMBL321180,P08254,,QVHQLFLTQMCYLJ-MDASCCDHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,1.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1364852,DTCC00282747,193949,2897
CHEMBL3215861,P08254,,CHLPUMOYKYJFFH-PFNYCKIMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21634430,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MMP3 at 10 uM,Not Active,"Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile.",J. Med. Chem.,2011,54,13,"Wang H, Yu N, Chen D, Lee KC, Lye PL, Chang JW, Deng W, Ng MC, Lu T, Khoo ML, Poulsen A, Sangthongpitag K, Wu X, Hu C, Goh KC, Wang X, Fang L, Goh KL, Khng HH, Goh SK, Yeo P, Liu X, Bonday Z, Wood JM, Dymock BW, Kantharaj E, Sun ET",,768285,DTCT0024060,6108550,DTCC01463279,1446956,45875
CHEMBL321602,P08254,,QESYNYYOSNECPA-VJGNERBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,110,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1375237,DTCC00283008,615511,2897
CHEMBL321613,P08254,,OJHBBJNOLVTWJS-NOZRDPDXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,3700,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1016975,DTCC00284172,465379,1950
CHEMBL321633,P08254,,REZSPXZZCJTZIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15177439,IC50,=,4.2,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,104896,DTCT0024060,1495041,DTCC00288306,1915036,6475
CHEMBL322142,P08254,,IXVVVBIIUONGJK-MVSFAKPFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,56,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1050537,DTCC00284125,401604,1950
CHEMBL3221863,P08254,,BJIOETDXHXZDRQ-LEAFIULHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,1082,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) by fluorescence-based FRET assay,,,MedChemComm,2011,2,10,,,1328283,DTCT0024060,13572209,DTCC01468798,1845949,39059
CHEMBL3221864,P08254,,OKHKINWJYOOKOF-GGXMVOPNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,1020,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) by fluorescence-based FRET assay,,,MedChemComm,2011,2,10,,,1328283,DTCT0024060,13572210,DTCC01468799,396851,39059
CHEMBL322412,P08254,,ZAVWWISQYKVWCT-GFOWMXPYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543676,IC50,=,10.1,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,104730,DTCT0024060,1194619,DTCC00273571,615409,16385
CHEMBL322540,P08254,,DHOAHVLHKCBDJS-BHYZAODMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,63,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1034079,DTCC00107039,1818473,1950
CHEMBL32285,P08254,,RMDCZACTUKUROI-GLDPYIMESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873367,IC50,=,95,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104581,DTCT0024060,860971,DTCC00171277,1078543,2600
CHEMBL322888,P08254,,VOEOVKSVTSGALB-ZGTCLIOFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543676,IC50,=,136,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,104730,DTCT0024060,1183566,DTCC00273544,583007,16385
CHEMBL323148,P08254,,YUYXLIRWRFFNDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11212095,IC50,=,71,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104720,DTCT0024060,640134,DTCC00269613,615363,4635
CHEMBL323228,P08254,,IJCQDLHWIZVIEL-VNQPRFMTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10560745,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease (MMP-3),,Selective inhibition of low affinity IgE receptor (CD23) processing: P1' bicyclomethyl substituents.,Bioorg. Med. Chem. Lett.,1999,9,21,"Bailey S, Bolognese B, Faller A, Louis-Flamberg P, MacPherson DT, Mayer RJ, Marshall LA, Milner PH, Mistry J, Smith DG, Ward JG",,105818,DTCT0024060,1430423,DTCC00278972,141082,3450
CHEMBL32325,P08254,,UHNRWKXPDCQTKE-FSSWDIPSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10360755,KI,=,38,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,"P1, P2'-linked macrocyclic amine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,10,"Duan JJ, Chen L, Xue CB, Wasserman ZR, Hardman KD, Covington MB, Copeland RR, Arner EC, Decicco CP",,104902,DTCT0024060,1594051,DTCC00171177,1692760,3139
CHEMBL323371,P08254,,PRCRNUDMWULKSO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11212095,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104720,DTCT0024060,640140,DTCC00269593,389494,4635
CHEMBL323575,P08254,,WNQMYJZKTYVQPU-BPGUCPLFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543676,IC50,=,16.7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,104730,DTCT0024060,1180466,DTCC00273545,1742428,16385
CHEMBL323917,P08254,,GQBXEDCNLAXENR-YPKYBTACSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,32,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,559673,DTCC00285308,1068100,1951
CHEMBL324004,P08254,,BXMNIXOHCAIUBA-BHYZAODMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,50,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1032849,DTCC00283938,788374,1950
CHEMBL324006,P08254,,BIDUKHOSNDIVKD-MVSFAKPFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,430,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101939,DTCT0024060,1041941,DTCC00284079,1980516,1950
CHEMBL324369,P08254,,ZUZHAPXKYPLQLC-ABAIWWIYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,2700,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102092,DTCT0024060,829876,DTCC00293038,1947632,1497
CHEMBL324664,P08254,,JMYNELQJPYBCPZ-ZVDOUQERSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,1.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1395131,DTCC00283009,193947,2897
CHEMBL324691,P08254,,LMJBKCLEHMNEQJ-ZFCSCTFJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,4.5,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1031817,DTCC00283882,788375,1950
CHEMBL324874,P08254,,QQWABDFFKSDQLH-XFAFFCHDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,5.1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1401310,DTCC00283022,129476,2897
CHEMBL325006,P08254,,PFJMJBQWTLBHRB-JBOQNHBVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,270,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,570493,DTCC00285574,1424573,1951
CHEMBL325007,P08254,,CWZUIJLHNLMGLG-QAXCHELISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,270,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,546658,DTCC00285575,938754,1951
CHEMBL325015,P08254,,NCIVMBVZAUECOS-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,39,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102092,DTCT0024060,822168,DTCC00293439,917740,1497
CHEMBL325041,P08254,BORTEZOMIB,GXJABQQUPOEUTA-RDJZCZTQSA-N,4,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18247547,INHIBITION,=,-1,%,,,,,,,,,,,,,,Inhibition of human MMP3 at 10 uM,,"Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer.",J. Med. Chem.,2008,51,4,"Dorsey BD, Iqbal M, Chatterjee S, Menta E, Bernardini R, Bernareggi A, Cassarà PG, D'Arasmo G, Ferretti E, De Munari S, Oliva A, Pezzoni G, Allievi C, Strepponi I, Ruggeri B, Ator MA, Williams M, Mallamo JP",,464576,DTCT0024060,2308368,DTCC00287769,1539678,25324
CHEMBL325163,P08254,,RWKJBOMUESGCBO-REUBFRLUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11585440,KI,=,2000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104869,DTCT0024060,1311922,DTCC00287408,1500490,16439
CHEMBL325163,P08254,,RWKJBOMUESGCBO-REUBFRLUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,KI,>,2000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457315,DTCC00287408,1503285,32556
CHEMBL325552,P08254,,JQYSJWITJMOASO-VXNXHJTFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,8.9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1371306,DTCC00282905,2001376,2897
CHEMBL325574,P08254,,DPHTYOHAIZCUCJ-RSXGOPAZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,54,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1031820,DTCC00284041,1371399,1950
CHEMBL325835,P08254,,AYKWMGZBLRUSIJ-BHYZAODMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,30,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1046816,DTCC00284043,691755,1950
CHEMBL325940,P08254,,ZAXDLNVDZOYNCA-GVAUOCQISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,3.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1371312,DTCC00282935,1228897,2897
CHEMBL32596,P08254,,JYPUUSQERHUIDJ-USQNYJEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10360755,KI,=,267,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,"P1, P2'-linked macrocyclic amine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,10,"Duan JJ, Chen L, Xue CB, Wasserman ZR, Hardman KD, Covington MB, Copeland RR, Arner EC, Decicco CP",,104902,DTCT0024060,1587460,DTCC00171178,28573,3139
CHEMBL326018,P08254,,HLTKMJZXSYKWCY-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,1500,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1053122,DTCC00284143,1047273,1950
CHEMBL326212,P08254,,FIAWMYOFRLETPB-DSPMFFIESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,190,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,566867,DTCC00285129,1359737,1951
CHEMBL32631,P08254,,PYHVMKLBOIYJOG-VJBWXMMDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10360755,KI,=,373,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,"P1, P2'-linked macrocyclic amine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,10,"Duan JJ, Chen L, Xue CB, Wasserman ZR, Hardman KD, Covington MB, Copeland RR, Arner EC, Decicco CP",,104902,DTCT0024060,1585150,DTCC00171113,1466837,3139
CHEMBL326489,P08254,,MDNBGABATBOAOY-YCLCTBJKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12877590,IC50,=,2.1,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3 (MMP-3),,"A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.",J. Med. Chem.,2003,46,16,"Fray MJ, Dickinson RP, Huggins JP, Occleston NL",,104716,DTCT0024060,1547324,DTCC00293235,258687,17445
CHEMBL326586,P08254,,TUHPBCNODYNMRM-YPKYBTACSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,110,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,576097,DTCC00285572,2034326,1951
CHEMBL326795,P08254,,KULPQNMXJAAJOM-QAXCHELISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,565725,DTCC00285692,1650454,1951
CHEMBL32685,P08254,,GITBBJRHJIWPLI-JBOQNHBVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,130,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,572709,DTCC00285372,615548,1951
CHEMBL327262,P08254,,JXGACOLDOLFHQF-LGTSYYJHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,970,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, MMP-3",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,101947,DTCT0024060,1309282,DTCC00257763,1968516,2323
CHEMBL32730,P08254,,JBRUCLKAHIYELE-IMJJTQAJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873367,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104581,DTCT0024060,894522,DTCC00171308,1849304,2600
CHEMBL327472,P08254,,RTQWWGKTAVZDQB-NOZRDPDXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,22.2,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,987689,DTCC00256826,1132702,1012
CHEMBL327578,P08254,,KFASYAQTQCGPKV-YLFCFFPRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12873504,KI,=,1.8,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,Structure--activity relationships of azasugar-based MMP/ADAM inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,16,"Moriyama H, Tsukida T, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104872,DTCT0024060,924282,DTCC00255474,1046980,5719
CHEMBL327780,P08254,,HADCYVFNVGINJC-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,1004545,DTCC00256802,1617950,1012
CHEMBL328005,P08254,,VFZUGYPXLGNLTO-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,,,,,,,,,,,,,,,,,Inhibition of Stromelysin (Not determined),Not Determined,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102090,DTCT0024060,989968,DTCC00256487,1488726,1012
CHEMBL328090,P08254,,LKMAUWKMMZAHHV-ZCNNSNEGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472217,KI,=,16.2,NM,,,,,,,,,,,,,,Inhibition of human MMP-3.,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104875,DTCT0024060,1660465,DTCC00251849,96867,16346
CHEMBL328092,P08254,,VGTPSCHBTJBJOQ-FTJBHMTQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,6.26,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,1014517,DTCC00256938,291523,1012
CHEMBL328162,P08254,,IRBWGGQXMBAYQL-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,60,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1453242,DTCC00264512,1014649,3373
CHEMBL328162,P08254,,IRBWGGQXMBAYQL-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,60.26,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258357,DTCC00264512,1005460,24803
CHEMBL328199,P08254,,GZISYEQJJGPWOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15125955,IC50,=,6000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104895,DTCT0024060,1365847,DTCC00265331,1047084,6400
CHEMBL328381,P08254,,NFRICHJLQIOONF-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1478667,DTCC00264486,1693757,3373
CHEMBL32839,P08254,,FOCKEUBBGLJYBX-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873367,IC50,=,170,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104581,DTCT0024060,858519,DTCC00171309,269235,2600
CHEMBL328645,P08254,,HAKDXLDJTCFTIE-HFTWOUSFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15125955,IC50,=,1600,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104895,DTCT0024060,1386233,DTCC00265462,982320,6400
CHEMBL328910,P08254,"2,4-DIHYDROXYBENZOIC ACID",UIAFKZKHHVMJGS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,3,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103317,DTCC00254453,1828599,43205
CHEMBL329002,P08254,,MQOPTJYOSJSPJX-UBFHEZILSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,1400,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, MMP-3",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,101947,DTCT0024060,1322233,DTCC00257795,1488748,2323
CHEMBL329124,P08254,,ZYKFUWMGGKBBNJ-IFIJOSMWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472217,KI,=,22.3,NM,,,,,,,,,,,,,,Inhibition of human MMP-3.,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104875,DTCT0024060,1672862,DTCC00250915,1617893,16346
CHEMBL329145,P08254,,RMAHZBKEPFXNHG-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,2600,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, MMP-3",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,101947,DTCT0024060,1310505,DTCC00257135,129155,2323
CHEMBL329287,P08254,,PTYZKNZXNKWTEF-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,6000,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1476065,DTCC00264543,465152,3373
CHEMBL329287,P08254,,PTYZKNZXNKWTEF-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,6025.6,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258354,DTCC00264543,455575,24803
CHEMBL329298,P08254,,GWEITLSXCOXESW-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1444452,DTCC00264987,205150,3373
CHEMBL329298,P08254,,GWEITLSXCOXESW-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258344,DTCC00264987,196121,24803
CHEMBL329313,P08254,,OKYUILRERWOFCH-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1457858,DTCC00265034,853467,3373
CHEMBL329313,P08254,,OKYUILRERWOFCH-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,30.2,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258348,DTCC00265034,844215,24803
CHEMBL329617,P08254,,LSAOZCAKUIANSQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327602,IC50,,,,,,,,,,,,,,,,,"Inhibition of Stromelysin, matrix metalloprotease-3 (not determined)",Not Determined,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,205497,DTCT0024060,971598,DTCC00256444,1981571,4784
CHEMBL329784,P08254,(CYCLOHEXYLAMINO)CARBONYLPHOSPHONIC ACID,QQRCALUVCOFAOX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,=,3000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1291831,DTCC00261567,401327,17838
CHEMBL329967,P08254,,BVQJLICESKJIJB-IADYIPOJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15125955,IC50,=,550,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104895,DTCT0024060,1388721,DTCC00265510,659401,6400
CHEMBL330028,P08254,,BGKNBDGHNBOSGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23287054,IC50,=,0.038,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944582,DTCT0024060,11835674,DTCC00252259,1158307,53820
CHEMBL330727,P08254,,WOZRCMBDSXXEAJ-RFQIPJPRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12873505,KI,=,3.7,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,"Design, synthesis and evaluation of novel azasugar-based MMP/ADAM inhibitors.",Bioorg. Med. Chem. Lett.,2003,13,16,"Moriyama H, Tsukida T, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104873,DTCT0024060,963614,DTCC00106483,1207710,5720
CHEMBL331095,P08254,,CRPDTHYTIJXWLZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,15,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1715016,DTCC00302754,1714460,16065
CHEMBL331095,P08254,,CRPDTHYTIJXWLZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,15,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,481178,DTCC00302754,1723715,16483
CHEMBL331364,P08254,,RYSYGNANNWCOSN-QAXCHELISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,28,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,555094,DTCC00285281,1164283,1951
CHEMBL331598,P08254,,WPWKYFZHRKLCAD-DSPMFFIESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,120,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,550243,DTCC00285309,615547,1951
CHEMBL332134,P08254,,DNGGPLKVDUPXFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,18,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1708418,DTCC00302701,712684,16065
CHEMBL332134,P08254,,DNGGPLKVDUPXFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,18,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,476482,DTCC00302701,724288,16483
CHEMBL332302,P08254,,YGXMCNARAMUPPX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,18,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1680203,DTCC00303015,1164477,16065
CHEMBL332302,P08254,,YGXMCNARAMUPPX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,18,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,496634,DTCC00303015,1176121,16483
CHEMBL332891,P08254,,SNQRPCRWYVZYNW-YGRLFVJLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,40000,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102092,DTCT0024060,854578,DTCC00293462,1338923,1497
CHEMBL33306,P08254,,LFRIKIYAMSRRPD-KSMMKXTCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873367,IC50,=,480,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104581,DTCT0024060,877764,DTCC00170902,819525,2600
CHEMBL333567,P08254,,IFUFBKYZHPAPTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9733482,IC50,=,1060,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,"Discovery of potent, achiral matrix metalloproteinase inhibitors.",J. Med. Chem.,1998,41,19,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Rydel T, Dunaway CM, Gu F, Mieling GE",,104724,DTCT0024060,1545440,DTCC00295351,357152,14767
CHEMBL333586,P08254,,QYFKTMNLZHLRIH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,5.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1718036,DTCC00303017,907231,16065
CHEMBL333586,P08254,,QYFKTMNLZHLRIH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,5.3,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,493059,DTCC00303017,917877,16483
CHEMBL333729,P08254,,BCWUIVYEXBBRHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9733482,IC50,=,33,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,"Discovery of potent, achiral matrix metalloproteinase inhibitors.",J. Med. Chem.,1998,41,19,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Rydel T, Dunaway CM, Gu F, Mieling GE",,104724,DTCT0024060,1520536,DTCC00295403,1839410,14767
CHEMBL3337869,P08254,,AARSEFXVCWMMKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25192810,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442063,DTCT0024060,13992243,DTCC01523362,1322384,59837
CHEMBL3337869,P08254,,AARSEFXVCWMMKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25264600,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431421,DTCT0024060,13989101,DTCC01523362,1302071,60036
CHEMBL3337894,P08254,,CDQRIIUMNLMHRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25192810,IC50,=,600,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442063,DTCT0024060,13992244,DTCC01523387,966370,59837
CHEMBL333831,P08254,,FYBKBNVRCAQIIE-QAXCHELISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,9.5,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,544477,DTCC00285470,1682595,1951
CHEMBL333973,P08254,2-METHOXYBENZENETHIOL,DSCJETUEDFKYGN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,-8,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103169,DTCC01742611,734155,43205
CHEMBL334107,P08254,,NWAZOLPVSMLDTN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9733482,IC50,=,22,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,"Discovery of potent, achiral matrix metalloproteinase inhibitors.",J. Med. Chem.,1998,41,19,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Rydel T, Dunaway CM, Gu F, Mieling GE",,104724,DTCT0024060,1525228,DTCC00295376,97361,14767
CHEMBL33418,P08254,,JKTJOHWXAHGOJM-WCYRKSIYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873367,IC50,=,91,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104581,DTCT0024060,873940,DTCC00171287,1046075,2600
CHEMBL334403,P08254,,FAEZTVRCESNVJN-NCOADZHNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,47,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1284043,DTCC00317608,1935934,16522
CHEMBL334567,P08254,,KIKBZIXCMWKZEI-NCOADZHNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,17,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1259735,DTCC00317250,1133425,16522
CHEMBL334709,P08254,,CAXAOIUOYPZXNV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,700,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1043541,DTCC00324372,162532,15462
CHEMBL334909,P08254,,RMKNDVDQYWXAON-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,90,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1399353,DTCC00325503,2078085,15412
CHEMBL334909,P08254,,RMKNDVDQYWXAON-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,89.13,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258579,DTCC00325503,2068205,24803
CHEMBL335009,P08254,,LAQQWJARJKOYJJ-PBDJWPIDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1257445,DTCC00317888,1133426,16522
CHEMBL335118,P08254,,XTRJAENNSAJIAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,50,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1052398,DTCC00324760,1650911,15462
CHEMBL3358151,P08254,,LNIRXDCIYOBRPL-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25415648,IC50,=,50000,NM,,,,,,,,,,,,,,Inhibition of human MMP3 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435762,DTCT0024060,14000060,DTCC01535600,2061710,60298
CHEMBL3358152,P08254,,GPHYVVDMOPSOAK-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25415648,IC50,,,,,,,,,,,,,,,,,Inhibition of human MMP3 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,Not Determined,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435762,DTCT0024060,14000061,DTCC01535601,1769989,60298
CHEMBL3358153,P08254,,KDEHHSHGVKUYEZ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25415648,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibition of human MMP3 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435762,DTCT0024060,14000062,DTCC01535602,1063499,60298
CHEMBL3358154,P08254,,WIKRDIGSYVQGTH-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25415648,IC50,=,20000,NM,,,,,,,,,,,,,,Inhibition of human MMP3 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435762,DTCT0024060,14000063,DTCC01535603,1996998,60298
CHEMBL3358155,P08254,,LBVBVIKJOWWVJX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25415648,IC50,=,1900,NM,,,,,,,,,,,,,,Inhibition of human MMP3 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435762,DTCT0024060,14000064,DTCC01535604,385128,60298
CHEMBL3358156,P08254,,NPWGFJCNOCYDSO-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25415648,IC50,=,38000,NM,,,,,,,,,,,,,,Inhibition of human MMP3 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435762,DTCT0024060,14000065,DTCC01535605,1387876,60298
CHEMBL3358157,P08254,,SZDCEHDWAAZEPH-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25415648,IC50,=,64000,NM,,,,,,,,,,,,,,Inhibition of human MMP3 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435762,DTCT0024060,14000066,DTCC01535606,676013,60298
CHEMBL3358158,P08254,,PDBQNZHFRVAZBC-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25415648,IC50,=,69000,NM,,,,,,,,,,,,,,Inhibition of human MMP3 using Mca-PQG1 peptide substrate assessed as substrate cleavage after 2 to 4 hrs,,Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.,J. Med. Chem.,2014,57,24,"Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR",,1435762,DTCT0024060,14000067,DTCC01535607,1128498,60298
CHEMBL3359091,P08254,,YNHGVYGMFAREOF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25264600,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431421,DTCT0024060,13989100,DTCC01536542,1108444,60036
CHEMBL336243,P08254,,JXSWSZIEDSTKDW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1038493,DTCC00324591,809612,15462
CHEMBL336419,P08254,,QZPAQYPSRXIPQS-DRTRNHDVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,IC50,=,12000,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205501,DTCT0024060,1267959,DTCC00318520,595220,12304
CHEMBL336425,P08254,,YKVNFNGMIAJYOQ-PMPSAXMXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,31,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1258553,DTCC00317268,1424905,16522
CHEMBL336786,P08254,,QXSADLFWPARWTP-QSBPQZLJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,282,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1269202,DTCC00317484,422831,16522
CHEMBL337042,P08254,,FWJFNXPZKLJJSG-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,203,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1261011,DTCC00317889,2001796,16522
CHEMBL337045,P08254,,FUDBZSGMQCENEH-BDXSIMOUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,156,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1258568,DTCC00317455,1553764,16522
CHEMBL337309,P08254,TAXIFOLIN,CXQWRCVTCMQVQX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,=,33910,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535399,DTCC00321631,912570,48665
CHEMBL337309,P08254,TAXIFOLIN,CXQWRCVTCMQVQX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827441,DTCT0024060,10535507,DTCC00321631,912570,48665
CHEMBL337512,P08254,,HDTMIVHMPQVMJD-AABGKKOBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,31,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1284037,DTCC00317763,1553765,16522
CHEMBL337585,P08254,,CSLRMNGVKPXZNV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,200,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1020046,DTCC00324623,907521,15462
CHEMBL337594,P08254,,XXOLBMKULOJKQR-WUJWULDRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1399358,DTCC00325473,1274023,15412
CHEMBL337761,P08254,,XIMLFZSNGXTRSL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,600,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1051063,DTCC00324498,971248,15462
CHEMBL337793,P08254,,UNRFEBNSHUZKHJ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1016237,DTCC00323912,1290020,15462
CHEMBL337915,P08254,,YGNKPZCQTQUWBQ-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,14000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,101940,DTCT0024060,1498712,DTCC00304262,1947782,1959
CHEMBL337946,P08254,,DAAIDRXNEKWJIQ-LQGLAIQGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,21,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,522117,DTCC00304579,1436012,13726
CHEMBL337986,P08254,,FSFVECJWHSGENK-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,316,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,543944,DTCC00304730,724287,13726
CHEMBL338007,P08254,,JDOCJRYXQAWUOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,8.9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1713844,DTCC00303044,938928,16065
CHEMBL338007,P08254,,JDOCJRYXQAWUOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,8.89,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,476483,DTCC00303044,950422,16483
CHEMBL338077,P08254,,QKXUIPRJJWLPIY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,9.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1688093,DTCC00302395,324604,16065
CHEMBL338077,P08254,,QKXUIPRJJWLPIY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,9.5,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,475360,DTCC00302395,336392,16483
CHEMBL338223,P08254,,VPTHOUBPDJAAER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,114,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1703163,DTCC00302941,1521507,16065
CHEMBL338223,P08254,,VPTHOUBPDJAAER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,114,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,510167,DTCC00302941,1533089,16483
CHEMBL338453,P08254,,JZJWCJQEWXNHBE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,173,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1711250,DTCC00302163,1585796,16065
CHEMBL338453,P08254,,JZJWCJQEWXNHBE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,172.98,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,512604,DTCC00302163,1597558,16483
CHEMBL338829,P08254,,SWCNAUZRMGDSGP-KCHLEUMXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,101940,DTCT0024060,1490537,DTCC00304294,1436009,1959
CHEMBL338877,P08254,,QOOGIVWLICWQOB-HARLFGEKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,134,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,533628,DTCC00304546,1629864,13726
CHEMBL339137,P08254,,IDKKXCKXGPPWMS-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,62,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,521064,DTCC00304581,76740,13726
CHEMBL33915,P08254,,SCDTVKKBOXTTSJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11378378,IC50,=,2500,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,104899,DTCT0024060,1023411,DTCC00173329,743590,4214
CHEMBL339191,P08254,,SMGJLVKJUBCWKY-STXQHDJLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,IC50,=,27300,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205501,DTCT0024060,1276779,DTCC00318327,1176276,12304
CHEMBL339219,P08254,,CCVGKLVIMFBNBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,54,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1681654,DTCC00302907,1774584,16065
CHEMBL339219,P08254,,CCVGKLVIMFBNBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,54,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,475361,DTCC00302907,1786180,16483
CHEMBL3392650,P08254,,MAVDNGWEBZTACC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,10,NM,,,,,,,,,,,,,,"BindingDB_Patents: Enzyme Assay. The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAMS and ADAM10 according to the same protocol as that described for the TACE enzyme in example 28 but with different substrates (MMP R and D system reference: P126-990 and ADAM R and D system reference: ES003).",320814,"N-[2-hydroxycarbamoyl-2-(piperazinyl) ethyl] benzamide compounds, their preparation and their use as TACE inhibitors",,2015,,,,,1535920,DTCT0024060,162326,DTCC01539841,754518,65180
CHEMBL339315,P08254,,CJLBNTMKOCAXSY-GKCIPKSASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,542951,DTCC00304908,1533087,13726
CHEMBL339381,P08254,,ZAUSLRXPYLUTHB-KJFGXLEFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11708926,IC50,=,155,NM,,,,,,,,,,,,,,Inhibition potency was determined by fluorescence-based peptide assay against matrix metalloprotease-3,,Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,J. Med. Chem.,2001,44,24,"Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, Leesnitzer MA, McDougald DL, Moss ML, Musso DL, Rizzolio MC",,104568,DTCT0024060,1264656,DTCC00317485,129863,16522
CHEMBL3394285,P08254,,ABKAFUZUCJSIKV-ZZXKWVIFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26753813,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 expressed in Escherichia coli using (5-FAM/QXLTM) FRET peptide as substrate,,Design and synthesis of an activity-based protein profiling probe derived from cinnamic hydroxamic acid.,Bioorg. Med. Chem.,2016,24,4,"Ai T, Qiu L, Xie J, Geraghty RJ, Chen L.",,1547671,DTCT0024060,50483,DTCC01541321,1869229,65891
CHEMBL339588,P08254,,QKYPFBUZQDJQHX-DQMJNTIXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,5.2,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,539249,DTCC00304182,1915219,13726
CHEMBL339610,P08254,,FWGPCZGIMGDSOM-APTRMMRNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,305,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,521076,DTCC00304804,1339064,13726
CHEMBL33977,P08254,,FDJBYAHLPYLRKD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11378378,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,104899,DTCT0024060,1035539,DTCC00173295,1805633,4214
CHEMBL3398610,P08254,,QWEOUVPDSNDRKX-NTEUORMPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25725607,IC50,=,97350,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463480,DTCT0024060,14035823,DTCC01543560,2009318,61492
CHEMBL3398611,P08254,,KSMDDSYBDLFHEC-NTEUORMPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25725607,IC50,>=,100000,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463480,DTCT0024060,14035824,DTCC01543561,397684,61492
CHEMBL339903,P08254,,WQWMOIIWRWXUJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,60,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1716496,DTCC00302725,648520,16065
CHEMBL339903,P08254,,WQWMOIIWRWXUJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,60.01,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,487968,DTCC00302725,659813,16483
CHEMBL340345,P08254,,JIIMVBXHLBKVOM-SNRMKQJTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,21,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,523134,DTCC00304892,336391,13726
CHEMBL340373,P08254,,UIOYIKWFHNKXFS-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,101940,DTCT0024060,1503894,DTCC00304236,950420,1959
CHEMBL340455,P08254,,AXIUEWMOHLWPSR-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,45,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,541132,DTCC00304315,917875,13726
CHEMBL340680,P08254,,GLQCFJAGQWNMRY-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,101940,DTCT0024060,1500829,DTCC00304340,627563,1959
CHEMBL340771,P08254,,HIYYLOFJQXHPRU-OPXMRZJTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,5,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,526006,DTCC00304552,1786179,13726
CHEMBL34085,P08254,,UEXHODHUQXSZDN-AABGKKOBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10360755,KI,=,265,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,"P1, P2'-linked macrocyclic amine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,10,"Duan JJ, Chen L, Xue CB, Wasserman ZR, Hardman KD, Covington MB, Copeland RR, Arner EC, Decicco CP",,104902,DTCT0024060,1574364,DTCC00172830,1660617,3139
CHEMBL340923,P08254,,BSHJFYSJFLAHQN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,27,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1690784,DTCC00302218,842153,16065
CHEMBL340923,P08254,,BSHJFYSJFLAHQN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,27,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,481177,DTCC00302218,853895,16483
CHEMBL341249,P08254,,IFCFGMLOBSUCSN-NWVWQQAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,694,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,530755,DTCC00304771,627569,13726
CHEMBL341570,P08254,,AHBFOOOWLVWQFO-MFKMUULPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,7.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1375738,DTCC00325536,1404317,15412
CHEMBL341604,P08254,,VZEDRBAGPXKVHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1054933,DTCC00324354,1489528,15462
CHEMBL3417740,P08254,,QHIZCDREFZNGBI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,18900,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105234,DTCC01554156,24704,61965
CHEMBL3417741,P08254,,RZQCWUNWENLXFE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,96,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105233,DTCC01554157,655861,61965
CHEMBL3417742,P08254,,GHWPTWVNZOSEBR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105232,DTCC01554158,1140955,61965
CHEMBL3417743,P08254,,GCMYZCWWNHCRJP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,178,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105231,DTCC01554159,591026,61965
CHEMBL3417744,P08254,,JONRIZRYNPVHFC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,20000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105230,DTCC01554160,978686,61965
CHEMBL3417745,P08254,,PJTIDEQBVYCKIC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105229,DTCC01554161,1561095,61965
CHEMBL3417746,P08254,,MVYFKOXRGAPNAN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105228,DTCC01554162,688041,61965
CHEMBL3417747,P08254,,LSKFDQCNRGUBOL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,114,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105227,DTCC01554163,914980,61965
CHEMBL3417748,P08254,,BJBBGWSFUXQTAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105226,DTCC01554164,1593436,61965
CHEMBL3417749,P08254,,XGAABSVAAOEGKA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,21,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105225,DTCC01554165,978687,61965
CHEMBL3417750,P08254,,JVKDGTTXLCSABF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105224,DTCC01554166,1076057,61965
CHEMBL3417751,P08254,,ZUZGJCNWNOCKEB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,21,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105223,DTCC01554167,946456,61965
CHEMBL3417752,P08254,,CQORHEXIKLKTGU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,19,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105222,DTCC01554168,1269819,61965
CHEMBL3417753,P08254,,CPHDTZDAGOQCET-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,7270,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105221,DTCC01554169,1140956,61965
CHEMBL3417754,P08254,,LTJSRJHCFOHUDW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105220,DTCC01554170,2041932,61965
CHEMBL3417755,P08254,,FIQXBPSAOMLPLJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105219,DTCC01554171,849885,61965
CHEMBL3417756,P08254,,VPRBKPRUOSPYMW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,916,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105218,DTCC01554172,105093,61965
CHEMBL3417757,P08254,,BXWCXHOLABLTBZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,65,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105217,DTCC01554173,1335000,61965
CHEMBL3417758,P08254,,MCNYTLRBBWYLSQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,38600,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105216,DTCC01554174,2009429,61965
CHEMBL3417759,P08254,,WQJPTWWOCNRCBI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,314,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105215,DTCC01554175,849886,61965
CHEMBL3417760,P08254,,RCSJFBBGCSVIIU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,46,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105214,DTCC01554176,1432058,61965
CHEMBL3417761,P08254,,NKVXPWMSTSLIPX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,39,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105213,DTCC01554177,817005,61965
CHEMBL3417762,P08254,,MFBLVISEWUOWKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,476,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105212,DTCC01554178,1432059,61965
CHEMBL3417763,P08254,,MKCKIGOKGYMJOH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,9600,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105211,DTCC01554179,1976632,61965
CHEMBL3417764,P08254,,ZQKGUWOTJVDTGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105210,DTCC01554180,1943630,61965
CHEMBL3417765,P08254,,VUEMJXMTPAGVNJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,6,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105209,DTCC01554181,817006,61965
CHEMBL3417766,P08254,,DYBVZAZWVGRLPI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105208,DTCC01554182,266685,61965
CHEMBL3417767,P08254,,AYPBWVMVAOAQCE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,15,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105207,DTCC01554183,2041933,61965
CHEMBL3417768,P08254,,FNFHIYYWCVXHOL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,132,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105206,DTCC01554184,1204295,61965
CHEMBL3417769,P08254,,ZUZGJCNWNOCKEB-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105205,DTCC01554185,978688,61965
CHEMBL3417770,P08254,,ZUZGJCNWNOCKEB-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25686153,IC50,=,15,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin) measured every minute for 1 hr by fluorescence assay,,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472743,DTCT0024060,14105204,DTCC01554186,1721447,61965
CHEMBL342005,P08254,,UFZFZIFQIKBQDH-NGXZDTIWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,IC50,=,42000,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205501,DTCT0024060,1263210,DTCC00318989,1533258,12304
CHEMBL34206,P08254,,SYAAEFMNVNGONW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11378378,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,104899,DTCT0024060,1018306,DTCC00173335,290571,4214
CHEMBL342102,P08254,,TWPPWHMOPIWZMY-XJKSGUPXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104571,DTCT0024060,1603805,DTCC00333548,713072,16049
CHEMBL342172,P08254,,IBRCQOLHLBIVAH-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,0.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1383316,DTCC00325535,205840,15412
CHEMBL342210,P08254,,CQRAUIRVDKNRIO-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,6.9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1367831,DTCC00325532,238281,15412
CHEMBL342210,P08254,,CQRAUIRVDKNRIO-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,6.92,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258581,DTCC00325532,228500,24803
CHEMBL342248,P08254,,RRETZYBLLSHELY-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,18.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1384555,DTCC00326418,854146,15412
CHEMBL342374,P08254,,HPJZLIJTRCEDRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,6000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1035832,DTCC00324181,1586061,15462
CHEMBL342548,P08254,,TZQQXIZDSZWWPC-GXFFZTMASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1601104,DTCC00333817,65497,16049
CHEMBL342570,P08254,,BGDARAHTNRWTGV-FXAWDEMLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,10,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1613766,DTCC00333307,1904159,16049
CHEMBL342710,P08254,,FJVADCMHIAHBER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,900,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1049759,DTCC00324396,1360201,15462
CHEMBL342889,P08254,,IKSAVMPIZWWMKE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,400,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1031128,DTCC00324252,97713,15462
CHEMBL343082,P08254,,SEQZHNNPDSVBRC-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,25,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1388158,DTCC00325373,1274022,15412
CHEMBL343082,P08254,,SEQZHNNPDSVBRC-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,25.12,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258574,DTCC00325373,1264013,24803
CHEMBL343220,P08254,,XSMMFHYHIAOGPC-QGTPRVQTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1633011,DTCC00333737,680818,16049
CHEMBL343326,P08254,,IMRWXXAPWNPDGA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,6000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1020034,DTCC00323913,65377,15462
CHEMBL343378,P08254,,SQLYTESBAWLCTR-IDERCBEYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,KI,=,110,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205627,DTCT0024060,1266751,DTCC00318922,1947941,12304
CHEMBL343392,P08254,,CWDNVRNHSFACNA-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1049769,DTCC00324624,1294865,15462
CHEMBL343414,P08254,,REJAGHRLIZEVSB-SUMWQHHRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,11,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1618977,DTCC00333040,1714822,16049
CHEMBL34353,P08254,,LQNNJMYUCBDMHA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11378378,IC50,>,2000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,104899,DTCT0024060,1015890,DTCC00173334,1520107,4214
CHEMBL343547,P08254,,BAAHKTZFKMCWLC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1039865,DTCC00324337,1618734,15462
CHEMBL343653,P08254,,KJBQTISDZZFFDE-LAUBAEHRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1599907,DTCC00333213,1262491,16049
CHEMBL343718,P08254,,UUAWXQCKXNEYJL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,175,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1399350,DTCC00325337,886414,15412
CHEMBL343775,P08254,,NYWZLYBVEDVMSN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1052401,DTCC00325260,1036212,15462
CHEMBL343818,P08254,,RNMKXQYTQJNJRJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,400,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1054927,DTCC00324445,357522,15462
CHEMBL343855,P08254,,YIYXDKFJIKECAM-KBXCAEBGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1638034,DTCC00333078,1683203,16049
CHEMBL343860,P08254,,QXMQRADDQYZCBO-SMDDNHRTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,33,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1622912,DTCC00333524,907645,16049
CHEMBL343911,P08254,,NXRASPQMAAGLPZ-DFCKQENNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,10,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1624047,DTCC00333891,2034900,16049
CHEMBL344029,P08254,,IGJDRNDPWLIBBQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1043546,DTCC00323987,1807303,15462
CHEMBL344410,P08254,,OTJGAHJWYSLTDB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,500,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1026188,DTCC00324852,453846,15462
CHEMBL344453,P08254,,MIWJQVMHJSFHGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,737,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1386973,DTCC00326246,1723968,15412
CHEMBL344545,P08254,,WIWASQOQNPNFMY-SMDDNHRTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,13,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1627972,DTCC00333585,1457036,16049
CHEMBL344587,P08254,,JROHDXNIWULULC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1023702,DTCC00323938,712960,15462
CHEMBL344633,P08254,,TUSYEXLVYIINDP-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,1.1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1381937,DTCC00325573,1306625,15412
CHEMBL344634,P08254,,VCUJZXCWHYPIIH-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,6.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1369146,DTCC00325533,1176355,15412
CHEMBL344714,P08254,,NGILBKZKRQUURV-SWLSCSKDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1608709,DTCC00333523,1521889,16049
CHEMBL344778,P08254,,HDBHDPIRGZHXCM-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,12,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1631636,DTCC00333705,162628,16049
CHEMBL344827,P08254,,HXTKAAOSFRMCEF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,500,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1049765,DTCC00324547,971250,15462
CHEMBL344828,P08254,,XGJAXXYDMLECBQ-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,17,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1394379,DTCC00325372,1404315,15412
CHEMBL344828,P08254,,XGJAXXYDMLECBQ-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,16.98,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258573,DTCC00325372,1394250,24803
CHEMBL344999,P08254,,PDYICDUZWJCQQF-MAUKXSAKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1636638,DTCC00333620,616105,16049
CHEMBL345054,P08254,,SKVZRQFKXKDXCW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,15,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1381927,DTCC00325338,1112941,15412
CHEMBL345200,P08254,,ISNHZTGWQYYHNX-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104905,DTCT0024060,646293,DTCC00350698,1145547,15057
CHEMBL345244,P08254,,UAZHKINNICKCCP-WSMRJJHLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,965,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1427026,DTCC00353507,1915756,12880
CHEMBL345305,P08254,,MDHGHVZOCBQJRL-BCAKYAHRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229774,IC50,=,770,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-3 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,104580,DTCT0024060,562258,DTCC00344460,141852,4692
CHEMBL345305,P08254,,MDHGHVZOCBQJRL-BCAKYAHRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,776.25,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258551,DTCC00344460,131664,24803
CHEMBL345306,P08254,,PCGCWQHPTVXXQZ-JZTDYHMVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229774,IC50,=,110,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-3 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,104580,DTCT0024060,559905,DTCC00344461,1724206,4692
CHEMBL345306,P08254,,PCGCWQHPTVXXQZ-JZTDYHMVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,109.65,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258552,DTCC00344461,1716221,24803
CHEMBL345445,P08254,,GBABKPSGHJLCTJ-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,275,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1112968,DTCC00344216,402313,4691
CHEMBL345445,P08254,,GBABKPSGHJLCTJ-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,275.42,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258403,DTCC00344216,391950,24803
CHEMBL345447,P08254,,FKSBYESEMYJJHL-KXUYPQTPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229774,IC50,=,2.6,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-3 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,104580,DTCT0024060,572889,DTCC00344326,1208729,4692
CHEMBL345447,P08254,,FKSBYESEMYJJHL-KXUYPQTPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,2.57,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258560,DTCC00344326,1198922,24803
CHEMBL345597,P08254,,NLABJQQLMHAJIL-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104905,DTCT0024060,631637,DTCC00350721,1274348,15057
CHEMBL345640,P08254,,IHNXSBCQZROJCS-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,1895,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1427029,DTCC00353657,595629,12880
CHEMBL345768,P08254,THIOURACIL,ZEMGGZBWXRYJHK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,47,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103732,DTCC00337992,1283745,43205
CHEMBL345818,P08254,,WQVQASAGIHVFJO-ZJSXRUAMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,>,10000,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1110317,DTCC00344057,1565527,4691
CHEMBL346256,P08254,,RBLCSCFFNCADJO-DNOBIOAJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831905,KI,>,650,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugs.,J. Med. Chem.,2002,45,4,"Sawa M, Tsukamoto T, Kiyoi T, Kurokawa K, Nakajima F, Nakada Y, Yokota K, Inoue Y, Kondo H, Yoshino K",,104744,DTCT0024060,577517,DTCC00345318,854711,17148
CHEMBL346256,P08254,,RBLCSCFFNCADJO-DNOBIOAJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11844676,KI,>,650,NM,,,,,,,,,,,,,,Inhibitory constant against recombinant human stromelysin-1 (Matrix metalloprotease-3),,Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.,Bioorg. Med. Chem. Lett.,2002,12,4,"Sawa M, Kondo H, Nishimura S",,104879,DTCT0024060,1406537,DTCC00345318,842676,5346
CHEMBL346442,P08254,,YBRVBUDXSMPLGQ-YPFLROGLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,<,1,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,490551,DTCC00340681,1145418,15546
CHEMBL346575,P08254,,OATYFBJQDLKLNJ-QGFSVNGOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11844676,KI,=,47.5,NM,,,,,,,,,,,,,,Inhibitory constant against recombinant human stromelysin-1 (Matrix metalloprotease-3),,Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.,Bioorg. Med. Chem. Lett.,2002,12,4,"Sawa M, Kondo H, Nishimura S",,104879,DTCT0024060,1437188,DTCC00345668,1229718,5346
CHEMBL346624,P08254,,QRDYOYPORKWZCP-YDRQLGOLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,16,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,477743,DTCC00340174,1786615,15546
CHEMBL347021,P08254,,KFUADVZPCULIED-KWMCUTETSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11844676,KI,>,650,NM,,,,,,,,,,,,,,Inhibitory constant against recombinant human stromelysin-1 (Matrix metalloprotease-3),,Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.,Bioorg. Med. Chem. Lett.,2002,12,4,"Sawa M, Kondo H, Nishimura S",,104879,DTCT0024060,1429474,DTCC00345408,1229719,5346
CHEMBL347209,P08254,,SQYRXZTYDRVAMZ-UKPGIYTDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11844676,KI,=,30,NM,,,,,,,,,,,,,,Inhibitory constant against recombinant human stromelysin-1 (Matrix metalloprotease-3),,Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.,Bioorg. Med. Chem. Lett.,2002,12,4,"Sawa M, Kondo H, Nishimura S",,104879,DTCT0024060,1441080,DTCC00345299,1360430,5346
CHEMBL347249,P08254,,PEYDLXUGPQEGEZ-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,2194,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1424554,DTCC00353292,206212,12880
CHEMBL347440,P08254,,DZWVTHAIOWIVNT-ZQHDKMAOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831905,KI,=,6.75,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugs.,J. Med. Chem.,2002,45,4,"Sawa M, Tsukamoto T, Kiyoi T, Kurokawa K, Nakajima F, Nakada Y, Yokota K, Inoue Y, Kondo H, Yoshino K",,104744,DTCT0024060,545046,DTCC00345289,886960,17148
CHEMBL347440,P08254,,DZWVTHAIOWIVNT-ZQHDKMAOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11844676,KI,=,6.75,NM,,,,,,,,,,,,,,Inhibitory constant against recombinant human stromelysin-1 (Matrix metalloprotease-3),,Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.,Bioorg. Med. Chem. Lett.,2002,12,4,"Sawa M, Kondo H, Nishimura S",,104879,DTCT0024060,1408735,DTCC00345289,875202,5346
CHEMBL347594,P08254,,FYHSMVNHGKEDAV-VDKIKQQVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,3200,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1133925,DTCC00344077,109424,4691
CHEMBL347594,P08254,,FYHSMVNHGKEDAV-VDKIKQQVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,3235.94,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258394,DTCC00344077,99394,24803
CHEMBL347595,P08254,,ITYFHVLIAPNWSK-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,4.4,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1133922,DTCC00343820,109422,4691
CHEMBL347595,P08254,,ITYFHVLIAPNWSK-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,4.37,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258418,DTCC00343820,99392,24803
CHEMBL347673,P08254,,MSDABIFBXLTNAU-KIFXHHALSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229774,IC50,=,25,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-3 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,104580,DTCT0024060,555342,DTCC00344372,2078318,4692
CHEMBL347673,P08254,,MSDABIFBXLTNAU-KIFXHHALSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,25.12,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258548,DTCC00344372,2068204,24803
CHEMBL347883,P08254,,ZJYCLDORACELQK-AYLZSAKASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11844676,KI,>,650,NM,,,,,,,,,,,,,,Inhibitory constant against recombinant human stromelysin-1 (Matrix metalloprotease-3),,Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.,Bioorg. Med. Chem. Lett.,2002,12,4,"Sawa M, Kondo H, Nishimura S",,104879,DTCT0024060,1407591,DTCC00345300,1936267,5346
CHEMBL348210,P08254,,AJUUQAWYLUYLDD-SBXXRYSUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,20,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,476536,DTCC00340474,563217,15546
CHEMBL348688,P08254,,QFUASBJNVCIDLY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,IC50,=,460,NM,,,,,,,,,,,,,,Inhibition of Stromelysin (MMP-3),,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205630,DTCT0024060,1268237,DTCC00343243,1883438,17092
CHEMBL348755,P08254,,QTEIHMLBMPKKIZ-RPWUZVMVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,12500,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1408827,DTCC00353752,660389,12880
CHEMBL348784,P08254,,JYFVLQFUNILWSZ-SGNDLWITSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,3570,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1436105,DTCC00353481,1404664,12880
CHEMBL348826,P08254,,ZPYLLHLHJRMHKM-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,1485,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1419520,DTCC00352938,1915757,12880
CHEMBL348878,P08254,,ZFQPFNFJKNLTIW-KFACBJOOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229774,IC50,=,26,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-3 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,104580,DTCT0024060,547924,DTCC00344327,1565535,4692
CHEMBL348878,P08254,,ZFQPFNFJKNLTIW-KFACBJOOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,25.7,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258562,DTCC00344327,1555535,24803
CHEMBL349099,P08254,,YXFLQXXMKGQVQR-BPUDTRNYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,2800,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1124753,DTCC00344070,1630285,4691
CHEMBL349099,P08254,,YXFLQXXMKGQVQR-BPUDTRNYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,5370.32,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258398,DTCC00344070,1620399,24803
CHEMBL349124,P08254,,NXKGLSOWQLOKML-FPNNDXFKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,10,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1095574,DTCC00343873,466084,4691
CHEMBL349397,P08254,,HQKHAIXFILRCNW-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,5800,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,7,,,102093,DTCT0024060,594949,DTCC00362577,2066954,2023
CHEMBL349800,P08254,,SHHQJBCQHBRODF-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,2976,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1420826,DTCC00352961,1786771,12880
CHEMBL350140,P08254,,DXBIPBLPCDPKOH-VJBWXMMDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,2169,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1443450,DTCC00352840,1819328,12880
CHEMBL350231,P08254,,OFJQHDDSKOHCOJ-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,6.8,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1121175,DTCC00343896,271244,4691
CHEMBL350231,P08254,,OFJQHDDSKOHCOJ-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,6.76,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258417,DTCC00343896,260721,24803
CHEMBL350789,P08254,,BOROQFAWARDBDC-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,295,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1411013,DTCC00353885,1176698,12880
CHEMBL351344,P08254,,UEGCVARAGOWYMY-RVHYNSKXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,5633,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1439746,DTCC00353588,304369,12880
CHEMBL351887,P08254,,WSCXNRYTEGYOOB-VJBWXMMDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,5970,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1408864,DTCC00353448,563379,12880
CHEMBL351888,P08254,,IZXHKSIJYAXOFC-DUGVZXTISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,631,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1438573,DTCC00352919,499093,12880
CHEMBL351968,P08254,,OMXCPVVQAGTBGJ-PVHODMMVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,72,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1413643,DTCC00352920,628129,12880
CHEMBL352066,P08254,,FICMSWGEHHLVLO-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,>,10000,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1431973,DTCC00353629,109555,12880
CHEMBL352068,P08254,,IPBUPOIKMNEPGS-ULNSLHSMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,216,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1429586,DTCC00353368,692555,12880
CHEMBL352231,P08254,,PAILGNIROCKBQU-ZNZIZOMTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,1370,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1423508,DTCC00353537,1598163,12880
CHEMBL352232,P08254,,FRRDNYNCIZOSSI-ZNZIZOMTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,427,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1407674,DTCC00352800,1662652,12880
CHEMBL352609,P08254,,NKDAHLSBYWSQCA-NOZRDPDXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,140,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,7,,,102093,DTCT0024060,598602,DTCC00362073,2002344,2023
CHEMBL353382,P08254,,SRVJEHMEZKLIMK-TWOQFEAHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871551,KI,=,13,NM,,,,,,,,,,,,,,Binding affinity against human matrix metalloprotease-3.,,Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,7,"Jacobson IC, Reddy PG, Wasserman ZR, Hardman KD, Covington MB, Arner EC, Copeland RA, Decicco CP, Magolda RL",,101949,DTCT0024060,478550,DTCC00365163,681136,3059
CHEMBL353383,P08254,,ZLRCEJNKSZLBHZ-SFYKDHMMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871551,KI,=,25,NM,,,,,,,,,,,,,,Binding affinity against human matrix metalloprotease-3.,,Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,7,"Jacobson IC, Reddy PG, Wasserman ZR, Hardman KD, Covington MB, Arner EC, Copeland RA, Decicco CP, Magolda RL",,101949,DTCT0024060,488894,DTCC00364600,227275,3059
CHEMBL353479,P08254,,LMQSRMOBSSJUST-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9888835,IC50,=,700,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,104722,DTCT0024060,1137930,DTCC00370460,1501483,15162
CHEMBL35348,P08254,,MVNUXJNXEWKALY-SPEDKVCISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873367,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104581,DTCT0024060,871401,DTCC00171501,1881622,2600
CHEMBL353536,P08254,,SQYRXZTYDRVAMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,29.6,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1409286,DTCC00372444,32662,17147
CHEMBL353775,P08254,,OSDJVSPJKNBXKV-SKPFHBQLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871551,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity against human matrix metalloprotease-3.,,Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,7,"Jacobson IC, Reddy PG, Wasserman ZR, Hardman KD, Covington MB, Arner EC, Copeland RA, Decicco CP, Magolda RL",,101949,DTCT0024060,476127,DTCC00365143,1651383,3059
CHEMBL354007,P08254,,NKAFEKVEMSYZIX-YDHSSHFGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871551,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity against human matrix metalloprotease-3.,,Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,7,"Jacobson IC, Reddy PG, Wasserman ZR, Hardman KD, Covington MB, Arner EC, Copeland RA, Decicco CP, Magolda RL",,101949,DTCT0024060,486583,DTCC00365190,552023,3059
CHEMBL35476,P08254,,CTGVDIGFCHCCJU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11378378,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,104899,DTCT0024060,1042178,DTCC00173371,1002127,4214
CHEMBL355418,P08254,,XCMRAHNFEHFBSX-DZNDNOMISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871551,KI,=,7,NM,,,,,,,,,,,,,,Binding affinity against human matrix metalloprotease-3.,,Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,7,"Jacobson IC, Reddy PG, Wasserman ZR, Hardman KD, Covington MB, Arner EC, Copeland RA, Decicco CP, Magolda RL",,101949,DTCT0024060,493847,DTCC00364599,454326,3059
CHEMBL355745,P08254,,KZEKPHQHOHAGJZ-ZYLNGJIFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871551,KI,=,70,NM,,,,,,,,,,,,,,Binding affinity against human matrix metalloprotease-3.,,Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,7,"Jacobson IC, Reddy PG, Wasserman ZR, Hardman KD, Covington MB, Arner EC, Copeland RA, Decicco CP, Magolda RL",,101949,DTCT0024060,488891,DTCC00365410,162990,3059
CHEMBL355752,P08254,,GPPXSZZXGYMBHW-QKFKETGDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9888835,IC50,=,67.9,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,104722,DTCT0024060,1144683,DTCC00372315,854716,15162
CHEMBL355754,P08254,,VERLVIKCRNRVAE-BLVKFPJESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9888835,IC50,=,130500,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,104722,DTCT0024060,1174151,DTCC00372098,369792,15162
CHEMBL355797,P08254,,QSFJZGINKPYVRC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,0.53,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1431012,DTCC00370549,109746,17147
CHEMBL356011,P08254,,CYBDDZKSRZPTQR-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,14,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,510232,DTCC00340538,1851292,15546
CHEMBL35602,P08254,,GKHRDWHFKKUYAX-KURKYZTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873367,IC50,=,59,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104581,DTCT0024060,867409,DTCC00171530,2044385,2600
CHEMBL356079,P08254,,HZELUBQHAZKZKC-SWLSCSKDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,23,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1636651,DTCC00332987,551673,16049
CHEMBL356197,P08254,,SJEZCZDPHRGCGU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,IC50,=,450,NM,,,,,,,,,,,,,,Inhibition of Stromelysin (MMP-3),,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205630,DTCT0024060,1251651,DTCC00343347,271229,17092
CHEMBL356413,P08254,,BQKZRXTUCVWMIN-AUSIDOKSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229774,IC50,=,40,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-3 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,104580,DTCT0024060,547927,DTCC00344506,1786666,4692
CHEMBL356413,P08254,,BQKZRXTUCVWMIN-AUSIDOKSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,39.81,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258549,DTCC00344506,1776495,24803
CHEMBL356471,P08254,,RYMINZKMUZXTLF-CDCQXCROSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,512673,DTCC00340433,1339485,15546
CHEMBL356504,P08254,,WUVSVKLVNMIEJM-WMLDXEAASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,46,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1606318,DTCC00333828,292453,16049
CHEMBL356520,P08254,,SBIQGLZKCCTUIC-HEHGZKQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,10,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1603800,DTCC00333766,1651018,16049
CHEMBL356837,P08254,,KTYADSSNJMMACA-NHTMILBNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,850,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,6,,,102085,DTCT0024060,994990,DTCC00340622,1036386,1529
CHEMBL357050,P08254,,OECFBMNWNGPPFC-RQNDZEIBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,15,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,506542,DTCC00340841,756859,15546
CHEMBL357233,P08254,,SSVAOOCBANMUMS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,5.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1394370,DTCC00326279,1981003,15412
CHEMBL357728,P08254,,BUOKQWSUTKFXOW-NLKUQUHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,476530,DTCC00340744,402280,15546
CHEMBL357796,P08254,,AKTPDJLIUXRMDA-SBXXRYSUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,222,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,491840,DTCC00340775,660245,15546
CHEMBL357871,P08254,,WEXOVDYJKZSHRN-SMDDNHRTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1599904,DTCC00333966,971368,16049
CHEMBL357904,P08254,,VLGURNLPQGCFIS-JOYOIKCWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,300,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1630557,DTCC00333334,162629,16049
CHEMBL357934,P08254,,GWZMHEYDUOAMNJ-AFDUHFSSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,12,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,495551,DTCC00340680,1113106,15546
CHEMBL358061,P08254,,HAIGFFSNUYJTQK-MAUKXSAKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1608705,DTCC00333706,97822,16049
CHEMBL358064,P08254,,ULDXUWXTVRRUND-SWLSCSKDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,16,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1624037,DTCC00333936,1229583,16049
CHEMBL358149,P08254,,YYRRVFYCIQQYHU-CQGGRAHPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11844676,KI,>,650,NM,,,,,,,,,,,,,,Inhibitory constant against recombinant human stromelysin-1 (Matrix metalloprotease-3),,Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.,Bioorg. Med. Chem. Lett.,2002,12,4,"Sawa M, Kondo H, Nishimura S",,104879,DTCT0024060,1441077,DTCC00345847,1197503,5346
CHEMBL358182,P08254,,NIUQIJFMBOIHLA-WPZCJLIBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,21,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,502900,DTCC00340840,1786616,15546
CHEMBL358397,P08254,,GYNSLTWFIKRZQF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,IC50,=,640,NM,,,,,,,,,,,,,,Inhibition of Stromelysin (MMP-3),,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205630,DTCT0024060,1273823,DTCC00343534,1404547,17092
CHEMBL358405,P08254,,RQEBSVZFRXVOLZ-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,69,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,496679,DTCC00340792,1241485,15546
CHEMBL358697,P08254,MERCAPTOPROPIONIC ACID,DKIDEFUBRARXTE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,=,3000000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in place of acetohydroxamic acid.,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205633,DTCT0024060,1282857,DTCC00343504,1565514,17092
CHEMBL358812,P08254,,KJQLQEWCQDLQEA-GXFFZTMASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1615061,DTCC00333618,1683204,16049
CHEMBL359716,P08254,,RAGDORVOHODYFH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15686921,KI,=,1300,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302480,DTCT0024060,1744793,DTCC00381579,1586741,18787
CHEMBL360040,P08254,,ZHAOFRAGRRVGNI-NQCNTLBGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15780605,CONCENTRATION,=,1000,NM,,,,,,,,,,,,,,Binding affinity for human Matrix metalloprotease-3,,QSAR-by-NMR: quantitative insights into structural determinants for binding affinity by analysis of 1H/15N chemical shift differences in MMP-3 ligands.,Bioorg. Med. Chem. Lett.,2005,15,7,"Matter H, Schudok M, Elshorst B, Jacobs DM, Saxena K, Kogler H",,308392,DTCT0024060,1748667,DTCC00383434,692946,18912
CHEMBL360609,P08254,,YKSIUQZREKHXCH-AEFFLSMTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15369398,INHIBITION,=,68,%,,,,,,,,,,,,,,Inhibition of MMP-3 (matrix metalloprotease) at 1 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307796,DTCT0024060,1789969,DTCC00392956,616784,19089
CHEMBL360609,P08254,,YKSIUQZREKHXCH-AEFFLSMTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15369398,INHIBITION,=,73,%,,,,,,,,,,,,,,Inhibition of MMP-3 (matrix metalloprotease) at 10 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307803,DTCT0024060,1789959,DTCC00392956,616784,19089
CHEMBL361219,P08254,,OYIPUXHXYNUYPO-VYRBHSGPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15780605,CONCENTRATION,=,400,NM,,,,,,,,,,,,,,Binding affinity for human Matrix metalloprotease-3,,QSAR-by-NMR: quantitative insights into structural determinants for binding affinity by analysis of 1H/15N chemical shift differences in MMP-3 ligands.,Bioorg. Med. Chem. Lett.,2005,15,7,"Matter H, Schudok M, Elshorst B, Jacobs DM, Saxena K, Kogler H",,308392,DTCT0024060,1748663,DTCC00383281,1787127,18912
CHEMBL361449,P08254,,NKJYIBRDRYQXFN-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15369398,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP-3 (matrix metalloprotease) at 1 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307796,DTCT0024060,1791015,DTCC00392763,1295652,19089
CHEMBL361449,P08254,,NKJYIBRDRYQXFN-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15369398,INHIBITION,=,8,%,,,,,,,,,,,,,,Inhibition of MMP-3 (matrix metalloprotease) at 10 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307803,DTCT0024060,1791005,DTCC00392763,1295652,19089
CHEMBL361527,P08254,,QBWALRVIJDSECI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15686921,KI,=,92,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302480,DTCT0024060,1745331,DTCC00381643,1360847,18787
CHEMBL361527,P08254,,QBWALRVIJDSECI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15686921,KI,=,1200,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302480,DTCT0024060,1745337,DTCC00381643,1360848,18787
CHEMBL3617400,P08254,,NUFBSNVYZRUJSW-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26263024,IC50,=,450,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP3 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518238,DTCT0024060,14545600,DTCC01663485,1291518,63632
CHEMBL3617401,P08254,,KUDQLMASLRCXLF-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26263024,IC50,=,71,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP3 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518238,DTCT0024060,14545599,DTCC01663486,839147,63632
CHEMBL3617402,P08254,,QHHHTEGVVKPDKH-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26263024,IC50,=,47,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP3 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518238,DTCT0024060,14545617,DTCC01663487,126658,63632
CHEMBL3617403,P08254,,NJZUERVIVLYZMO-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26263024,IC50,=,120,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP3 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518238,DTCT0024060,14545618,DTCC01663488,94439,63632
CHEMBL3617404,P08254,,UJKKQEHHLXCTJE-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26263024,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP3 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518238,DTCT0024060,14545619,DTCC01663489,1161438,63632
CHEMBL3617405,P08254,,WVPKYEATTXWJLC-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26263024,IC50,=,36,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP3 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518238,DTCT0024060,14545620,DTCC01663490,1739733,63632
CHEMBL3617407,P08254,,WQCXDERWRJMJQA-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26263024,IC50,=,105,NM,,,,,,,,,,,,,,Inhibition of recombinant human activated-MMP3 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as fluorogenic substrate incubated for 4 hrs followed by substrate addition measured every 10 secs for 20 mins by fluorometric assay,,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,J. Med. Chem.,2015,58,18,"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A",,1518238,DTCT0024060,14545621,DTCC01663492,2063303,63632
CHEMBL362651,P08254,,PKVXJRTWUNPBJP-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15713379,IC50,=,130,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305734,DTCT0024060,1747895,DTCC00381850,1936708,18841
CHEMBL3639695,P08254,,PZMQNEDVJSDLAW-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,85,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247472,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,178481,DTCC01703280,1130506,64498
CHEMBL3639744,P08254,,SAIHVCSOGMUZPK-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247506,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,173473,DTCC01708180,1615862,64498
CHEMBL3643914,P08254,,XYPVMSYCSIAWKF-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,4500,NM,,,,,,,,,,,,,,"BindingDB_Patents: Enzymatic Assay. The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentration range of from 10 uM to 0.5 nM final concentration. The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19,155-161) and is added so as to have a signal equivalent to 6 times the background noise in 2 h at 37C. The reaction is carried out in 50 mM Tris buffered medium containing 4% glycerol, pH 7.4. The fluorescent substrate is MCA-Pro-Leu-Ala-Val-(Dpa)-Arg-Ser-Ser-Arg-NH2 (R and D systems, reference: ES003). The substrate is cleaved by the enzyme between the alanine and the valine, thus releasing a fluorescent peptide (excitation: 320 nm, emission: 420 nm). The substrate is used at 40 uM. The reaction is carried out in a final volume of 10 ul (4 ul inhibitor, 4 ul substrate, 2 ul enzyme) in a low volume 384-well plate (Corning reference: 3676).",255759,"Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics",,2014,,,,,1535113,DTCT0024060,168975,DTCC01676227,1336121,64597
CHEMBL3643916,P08254,,KHOXRRQYROMPSZ-QHCPKHFHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,3034,NM,,,,,,,,,,,,,,"BindingDB_Patents: Enzymatic Assay. The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentration range of from 10 uM to 0.5 nM final concentration. The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19,155-161) and is added so as to have a signal equivalent to 6 times the background noise in 2 h at 37C. The reaction is carried out in 50 mM Tris buffered medium containing 4% glycerol, pH 7.4. The fluorescent substrate is MCA-Pro-Leu-Ala-Val-(Dpa)-Arg-Ser-Ser-Arg-NH2 (R and D systems, reference: ES003). The substrate is cleaved by the enzyme between the alanine and the valine, thus releasing a fluorescent peptide (excitation: 320 nm, emission: 420 nm). The substrate is used at 40 uM. The reaction is carried out in a final volume of 10 ul (4 ul inhibitor, 4 ul substrate, 2 ul enzyme) in a low volume 384-well plate (Corning reference: 3676).",255760,"Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics",,2014,,,,,1535113,DTCT0024060,164124,DTCC01676229,431255,64597
CHEMBL364979,P08254,,NUMGTAZEZUDGNC-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15369398,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP-3 (matrix metalloprotease) at 1 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307796,DTCT0024060,1790896,DTCC00392916,98440,19089
CHEMBL364979,P08254,,NUMGTAZEZUDGNC-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15369398,INHIBITION,=,6,%,,,,,,,,,,,,,,Inhibition of MMP-3 (matrix metalloprotease) at 10 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307803,DTCT0024060,1790993,DTCC00392916,98440,19089
CHEMBL365632,P08254,,PGPCNXNVLLYCGR-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15369398,INHIBITION,=,81,%,,,,,,,,,,,,,,Inhibition of MMP-3 (matrix metalloprotease) at 1 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307796,DTCT0024060,1789957,DTCC00392926,908338,19089
CHEMBL365632,P08254,,PGPCNXNVLLYCGR-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15369398,INHIBITION,=,99,%,,,,,,,,,,,,,,Inhibition of MMP-3 (matrix metalloprotease) at 10 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307803,DTCT0024060,1789842,DTCC00392926,908338,19089
CHEMBL365910,P08254,,RANUWAUPDVMUKD-NHCUHLMSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15369398,INHIBITION,=,3,%,,,,,,,,,,,,,,Inhibition of MMP-3 (matrix metalloprotease) at 1 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307796,DTCT0024060,1790764,DTCC00392611,908333,19089
CHEMBL365910,P08254,,RANUWAUPDVMUKD-NHCUHLMSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15369398,INHIBITION,=,4,%,,,,,,,,,,,,,,Inhibition of MMP-3 (matrix metalloprotease) at 10 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307803,DTCT0024060,1790765,DTCC00392611,908333,19089
CHEMBL365947,P08254,,WXPUJRINFGPEGC-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16153831,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against MMP-3; - = not available,Not Determined,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321291,DTCT0024060,1860382,DTCC00407674,1695368,19837
CHEMBL366111,P08254,,WJULIBHPWZXMJA-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15324896,IC50,=,55,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease 3,,3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.,Bioorg. Med. Chem. Lett.,2004,14,18,"Noe MC, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Liras JL, Vaughn M",,305043,DTCT0024060,1768935,DTCC00388400,142333,18227
CHEMBL36615,P08254,,MJDJFIONJBJENE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,62,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1577254,DTCC00180255,1913767,4273
CHEMBL366478,P08254,,RBLCSCFFNCADJO-UEEDVJNSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,5.2,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1419882,DTCC00371830,1786982,17147
CHEMBL366759,P08254,,FTSDPRIBDLXKCA-OYLFLEFRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9888835,IC50,=,49300,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,104722,DTCT0024060,1156537,DTCC00373331,1501484,15162
CHEMBL36682,P08254,,UCIQGUFPHONIDI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,IC50,=,143000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104727,DTCT0024060,888327,DTCC00178294,549804,15677
CHEMBL36682,P08254,,UCIQGUFPHONIDI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,85000,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,888328,DTCC00178294,549804,15677
CHEMBL3670691,P08254,,FBDOWURNGYMLPJ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,118,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247466,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,174425,DTCC01703274,839513,64498
CHEMBL3670692,P08254,,KOVQMCGGWATESY-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,240,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247467,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,173249,DTCC01703275,127019,64498
CHEMBL3670693,P08254,,KOVQMCGGWATESY-FCHUYYIVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247468,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,180964,DTCC01703276,1098405,64498
CHEMBL3670694,P08254,,KOVQMCGGWATESY-FGZHOGPDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,897,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247469,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,173611,DTCC01703277,289306,64498
CHEMBL3670695,P08254,,QCVLVTVGVJUODZ-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,243,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247470,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,184057,DTCC01703278,2031908,64498
CHEMBL3670696,P08254,,MFTZEUCXFCXINH-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,381,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247471,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,181159,DTCC01703279,1518861,64498
CHEMBL3670697,P08254,,CNPRJTXDIHRZPF-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,302,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247473,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,178686,DTCC01703281,1357220,64498
CHEMBL3670698,P08254,,LFUNCOOVDREPBK-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,129,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247474,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,185288,DTCC01703282,1711859,64498
CHEMBL3670699,P08254,,QDHXNZRPVLUOML-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,575,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247475,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,160596,DTCC01703283,774361,64498
CHEMBL3670700,P08254,,HCTHWCGSCVVHLJ-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247477,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,167343,DTCC01703284,1583049,64498
CHEMBL3670701,P08254,,FFHINXVCVWQCSG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,78,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247478,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,161188,DTCC01703285,904397,64498
CHEMBL3670702,P08254,,HXOLPPZDNXMRHR-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,699,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247479,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,167546,DTCC01703286,1357221,64498
CHEMBL3670703,P08254,,BMJUABISSDGKOA-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,440,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247480,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,183524,DTCC01703287,580739,64498
CHEMBL3670704,P08254,,NZUPMMOEPOVBQE-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,750,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247481,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,167232,DTCC01703288,1680152,64498
CHEMBL3670705,P08254,,JUEZHKLAFJJQNE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247482,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,176932,DTCC01703289,1389860,64498
CHEMBL3670706,P08254,,OFRXWZGHEVNQHU-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,105,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247483,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,158715,DTCC01703290,1836770,64498
CHEMBL3670707,P08254,,VFEIVMVXXWQZER-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247484,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,161983,DTCC01703291,1259462,64498
CHEMBL3670708,P08254,,IIUXBHAJTPNCIR-KKSFZXQISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,460,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247485,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,171591,DTCC01703292,1291821,64498
CHEMBL3670709,P08254,,KNJBHXZWYFARSA-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247486,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,178879,DTCC01703293,1647965,64498
CHEMBL3670710,P08254,,FRXRVVOCWBNHOQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247487,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,179282,DTCC01703294,1065482,64498
CHEMBL3670711,P08254,,MNXXFUIRJNLTHG-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247488,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,178471,DTCC01703295,1771871,64498
CHEMBL3670712,P08254,,XNQPIVCSZRQAQO-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247489,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,166237,DTCC01703296,420053,64498
CHEMBL3670713,P08254,,ACXIBBRPTTWRDM-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247490,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,171953,DTCC01703297,839514,64498
CHEMBL3670714,P08254,,RAOGWYCOADLHPD-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247491,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,179961,DTCC01703298,548550,64498
CHEMBL3670715,P08254,,AVFCHUYQSZAIFE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247492,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,166034,DTCC01703299,1998926,64498
CHEMBL3670716,P08254,,GSEYFLJSDKPLAI-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247493,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,163510,DTCC01703300,1550906,64498
CHEMBL3670717,P08254,,VIPIKALUTUDDKU-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247494,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,159103,DTCC01703301,1771872,64498
CHEMBL3670718,P08254,,YUQQWAKBRAEWQZ-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247495,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,180868,DTCC01703302,710012,64498
CHEMBL3670719,P08254,,PLIPLRCYJWMTFY-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247496,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,173633,DTCC01703303,968343,64498
CHEMBL3670720,P08254,,BFJIOGLKGISOKV-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,281,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247497,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,171333,DTCC01703304,1226403,64498
CHEMBL3670721,P08254,,UOTSSZSXOLHXGG-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247498,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,174220,DTCC01703305,1291822,64498
CHEMBL367420,P08254,,BGYCEGKSSQJQNQ-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9888835,IC50,=,1040,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,104722,DTCT0024060,1154119,DTCC00371429,1630618,15162
CHEMBL367524,P08254,,XWZIZWWEAJZAMO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327602,IC50,=,9000,NM,,,,,,,,,,,,,,"Inhibition of Stromelysin, matrix metalloprotease-3",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,205496,DTCT0024060,971603,DTCC00374233,174399,4784
CHEMBL3675541,P08254,,RESDGLIYQGGYGR-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247499,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,165920,DTCC01708173,1615861,64498
CHEMBL3675542,P08254,,AEOWLQGPNGMHBP-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,337,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247500,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,183494,DTCC01708174,613076,64498
CHEMBL3675543,P08254,,XLKQIIIKETWLMI-HKUYNNGSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,88,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247501,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,176302,DTCC01708175,742365,64498
CHEMBL3675544,P08254,,YWXFICBFTYVHJU-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247502,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,182180,DTCC01708176,1324414,64498
CHEMBL3675545,P08254,,JYGPMNNMAQCQMG-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247503,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,179820,DTCC01708177,645830,64498
CHEMBL3675546,P08254,,VXYUSBYRYYLNHT-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247504,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,180635,DTCC01708178,2031940,64498
CHEMBL3675547,P08254,,DKTMPYACSYBQIF-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247505,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,180818,DTCC01708179,1194373,64498
CHEMBL3675548,P08254,,IIRLMDJELCRLPB-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247507,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,172463,DTCC01708181,548584,64498
CHEMBL3675549,P08254,,MXXLMDWJDJQNCZ-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247508,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,184295,DTCC01708182,968371,64498
CHEMBL3675550,P08254,,OTOPPWBRBAVQCM-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247509,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,179077,DTCC01708183,450759,64498
CHEMBL3675551,P08254,,LHURUBKIFBZDNZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247510,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,170481,DTCC01708184,2031941,64498
CHEMBL3675552,P08254,,MTMSSQNYFAAJSR-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,50000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247511,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,177724,DTCC01708185,321876,64498
CHEMBL3675553,P08254,,XTHLTIMASWPNRH-AKRCKQFNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247512,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,171016,DTCC01708186,904423,64498
CHEMBL3675554,P08254,,SJWYFGLDVUQIEF-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247513,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,183331,DTCC01708187,1259488,64498
CHEMBL3675555,P08254,,HXQNDQXHRNVKIA-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247514,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,178473,DTCC01708188,127053,64498
CHEMBL3675556,P08254,,UIEDXQBYCVBGGE-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247515,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,167252,DTCC01708189,1966318,64498
CHEMBL3675557,P08254,,BBERXYYXGJGELS-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,878,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247516,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,170965,DTCC01708190,127054,64498
CHEMBL3675558,P08254,,YUUVADHCMFJYGO-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247517,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,163401,DTCC01708191,872152,64498
CHEMBL3675559,P08254,,MVSSFLIDOBOIBL-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247518,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,161582,DTCC01708192,1098436,64498
CHEMBL3675560,P08254,,YWAKWFLUKNCYMP-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247519,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,180460,DTCC01708193,1194374,64498
CHEMBL3675561,P08254,,FHLZDDVMTVCEOC-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247520,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,161442,DTCC01708194,1804477,64498
CHEMBL3675562,P08254,,ZQBDVTJLOHIYJN-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247521,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,157967,DTCC01708195,1550939,64498
CHEMBL3675563,P08254,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,64,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247533,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,160227,DTCC01708196,645831,64498
CHEMBL3675563,P08254,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,74,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247522,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,165540,DTCC01708196,645831,64498
CHEMBL3675564,P08254,,RIICMTINBCLPOY-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,244,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247523,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,182068,DTCC01708197,806748,64498
CHEMBL3675565,P08254,,BVKYTKVUMKYONQ-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247524,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,177129,DTCC01708198,1389896,64498
CHEMBL3675566,P08254,,XHPUXKQBUUHEIP-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,168,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247525,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,178167,DTCC01708199,1130545,64498
CHEMBL3675567,P08254,,NHZSRXRDEWWJJS-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,620,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247526,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,174365,DTCC01708200,1065520,64498
CHEMBL3675568,P08254,,MDMQULYGCYNXQN-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,238,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247527,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,183689,DTCC01708201,321877,64498
CHEMBL3675569,P08254,,SAJAWNZBKHGJOW-MBMZGMDYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,337,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247528,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,185293,DTCC01708202,1550940,64498
CHEMBL3675570,P08254,,ZQUJAHCTHDEZMJ-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,108,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247529,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,159242,DTCC01708203,211,64498
CHEMBL3675571,P08254,,CKYKLNXMCJIGPN-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,258,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247530,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,164691,DTCC01708204,839552,64498
CHEMBL3675572,P08254,,WLZQVNRDQZYTID-PEFOLFAWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,231,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247531,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,182101,DTCC01708205,2063689,64498
CHEMBL3675573,P08254,,OUZMHHWAGJCAFA-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,34,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247532,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,160894,DTCC01708206,1000927,64498
CHEMBL3675574,P08254,,TYSBKRRVVCMKQG-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,300,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247534,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,169501,DTCC01708207,1518882,64498
CHEMBL3675575,P08254,,BICNEVCTASLTLM-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,16,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247535,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,180882,DTCC01708208,1161801,64498
CHEMBL3675576,P08254,,CWSSLFKLYYDKBD-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,252,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247536,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,169016,DTCC01708209,516548,64498
CHEMBL3675577,P08254,,NLIWJNDBQYUCSF-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,142,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247537,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,175213,DTCC01708210,321878,64498
CHEMBL3675578,P08254,,KHHNQNYSKXXUCV-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247538,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,182507,DTCC01708211,2063690,64498
CHEMBL3675579,P08254,,KAUWQENTXQTKQG-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,116,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247539,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,165351,DTCC01708212,1771918,64498
CHEMBL3675580,P08254,,IADFBNIHFKDTRS-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,203,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247540,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,178345,DTCC01708213,1194375,64498
CHEMBL3675581,P08254,,CXPHOOFGGKZGTC-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247541,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,177067,DTCC01708214,212,64498
CHEMBL3675582,P08254,,GIEQMQWMJSYCKB-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247542,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,170715,DTCC01708215,1033284,64498
CHEMBL3675583,P08254,,CPYISUHNJGFCRY-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247543,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,175521,DTCC01708216,1486575,64498
CHEMBL3675584,P08254,,VCJGVCZITQVJET-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247544,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,159064,DTCC01708217,1901139,64498
CHEMBL3675585,P08254,,QQGKYSPTORHWNZ-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247545,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,157212,DTCC01708218,1804478,64498
CHEMBL3675586,P08254,,UWVBDELWTIGPFO-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247546,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,167103,DTCC01708219,62372,64498
CHEMBL3675587,P08254,,ZMGHGYMGQVMACZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247547,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,183988,DTCC01708220,1486576,64498
CHEMBL3675588,P08254,,GWHSSPUFNDIEEQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247548,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,179125,DTCC01708221,677985,64498
CHEMBL3675589,P08254,,CTCTZAXBKWKMKL-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247549,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,181339,DTCC01708222,904424,64498
CHEMBL3675590,P08254,,PXQPONLRTWLOTH-IJHRGXPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,100000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247550,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,158198,DTCC01708223,1000928,64498
CHEMBL3675591,P08254,,DUPWUQYVKWCUOG-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247551,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,163626,DTCC01708224,839553,64498
CHEMBL3675592,P08254,,KEHDBOGRIVHUBV-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247552,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,166273,DTCC01708225,968372,64498
CHEMBL3675593,P08254,,QFGALMYSDQBVRH-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,108,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247553,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,175055,DTCC01708226,936273,64498
CHEMBL3675594,P08254,,ZWXRGJMHGHMUMB-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247554,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,172222,DTCC01708227,1740101,64498
CHEMBL3675595,P08254,,VLFDPMJDVIHWPI-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247555,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,183497,DTCC01708228,645832,64498
CHEMBL3675596,P08254,,KGPPRBTYRFIDAL-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247559,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,158285,DTCC01708229,904425,64498
CHEMBL3675597,P08254,,MUGAWCXYWNGHML-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247560,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,184642,DTCC01708230,420085,64498
CHEMBL3675598,P08254,,JMWVTDZGNUFBMO-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247561,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,176165,DTCC01708231,1740102,64498
CHEMBL3675599,P08254,,UUDTVMMARAFNKG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247562,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,173091,DTCC01708232,904426,64498
CHEMBL3675600,P08254,,GOLLITFKIKKRMV-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247563,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,169239,DTCC01708233,1259489,64498
CHEMBL3675601,P08254,,BLDFRIYOIZRRJI-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247564,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,167365,DTCC01708234,645833,64498
CHEMBL3675602,P08254,,FXBVEEBXIZYGRY-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247565,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,168867,DTCC01708235,580782,64498
CHEMBL3675603,P08254,,FKTHQTYGTOEBAW-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,791,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247567,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,164103,DTCC01708236,159656,64498
CHEMBL3675604,P08254,,KSDQQJBQFBNDIC-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247568,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,170439,DTCC01708237,159657,64498
CHEMBL3675605,P08254,,NIAIEBGBRXKPAO-NHTMILBNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,579,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248219,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,173403,DTCC01708238,256074,64498
CHEMBL3675606,P08254,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20817735,KI,=,3880,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14747517,DTCC01708239,2106911,69686
CHEMBL3675606,P08254,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22689580,KI,=,1000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14747518,DTCC01708239,2106910,68703
CHEMBL3675606,P08254,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247558,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,157403,DTCC01708239,1901140,64498
CHEMBL3675607,P08254,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22689580,KI,=,2995,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14759264,DTCC01708240,2111479,68703
CHEMBL3675607,P08254,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22689580,KI,=,2995,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14759913,DTCC01708240,2111479,68703
CHEMBL3675607,P08254,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247566,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535880,DTCT0024060,158214,DTCC01708240,289344,64498
CHEMBL367675,P08254,,VERLVIKCRNRVAE-CWTRNNRKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9888835,IC50,=,2550,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,104722,DTCT0024060,1145889,DTCC00371988,1274599,15162
CHEMBL367710,P08254,,HFCXLBPJFPHTAN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,67,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1416485,DTCC00371039,1209047,17147
CHEMBL368205,P08254,,LICJLIVFDQFASY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,24,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1417562,DTCC00373685,1851653,17147
CHEMBL368347,P08254,(+)-SECOISOLARICIRESINOL,PUETUDUXMCLALY-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535401,DTCC00371311,1812173,48665
CHEMBL368857,P08254,,GMNFREWQYNXZAF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,5.43,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1411446,DTCC00109175,951234,17147
CHEMBL368946,P08254,,KGUVBHLPMGERAT-BCHFMIIMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9888835,IC50,=,9170,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,104722,DTCT0024060,1161508,DTCC00373472,1819560,15162
CHEMBL370333,P08254,,HOXYEQZQHOZJQN-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16153831,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against MMP-3; - = not available,Not Determined,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321291,DTCT0024060,1860430,DTCC00407680,370185,19837
CHEMBL3704903,P08254,,GHBQSNPRMVUGFE-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,6306,NM,,,,,,,,,,,,,,"BindingDB_Patents: Enzyme Assay. The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAMS and ADAM10 according to the same protocol as that described for the TACE enzyme in example 28 but with different substrates (MMP R and D system reference: P126-990 and ADAM R and D system reference: ES003).",320811,"N-[2-hydroxycarbamoyl-2-(piperazinyl) ethyl] benzamide compounds, their preparation and their use as TACE inhibitors",,2015,,,,,1535920,DTCT0024060,165984,DTCC01737547,366999,65180
CHEMBL3704910,P08254,,PNRXTCCMSJTZGK-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,6827,NM,,,,,,,,,,,,,,"BindingDB_Patents: Enzyme Assay. The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAMS and ADAM10 according to the same protocol as that described for the TACE enzyme in example 28 but with different substrates (MMP R and D system reference: P126-990 and ADAM R and D system reference: ES003).",320812,"N-[2-hydroxycarbamoyl-2-(piperazinyl) ethyl] benzamide compounds, their preparation and their use as TACE inhibitors",,2015,,,,,1535920,DTCT0024060,174067,DTCC01737554,1337005,65180
CHEMBL3704919,P08254,,PWHWIWBGOFSUOR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,>,10000,NM,,,,,,,,,,,,,,"BindingDB_Patents: Enzyme Assay. The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAMS and ADAM10 according to the same protocol as that described for the TACE enzyme in example 28 but with different substrates (MMP R and D system reference: P126-990 and ADAM R and D system reference: ES003).",320813,"N-[2-hydroxycarbamoyl-2-(piperazinyl) ethyl] benzamide compounds, their preparation and their use as TACE inhibitors",,2015,,,,,1535920,DTCT0024060,169043,DTCC01737563,1784183,65180
CHEMBL370631,P08254,,RPOIZUWTBLHTNU-YTTGMZPUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16153831,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against MMP-3; - = not available,Not Determined,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321291,DTCT0024060,338862,DTCC00407679,1566231,19837
CHEMBL37147,P08254,,NVYQUIXKTUPQLY-VIFPVBQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,400,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,883437,DTCC00178205,257351,15677
CHEMBL373261,P08254,,DZOZBHZWCFMSKH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16392792,IC50,=,20,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.,J. Med. Chem.,2006,49,1,"Pirard B, Matter H",,329821,DTCT0024060,1880234,DTCC00411745,1230448,20214
CHEMBL373532,P08254,,SCOVLRMEIYKGOU-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17256836,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425540,DTCT0024060,2019779,DTCC00438874,467214,21880
CHEMBL373532,P08254,,SCOVLRMEIYKGOU-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,=,1237,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276523,DTCC00438874,455616,25086
CHEMBL373853,P08254,,CDQQKPZINNWUDS-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17256836,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425540,DTCT0024060,2019774,DTCC00438907,790106,21880
CHEMBL374377,P08254,,VWKXFDZWHLCIIU-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17088065,IC50,=,150,NM,,,,,,,,,,,,,,Inhibition of MMP3,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432504,DTCT0024060,2061770,DTCC00447804,1684492,22402
CHEMBL37537,P08254,PROTOCATECHUIC ACID,YQUVCSBJEUQKSH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103318,DTCC00174549,313612,43205
CHEMBL375418,P08254,,ZCDHAHOTIYZFKF-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17256836,IC50,=,450,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425540,DTCT0024060,2019771,DTCC00438915,1566520,21880
CHEMBL375418,P08254,,ZCDHAHOTIYZFKF-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,=,450,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276505,DTCC00438915,1555575,25086
CHEMBL3758299,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,73235,DTCC00074435,561086,65989
CHEMBL3758350,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,72563,DTCC00074407,948585,65989
CHEMBL3758501,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,72549,DTCC00074412,1304589,65989
CHEMBL3758580,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26641525,IC50,=,45000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin),,Azaphilones from an Acid Mine Extremophile Strain of a Pleurostomophora sp.,J. Nat. Prod.,2015,78,12,"Stierle AA, Stierle DB, Girtsman T, Mou TC, Antczak C, Djaballah H.",,1551982,DTCT0024060,68103,DTCC00074101,1816914,65977
CHEMBL3758625,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,72553,DTCC00074416,74878,65989
CHEMBL3758657,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,=,7210,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,72552,DTCC00074415,1271994,65989
CHEMBL3758659,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,72559,DTCC00074433,819184,65989
CHEMBL3758726,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,72564,DTCC00074406,754685,65989
CHEMBL3758757,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,72550,DTCC00074413,1434205,65989
CHEMBL3758763,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,72545,DTCC00074408,74877,65989
CHEMBL3759003,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,72558,DTCC00074421,1402218,65989
CHEMBL3759287,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,72548,DTCC00074411,1110924,65989
CHEMBL3759333,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26641525,IC50,=,130000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin),,Azaphilones from an Acid Mine Extremophile Strain of a Pleurostomophora sp.,J. Nat. Prod.,2015,78,12,"Stierle AA, Stierle DB, Girtsman T, Mou TC, Antczak C, Djaballah H.",,1551982,DTCT0024060,68862,DTCC00074098,948581,65977
CHEMBL3759468,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,73234,DTCC00074434,722469,65989
CHEMBL3759511,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,72555,DTCC00074418,981031,65989
CHEMBL3759520,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,72546,DTCC00074409,302011,65989
CHEMBL3759602,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26641525,IC50,=,15000,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (unknown origin),,Azaphilones from an Acid Mine Extremophile Strain of a Pleurostomophora sp.,J. Nat. Prod.,2015,78,12,"Stierle AA, Stierle DB, Girtsman T, Mou TC, Antczak C, Djaballah H.",,1551982,DTCT0024060,68117,DTCC00074099,236255,65977
CHEMBL3759716,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,=,8730,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,72547,DTCC00074410,561085,65989
CHEMBL3759727,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,72556,DTCC00074419,884425,65989
CHEMBL3759916,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,72557,DTCC00074420,268874,65989
CHEMBL3759952,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,72566,DTCC00074405,1369818,65989
CHEMBL3759997,P08254,,,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,72554,DTCC00074417,107149,65989
CHEMBL376557,P08254,,BUKCBCDGRPOFJP-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17088065,IC50,=,28,NM,,,,,,,,,,,,,,Inhibition of MMP3,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432504,DTCT0024060,2061769,DTCC00447810,1005132,22402
CHEMBL381189,P08254,,NSZHVJWSFHBPMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16392792,KI,=,2900,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.,J. Med. Chem.,2006,49,1,"Pirard B, Matter H",,329821,DTCT0024060,1880233,DTCC00411959,391231,20214
CHEMBL382201,P08254,,BZVYQWLRCHLAGK-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16451058,INHIBITION,<,15,%,,,,,,,,,,,,,,Inhibitory activity against MMP3 at 0.1 mM,,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330548,DTCT0024060,1887712,DTCC00413190,563987,20245
CHEMBL382201,P08254,,BZVYQWLRCHLAGK-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17088065,INHIBITION,=,16,%,,,,,,,,,,,,,,Inhibition of MMP3 at 100 uM,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432511,DTCT0024060,2061730,DTCC00413190,552885,22402
CHEMBL38263,P08254,,QMRMTXPZBMQCIT-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,810,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,889617,DTCC00178125,128275,15677
CHEMBL382705,P08254,,NRCQPJPKKZDRND-HRCADAONSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16516469,KI,=,5,NM,,,,,,,,,,,,,,Binding affinity to recombinant MMP3,,A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,10,"Janser P, Neumann U, Miltz W, Feifel R, Buhl T",,354052,DTCT0024060,1926033,DTCC00422716,1307795,20779
CHEMBL38419,P08254,,PBVQVXZZIHDYRZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,16000,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,892184,DTCC00178572,549803,15677
CHEMBL38571,P08254,,WBEQGNQOCQGJAT-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,460,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,857533,DTCC00178260,743627,15677
CHEMBL38572,P08254,,OAIBNFSRNNTWCO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,IC50,>,1000000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104727,DTCT0024060,875654,DTCC00178822,1520152,15677
CHEMBL38573,P08254,,MERJKQXKRDMMLJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,IC50,=,694000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104727,DTCT0024060,875653,DTCC00178823,1227729,15677
CHEMBL38604,P08254,,XEYQHDFSWLWGDC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,IC50,=,289000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104727,DTCT0024060,857530,DTCC00178771,1099731,15677
CHEMBL38629,P08254,,NFXJRNUPKGYOFE-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,270,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,885897,DTCC00178743,1584381,15677
CHEMBL38717,P08254,,MSWYFTOHLLVIHA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,21000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1581307,DTCC00179305,1046165,4273
CHEMBL387202,P08254,,NJCBPLQYZDLBCA-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17256836,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425540,DTCT0024060,2019770,DTCC00438921,1663624,21880
CHEMBL387202,P08254,,NJCBPLQYZDLBCA-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19457660,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of human MMP3,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523766,DTCT0024060,2828351,DTCC00438921,1653468,33677
CHEMBL38851,P08254,,XZWFHJUEAVOHHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11212095,IC50,=,47,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104720,DTCT0024060,643366,DTCC00180222,1261750,4635
CHEMBL38851,P08254,,XZWFHJUEAVOHHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,57,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1586509,DTCC00180222,1272449,4273
CHEMBL38851,P08254,,XZWFHJUEAVOHHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15214773,IC50,=,25,NM,,,,,,,,,,,,,,Inhibition of Matrix Metalloprotease-3 (MMP-3),,Fragment-based drug discovery.,J. Med. Chem.,2004,47,14,"Erlanson DA, McDowell RS, O'Brien T",,104898,DTCT0024060,628269,DTCC00180222,1273645,17883
CHEMBL38851,P08254,,XZWFHJUEAVOHHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19942433,KD,=,100,NM,,,,,,,,,,,,,,Binding affinity to stromelysin-1 catalytic domain,,A single step purification for autolytic zinc proteinases.,Bioorg. Med. Chem. Lett.,2010,20,1,"Wilfong EM, Locklear U, Toone EJ",,603251,DTCT0024060,3177039,DTCC00180222,1277187,36833
CHEMBL38851,P08254,,XZWFHJUEAVOHHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19942433,KD,=,110,NM,,,,,,,,,,,,,,Binding affinity to stromelysin-1 catalytic domain expressed in Escherichia coli BL21 (DE3) by isothermal titration colorimetry,,A single step purification for autolytic zinc proteinases.,Bioorg. Med. Chem. Lett.,2010,20,1,"Wilfong EM, Locklear U, Toone EJ",,603252,DTCT0024060,3177043,DTCC00180222,1277187,36833
CHEMBL38900,P08254,,OHBSIIOTSUMCLG-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,14,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,884553,DTCC00178707,1649263,15677
CHEMBL389020,P08254,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17591762,IC50,=,91000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440139,DTCT0024060,2113793,DTCC00452712,195826,23023
CHEMBL389020,P08254,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP3 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440145,DTCT0024060,2113821,DTCC00452712,195826,23023
CHEMBL389020,P08254,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP3 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440151,DTCT0024060,2113849,DTCC00452712,195826,23023
CHEMBL389020,P08254,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP3 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440157,DTCT0024060,2113878,DTCC00452712,195826,23023
CHEMBL389020,P08254,,NEGPFWDWNNSJRQ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,KI,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457529,DTCC00452712,208200,32556
CHEMBL38967,P08254,,OWTDUWLWAOCZOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,IC50,>,2000000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104727,DTCT0024060,869066,DTCC00178356,388478,15677
CHEMBL389898,P08254,,HTKNWYDCBWYORK-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17088065,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of MMP3,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432504,DTCT0024060,2061989,DTCC00447846,1555210,22402
CHEMBL39035,P08254,,BXGFONUNBZSLOU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,300000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1591708,DTCC00179902,1849414,4273
CHEMBL391288,P08254,,VDZXMXGMCNRNLP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215343,DTCC00477194,1313064,24158
CHEMBL391376,P08254,,BIMPKRWFMWVAKJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215341,DTCC00477196,310264,24158
CHEMBL391388,P08254,,CYAPFFVOYRXNFZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240596,DTCC00479007,83226,24538
CHEMBL391509,P08254,,FNYMWMSAYUTPPB-IJULCPIYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17512742,IC50,=,21000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447906,DTCT0024060,2176036,DTCC00468628,909116,23716
CHEMBL392231,P08254,,ONXPGSKZKJFIFD-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240630,DTCC00479021,472421,24538
CHEMBL392232,P08254,,HOQRRVLBMMILPN-JTHBVZDNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240626,DTCC00479025,1921648,24538
CHEMBL392837,P08254,,XDKBCKDIDNIGIV-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240638,DTCC00479013,795216,24538
CHEMBL392867,P08254,,AJLMUTLJMXTHCS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215344,DTCC00477193,2020086,24158
CHEMBL39309,P08254,,IRBTZGUNVJTAPX-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,1300,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,890918,DTCC00178065,873398,15677
CHEMBL39316,P08254,,BFEUMQAVESBAEM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,IC50,=,34000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104727,DTCT0024060,861355,DTCC00177985,2033149,15677
CHEMBL393443,P08254,,JCIVWVZJOHHYOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240639,DTCC00479012,1668694,24538
CHEMBL39358,P08254,,PTWLELXABRMCEI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,36000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1580077,DTCC00179315,1434636,4273
CHEMBL39392,P08254,,LPFSLMPTCVEYCI-VIFPVBQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,290,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,896436,DTCC00178270,517800,15677
CHEMBL393944,P08254,,MCRBDLJEZXPESB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215355,DTCC00477176,277532,24158
CHEMBL394084,P08254,,FREFRJYSKQLKFN-PZJWPPBQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240636,DTCC00479015,730895,24538
CHEMBL394294,P08254,,DRAXUTSANKJHDR-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17576061,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2007,17,16,"Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJ",,456576,DTCT0024060,2240634,DTCC00479017,537223,24538
CHEMBL39553,P08254,,WFELCPTZICREII-QMMMGPOBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,3300,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,866447,DTCC00177963,1902367,15677
CHEMBL39553,P08254,,WFELCPTZICREII-QMMMGPOBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15163188,KI,=,3300,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (MMP-3),,A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized born molecular dynamics simulations.,J. Med. Chem.,2004,47,12,"Rizzo RC, Toba S, Kuntz ID",,104749,DTCT0024060,1539082,DTCC00177963,1914835,17850
CHEMBL39580,P08254,,HRPDZLPODXSSSP-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,420,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,870475,DTCC00178509,290628,15677
CHEMBL395877,P08254,,ZRAQZYQKZITEAG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215359,DTCC00477172,1857247,24158
CHEMBL395878,P08254,,WFZMQTYFKFRTGC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215358,DTCC00477173,1987169,24158
CHEMBL395880,P08254,,FMMBVZGWJZFRLY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215349,DTCC00477188,730829,24158
CHEMBL395880,P08254,,FMMBVZGWJZFRLY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2456518,DTCC00477188,726868,32556
CHEMBL39699,P08254,,NAGNQAOMYYQEAN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,IC50,=,173000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104727,DTCT0024060,897727,DTCC00177962,1131839,15677
CHEMBL39726,P08254,,WRCBYIDAMSAFKR-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,510,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,865233,DTCC00177712,160931,15677
CHEMBL398265,P08254,,VJUDEGHVGRIZAQ-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18083558,IC50,=,137,NM,,,,,,,,,,,,,,Inhibition of MMP3,,beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.,Bioorg. Med. Chem. Lett.,2008,18,3,"Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV",,461912,DTCT0024060,2278674,DTCC00489424,1987318,25112
CHEMBL398639,P08254,,XRBRLEUPIULYDY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,420,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266868,DTCC00486111,650417,24951
CHEMBL398640,P08254,,GIXYBRZLOBPOLX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,51,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266861,DTCC00486118,779010,24951
CHEMBL398641,P08254,,XMVZJCLXRBLZHB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266858,DTCC00486121,1523447,24951
CHEMBL398702,P08254,,RKWXKADYTDWZIJ-SECBINFHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,5300,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,880862,DTCC00487075,711285,15677
CHEMBL398702,P08254,,RKWXKADYTDWZIJ-SECBINFHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,5248.07,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258569,DTCC00487075,714625,24803
CHEMBL398703,P08254,,UIDLYJIJZDRTDQ-VIFPVBQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,4100,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,888315,DTCC00487076,2570,15677
CHEMBL398703,P08254,,UIDLYJIJZDRTDQ-VIFPVBQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,4073.8,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258568,DTCC00487076,8956,24803
CHEMBL399155,P08254,,APZXMNAVJKZQEI-QMMMGPOBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,4100,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,890916,DTCC00487078,63656,15677
CHEMBL399155,P08254,,APZXMNAVJKZQEI-QMMMGPOBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,4073.8,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258566,DTCC00487078,67156,24803
CHEMBL399351,P08254,,JGSJEYLQTZAQRG-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18068976,IC50,=,925,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461865,DTCT0024060,2278076,DTCC00489339,1744698,25102
CHEMBL400083,P08254,,SBUWCTGSDDXCCA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266855,DTCC00486124,1841460,24951
CHEMBL400163,P08254,,IROSASOHPXXTQE-LEOXJPRUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,218.78,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258527,DTCC00487071,844218,24803
CHEMBL400163,P08254,,IROSASOHPXXTQE-LEOXJPRUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,220,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,827237,DTCC00487071,841464,1379
CHEMBL400206,P08254,,BUDIJDXJWOVXRJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17064892,IC50,=,1500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Identification of potent and selective TACE inhibitors via the S1 pocket.,Bioorg. Med. Chem. Lett.,2007,17,1,"Condon JS, Joseph-McCarthy D, Levin JI, Lombart HG, Lovering FE, Sun L, Wang W, Xu W, Zhang Y",,440762,DTCT0024060,2153850,DTCC00461899,972679,23077
CHEMBL400258,P08254,,GZIZNKPMCZYCDA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,164,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266878,DTCC00486101,1329184,24951
CHEMBL400314,P08254,,YZJVCXDOAAOGHA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,166000,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,867836,DTCC00487074,1773157,15677
CHEMBL400314,P08254,,YZJVCXDOAAOGHA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15163188,KI,=,166000,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (MMP-3),,A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized born molecular dynamics simulations.,J. Med. Chem.,2004,47,12,"Rizzo RC, Toba S, Kuntz ID",,104749,DTCT0024060,1540256,DTCC00487074,1785836,17850
CHEMBL400314,P08254,,YZJVCXDOAAOGHA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,165958.69,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258563,DTCC00487074,1776496,24803
CHEMBL40034,P08254,,LUPLBSDRRWYFTC-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,2300,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,893623,DTCC00177713,1391204,15677
CHEMBL40034,P08254,,LUPLBSDRRWYFTC-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15163188,KI,=,2300,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (MMP-3),,A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized born molecular dynamics simulations.,J. Med. Chem.,2004,47,12,"Rizzo RC, Toba S, Kuntz ID",,104749,DTCT0024060,1527413,DTCC00177713,1403699,17850
CHEMBL40041,P08254,,XTEMUHHTESGVEO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,69000,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,883436,DTCC00178758,905707,15677
CHEMBL400463,P08254,,WKVUGFBWMFZOMW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,205,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266872,DTCC00486107,714648,24951
CHEMBL400514,P08254,BERKELEYDIONE,RBGYOLFHIDJTOX-VMXKAMJHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17970594,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP3,Active,"The berkeleyacetals, three meroterpenes from a deep water acid mine waste Penicillium.",J. Nat. Prod.,2007,70,11,"Stierle DB, Stierle AA, Patacini B",,459798,DTCT0024060,2265358,DTCC00112409,521167,24916
CHEMBL400716,P08254,BERKELEYACETAL C,PCBBMDQLBUYDDZ-MBEBNAQTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17970594,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP3,Active,"The berkeleyacetals, three meroterpenes from a deep water acid mine waste Penicillium.",J. Nat. Prod.,2007,70,11,"Stierle DB, Stierle AA, Patacini B",,459798,DTCT0024060,2265366,DTCC00486776,1808968,24916
CHEMBL40143,P08254,ABT-770,IIHFBHZWJNGWRC-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412980,IC50,=,42,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104729,DTCT0024060,1450793,DTCC01739757,464200,4274
CHEMBL40143,P08254,ABT-770,IIHFBHZWJNGWRC-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,IC50,=,42,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457393,DTCC01739757,468359,32556
CHEMBL401445,P08254,,RTWRPNRMLWESPM-VLBBBODESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17512742,IC50,=,1920,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447906,DTCT0024060,2176038,DTCC00468604,1808775,23716
CHEMBL401870,P08254,,RAJATBMMJHSJNJ-FQECFTEESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,>,5000,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276509,DTCC00488459,294069,25086
CHEMBL402118,P08254,,YJSYFCHNFUBPQY-VQTJNVASSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18282708,KI,=,2719,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463862,DTCT0024060,2317247,DTCC00499916,1857435,25272
CHEMBL40237,P08254,,YIJAXOAFVMWOOR-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,112,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1996,6,13,,,205490,DTCT0024060,1387647,DTCC00182853,787310,1703
CHEMBL402393,P08254,,SXDMGWZDRWQMPS-DLBZAZTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18282708,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463862,DTCT0024060,2317238,DTCC00499750,957099,25272
CHEMBL402393,P08254,,SXDMGWZDRWQMPS-DLBZAZTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457219,DTCC00499750,952985,32556
CHEMBL402436,P08254,,SDNMPMDMJTYOAW-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18242982,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462365,DTCT0024060,2282331,DTCC00488433,1873486,25163
CHEMBL402636,P08254,,HDDGWKVPDOMYLP-RBUKOAKNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18282708,KI,=,627,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463862,DTCT0024060,2317248,DTCC00499961,1728809,25272
CHEMBL402745,P08254,,LFOGEPKUSWRLCL-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,345,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1316691,DTCC00487205,808682,16328
CHEMBL403185,P08254,,PEAOAVRAGQRJEO-AKQSQHNNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,=,2601,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276512,DTCC00488434,909316,25086
CHEMBL403186,P08254,,WMWPLQAXVKBJIC-PZJWPPBQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18242982,KI,=,2609,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462365,DTCT0024060,2282340,DTCC00488436,260773,25163
CHEMBL403340,P08254,,LIMPVKGGFOEWHH-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,2000,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,863946,DTCC00487080,1260779,15677
CHEMBL403340,P08254,,LIMPVKGGFOEWHH-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,1995.26,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258564,DTCC00487080,1264012,24803
CHEMBL403380,P08254,,JLFCWOIZNQXZMP-ICSRJNTNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,=,3500,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276518,DTCC00488376,972978,25086
CHEMBL40351,P08254,,JCVSSJUXUIJGBT-QAPCUYQASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,5,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1996,6,13,,,205490,DTCT0024060,1376570,DTCC00182854,2012202,1703
CHEMBL403539,P08254,,FLPIBFXJTDQPCO-VQTJNVASSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18282708,KI,=,3305,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463862,DTCT0024060,2317240,DTCC00499796,343119,25272
CHEMBL403777,P08254,,MMRITKOLOPLQTB-RBUKOAKNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18282708,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463862,DTCT0024060,2317244,DTCC00499875,343118,25272
CHEMBL403778,P08254,,YXKKEOGFLPKGED-ZWKOTPCHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18282708,KI,>,4501,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463862,DTCT0024060,2317245,DTCC00499877,666501,25272
CHEMBL404019,P08254,,PVXFXCXPVPZDJJ-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18282708,KI,=,2970,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463862,DTCT0024060,2317189,DTCC00500052,1054123,25272
CHEMBL404132,P08254,,KAJHXHOIEARPHN-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,>,1000,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276516,DTCC00488393,844255,25086
CHEMBL404409,P08254,,IDSXRTDVRWTZOK-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18068976,IC50,=,366,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,Bioorg. Med. Chem. Lett.,2008,18,2,"Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W",,461865,DTCT0024060,2278103,DTCC00489354,1296629,25102
CHEMBL40589,P08254,,UVBJVUYVRZYYHC-ZHRRBRCNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,29,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1996,6,13,,,205490,DTCT0024060,1397656,DTCC00182822,852578,1703
CHEMBL406131,P08254,,LNSULHYVZXTWFG-RDTXWAMCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,38,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,490381,DTCC00106242,225888,13104
CHEMBL406939,P08254,,SLHHOJZYTMNFRR-OKXSDPAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831905,KI,=,3.33,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugs.,J. Med. Chem.,2002,45,4,"Sawa M, Tsukamoto T, Kiyoi T, Kurokawa K, Nakajima F, Nakada Y, Yokota K, Inoue Y, Kondo H, Yoshino K",,104744,DTCT0024060,553317,DTCC00345288,951239,17148
CHEMBL406939,P08254,,SLHHOJZYTMNFRR-OKXSDPAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11844676,KI,=,3.33,NM,,,,,,,,,,,,,,Inhibitory constant against recombinant human stromelysin-1 (Matrix metalloprotease-3),,Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.,Bioorg. Med. Chem. Lett.,2002,12,4,"Sawa M, Kondo H, Nishimura S",,104879,DTCT0024060,1429477,DTCC00345288,939447,5346
CHEMBL407151,P08254,,JYMZMJPXMAFCPA-ZROIWOOFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25725607,IC50,=,43000,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463480,DTCT0024060,14035827,DTCC00495878,978589,61492
CHEMBL407443,P08254,,PONKMSIAUNHYAM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,4.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1373016,DTCC00273294,1723389,16392
CHEMBL40746,P08254,,MACBSAQGLFHSQT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,KI,=,60,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-3.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104880,DTCT0024060,706273,DTCC00184695,1531824,3810
CHEMBL407640,P08254,,WTVDGWPQROHFND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,=,15400,NM,,,,,,,,,,,,,,Inhibitory activity against human matrix metalloprotease-3 (MMP-3) (at pH 7.4),,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104717,DTCT0024060,950841,DTCC00138732,239822,16645
CHEMBL40790,P08254,,GYHXBKOKZOVYIA-VIFPVBQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,100,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,873121,DTCC00178269,1455288,15677
CHEMBL408366,P08254,,WIAJGSYMEDWMGP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17981034,IC50,=,79.1,NM,,,,,,,,,,,,,,Inhibition of MMP3,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469431,DTCT0024060,2289322,DTCC00501132,1971170,25715
CHEMBL408682,P08254,,OHYRHJPFKZKXOS-XGHQBKJUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871551,KI,=,32,NM,,,,,,,,,,,,,,Binding affinity against human matrix metalloprotease-3.,,Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,7,"Jacobson IC, Reddy PG, Wasserman ZR, Hardman KD, Covington MB, Arner EC, Copeland RA, Decicco CP, Magolda RL",,101949,DTCT0024060,488888,DTCC00364246,487712,3059
CHEMBL409502,P08254,,SFZMBRAWNOHSKH-UVTDQMKNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25725607,IC50,>=,100000,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463480,DTCT0024060,14035833,DTCC00495941,1879030,61492
CHEMBL409536,P08254,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17623656,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507873,DTCT0024060,2388608,DTCC00503784,1950627,29282
CHEMBL409536,P08254,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18251495,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain,,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465547,DTCT0024060,2311307,DTCC00503784,1954666,25409
CHEMBL409536,P08254,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP3 up to 100 uM,Not Active,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497428,DTCT0024060,2457340,DTCC00503784,1950505,32556
CHEMBL409536,P08254,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25265401,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),,"Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.",J. Med. Chem.,2014,57,24,"Fabre B, Ramos A, de Pascual-Teresa B",,1433219,DTCT0024060,13993809,DTCC00503784,1943413,60040
CHEMBL410259,P08254,,ABOVSYRJLZIGMD-CTNGQTDRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,28,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,499033,DTCC00247104,1838852,13104
CHEMBL410259,P08254,,ABOVSYRJLZIGMD-CTNGQTDRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,28.18,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258514,DTCC00247104,1841439,24803
CHEMBL410259,P08254,,ABOVSYRJLZIGMD-CTNGQTDRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,<,100,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3 (potent inhibitor)",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102096,DTCT0024060,582299,DTCC00247104,1850705,1496
CHEMBL410259,P08254,,ABOVSYRJLZIGMD-CTNGQTDRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,28,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102092,DTCT0024060,833845,DTCC00247104,1850728,1497
CHEMBL410259,P08254,,ABOVSYRJLZIGMD-CTNGQTDRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,28,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102097,DTCT0024060,582298,DTCC00247104,1850705,1496
CHEMBL410649,P08254,,PLFJMTKUJWPCGG-ZROIWOOFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25725607,IC50,>=,100000,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463480,DTCT0024060,14035832,DTCC00495839,1140869,61492
CHEMBL41067,P08254,,FQLYLGDLLIEWGU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,620000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1559348,DTCC00179875,1206900,4273
CHEMBL41100,P08254,,JXKUSYFOHKHALF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,14000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1593043,DTCC00179908,755084,4273
CHEMBL41102,P08254,,UZBOAJFAUCURIC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,24000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1582786,DTCC00179969,1206901,4273
CHEMBL411851,P08254,,LXWSFODDORIHFJ-HBMCJLEFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,6.6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1369999,DTCC00282992,1682565,2897
CHEMBL412064,P08254,,UDEPBQKCNHEJQR-ZROIWOOFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25725607,IC50,=,5060,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain (unknown origin) assessed as reduction in hydrolysis of Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate measured for 3 mins after substrate addition by fluorescence assay,,2-Benzisothiazolylimino-5-benzylidene-4-thiazolidinones as protective agents against cartilage destruction.,Bioorg. Med. Chem.,2015,23,7,"Crascì L, Vicini P, Incerti M, Cardile V, Avondo S, Panico A",,1463480,DTCT0024060,14035826,DTCC00495837,1943511,61492
CHEMBL414626,P08254,,QZATUGXXMHCJRV-GIFXNVAJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,5000,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1126154,DTCC00344067,1851326,4691
CHEMBL414626,P08254,,QZATUGXXMHCJRV-GIFXNVAJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,6165.95,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258396,DTCC00344067,1841438,24803
CHEMBL41485,P08254,,VRDVYZAEYHXMTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,130000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1561986,DTCC00179243,819628,4273
CHEMBL41497,P08254,,FVGUURIXHJHLQF-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,5900,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1996,6,13,,,205490,DTCT0024060,1389028,DTCC00182852,1111391,1703
CHEMBL415074,P08254,,UBPYMHQGZFVTLG-WDYNHAJCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,5.44,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,548189,DTCC00232756,29798,16308
CHEMBL415074,P08254,,UBPYMHQGZFVTLG-WDYNHAJCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,5.44,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,984195,DTCC00232756,4194,1012
CHEMBL415482,P08254,,GETQXLAMYOMSJS-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327577,IC50,=,3.3,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104725,DTCT0024060,1311759,DTCC00133489,1725495,4760
CHEMBL415872,P08254,,DRMZKUIIQMVRSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,37000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1580082,DTCC00179304,432757,4273
CHEMBL415879,P08254,PHENANTHROLINE,DGEZNRSVGBDHLK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,91,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103943,DTCC00177236,247838,43205
CHEMBL416510,P08254,,LBNTZOSDPQSCQC-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,20000,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,673016,DTCC00209043,485907,2288
CHEMBL416857,P08254,,WQNVXJKGBVCILF-KURKYZTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873489,IC50,=,21,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,Design and synthesis of conformationally-constrained MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,16,"Natchus MG, Cheng M, Wahl CT, Pikul S, Almstead NG, Bradley RS, Taiwo YO, Mieling GE, Dunaway CM, Snider CE, McIver JM, Barnett BL, McPhail SJ, Anastasio MB, De B",,101941,DTCT0024060,735626,DTCC00214839,529665,2711
CHEMBL417086,P08254,,WGUOMVALEOXXIU-ABHNRTSZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,860,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1547969,DTCC00146363,1016872,2559
CHEMBL417537,P08254,BB-16,XDJHCLNLKWGZCM-IAOVAPTHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9599225,KI,=,1.93,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (Matrix metalloprotease-3),,Design and synthesis of cyclic inhibitors of matrix metalloproteinases and TNF-alpha production.,J. Med. Chem.,1998,41,11,"Xue CB, He X, Roderick J, DeGrado WF, Cherney RJ, Hardman KD, Nelson DJ, Copeland RA, Jaffee BD, Decicco CP",,104745,DTCT0024060,575741,DTCC01740029,1239828,14639
CHEMBL417537,P08254,BB-16,XDJHCLNLKWGZCM-IAOVAPTHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472217,KI,=,1.93,NM,,,,,,,,,,,,,,Inhibition of human MMP-3.,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104875,DTCT0024060,1678864,DTCC01740029,1228536,16346
CHEMBL417574,P08254,,MOBAWCSMNMHMJW-MCIONIFRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873489,IC50,=,215,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,Design and synthesis of conformationally-constrained MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,16,"Natchus MG, Cheng M, Wahl CT, Pikul S, Almstead NG, Bradley RS, Taiwo YO, Mieling GE, Dunaway CM, Snider CE, McIver JM, Barnett BL, McPhail SJ, Anastasio MB, De B",,101941,DTCT0024060,768577,DTCC00214482,2076885,2711
CHEMBL417697,P08254,,OTGZLNPNCCOMIR-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,930,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,896438,DTCC00178378,517801,15677
CHEMBL417885,P08254,,FZQDTUCHCVJYHU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,IC50,=,99000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104727,DTCT0024060,878099,DTCC00178990,1681405,15677
CHEMBL417977,P08254,,SCKGCOPJBBAWME-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11297453,IC50,,,,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3 at pH 7.4 (Not determined),Not Determined,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,2001,44,7,"Natchus MG, Bookland RG, Laufersweiler MJ, Pikul S, Almstead NG, De B, Janusz MJ, Hsieh LC, Gu F, Pokross ME, Patel VS, Garver SM, Peng SX, Branch TM, King SL, Baker TR, Foltz DJ, Mieling GE",,104718,DTCT0024060,956220,DTCC00138723,1340877,16645
CHEMBL418028,P08254,,HCAGVHGQPPXQPY-IXDOHACOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871766,ACTIVITY,=,30,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (Stromelysin-1),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,104574,DTCT0024060,625539,DTCC00164379,840691,2586
CHEMBL418063,P08254,,ZRGXZRGPZWOKOK-VIFPVBQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,KI,=,330,NM,,,,,,,,,,,,,,Binding affinity for matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104736,DTCT0024060,884548,DTCC00177964,1838094,15677
CHEMBL41821,P08254,,NXWFYCXTAINJMY-BRSBDYLESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15006405,KI,=,11.5,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,Synthesis and biological activity of selective azasugar-based TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,6,"Tsukida T, Moriyama H, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104877,DTCT0024060,835895,DTCC00180268,1013753,6743
CHEMBL418291,P08254,,RGQWTGAVFAYQEF-NXCFDTQHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873491,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibition of fibroblast stromelysin (MMP-3),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101938,DTCT0024060,1641187,DTCC00215868,497564,2712
CHEMBL418292,P08254,,BJOZETKUSDMMAN-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873491,IC50,=,3.9,NM,,,,,,,,,,,,,,Inhibition of fibroblast stromelysin (MMP-3),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101938,DTCT0024060,1645905,DTCC00215765,1693218,2712
CHEMBL418292,P08254,,BJOZETKUSDMMAN-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1380026,DTCC00215765,1682566,2897
CHEMBL418335,P08254,,BLSXPNUDVKINQR-LCRMXPIESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,82,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,528187,DTCC00135999,1099282,14548
CHEMBL418442,P08254,,INVXSBCIDABVMG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,10,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,904793,DTCC00186442,1046249,15892
CHEMBL418442,P08254,,INVXSBCIDABVMG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17088065,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP3,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432504,DTCT0024060,2061971,DTCC00186442,1037472,22402
CHEMBL418443,P08254,,GSXKMMPZFVRZAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,730617,DTCC00184906,236734,3810
CHEMBL418472,P08254,,DGZARDVMPOFZHA-GDBMZVCRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,30000,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,671854,DTCC00208586,841134,2288
CHEMBL418521,P08254,,YKOGGKVKSNWIHK-MBDJBHLASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,1400,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,543142,DTCC00136024,678810,14548
CHEMBL418639,P08254,,KHCVBQLHKXPRJT-GMLYINLCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,1340,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1543374,DTCC00208671,691009,4358
CHEMBL418655,P08254,,RBLCSCFFNCADJO-MYUZEXMDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,>,650,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1424987,DTCC00211377,1469171,17147
CHEMBL418655,P08254,,RBLCSCFFNCADJO-MYUZEXMDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12781187,INHIBITION,=,9,%,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-3 at 1000 nM,,Discovery of selective phosphonamide-based inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Sawa M, Kurokawa K, Inoue Y, Kondo H, Yoshino K",,104734,DTCT0024060,1055885,DTCC00211377,1467317,5595
CHEMBL418725,P08254,,BJBDOOZTEPGOJP-TVKKRMFBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871727,IC50,=,500,NM,,,,,,,,,,,,,,In vitro inhibitory activity against stromelysin-3 (MMP-3),,"Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,10,"Campbell DA, Xiao XY, Harris D, Ida S, Mortezaei R, Ngu K, Shi L, Tien D, Wang Y, Navre M, Patel DV, Sharr MA, DiJoseph JF, Killar LM, Leone CL, Levin JI, Skotnicki JS",,104711,DTCT0024060,1521036,DTCC00146358,1725618,2559
CHEMBL41892,P08254,,ZOQRCAUTYNYRRI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,4000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1560674,DTCC00180196,2044483,4273
CHEMBL419011,P08254,,LPRBYIANGHPFSM-ZCNNSNEGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,3.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1393903,DTCC00282939,648278,2897
CHEMBL41923,P08254,,ADLXGSBFAAQQTN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,45000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1567004,DTCC00179933,1206902,4273
CHEMBL41928,P08254,,YBEJDLYIFZAISG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,80000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1559345,DTCC00179962,1272450,4273
CHEMBL41928,P08254,,YBEJDLYIFZAISG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16242329,IC50,=,80000,NM,,,,,,,,,,,,,,Inhibitory activity against MMP3,,N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.,Bioorg. Med. Chem. Lett.,2006,16,1,"Campestre C, Agamennone M, Tortorella P, Preziuso S, Biasone A, Gavuzzo E, Pochetti G, Mazza F, Hiller O, Tschesche H, Consalvi V, Gallina C",,327979,DTCT0024060,1875152,DTCC00179962,1263318,20151
CHEMBL41928,P08254,,YBEJDLYIFZAISG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16242329,INHIBITION,=,22,%,,,,,,,,,,,,,,Inhibitory activity against MMP3 at 120 uM,,N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.,Bioorg. Med. Chem. Lett.,2006,16,1,"Campestre C, Agamennone M, Tortorella P, Preziuso S, Biasone A, Gavuzzo E, Pochetti G, Mazza F, Hiller O, Tschesche H, Consalvi V, Gallina C",,327980,DTCT0024060,1875158,DTCC00179962,1263318,20151
CHEMBL419301,P08254,,AILNNKVMFUWMQL-NFBKMPQASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,14,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,481137,DTCC00247295,1293935,13104
CHEMBL419301,P08254,,AILNNKVMFUWMQL-NFBKMPQASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,14,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102092,DTCT0024060,837377,DTCC00247295,1306247,1497
CHEMBL419395,P08254,,AMLWSGUFQAEWAD-KYJUHHDHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,2800,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,101939,DTCT0024060,1049328,DTCC00283901,627313,1950
CHEMBL41943,P08254,,IIHFBHZWJNGWRC-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412980,IC50,=,3100,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,"Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.",Bioorg. Med. Chem. Lett.,2001,11,12,"Curtin ML, Florjancic AS, Heyman HR, Michaelides MR, Garland RB, Holms JH, Steinman DH, Dellaria JF, Gong J, Wada CK, Guo Y, Elmore IB, Tapang P, Albert DH, Magoc TJ, Marcotte PA, Bouska JJ, Goodfellow CL, Bauch JL, Marsh KC, Morgan DW, Davidsen SK",,104729,DTCT0024060,1472601,DTCC00179722,172253,4274
CHEMBL419430,P08254,,GUHYZHHGWPARCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,13,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1700465,DTCC00302952,2066272,16065
CHEMBL419430,P08254,,GUHYZHHGWPARCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,13,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,483370,DTCC00302952,2077862,16483
CHEMBL419491,P08254,,ZGRVOFLPJDUPKV-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,42,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1313486,DTCC00244022,1935112,14264
CHEMBL419503,P08254,,AHSZJHCTCQGTRY-GBJTYRQASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12873504,KI,=,42,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,Structure--activity relationships of azasugar-based MMP/ADAM inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,16,"Moriyama H, Tsukida T, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104872,DTCT0024060,899674,DTCC00255638,1046981,5719
CHEMBL419607,P08254,,WQCOVODIHQDZNG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,410,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1698003,DTCC00303281,1101115,16065
CHEMBL419607,P08254,,WQCOVODIHQDZNG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,410.02,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,504010,DTCC00303281,1112721,16483
CHEMBL419896,P08254,,KBRVEWFSDCONMH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15125955,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104895,DTCT0024060,1403500,DTCC00265483,1047085,6400
CHEMBL420259,P08254,,ZJYOUKFITJWMLH-FOWTUZBSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,14611841,IC50,=,665,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,MMPs inhibitors: new succinylhydroxamates with selective inhibition of MMP-2 over MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,17,"Marcq V, Mirand C, Decarme M, Emonard H, Hornebeck W",,104721,DTCT0024060,879103,DTCC00263309,1003086,5741
CHEMBL420376,P08254,,LMZDADMPZWYRMS-SQHAQQRYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,358,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,569689,DTCC00232219,1914378,16308
CHEMBL420376,P08254,,LMZDADMPZWYRMS-SQHAQQRYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,358,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1707996,DTCC00232219,1914648,1013
CHEMBL42040,P08254,,RZEIFKHIQYQVQH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,KI,=,184,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-3.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104880,DTCT0024060,715186,DTCC00185207,1370312,3810
CHEMBL420656,P08254,,WHTRIFCXCJYQKX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,3.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1400613,DTCC00273612,2013184,16392
CHEMBL420657,P08254,,ZPNXAVJYHSAOKF-YSSMNDQQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543676,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.,J. Med. Chem.,2001,44,19,"Hanessian S, MacKay DB, Moitessier N",,104730,DTCT0024060,1176097,DTCC00273546,1424440,16385
CHEMBL42067,P08254,,UKLIIGXGTPSYBF-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,135,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,901107,DTCC00186535,658583,15892
CHEMBL420674,P08254,,NWYFRVGJVQHAJF-JOMNFKBKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,1.4,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102082,DTCT0024060,1031814,DTCC00284346,1914967,1950
CHEMBL420784,P08254,,JUSOSBKBFCYTPA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,1260,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1288219,DTCC00242696,128992,14264
CHEMBL420786,P08254,,BNESXKYVXODIPJ-PXDATVDWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,5,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,487876,DTCC00247347,970402,13104
CHEMBL421029,P08254,,UGEYJONPMBOKNN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11543675,IC50,=,2.5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,"N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.",J. Med. Chem.,2001,44,19,"Hanessian S, Moitessier N, Gauchet C, Viau M",,104709,DTCT0024060,1404221,DTCC00273395,562502,16392
CHEMBL421036,P08254,,VVXLFFIFNVKFBD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,>,25000000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in place of acetohydroxamic acid.,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205633,DTCT0024060,1284203,DTCC00275605,1851317,17092
CHEMBL42104,P08254,,OHZWWRAGTGIQOP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,730613,DTCC00184247,1692908,3810
CHEMBL42114,P08254,,LKVAANCBUJLQIE-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,36,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,901101,DTCC00186439,1046251,15892
CHEMBL421161,P08254,,DZZFIOQATPLRLB-RDTXWAMCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,9,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,500145,DTCC00106243,906532,13104
CHEMBL421188,P08254,,QBERFMAYWTXPQT-MXHVWWQHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,14611841,IC50,,,,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3 (inactive),Not Active,MMPs inhibitors: new succinylhydroxamates with selective inhibition of MMP-2 over MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,17,"Marcq V, Mirand C, Decarme M, Emonard H, Hornebeck W",,104723,DTCT0024060,861049,DTCC00262787,1774097,5741
CHEMBL42152,P08254,,LZZFXVQBLDVWTK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,696806,DTCC00184315,1499405,3810
CHEMBL421644,P08254,,XSGJDCITTFQFMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,66,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1681649,DTCC00302815,648521,16065
CHEMBL421644,P08254,,XSGJDCITTFQFMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,66.07,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,486877,DTCC00302815,659814,16483
CHEMBL421699,P08254,,XFKRGURHEZYQDK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944582,DTCT0024060,11835672,DTCC00237568,1126998,53820
CHEMBL421766,P08254,,MTGNBEKVSCTMSE-OXJNMPFZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1620379,DTCC00332988,648884,16049
CHEMBL421882,P08254,,GJOCABIDMCKCEG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23287054,IC50,=,0.007,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944582,DTCT0024060,11835673,DTCC00252532,1158308,53820
CHEMBL421932,P08254,,ZHLANTZRDCBWFM-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,45,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1385766,DTCC00325502,238280,15412
CHEMBL421966,P08254,,KXEGEKRSCUZQMH-OJSPLJLUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,<,1,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,495545,DTCC00340473,1724168,15546
CHEMBL421985,P08254,,URGYPDKRIKINRO-GIFXNVAJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,18,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1123572,DTCC00343843,1819208,4691
CHEMBL421985,P08254,,URGYPDKRIKINRO-GIFXNVAJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,39.81,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258411,DTCC00343843,1808954,24803
CHEMBL422058,P08254,,BUFVDSAQIYWDGD-UHSQPCAPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,6.35,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,569695,DTCC00231929,1946978,16308
CHEMBL422105,P08254,,KVMNMFKBWZIOKY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,30,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1020031,DTCC00323965,1489533,15462
CHEMBL422266,P08254,,RFUWBCJNXALDEH-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,IC50,=,320,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205501,DTCT0024060,1254803,DTCC00318566,1145155,12304
CHEMBL422266,P08254,,RFUWBCJNXALDEH-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,KI,=,6.5,NM,,,,,,,,,,,,,,Inhibition of rabbit fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205628,DTCT0024060,1254809,DTCC00318566,1145155,12304
CHEMBL422266,P08254,,RFUWBCJNXALDEH-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,KI,=,470,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205627,DTCT0024060,1254804,DTCC00318566,1145155,12304
CHEMBL422799,P08254,,ITAGUEQBTLVHLX-LEOXJPRUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,KI,=,590,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205627,DTCT0024060,1271309,DTCC00318920,821145,12304
CHEMBL422848,P08254,,ITNSNSYBFZWVPE-OXJNMPFZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1605201,DTCC00333431,1683202,16049
CHEMBL423001,P08254,,UOAOZROEXYBQHF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,200,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1026184,DTCC00324329,1327431,15462
CHEMBL423015,P08254,,QGTWMCXPSZIGIN-XJKSGUPXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1626772,DTCC00333068,1229582,16049
CHEMBL42311,P08254,,YZOKWMYHTLQIDP-PXAZEXFGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,68,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1996,6,13,,,205490,DTCT0024060,1401345,DTCC00182309,1174735,1703
CHEMBL423366,P08254,,QZGLUUHBLOQISE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1039867,DTCC00324648,1229457,15462
CHEMBL42351,P08254,,WIFYOBIYNQFFIB-KXXATPMCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,42,%,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-3 (Stromelysin) at 10 uM,,,Bioorg. Med. Chem. Lett.,1995,5,15,,,205622,DTCT0024060,665623,DTCC00184570,711361,1239
CHEMBL423572,P08254,,OPSKOPUCTQQUTB-WMLDXEAASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1622909,DTCC00333780,713073,16049
CHEMBL423686,P08254,,JUASDDPTEREPES-VJBWXMMDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,350,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,546654,DTCC00285160,615546,1951
CHEMBL42378,P08254,,PYGGWLWYZUEZDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,701647,DTCC00184370,1174762,3810
CHEMBL424,P08254,SALICYLIC ACID,YGSDEFSMJLZEOE-UHFFFAOYSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,>,25000000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in place of acetohydroxamic acid.,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205633,DTCT0024060,1257569,DTCC00133347,32048,17092
CHEMBL424,P08254,SALICYLIC ACID,YGSDEFSMJLZEOE-UHFFFAOYSA-N,3,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,-2,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5104049,DTCC00133347,47753,43205
CHEMBL424106,P08254,,GEFPLKDZRKGIKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1017362,DTCC00323914,1003830,15462
CHEMBL42420,P08254,PD-169469,GJOCABIDMCKCEG-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,927055,DTCC01739891,1272542,15892
CHEMBL42420,P08254,PD-169469,GJOCABIDMCKCEG-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16451058,KI,=,54.9,NM,,,,,,,,,,,,,,Inhibitory activity against MMP3,,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330546,DTCT0024060,1887714,DTCC01739891,1274997,20245
CHEMBL424311,P08254,,XXFJWMXXEYWBBT-SMDDNHRTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,87,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1616287,DTCC00333805,487344,16049
CHEMBL424472,P08254,,BLDIAFCHXVRHEP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,500,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1028715,DTCC00324357,939176,15462
CHEMBL424473,P08254,,HRMWQQBRFJMAPM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,500,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1026191,DTCC00325023,712957,15462
CHEMBL42449,P08254,,QXMYNGZVAQOGPB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,724637,DTCC00184949,1466985,3810
CHEMBL424646,P08254,,WKMOUFIFYFASPS-MDZRGWNJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,INHIBITION,=,23,%,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin at pH 7.5 and 6.5 uM,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205623,DTCT0024060,1254712,DTCC00318539,886345,12304
CHEMBL42481,P08254,,VUAHLIXSRRYNJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,KI,>,10000,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-3.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104880,DTCT0024060,717527,DTCC00185613,949109,3810
CHEMBL425020,P08254,,PYNQNWZHEDOQHX-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16153831,IC50,=,442,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-3,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321186,DTCT0024060,1860371,DTCC00407673,1177224,19837
CHEMBL42521,P08254,,FCCDGLDMUDUABZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10052961,KI,=,200,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3 (MMP-3), stromelysin-1",,Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.,J. Med. Chem.,1999,42,4,"Groneberg RD, Burns CJ, Morrissette MM, Ullrich JW, Morris RL, Darnbrough S, Djuric SW, Condon SM, McGeehan GM, Labaudiniere R, Neuenschwander K, Scotese AC, Kline JA",,104735,DTCT0024060,857522,DTCC00185111,1436408,15577
CHEMBL42521,P08254,,FCCDGLDMUDUABZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,KI,=,350,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-3.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104880,DTCT0024060,728411,DTCC00185111,1434702,3810
CHEMBL425316,P08254,,BJNHISLNENZLDD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,0.5,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1431017,DTCC00370635,1695014,17147
CHEMBL42537,P08254,,SZVMBGCUMABOMY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,KI,=,3300,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-3.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104880,DTCT0024060,699328,DTCC00184757,1563731,3810
CHEMBL425702,P08254,,SCMUFXMYUJBJMV-UXMRNZNESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15780605,CONCENTRATION,=,50,NM,,,,,,,,,,,,,,Binding affinity for human Matrix metalloprotease-3,,QSAR-by-NMR: quantitative insights into structural determinants for binding affinity by analysis of 1H/15N chemical shift differences in MMP-3 ligands.,Bioorg. Med. Chem. Lett.,2005,15,7,"Matter H, Schudok M, Elshorst B, Jacobs DM, Saxena K, Kogler H",,308392,DTCT0024060,1748666,DTCC00383307,660712,18912
CHEMBL425844,P08254,,IAGAVMMBKLNEPN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831905,KI,>,650,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugs.,J. Med. Chem.,2002,45,4,"Sawa M, Tsukamoto T, Kiyoi T, Kurokawa K, Nakajima F, Nakada Y, Yokota K, Inoue Y, Kondo H, Yoshino K",,104744,DTCT0024060,559184,DTCC00372236,304589,17148
CHEMBL426388,P08254,,RINLHBFSMHCDCB-ZWBSKUQPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17256836,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425540,DTCT0024060,2019773,DTCC00438908,1114131,21880
CHEMBL427366,P08254,,USIMDPVZFWUXPH-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16153831,IC50,=,492,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-3,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321186,DTCT0024060,1860415,DTCC00407677,1113845,19837
CHEMBL42739,P08254,,PLJQSRJZKINNOL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,728343,DTCC00184758,2012229,3810
CHEMBL427616,P08254,,KKVTZTBYJGHGCO-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327577,IC50,=,6.3,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104725,DTCT0024060,1284940,DTCC00133624,2079565,4760
CHEMBL42771,P08254,,ZLXAYIGZHIXCJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,KI,=,676,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-3.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104880,DTCT0024060,711916,DTCC00185141,1466984,3810
CHEMBL427861,P08254,,CLZKGFRECSRANT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215364,DTCC00477167,1792876,24158
CHEMBL428212,P08254,,QQRACKPWBYRJJI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215356,DTCC00477175,1954457,24158
CHEMBL42862,P08254,,YGUKHRAGYHDVCC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,120000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1572092,DTCC00179905,884814,4273
CHEMBL428767,P08254,,DRNABTKZDYWZBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266866,DTCC00486113,1523446,24951
CHEMBL429112,P08254,,IANBHIHXRLTEEH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215342,DTCC00477195,1889544,24158
CHEMBL429319,P08254,PYCNIDIONE,BWTQHPFSWXJOGP-BGTYSOBZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18095654,IC50,=,31000,NM,,,,,,,,,,,,,,Inhibition of stromelysin mediated beta-casein cleavage,,"Noreupenifeldin, a tropolone from an unidentified ascomycete.",J. Nat. Prod.,2008,71,3,"Ayers S, Zink DL, Powell JS, Brown CM, Grund A, Bills GF, Platas G, Thompson D, Singh SB",,467083,DTCT0024060,2354779,DTCC00490657,455692,25531
CHEMBL42938,P08254,,AGRDSOUIPBKOKQ-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,930631,DTCC00185902,1531845,15892
CHEMBL42958,P08254,,KDMOASCHWTZIML-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,715086,DTCC00184796,464257,3810
CHEMBL42962,P08254,,VDQWNVBJBNZACE-ZOIVMXBYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,58,%,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-3 (Stromelysin) at 10 uM,,,Bioorg. Med. Chem. Lett.,1995,5,15,,,205622,DTCT0024060,676841,DTCC00184953,1584442,1239
CHEMBL429669,P08254,,ZMPZOWIAKRPTEQ-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,=,4000,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276508,DTCC00112467,585443,25086
CHEMBL429674,P08254,,ITVUSPVMUHFUQB-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18282708,KI,=,3306,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463862,DTCT0024060,2317241,DTCC00499830,43779,25272
CHEMBL43011,P08254,,JNJHUFNAFHUGBJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,KI,=,4420,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-3.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104880,DTCT0024060,727177,DTCC00185140,1143663,3810
CHEMBL43026,P08254,,GMIPYLIWDLRSEB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1572089,DTCC00179841,1817345,4273
CHEMBL43050,P08254,,YIASDUXALBOMQY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,KI,>,10000,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-3.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104880,DTCT0024060,728417,DTCC00185003,172321,3810
CHEMBL430524,P08254,,BZTWELLPCHJZLB-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,1.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1396272,DTCC00282956,258568,2897
CHEMBL430524,P08254,,BZTWELLPCHJZLB-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18053726,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality.,Bioorg. Med. Chem.,2008,16,4,"Maryanoff BE, Costanzo MJ",,469280,DTCT0024060,2295125,DTCC00282956,260885,25694
CHEMBL43063,P08254,,NZVNFHULUBKMQI-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,10,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,904823,DTCC00186612,755163,15892
CHEMBL43065,P08254,OXYRESVERATROL,PDHAOJSHSJQANO-OWOJBTEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,Not Determined,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535404,DTCC00185244,1169674,48665
CHEMBL430838,P08254,,ALDQBTGTDJBFBQ-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,92,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,454133,DTCC00246969,1617841,13104
CHEMBL430838,P08254,,ALDQBTGTDJBFBQ-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,91.2,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258520,DTCC00246969,1620400,24803
CHEMBL430838,P08254,,ALDQBTGTDJBFBQ-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,<,100,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3 (potent inhibitor)",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102098,DTCT0024060,604516,DTCC00246969,1629724,1496
CHEMBL430838,P08254,,ALDQBTGTDJBFBQ-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,92,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102097,DTCT0024060,604514,DTCC00246969,1629724,1496
CHEMBL43087,P08254,,WSWMIGCNSWBCNT-KBUPBQIOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15006405,KI,=,3.3,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,Synthesis and biological activity of selective azasugar-based TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,6,"Tsukida T, Moriyama H, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104877,DTCT0024060,832297,DTCC00180267,949058,6743
CHEMBL43087,P08254,,WSWMIGCNSWBCNT-KBUPBQIOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15055993,KI,=,3.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease 3,,Azasugar-based MMP/ADAM inhibitors as antipsoriatic agents.,J. Med. Chem.,2004,47,8,"Moriyama H, Tsukida T, Inoue Y, Yokota K, Yoshino K, Kondo H, Miura N, Nishimura S",,104746,DTCT0024060,1366766,DTCC00180267,937857,18075
CHEMBL430912,P08254,,IOVJYYHXSIOAJG-ACEFPKFPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,1900,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,788842,DTCC00152490,678980,772
CHEMBL43113,P08254,,MZIZOOUSSMSGAV-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,3,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,908482,DTCC00186443,1979397,15892
CHEMBL431130,P08254,,LZROMIIQKWLGFK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,703822,DTCC00184915,2076585,3810
CHEMBL431210,P08254,BB-3497,AVDLWYHBABSSHC-CHWSQXEVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11551755,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.,Bioorg. Med. Chem. Lett.,2001,11,19,"Pratt LM, Beckett RP, Davies SJ, Launchbury SB, Miller A, Spavold ZM, Todd RS, Whittaker M",,104889,DTCT0024060,1068923,DTCC01741522,1968386,4468
CHEMBL431226,P08254,,IDKUTWZTCGVYET-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15125955,IC50,=,280,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104895,DTCT0024060,1381120,DTCC00265456,982319,6400
CHEMBL431268,P08254,,PBUKUIIGUHJHQN-OJSMNCEXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,2600,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, MMP-3",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,101947,DTCT0024060,1316166,DTCC00258271,1294064,2323
CHEMBL431408,P08254,,OWRYEBLJLNYOPC-DYESRHJHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,2,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,506439,DTCC00246782,258156,13104
CHEMBL43147,P08254,,BGKNBDGHNBOSGD-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,38,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,904781,DTCC00186340,787356,15892
CHEMBL43147,P08254,,BGKNBDGHNBOSGD-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23453072,INH,=,38,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),,"Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.",Bioorg. Med. Chem. Lett.,2013,23,7,"Atobe M, Maekawara N, Kawanishi M, Suzuki H, Tanaka E, Miyoshi S",,953883,DTCT0024060,11856713,DTCC00186340,783143,54223
CHEMBL43148,P08254,,PSHCHUIVTMBGMR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,725766,DTCC00184297,1628774,3810
CHEMBL43152,P08254,PD-166793,GJOCABIDMCKCEG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,915393,DTCC01739899,2012246,15892
CHEMBL43152,P08254,PD-166793,GJOCABIDMCKCEG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16451058,KI,=,4.4,NM,,,,,,,,,,,,,,Inhibitory activity against MMP3,,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330546,DTCT0024060,1887713,DTCC01739899,2014806,20245
CHEMBL43152,P08254,PD-166793,GJOCABIDMCKCEG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23287054,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944582,DTCT0024060,11835678,DTCC01739899,2028335,53820
CHEMBL431601,P08254,,KVGBDBGJVRTGTB-RDTXWAMCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,112,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,478838,DTCC00106241,1806401,13104
CHEMBL431680,P08254,,DQLDJYJWPVFOFC-REUBFRLUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11585440,KI,=,582,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104869,DTCT0024060,1294912,DTCC00286954,336147,16439
CHEMBL43206,P08254,,NEOOWKPSCAQYPI-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,290,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,931895,DTCC00186341,1111450,15892
CHEMBL432079,P08254,BB-1101,GKHRDWHFKKUYAX-KSZLIROESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873367,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,Broad spectrum matrix metalloproteinase inhibitors: an examination of succinamide hydroxamate inhibitors with P1 C alpha gem-disubstitution.,Bioorg. Med. Chem. Lett.,1998,8,12,"Curtin ML, Garland RB, Davidsen SK, Marcotte PA, Albert DH, Magoc TJ, Hutchins C",,104581,DTCT0024060,865992,DTCC01739584,497069,2600
CHEMBL432079,P08254,BB-1101,GKHRDWHFKKUYAX-KSZLIROESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,12,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1378803,DTCC01739584,486746,2897
CHEMBL432299,P08254,,WDJVSROJMOYUQL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10052961,KI,>,10000,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3 (MMP-3), stromelysin-1",,Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.,J. Med. Chem.,1999,42,4,"Groneberg RD, Burns CJ, Morrissette MM, Ullrich JW, Morris RL, Darnbrough S, Djuric SW, Condon SM, McGeehan GM, Labaudiniere R, Neuenschwander K, Scotese AC, Kline JA",,104735,DTCT0024060,869057,DTCC00184942,304185,15577
CHEMBL432299,P08254,,WDJVSROJMOYUQL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,716315,DTCC00184942,302452,3810
CHEMBL432307,P08254,,UJVIDDIDLMDARE-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,12,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,911871,DTCC00186526,1467007,15892
CHEMBL432346,P08254,,CXBAZJDTLXTASG-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,952,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,561309,DTCC00232874,302963,16308
CHEMBL432346,P08254,,CXBAZJDTLXTASG-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,952,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1688988,DTCC00232874,303238,1013
CHEMBL432385,P08254,,ZCIXKXJJBYSJKM-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,81,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1313485,DTCC00244024,590001,14264
CHEMBL432397,P08254,,IOTJDDOXTYOJJN-JZWVFAODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,7.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1377681,DTCC00283116,1806814,2897
CHEMBL43256,P08254,,OFWLISQOQVGMBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,706239,DTCC00184278,819686,3810
CHEMBL432572,P08254,,MCNVXBJRJXJQBP-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,69,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1304056,DTCC00243612,1682114,14264
CHEMBL432583,P08254,,XHPRSCKHNNCQRZ-IXDOHACOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10560745,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease (MMP-3),,Selective inhibition of low affinity IgE receptor (CD23) processing: P1' bicyclomethyl substituents.,Bioorg. Med. Chem. Lett.,1999,9,21,"Bailey S, Bolognese B, Faller A, Louis-Flamberg P, MacPherson DT, Mayer RJ, Marshall LA, Milner PH, Mistry J, Smith DG, Ward JG",,105818,DTCT0024060,1431634,DTCC00278788,108679,3450
CHEMBL432642,P08254,,ONJATSAJIVHMLQ-GVAUOCQISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,320,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,564675,DTCC00285218,1164281,1951
CHEMBL43276,P08254,,GSCKLBZEPMMUCA-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,20,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,906085,DTCC00185835,658585,15892
CHEMBL432760,P08254,,MAVRREDBECZBFO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,50,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1319373,DTCC00243517,1163782,14264
CHEMBL432842,P08254,,YPHZFHQBHSELGO-QUCCMNQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9548812,IC50,=,9.6,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-3 (MMP-3).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,104576,DTCT0024060,980291,DTCC00151632,1725664,15116
CHEMBL432882,P08254,,NQPIHEUUYRAYII-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,4,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,917731,DTCC00186511,2044570,15892
CHEMBL432882,P08254,,NQPIHEUUYRAYII-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16451058,IC50,=,4,NM,,,,,,,,,,,,,,Inhibitory activity against MMP3,,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330546,DTCT0024060,1887727,DTCC00186511,2047007,20245
CHEMBL432991,P08254,,PJKWYBIJVPNFJI-FBLLAGFSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,2.3,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1390293,DTCC00283278,648277,2897
CHEMBL433063,P08254,,LJNWPYWHBAYDNO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,250,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1536364,DTCC00209041,949376,4358
CHEMBL433250,P08254,,UTTKOYMMTNAAJL-KSZLIROESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873491,IC50,=,2100,NM,,,,,,,,,,,,,,Inhibition of fibroblast stromelysin (MMP-3),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101938,DTCT0024060,1671245,DTCC00215896,691090,2712
CHEMBL433262,P08254,,VHCRBJFCQRNNFG-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,934328,DTCC00185901,1660789,15892
CHEMBL433262,P08254,,VHCRBJFCQRNNFG-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16451058,IC50,=,8,NM,,,,,,,,,,,,,,Inhibitory activity against MMP3,,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330546,DTCT0024060,1887725,DTCC00185901,1663324,20245
CHEMBL433314,P08254,,MOODLLAARDEUNJ-GRYCIOLGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12014967,KI,=,9.8,NM,,,,,,,,,,,,,,Inhibitory potency against Matrix metalloprotease-3 (MMP-3),,Beta-aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme.,J. Med. Chem.,2002,45,11,"Kottirsch G, Koch G, Feifel R, Neumann U",,104903,DTCT0024060,792663,DTCC00229842,1532258,16740
CHEMBL43338,P08254,,FGYNRNOOSHCFPR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,713015,DTCC00184933,1013798,3810
CHEMBL433381,P08254,,CFUYAVWBVRZFLA-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472217,KI,=,48,NM,,,,,,,,,,,,,,Inhibition of human MMP-3.,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104875,DTCT0024060,1672865,DTCC00251792,1488671,16346
CHEMBL433426,P08254,,GJLVFYXHGPXLCC-QUCCMNQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9548812,IC50,=,100,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-3 (MMP-3).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,104576,DTCT0024060,998141,DTCC00151649,1081960,15116
CHEMBL433455,P08254,,JNBNCWQZPZWAOV-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1042545,DTCC00204641,1553845,15462
CHEMBL433816,P08254,,DYKLASPWVUKEIT-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9548812,IC50,=,61,NM,,,,,,,,,,,,,,Activity against Matrix metalloprotease-3 (MMP-3).,,Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.,J. Med. Chem.,1998,41,8,"Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y",,104576,DTCT0024060,990675,DTCC00151405,1725663,15116
CHEMBL433902,P08254,,OEVLRZHPDAKFSL-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,1523,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1418359,DTCC00353751,466217,12880
CHEMBL433934,P08254,,QZATUGXXMHCJRV-VDKIKQQVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,6100,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1122409,DTCC00344103,304230,4691
CHEMBL433934,P08254,,QZATUGXXMHCJRV-VDKIKQQVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,5011.87,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258397,DTCC00344103,294023,24803
CHEMBL433981,P08254,,RBLCSCFFNCADJO-MKAWVKDUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,>,650,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1422593,DTCC00372420,531405,17147
CHEMBL43403,P08254,,KJVHFBOUABDIQV-KDOFPFPSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,280,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1996,6,13,,,205490,DTCT0024060,1366118,DTCC00182285,1979346,1703
CHEMBL434201,P08254,,QUCIMBXHIZZKDW-HZSPNIEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871766,ACTIVITY,=,40,,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (Stromelysin-1),,The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,1998,8,11,"Pratt LM, Beckett RP, Bellamy CL, Corkill DJ, Cossins J, Courtney PF, Davies SJ, Davidson AH, Drummond AH, Helfrich K, Lewis CN, Mangan M, Martin FM, Miller K, Nayee P, Ricketts ML, Thomas W, Todd RS, Whittaker M",,104574,DTCT0024060,637666,DTCC00164279,1616972,2586
CHEMBL434204,P08254,,ZVOOITOWQYKKKH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11412979,IC50,=,11000,NM,,,,,,,,,,,,,,In vitro inhibition of Matrix metalloprotease-3,,"Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,12,"Michaelides MR, Dellaria JF, Gong J, Holms JH, Bouska JJ, Stacey J, Wada CK, Heyman HR, Curtin ML, Guo Y, Goodfellow CL, Elmore IB, Albert DH, Magoc TJ, Marcotte PA, Morgan DW, Davidsen SK",,104731,DTCT0024060,1587717,DTCC00179314,916394,4273
CHEMBL434446,P08254,,GEPDPACRTHVSTD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,30,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1041220,DTCC00324369,809610,15462
CHEMBL43447,P08254,,ZIHRXQGOGSXZRF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,KI,=,404,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-3.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104880,DTCT0024060,724709,DTCC00184756,1979378,3810
CHEMBL434505,P08254,,YBPDYJXZXAPGSU-MAUKXSAKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11150165,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease -3 (stromelysin),,Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.,J. Med. Chem.,2000,43,26,"Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO",,104707,DTCT0024060,1618982,DTCC00333855,292454,16049
CHEMBL434567,P08254,,CKZHFOKQZRZCPF-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17256836,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.",J. Med. Chem.,2007,50,4,"Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B",,425540,DTCT0024060,2019768,DTCC00438928,33872,21880
CHEMBL434567,P08254,,CKZHFOKQZRZCPF-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,IC50,=,3560,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457493,DTCC00438928,36639,32556
CHEMBL434624,P08254,,IYVMXEVATLANJM-QMMLZNLJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205501,DTCT0024060,1266749,DTCC00318567,205760,12304
CHEMBL434655,P08254,,PVTAZXXDKDMCRE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1018573,DTCC00324356,1319548,15462
CHEMBL434769,P08254,,ZBQHXFYPSULVDX-DJHFWHLDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,1900,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant stromelysin-1.,,,Bioorg. Med. Chem. Lett.,1994,4,10,,,205642,DTCT0024060,777841,DTCC00152879,421021,772
CHEMBL43479,P08254,,UKLIIGXGTPSYBF-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,5,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,910701,DTCC00186429,107667,15892
CHEMBL435206,P08254,,COEWKMGFIMMVCE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,11,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1700447,DTCC00302719,1262122,16065
CHEMBL435206,P08254,,COEWKMGFIMMVCE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,10.99,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,500202,DTCC00302719,1273796,16483
CHEMBL435271,P08254,,NKAFEKVEMSYZIX-SFYKDHMMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9871551,KI,=,526,NM,,,,,,,,,,,,,,Binding affinity against human matrix metalloprotease-3.,,Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,1998,8,7,"Jacobson IC, Reddy PG, Wasserman ZR, Hardman KD, Covington MB, Arner EC, Copeland RA, Decicco CP, Magolda RL",,101949,DTCT0024060,476128,DTCC00364329,1425460,3059
CHEMBL435462,P08254,,YYRRVFYCIQQYHU-JWRCQZCYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831905,KI,=,6.67,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugs.,J. Med. Chem.,2002,45,4,"Sawa M, Tsukamoto T, Kiyoi T, Kurokawa K, Nakajima F, Nakada Y, Yokota K, Inoue Y, Kondo H, Yoshino K",,104744,DTCT0024060,564054,DTCC00345291,1404891,17148
CHEMBL435462,P08254,,YYRRVFYCIQQYHU-JWRCQZCYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11844676,KI,=,6.67,NM,,,,,,,,,,,,,,Inhibitory constant against recombinant human stromelysin-1 (Matrix metalloprotease-3),,Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.,Bioorg. Med. Chem. Lett.,2002,12,4,"Sawa M, Kondo H, Nishimura S",,104879,DTCT0024060,1422069,DTCC00345291,1392847,5346
CHEMBL435820,P08254,,ICZVHRMXNBNXEY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1028718,DTCC00108082,1360203,15462
CHEMBL43587,P08254,,HTLIQNNZGMWTCP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,713019,DTCC00184798,1979379,3810
CHEMBL436049,P08254,,XRIFBRFEZLXEFP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,162,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1417571,DTCC00371043,499304,17147
CHEMBL436205,P08254,,NOXYNXIAEWTFQX-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,2.7,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1370529,DTCC00325471,1754229,15412
CHEMBL436205,P08254,,NOXYNXIAEWTFQX-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,2.69,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258576,DTCC00325471,1744659,24803
CHEMBL436230,P08254,,HMXIGWYKQCGDNX-GGXMVOPNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,48,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1112973,DTCC00344112,1565528,4691
CHEMBL436230,P08254,,HMXIGWYKQCGDNX-GGXMVOPNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229774,IC50,=,48,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-3 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,104580,DTCT0024060,553018,DTCC00344112,1565536,4692
CHEMBL436230,P08254,,HMXIGWYKQCGDNX-GGXMVOPNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,47.86,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258407,DTCC00344112,1555529,24803
CHEMBL43644,P08254,,VHCRBJFCQRNNFG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,810,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,904833,DTCC00186536,172340,15892
CHEMBL43644,P08254,,VHCRBJFCQRNNFG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16451058,IC50,=,810,NM,,,,,,,,,,,,,,Inhibitory activity against MMP3,,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330546,DTCT0024060,1887726,DTCC00186536,174787,20245
CHEMBL436580,P08254,,QKBHNYUMIYQZNJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669564,IC50,=,147,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3 (MMP-3),,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,J. Med. Chem.,2000,43,3,"Cheng M, De B, Pikul S, Almstead NG, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Dowty ME, Mieling GE, Janusz MJ, Wang-Weigand S",,104704,DTCT0024060,1704463,DTCC00302785,1133237,16065
CHEMBL436580,P08254,,QKBHNYUMIYQZNJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11689071,IC50,=,146.99,NM,,,,,,,,,,,,,,Binding affinity towards matrix metalloprotease-3,,"Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a ""divide and conquer"" strategy.",J. Med. Chem.,2001,44,23,"Ambrose Amin E, Welsh WJ",,104886,DTCT0024060,491753,DTCC00302785,1144991,16483
CHEMBL436623,P08254,,YCHWBZQRFSMZCL-PVHODMMVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8126708,IC50,=,1400,NM,,,,,,,,,,,,,,Activity against human stromelysin (MMP-3).,,Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.,J. Med. Chem.,1994,37,5,"Brown FK, Brown PJ, Bickett DM, Chambers CL, Davies HG, Deaton DN, Drewry D, Foley M, McElroy AB, Gregson M",,101937,DTCT0024060,1425858,DTCC00353587,789183,12880
CHEMBL43667,P08254,,MTRUAHVPTPWCQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,KI,=,300,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-3.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104880,DTCT0024060,696905,DTCC00185139,916461,3810
CHEMBL436817,P08254,,ONXROKMQGCSOMG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17848581,IC50,=,2300,NM,,cell_based,,,,,,,,,,,,Inhibition of IL-1-beta-stimulated MMP3 in human RA-FLS cells by immunoblot analysis,,"Pharmacologic inhibition of tpl2 blocks inflammatory responses in primary human monocytes, synoviocytes, and blood.",J. Biol. Chem.,2007,282,46,"Hall JP, Kurdi Y, Hsu S, Cuozzo J, Liu J, Telliez JB, Seidl KJ, Winkler A, Hu Y, Green N, Askew GR, Tam S, Clark JD, Lin LL",,529508,DTCT0024060,2390284,DTCC00457741,1788338,29311
CHEMBL43704,P08254,,NATAMMXFTCDJKF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,KI,=,86,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-3.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104880,DTCT0024060,715180,DTCC00184727,1143664,3810
CHEMBL43806,P08254,,URQYGZHYLQIBIU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,719760,DTCC00184977,626231,3810
CHEMBL438125,P08254,,FLELGRFHQSJQFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215361,DTCC00477170,147992,24158
CHEMBL43854,P08254,,CPQOAVVNIOSBCP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,702811,DTCC00184371,529330,3810
CHEMBL438810,P08254,"1,3,2'-TRIGUANIDINONEAMINE",ZPDRGOJGQGWHOF-HKEUSBCWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16870442,KI,>,300000,NM,,,,,,,,,,,,,,Activity at MMP3,,Selectively guanidinylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease.,Bioorg. Med. Chem. Lett.,2006,16,19,"Jiao GS, Simo O, Nagata M, O'Malley S, Hemscheidt T, Cregar L, Millis SZ, Goldman ME, Tang C",,393599,DTCT0024060,1981412,DTCC00001996,1048918,21299
CHEMBL438964,P08254,,MHYRZRJQEBSULL-ZWKOTPCHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16516469,KI,=,187,NM,,,,,,,,,,,,,,Binding affinity to recombinant MMP3,,A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,10,"Janser P, Neumann U, Miltz W, Feifel R, Buhl T",,354052,DTCT0024060,1926037,DTCC00422273,1372962,20779
CHEMBL439012,P08254,,JBPHFUSOSQRLMX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17591762,IC50,=,76000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440139,DTCT0024060,2113792,DTCC00452723,1715977,23023
CHEMBL439012,P08254,,JBPHFUSOSQRLMX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP3 at 10 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440145,DTCT0024060,2113820,DTCC00452723,1715977,23023
CHEMBL439012,P08254,,JBPHFUSOSQRLMX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP3 at 100 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440151,DTCT0024060,2113848,DTCC00452723,1715977,23023
CHEMBL439012,P08254,,JBPHFUSOSQRLMX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17591762,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of MMP3 at 30 uM,,Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.,J. Med. Chem.,2007,50,15,"Fish PV, Allan GA, Bailey S, Blagg J, Butt R, Collis MG, Greiling D, James K, Kendall J, McElroy A, McCleverty D, Reed C, Webster R, Whitlock GA",,440157,DTCT0024060,2113877,DTCC00452723,1715977,23023
CHEMBL439330,P08254,,COUUBDFXGTZTPW-HRCADAONSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16516469,KI,,,,,,,,,,,,,,,,,Binding affinity to recombinant MMP3,Not Determined,A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,10,"Janser P, Neumann U, Miltz W, Feifel R, Buhl T",,354052,DTCT0024060,1926035,DTCC00422638,337728,20779
CHEMBL439944,P08254,,WWNOVCQMRIZSRV-UTUOFQBUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,47,NM,,,,,,,,,,,,,,"Inhibition of human stromelysin-1, MMP-3",,,Bioorg. Med. Chem. Lett.,1997,7,17,,,205639,DTCT0024060,1055714,DTCC00230313,1914352,2236
CHEMBL440048,P08254,,ZVQXOBXYAOIXSK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,=,3690,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215366,DTCC00477165,1214780,24158
CHEMBL440124,P08254,,IDOUEUWKDVPZSO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of recombinant full length stromelysin (FLS).,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205498,DTCT0024060,756099,DTCC00215473,3353,12439
CHEMBL440124,P08254,,IDOUEUWKDVPZSO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,18,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,756097,DTCC00215473,3353,12439
CHEMBL440124,P08254,,IDOUEUWKDVPZSO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,KI,=,13,NM,,,,,,,,,,,,,,Inhibition of recombinant full length stromelysin (FLS),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205624,DTCT0024060,756100,DTCC00215473,3353,12439
CHEMBL440124,P08254,,IDOUEUWKDVPZSO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,KI,=,15,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205625,DTCT0024060,756098,DTCC00215473,3353,12439
CHEMBL440178,P08254,,UBBBKPVDKLDZNE-AXVPLRHPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,17,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,506548,DTCC00340689,1047919,15546
CHEMBL440355,P08254,,XJMLKUIRAXOATH-YZYPPFLQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10639284,IC50,=,2,NM,,,,,,,,,,,,,,In vitro inhibition activity of human recombinant stromelysin (Matrix metalloprotease-3),,"Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.",J. Med. Chem.,1999,42,26,"Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M",,104710,DTCT0024060,484625,DTCC00340443,1598008,15546
CHEMBL44045,P08254,,XNBVIEGDQYIRRA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,KI,=,734,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-3.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104880,DTCT0024060,699334,DTCC00184665,1881770,3810
CHEMBL440498,P08254,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669559,KI,=,9.3,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104750,DTCT0024060,1060824,DTCC01741261,583202,16063
CHEMBL440498,P08254,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15686921,KI,=,9.3,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).,Bioorg. Med. Chem. Lett.,2005,15,4,"Kim SH, Pudzianowski AT, Leavitt KJ, Barbosa J, McDonnell PA, Metzler WJ, Rankin BM, Liu R, Vaccaro W, Pitts W",,302480,DTCT0024060,1744919,DTCC01741261,584379,18787
CHEMBL440498,P08254,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16220987,KI,=,17.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14741470,DTCC01741261,2107724,69259
CHEMBL440498,P08254,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19422229,IC50,=,7.1,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500583,DTCT0024060,2824177,DTCC01741261,585998,33635
CHEMBL440498,P08254,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25192810,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442063,DTCT0024060,13992245,DTCC01741261,611029,59837
CHEMBL440498,P08254,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25264600,IC50,=,0.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431421,DTCT0024060,13989099,DTCC01741261,590804,60036
CHEMBL440527,P08254,,JYURJYKWTOMFTE-VSDWSMLSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8277511,IC50,=,6500,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin,,Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.,J. Med. Chem.,1993,36,26,"Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW",,205501,DTCT0024060,1272410,DTCC00318350,109124,12304
CHEMBL44062,P08254,,QVNUOLHHXUUNEH-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,927030,DTCC00104684,367719,15892
CHEMBL440921,P08254,,JDHBSANRAFEDMI-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9484512,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.,J. Med. Chem.,1998,41,4,"Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M",,104905,DTCT0024060,629628,DTCC00351020,1436536,15057
CHEMBL44138,P08254,,IOOPRDTXOWLHHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,711805,DTCC00184718,2012228,3810
CHEMBL441455,P08254,,UDRLJELCMCGPPH-DNVCBOLYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,41,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,454684,DTCC00247191,1742115,13104
CHEMBL441502,P08254,,GXQYQFOZGUYSTC-HZPDHXFCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15369398,INHIBITION,=,3,%,,,,,,,,,,,,,,Inhibition of MMP-3 (matrix metalloprotease) at 1 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307796,DTCT0024060,1789824,DTCC00392620,1360974,19089
CHEMBL441502,P08254,,GXQYQFOZGUYSTC-HZPDHXFCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15369398,INHIBITION,=,9,%,,,,,,,,,,,,,,Inhibition of MMP-3 (matrix metalloprotease) at 10 uM,,Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.,J. Med. Chem.,2004,47,20,"Hu X, Nguyen KT, Jiang VC, Lofland D, Moser HE, Pei D",,307803,DTCT0024060,1789825,DTCC00392620,1360974,19089
CHEMBL441662,P08254,,AKNDZTHCJLFZCF-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,7.2,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1367839,DTCC00326356,1565298,15412
CHEMBL441781,P08254,,AKBYHAYPWDTSCH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10229623,IC50,=,97000,NM,,,,,,,,,,,,,,Inhibitory concentration against Matrix metalloprotease-3,,Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.,J. Med. Chem.,1999,42,9,"Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, Maggiora LL, Stuchly CW, Laborde AL, Kubicek MF, Poorman RA, Beck JM, Miller HR, Petzold GL, Scott PS, Truesdell SE, Wallace TL, Wilks JW, Fisher C, Goodman LV, Kaytes PS",,104727,DTCT0024060,897726,DTCC00178620,192745,15677
CHEMBL442161,P08254,,AWCXQBIUITTYEE-UXPWSPDFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,550,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 by MCA peptide assay,,,Bioorg. Med. Chem. Lett.,1997,7,13,,,104747,DTCT0024060,659788,DTCC00194352,679415,2155
CHEMBL44225,P08254,,JXKHWYPWBNGVBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10052961,KI,=,600,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3 (MMP-3), stromelysin-1",,Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.,J. Med. Chem.,1999,42,4,"Groneberg RD, Burns CJ, Morrissette MM, Ullrich JW, Morris RL, Darnbrough S, Djuric SW, Condon SM, McGeehan GM, Labaudiniere R, Neuenschwander K, Scotese AC, Kline JA",,104735,DTCT0024060,875643,DTCC00185170,1915625,15577
CHEMBL44225,P08254,,JXKHWYPWBNGVBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,KI,=,1390,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-3.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104880,DTCT0024060,701710,DTCC00185170,1913830,3810
CHEMBL442423,P08254,,ODDQJXJHWIBVKQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17027261,KI,,,,,,,,,,,,,,,,,Inhibition of MMP3,Not Determined,Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2007,17,1,"Duan JJ, Chen L, Lu Z, Jiang B, Asakawa N, Sheppeck JE, Liu RQ, Covington MB, Pitts W, Kim SH, Decicco CP",,452972,DTCT0024060,2215348,DTCC00477189,147993,24158
CHEMBL442445,P08254,,DMYSRZBLJSUUJP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18029177,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP3,,A novel series of highly selective inhibitors of MMP-3.,Bioorg. Med. Chem. Lett.,2007,17,24,"Whitlock GA, Dack KN, Dickinson RP, Lewis ML",,459991,DTCT0024060,2266860,DTCC00486119,553270,24951
CHEMBL44250,P08254,,UDXFDWQRRZOFEH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10052961,KI,=,700,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3 (MMP-3), stromelysin-1",,Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.,J. Med. Chem.,1999,42,4,"Groneberg RD, Burns CJ, Morrissette MM, Ullrich JW, Morris RL, Darnbrough S, Djuric SW, Condon SM, McGeehan GM, Labaudiniere R, Neuenschwander K, Scotese AC, Kline JA",,104735,DTCT0024060,876856,DTCC00185109,238493,15577
CHEMBL44250,P08254,,UDXFDWQRRZOFEH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,KI,=,700,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-3.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104880,DTCT0024060,472137,DTCC00185109,236733,3810
CHEMBL44311,P08254,,LGIBSSWDUBGUGL-CFZCINTLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,38,%,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-3 (Stromelysin) at 10 uM,,,Bioorg. Med. Chem. Lett.,1995,5,15,,,205622,DTCT0024060,667996,DTCC00184566,96153,1239
CHEMBL443478,P08254,,YDDLGJKZEJWWDF-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1035829,DTCC00204203,97714,15462
CHEMBL443818,P08254,,ZWHGWUJFPYMQHK-QTQRRKOQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229774,IC50,=,10,NM,,,,,,,,,,,,,,Concentration required to inhibit the catalytic domain Matrix metalloprotease-3 using Nagase fluorogenic as a substrate.,,Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Dickinson RP",,104580,DTCT0024060,578278,DTCC00344563,1533562,4692
CHEMBL443818,P08254,,ZWHGWUJFPYMQHK-QTQRRKOQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258557,DTCC00344563,1523432,24803
CHEMBL44383,P08254,,MDWFJTBWOFNAQX-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,920970,DTCC00186509,593751,15892
CHEMBL44383,P08254,,MDWFJTBWOFNAQX-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,1890,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1297398,DTCC00186509,582683,16328
CHEMBL44383,P08254,,MDWFJTBWOFNAQX-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12798337,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents.,Bioorg. Med. Chem. Lett.,2003,13,13,"Fei X, Zheng QH, Liu X, Wang JQ, Sun HB, Mock BH, Stone KL, Miller KD, Sledge GW, Hutchins GD",,104573,DTCT0024060,1398932,DTCC00186509,594169,5629
CHEMBL44407,P08254,,AZKZIIQQPAZCKN-LLJXTTFASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,36,%,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-3 (Stromelysin) at 10 uM,,,Bioorg. Med. Chem. Lett.,1995,5,15,,,205622,DTCT0024060,689444,DTCC00184503,323229,1239
CHEMBL44415,P08254,,MMVAAAGUQUNADB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,694494,DTCC00184266,755131,3810
CHEMBL44455,P08254,,PLCPLXITTDSMSK-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,15,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,923305,DTCC00186527,626251,15892
CHEMBL445611,P08254,,JXLOCCNKUYGHHM-JBAPVGOWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,34,%,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-3 (Stromelysin) at 10 uM,,,Bioorg. Med. Chem. Lett.,1995,5,15,,,205622,DTCT0024060,686934,DTCC00184502,1681480,1239
CHEMBL445717,P08254,,KMMSPMPORWBMTE-QBDLAISOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19457660,IC50,=,4999,NM,,,,,,,,,,,,,,Inhibition of human MMP3,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523766,DTCT0024060,2828348,DTCC00554189,164925,33677
CHEMBL445971,P08254,,PHMPGOJWLISPFK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,KI,=,3600,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457373,DTCC00115941,371585,32556
CHEMBL445994,P08254,,MYTAFXBNPKBRNX-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17719700,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,Not Determined,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510905,DTCT0024060,2438477,DTCC00512741,1809282,30977
CHEMBL446457,P08254,,YZXVQIOBIKCYRB-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18036818,IC50,>,5000,NM,,,,,,,,,,,,,,Binding affinity to MMP3,,Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.,Bioorg. Med. Chem. Lett.,2008,18,1,"Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B",,461666,DTCT0024060,2276507,DTCC00488479,99430,25086
CHEMBL447211,P08254,,VRUANMLASZOUAG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,INHIBITION,=,32,%,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564424,DTCT0024060,2612848,DTCC00117301,2016407,33264
CHEMBL447787,P08254,,HWRTYSUSQVJAGF-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18242982,KI,=,3915,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462365,DTCT0024060,2282349,DTCC00488438,1684915,25163
CHEMBL448246,P08254,,RRXQHLQCQYPPMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18358729,ACTIVITY,=,43,%,,,,,,,,,,,,,,Inhibition recombinant MMP3 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518660,DTCT0024060,2708849,DTCC00516462,2047968,32215
CHEMBL448246,P08254,,RRXQHLQCQYPPMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18364257,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 200 uM by HxBPyne probe-based competitive activity based protein profiling assay in presence of 5 uM HxBpane competitor,Active,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518905,DTCT0024060,2708992,DTCC00516462,2047969,32218
CHEMBL448399,P08254,HYDROXYTOLUIC ACID,WHSXTWFYRGOBGO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,13,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103091,DTCC00565293,1703863,43205
CHEMBL44898,P08254,,YWAPUIQWVUXRRW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,10,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,902227,DTCC00104686,1046250,15892
CHEMBL44931,P08254,,YFSKDXWVNPXSTG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,699240,DTCC00184984,75408,3810
CHEMBL45035,P08254,,ILHVRYPRZRUQCQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,KI,>,10000,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-3.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104880,DTCT0024060,702863,DTCC00185002,2076584,3810
CHEMBL45040,P08254,,AGRDSOUIPBKOKQ-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,6,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,930619,DTCC00186467,1467008,15892
CHEMBL450431,P08254,,NRHSKONRJVZHAX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,47,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103234,DTCC00571871,896234,43205
CHEMBL45162,P08254,,CQIQKDQFHVTTKM-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10397503,IC50,=,29,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101943,DTCT0024060,528388,DTCC00188800,1099852,3181
CHEMBL45208,P08254,,LBHXVNIHKACCKG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,KI,=,1430,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-3.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104880,DTCT0024060,724697,DTCC00185114,1174761,3810
CHEMBL452082,P08254,,RMPMGGGCHRCWIU-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17719700,IC50,>,300000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510905,DTCT0024060,2438444,DTCC00512738,9768,30977
CHEMBL452083,P08254,,MOPRTFSMCQNUCT-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17719700,IC50,=,20000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510905,DTCT0024060,2438456,DTCC00512739,1841747,30977
CHEMBL452584,P08254,,MXMAVZMWYSUCJZ-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17719700,IC50,>,300000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510905,DTCT0024060,2438463,DTCC00512740,261085,30977
CHEMBL452947,P08254,,JUTPCQYEVUKCAU-MNNSJKJDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18782669,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain by spectrofluorimeter,Not Determined,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557957,DTCT0024060,2791198,DTCC00514936,392324,31586
CHEMBL45357,P08254,,FCYBWLNLMVDLRH-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10397503,IC50,=,45,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101943,DTCT0024060,539686,DTCC00188708,808145,3181
CHEMBL454808,P08254,"2,6-DIHYDROXYBENZOIC ACID",AKEUNCKRJATALU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,-4,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103987,DTCC00005081,86519,43205
CHEMBL45483,P08254,SC-44463,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12877590,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3 (MMP-3),,"A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.",J. Med. Chem.,2003,46,16,"Fray MJ, Dickinson RP, Huggins JP, Occleston NL",,104716,DTCT0024060,1541416,DTCC01740008,389797,17445
CHEMBL45483,P08254,SC-44463,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,<,10,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1997,7,18,,,104882,DTCT0024060,1585245,DTCC01740008,400992,2242
CHEMBL455885,P08254,,QDYJJDBZEHVSMQ-UXOAXIEHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15332861,MIC50,=,300,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Novel sesquiterpenoid matrix metalloproteinase-3 inhibitors from an acid mine waste extremophile.,J. Nat. Prod.,2004,67,8,"Stierle AA, Stierle DB, Kemp K",,481138,DTCT0024060,2646937,DTCC00556282,1842228,27631
CHEMBL45631,P08254,,USEJKZYMWYHGSP-KSZLIROESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9599225,KI,=,32.7,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (Matrix metalloprotease-3),,Design and synthesis of cyclic inhibitors of matrix metalloproteinases and TNF-alpha production.,J. Med. Chem.,1998,41,11,"Xue CB, He X, Roderick J, DeGrado WF, Cherney RJ, Hardman KD, Nelson DJ, Copeland RA, Jaffee BD, Decicco CP",,104745,DTCT0024060,566473,DTCC00192340,1402804,14639
CHEMBL45631,P08254,,USEJKZYMWYHGSP-KSZLIROESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873491,IC50,=,7.8,NM,,,,,,,,,,,,,,Inhibition of fibroblast stromelysin (MMP-3),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101938,DTCT0024060,1651076,DTCC00192340,1403047,2712
CHEMBL45631,P08254,,USEJKZYMWYHGSP-KSZLIROESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472217,KI,=,32.7,NM,,,,,,,,,,,,,,Inhibition of human MMP-3.,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104875,DTCT0024060,1654034,DTCC00192340,1391994,16346
CHEMBL460725,P08254,,QHDIXGPUTSAIJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19173605,IC50,<,100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).,J. Med. Chem.,2009,52,4,"Pochetti G, Montanari R, Gege C, Chevrier C, Taveras AG, Mazza F",,494618,DTCT0024060,2596035,DTCC00517113,715017,32135
CHEMBL460899,P08254,,ITADELAVAWJACR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19173605,IC50,>,2500,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).,J. Med. Chem.,2009,52,4,"Pochetti G, Montanari R, Gege C, Chevrier C, Taveras AG, Mazza F",,494618,DTCT0024060,2596044,DTCC00114032,1166828,32135
CHEMBL460899,P08254,,ITADELAVAWJACR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22689580,IC50,=,2500,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14718580,DTCC00114032,2101638,68703
CHEMBL460899,P08254,,ITADELAVAWJACR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25265401,IC50,>,2500,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),,"Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.",J. Med. Chem.,2014,57,24,"Fabre B, Ramos A, de Pascual-Teresa B",,1433219,DTCT0024060,13993811,DTCC00114032,1171843,60040
CHEMBL461220,P08254,,ZVRPHGZPZLMEPV-PIKZIKFNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18835710,KI,<,14000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496899,DTCT0024060,2456657,DTCC00529493,111525,31825
CHEMBL46183,P08254,,ZKUXVTKGURJPOW-YESZJQIVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9599226,KI,=,35000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Macrocyclic amino carboxylates as selective MMP-8 inhibitors.,J. Med. Chem.,1998,41,11,"Cherney RJ, Wang L, Meyer DT, Xue CB, Wasserman ZR, Hardman KD, Welch PK, Covington MB, Copeland RA, Arner EC, DeGrado WF, Decicco CP",,104881,DTCT0024060,1347400,DTCC00193499,969802,14640
CHEMBL462627,P08254,,MNYLANCSXOSQBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18358729,ACTIVITY,=,96,%,,,,,,,,,,,,,,Inhibition recombinant MMP3 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518660,DTCT0024060,2708844,DTCC00516390,758694,32215
CHEMBL462628,P08254,,ITQDPSGUKJGOJF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18358729,ACTIVITY,=,87,%,,,,,,,,,,,,,,Inhibition recombinant MMP3 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518660,DTCT0024060,2708845,DTCC00516392,565008,32215
CHEMBL462629,P08254,,XEXZOINHSIFHFY-XFXZXTDPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18358729,ACTIVITY,=,96,%,,,,,,,,,,,,,,Inhibition recombinant MMP3 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518660,DTCT0024060,2708846,DTCC00516393,175688,32215
CHEMBL465411,P08254,,NLHKOAOSUWNDDM-NRIAAUITSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15332861,MIC50,=,300,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Novel sesquiterpenoid matrix metalloproteinase-3 inhibitors from an acid mine waste extremophile.,J. Nat. Prod.,2004,67,8,"Stierle AA, Stierle DB, Kemp K",,481138,DTCT0024060,2646940,DTCC00556296,1136104,27631
CHEMBL466059,P08254,,GYETWAWIKBOMPE-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19422229,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500583,DTCT0024060,2824178,DTCC00536373,164710,33635
CHEMBL466132,P08254,,HDHGKKSSTJLVPS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18386916,ACTIVITY,=,325,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Chemical fragments as foundations for understanding target space and activity prediction.,J. Med. Chem.,2008,51,9,"Sutherland JJ, Higgs RE, Watson I, Vieth M",,532565,DTCT0024060,2414438,DTCC00542312,1716868,28753
CHEMBL466565,P08254,BERKELEYAMIDE A,KACACYYTPVUKSL-UAGQMJEPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18330993,IC50,=,330,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"The berkeleyamides, amides from the acid lake fungus Penicillum rubrum.",J. Nat. Prod.,2008,71,5,"Stierle AA, Stierle DB, Patacini B",,530936,DTCT0024060,2419317,DTCC00542301,392670,28715
CHEMBL466747,P08254,BERKELEYAMIDE D,KYPWBBBOBAOGSQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18330993,IC50,=,610,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"The berkeleyamides, amides from the acid lake fungus Penicillum rubrum.",J. Nat. Prod.,2008,71,5,"Stierle AA, Stierle DB, Patacini B",,530936,DTCT0024060,2419318,DTCC00542340,1524061,28715
CHEMBL467,P08254,HYDROXYUREA,VSNHCAURESNICA-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,>,25000000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in place of acetohydroxamic acid.,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205633,DTCT0024060,1265919,DTCC00136099,1145451,17092
CHEMBL467776,P08254,,OHBYAEPYMITRJA-BDYUSTAISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18386916,ACTIVITY,=,7.31,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Chemical fragments as foundations for understanding target space and activity prediction.,J. Med. Chem.,2008,51,9,"Sutherland JJ, Higgs RE, Watson I, Vieth M",,532565,DTCT0024060,2414432,DTCC00542248,521803,28753
CHEMBL46804,P08254,,KRFIIEPIJNLUBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,696810,DTCC00184869,2044540,3810
CHEMBL46818,P08254,,UWHPJOBPMXNVII-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,16,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,931901,DTCC00185806,464278,15892
CHEMBL46830,P08254,,ZGWIOFHKEXLJPC-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,8,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,924608,DTCC00186466,1979398,15892
CHEMBL468640,P08254,BERKELEYAMIDE B,VDFNZTMTSRBUGD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18330993,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP3,Active,"The berkeleyamides, amides from the acid lake fungus Penicillum rubrum.",J. Nat. Prod.,2008,71,5,"Stierle AA, Stierle DB, Patacini B",,530936,DTCT0024060,2419322,DTCC00115765,1842076,28715
CHEMBL468641,P08254,BERKELEYAMIDE C,SORSUPGCQWSYDP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18330993,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP3,Active,"The berkeleyamides, amides from the acid lake fungus Penicillum rubrum.",J. Nat. Prod.,2008,71,5,"Stierle AA, Stierle DB, Patacini B",,530936,DTCT0024060,2419321,DTCC00115766,489564,28715
CHEMBL468900,P08254,,NHPBWKYFMTXWAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP3 up to 100 uM,Not Active,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497428,DTCT0024060,2457350,DTCC00530186,2016158,32556
CHEMBL46915,P08254,,HBDOUVSVVYQJQQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,700491,DTCC00185271,1370313,3810
CHEMBL46963,P08254,,YFKWYMMUDUFOOX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,KI,=,590,NM,,,,,,,,,,,,,,In vitro inhibition of human recombinant Matrix metalloprotease-3.,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104880,DTCT0024060,714018,DTCC00185138,1692907,3810
CHEMBL469990,P08254,,WVAADEFBDRAILG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,INHIBITION,=,4,%,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564424,DTCT0024060,2612850,DTCC00569626,37404,33264
CHEMBL470194,P08254,AM-2S,ZOMMNLRHGAAUNM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,IC50,=,5600,NM,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564427,DTCT0024060,2612863,DTCC00009155,953231,33264
CHEMBL47076,P08254,,WLJUNQUGIMIQDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,7,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,924614,DTCC00104690,1467009,15892
CHEMBL470830,P08254,,ABYNUYKRSMWNED-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,IC50,=,16400,NM,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564427,DTCT0024060,2612860,DTCC00570503,1697035,33264
CHEMBL470830,P08254,,ABYNUYKRSMWNED-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,INHIBITION,=,97,%,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564424,DTCT0024060,2612811,DTCC00570503,1697035,33264
CHEMBL470831,P08254,,FDGGHYRGDJKCPG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,IC50,=,2400,NM,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564427,DTCT0024060,2612861,DTCC00570504,1211020,33264
CHEMBL470831,P08254,,FDGGHYRGDJKCPG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,INHIBITION,=,93,%,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564424,DTCT0024060,2612810,DTCC00570504,1211020,33264
CHEMBL47133,P08254,,RDXNYSSQQZEEJF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10937713,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant matrix metalloprotease-3,,Solid-phase synthesis of an arylsulfone hydroxamate library.,Bioorg. Med. Chem. Lett.,2000,10,15,"Salvino JM, Mathew R, Kiesow T, Narensingh R, Mason HJ, Dodd A, Groneberg R, Burns CJ, McGeehan G, Kline J, Orton E, Tang SY, Morrisette M, Labaudininiere R",,104733,DTCT0024060,730605,DTCC00184985,1206979,3810
CHEMBL47254,P08254,,HXNNABWLGZRTMD-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,9,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,904811,DTCC00186592,1596218,15892
CHEMBL473107,P08254,,YNKDEHKXKOAEBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18358729,ACTIVITY,=,75,%,,,,,,,,,,,,,,Inhibition recombinant MMP3 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518660,DTCT0024060,2708851,DTCC00515624,984986,32215
CHEMBL473314,P08254,,DIPCWZOATLQURP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18358729,ACTIVITY,=,95,%,,,,,,,,,,,,,,Inhibition recombinant MMP3 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518660,DTCT0024060,2708852,DTCC00515689,305973,32215
CHEMBL473326,P08254,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18364257,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 200 uM by HxBPyne probe-based competitive activity based protein profiling assay in presence of 5 uM HxBpane competitor,Not Active,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518905,DTCT0024060,2708990,DTCC00516458,694221,32218
CHEMBL473326,P08254,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22018790,ACTIVITY,=,96,%,,,,,,,,,,,,,,Inhibition of MMP3 expressed in Escherichia coli assessed as residual activity using Knight SSP as substrate at 100 uM after 1.5 to 4 hrs by spectrofluorometric analysis relative to control,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799331,DTCT0024060,7596130,DTCC00516458,704135,47025
CHEMBL473326,P08254,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25330343,INHIBITION,>,10,%,,,,,,,,,,,,,,Inhibition of recombinant human MMP-3 using GRIGFL substrate up to 20 uM,,Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.,J. Med. Chem.,2014,57,22,"Spicer TP, Jiang J, Taylor AB, Choi JY, Hart PJ, Roush WR, Fields GB, Hodder PS, Minond D",,1435006,DTCT0024060,14018310,DTCC00516458,687799,60192
CHEMBL473327,P08254,,ZHNBFYMZDUSWSL-OWBHPGMISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18358729,ACTIVITY,=,90,%,,,,,,,,,,,,,,Inhibition recombinant MMP3 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518660,DTCT0024060,2708847,DTCC00516459,597255,32215
CHEMBL47414,P08254,,MVTUAPMXVXQWFM-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10397503,IC50,=,90,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101943,DTCT0024060,516292,DTCC00188667,452197,3181
CHEMBL47468,P08254,,WHTRIFCXCJYQKX-SSEXGKCCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10397503,IC50,=,3.7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101943,DTCT0024060,524553,DTCC00188664,840936,3181
CHEMBL475540,P08254,,IQGHPUPMOUUHPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18358729,ACTIVITY,=,63,%,,,,,,,,,,,,,,Inhibition recombinant MMP3 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518660,DTCT0024060,2708841,DTCC00515616,1178193,32215
CHEMBL475540,P08254,,IQGHPUPMOUUHPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18364257,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 200 uM by HxBPyne probe-based competitive activity based protein profiling assay in presence of 5 uM HxBpane competitor,Active,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518905,DTCT0024060,2708993,DTCC00515616,1178199,32218
CHEMBL475742,P08254,,RLJYCZREXIWYAI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18358729,ACTIVITY,=,96,%,,,,,,,,,,,,,,Inhibition recombinant MMP3 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518660,DTCT0024060,2708842,DTCC00515618,2015780,32215
CHEMBL47728,P08254,,XXNCZTSFXIANIO-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10397503,IC50,=,37,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101943,DTCT0024060,531209,DTCC00188668,1584488,3181
CHEMBL48256,P08254,,DOXXSEYJDIFFAY-KMDXXIMOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9599226,KI,=,2400,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Macrocyclic amino carboxylates as selective MMP-8 inhibitors.,J. Med. Chem.,1998,41,11,"Cherney RJ, Wang L, Meyer DT, Xue CB, Wasserman ZR, Hardman KD, Welch PK, Covington MB, Copeland RA, Arner EC, DeGrado WF, Decicco CP",,104881,DTCT0024060,1359474,DTCC00193645,1099889,14640
CHEMBL482569,P08254,,XBFXJMMYLBDNIS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,INHIBITION,=,32,%,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564424,DTCT0024060,2612846,DTCC00569554,1406957,33264
CHEMBL482570,P08254,,DSVOZVDBZXHCJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,INHIBITION,=,26,%,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564424,DTCT0024060,2612849,DTCC00117302,501285,33264
CHEMBL48258,P08254,,PGWQPFWCLKSUIC-DYEKYZERSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9599225,KI,=,24.1,NM,,,,,,,,,,,,,,Inhibition of MMP-3 (Matrix metalloprotease-3),,Design and synthesis of cyclic inhibitors of matrix metalloproteinases and TNF-alpha production.,J. Med. Chem.,1998,41,11,"Xue CB, He X, Roderick J, DeGrado WF, Cherney RJ, Hardman KD, Nelson DJ, Copeland RA, Jaffee BD, Decicco CP",,104745,DTCT0024060,548589,DTCC00191817,400574,14639
CHEMBL48258,P08254,,PGWQPFWCLKSUIC-DYEKYZERSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472217,KI,=,24.1,NM,,,,,,,,,,,,,,Inhibition of human MMP-3.,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104875,DTCT0024060,1654030,DTCC00191817,389300,16346
CHEMBL482961,P08254,,JDHGPTDYDICLJB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,INHIBITION,=,36,%,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564424,DTCT0024060,2612844,DTCC00569552,1983467,33264
CHEMBL482962,P08254,,IVGSTMMMIBMQSJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,INHIBITION,=,18,%,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564424,DTCT0024060,2612845,DTCC00569553,2016406,33264
CHEMBL48310,P08254,HINOKITIOL,FUWUEFKEXZQKKA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,98,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103928,DTCC00192828,1763870,43205
CHEMBL483857,P08254,2-((4-PHENOXYPHENYLSULFONYL)METHYL)THIIRANE,LSONWRHLFZYHIN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,KI,=,15000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457379,DTCC00007664,1756562,32556
CHEMBL483857,P08254,2-((4-PHENOXYPHENYLSULFONYL)METHYL)THIIRANE,LSONWRHLFZYHIN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,ACTIVITY,=,0.018,10'-3/M/S,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain assessed as association rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702124,DTCT0024060,5064910,DTCC00007664,1746732,42713
CHEMBL483857,P08254,2-((4-PHENOXYPHENYLSULFONYL)METHYL)THIIRANE,LSONWRHLFZYHIN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,ACTIVITY,=,5.5,10'-3/M/S,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain assessed as dissociation rate constant by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702127,DTCT0024060,5066038,DTCC00007664,1746732,42713
CHEMBL483857,P08254,2-((4-PHENOXYPHENYLSULFONYL)METHYL)THIIRANE,LSONWRHLFZYHIN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,15000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain by substrate hydrolysis based fluorescence spectrophotometry,,,ACS Med. Chem. Lett.,2011,2,2,,,702133,DTCT0024060,5066071,DTCC00007664,1746732,42713
CHEMBL483857,P08254,2-((4-PHENOXYPHENYLSULFONYL)METHYL)THIIRANE,LSONWRHLFZYHIN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,15000,NM,,,,,,,,,,,,,,Competitive inhibition of human MMP3 using fluorogenic substrate by Dixon plot analysis,,,ACS Med. Chem. Lett.,2012,3,6,,,831071,DTCT0024060,10566514,DTCC00007664,1767161,48923
CHEMBL485492,P08254,,QNKSDDQPRLWOEC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,KI,=,12200,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457366,DTCC00115942,306350,32556
CHEMBL485492,P08254,,QNKSDDQPRLWOEC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21866961,KI,=,12200,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 assessed as hydrolysis of MOCAcPLGLA2pr(Dnp)AR-NH2 by fluorescence spectrofluorometry ,,Selective water-soluble gelatinase inhibitor prodrugs.,J. Med. Chem.,2011,54,19,"Gooyit M, Lee M, Schroeder VA, Ikejiri M, Suckow MA, Mobashery S, Chang M",,771366,DTCT0024060,6116317,DTCC00115942,296761,46049
CHEMBL48634,P08254,,OGRLFEDMYSWXHN-ZNZIZOMTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,42,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 by MCA peptide assay,,,Bioorg. Med. Chem. Lett.,1997,7,13,,,104747,DTCT0024060,691971,DTCC00194425,421432,2155
CHEMBL48773,P08254,,FHXAOXRZWHPONL-LEOXJPRUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,552,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 by MCA peptide assay,,,Bioorg. Med. Chem. Lett.,1997,7,13,,,104747,DTCT0024060,377575,DTCC00193902,517975,2155
CHEMBL48786,P08254,,WMVFFTPYCGKWCT-PCCBWWKXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9599226,KI,=,14088,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Macrocyclic amino carboxylates as selective MMP-8 inhibitors.,J. Med. Chem.,1998,41,11,"Cherney RJ, Wang L, Meyer DT, Xue CB, Wasserman ZR, Hardman KD, Welch PK, Covington MB, Copeland RA, Arner EC, DeGrado WF, Decicco CP",,104881,DTCT0024060,1355638,DTCC00193466,1934553,14640
CHEMBL488617,P08254,,YQOYDTYUPFCPKG-AMGIVPHBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18782669,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557957,DTCT0024060,2791190,DTCC00514928,650740,31586
CHEMBL489100,P08254,BMS-561392,QVNZBDLTUKCPGJ-SHQCIBLASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,285,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) by fluorescence-based FRET assay,,,MedChemComm,2011,2,10,,,1328283,DTCT0024060,13572211,DTCC00005548,590183,39059
CHEMBL489603,P08254,,HDDDAEIHJFNBGK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,IC50,=,19,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457388,DTCC00546721,1821316,32556
CHEMBL489603,P08254,,HDDDAEIHJFNBGK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21609408,IC50,=,19,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14717068,DTCC00546721,2100842,69102
CHEMBL48969,P08254,,UGLOKYALFGIDPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10230616,IC50,=,150,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,Discovery of a novel series of selective MMP inhibitors: identification of the gamma-sulfone-thiols.,Bioorg. Med. Chem. Lett.,1999,9,7,"Freskos JN, Mischke BV, DeCrescenzo GA, Heintz R, Getman DP, Howard SC, Kishore NN, McDonald JJ, Munie GE, Rangwala S, Swearingen CA, Voliva C, Welsch DJ",,102102,DTCT0024060,1714735,DTCC00193516,1425572,3610
CHEMBL491643,P08254,,AQXFSOLTNZQWIK-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457502,DTCC00546723,306348,32556
CHEMBL495502,P08254,,OBBSDCUMPDPHQF-BEEZEEGUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,KI,=,762,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457266,DTCC00547246,1983210,32556
CHEMBL495555,P08254,,OKNJOSGDEWUQIH-RNAHPLFWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18835710,KI,>,10000000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496899,DTCT0024060,2456659,DTCC00548438,694598,31825
CHEMBL495797,P08254,,VXPAAABROXRBQT-XHXISMBCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19457660,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of human MMP3,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523766,DTCT0024060,2828349,DTCC00554190,715467,33677
CHEMBL496309,P08254,,QCSQWZYXJSYMSJ-DJUQAAIZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18835710,KI,>,10000000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496899,DTCT0024060,2456656,DTCC00547689,111517,31825
CHEMBL496628,P08254,,SPGSQKKTHWOODB-BVSLBCMMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19457660,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of human MMP3,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523766,DTCT0024060,2828356,DTCC00554399,1971829,33677
CHEMBL496829,P08254,,ZABUEZYWKJKVJI-MZBJOSPHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19457660,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of human MMP3,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523766,DTCT0024060,2828357,DTCC00554401,1167262,33677
CHEMBL496909,P08254,,OUGLYRIZWKQCPG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,INHIBITION,=,44,%,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564424,DTCT0024060,2612807,DTCC00570592,727134,33264
CHEMBL496910,P08254,,LEYALAQCHLCNCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,IC50,=,13900,NM,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564427,DTCT0024060,2612866,DTCC00570593,2080760,33264
CHEMBL496910,P08254,,LEYALAQCHLCNCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,INHIBITION,=,91,%,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564424,DTCT0024060,2612806,DTCC00570593,2080760,33264
CHEMBL496942,P08254,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17623656,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP3 catalytic domain,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507873,DTCT0024060,2388623,DTCC00547183,1983321,29282
CHEMBL496942,P08254,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP3 up to 100 uM,Not Active,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497428,DTCT0024060,2457332,DTCC00547183,1983207,32556
CHEMBL496942,P08254,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,25265401,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),,"Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.",J. Med. Chem.,2014,57,24,"Fabre B, Ramos A, de Pascual-Teresa B",,1433219,DTCT0024060,13993810,DTCC00547183,1976454,60040
CHEMBL497026,P08254,,SPGSQKKTHWOODB-GFUWAVFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19457660,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of human MMP3,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523766,DTCT0024060,2828354,DTCC00554324,779794,33677
CHEMBL497222,P08254,,AVCGYVHCLDMOAW-GFUWAVFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19457660,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of human MMP3,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523766,DTCT0024060,2828355,DTCC00554325,1874229,33677
CHEMBL497769,P08254,,PIRLKANLMCDQSE-UFHPHHKVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18835710,KI,>,10000000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496899,DTCT0024060,2456654,DTCC00547750,1917719,31825
CHEMBL497772,P08254,,KQIFSUSWYMDFOC-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,IC50,=,81,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457440,DTCC00547182,823604,32556
CHEMBL497810,P08254,,YOOJSKRBENNWQY-BWKNWUBXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18835710,KI,=,952000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496899,DTCT0024060,2456660,DTCC00548337,1983227,31825
CHEMBL497985,P08254,,HJNKYGBTSGQBDU-HOCLYGCPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457484,DTCC00547304,630170,32556
CHEMBL498272,P08254,,NSHZQFVEIUWJLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,INHIBITION,=,45,%,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564424,DTCT0024060,2612804,DTCC00570595,791396,33264
CHEMBL498274,P08254,,UHPIIBXLPOMYFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,INHIBITION,=,22,%,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564424,DTCT0024060,2612805,DTCC00570594,985625,33264
CHEMBL498915,P08254,,NIPJJOWPCLBDGS-CLOONOSVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18782669,IC50,=,920,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557957,DTCT0024060,2791191,DTCC00514929,67486,31586
CHEMBL50,P08254,QUERCETIN,REFJWTPEDVJJIY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,=,5570,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535393,DTCC00135230,18482,48665
CHEMBL50,P08254,QUERCETIN,REFJWTPEDVJJIY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827441,DTCT0024060,10535502,DTCC00135230,18482,48665
CHEMBL500351,P08254,,XMFWHLZTTUUQHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18358729,ACTIVITY,=,97,%,,,,,,,,,,,,,,Inhibition recombinant MMP3 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518660,DTCT0024060,2708848,DTCC00516461,984995,32215
CHEMBL500351,P08254,,XMFWHLZTTUUQHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18364257,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 200 uM by HxBPyne probe-based competitive activity based protein profiling assay in presence of 5 uM HxBpane competitor,Not Active,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518905,DTCT0024060,2708991,DTCC00516461,984998,32218
CHEMBL500361,P08254,,FZRWFGUOALKHJG-SNPRPXQTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15332861,MIC50,=,300,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Novel sesquiterpenoid matrix metalloproteinase-3 inhibitors from an acid mine waste extremophile.,J. Nat. Prod.,2004,67,8,"Stierle AA, Stierle DB, Kemp K",,481138,DTCT0024060,2646941,DTCC00556295,973764,27631
CHEMBL501715,P08254,,RMPMGGGCHRCWIU-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17719700,IC50,>,300000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510905,DTCT0024060,2438438,DTCC00560261,100290,30977
CHEMBL50228,P08254,,NSZHVJWSFHBPMB-OKZBNKHCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9599226,KI,=,13500,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Macrocyclic amino carboxylates as selective MMP-8 inhibitors.,J. Med. Chem.,1998,41,11,"Cherney RJ, Wang L, Meyer DT, Xue CB, Wasserman ZR, Hardman KD, Welch PK, Covington MB, Copeland RA, Arner EC, DeGrado WF, Decicco CP",,104881,DTCT0024060,1349979,DTCC00193676,969803,14640
CHEMBL50228,P08254,,NSZHVJWSFHBPMB-OKZBNKHCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,KI,=,13500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457445,DTCC00193676,985350,32556
CHEMBL502674,P08254,,MLPPJTCCWGPRTB-MYVCOICNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18782669,IC50,=,53,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557957,DTCT0024060,2791197,DTCC00514935,877015,31586
CHEMBL503231,P08254,,NFPKLGKUZSGXBR-BHYWQNONSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,IC50,=,2.1,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457450,DTCC00547118,888687,32556
CHEMBL503470,P08254,,HLLDDDNIWYZZJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18358729,ACTIVITY,=,92,%,,,,,,,,,,,,,,Inhibition recombinant MMP3 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518660,DTCT0024060,2708850,DTCC00516463,1082310,32215
CHEMBL503651,P08254,,ZBCPKTFDPDVKFC-ABFWBJRFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18782669,IC50,=,2538,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557957,DTCT0024060,2791193,DTCC00514931,714988,31586
CHEMBL504873,P08254,ISOACTEOSIDE,FNMHEHXNBNCPCI-QEOJJFGVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,IC50,=,91410,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827435,DTCT0024060,10535392,DTCC00506630,1169673,48665
CHEMBL504873,P08254,ISOACTEOSIDE,FNMHEHXNBNCPCI-QEOJJFGVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22658537,INHIBITION,>,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay,,Natural products as a gold mine for selective matrix metalloproteinases inhibitors.,Bioorg. Med. Chem.,2012,20,13,"Wang L, Li X, Zhang S, Lu W, Liao S, Liu X, Shan L, Shen X, Jiang H, Zhang W, Huang J, Li H",,827441,DTCT0024060,10535501,DTCC00506630,1169673,48665
CHEMBL504967,P08254,,CAFFLYYBQBVROH-XNTDXEJSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21208635,IC50,=,16700,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14717039,DTCC00512369,2100831,67860
CHEMBL506057,P08254,,PHCNKOHEKZYJCZ-OYRZRQNVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18835710,KI,>,10000000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,Bioorg. Med. Chem. Lett.,2008,18,21,"Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X",,496899,DTCT0024060,2456655,DTCC00547690,111518,31825
CHEMBL506570,P08254,,WSVIQCQIJLDTEK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,68,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103718,DTCC00571870,1381649,43205
CHEMBL507420,P08254,,PTUCPHGSAFOJAU-MGONOCMRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,KI,=,40,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457425,DTCC00115971,1788790,32556
CHEMBL507420,P08254,,PTUCPHGSAFOJAU-MGONOCMRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23343195,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP3 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by spectrophotometry,Active,Molecular determinants of a selective matrix metalloprotease-12 inhibitor: insights from crystallography and thermodynamic studies.,J. Med. Chem.,2013,56,3,"Czarny B, Stura EA, Devel L, Vera L, Cassar-Lajeunesse E, Beau F, Calderone V, Fragai M, Luchinat C, Dive V",,935214,DTCT0024060,11751209,DTCC00115971,1780525,53441
CHEMBL508335,P08254,,ODFXJYBYTABKHA-BTYSJIOQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18782669,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557957,DTCT0024060,2791192,DTCC00514930,877014,31586
CHEMBL508335,P08254,,ODFXJYBYTABKHA-BTYSJIOQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18782669,KI,=,415,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557957,DTCT0024060,2791220,DTCC00514930,877014,31586
CHEMBL508461,P08254,,VMTJQZUZINLEKC-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,IC50,=,390,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457356,DTCC00115944,1950497,32556
CHEMBL509027,P08254,,WRHZVMBBRYBTKZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,-8,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103768,DTCC00541055,669654,43205
CHEMBL509270,P08254,,HDFXAYMYXQRRFT-ATRWTNPRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18782669,IC50,=,174,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557957,DTCT0024060,2791195,DTCC00514933,132052,31586
CHEMBL509346,P08254,,QEEFWEXKMRZIRZ-RTYIMRNCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18782669,IC50,=,463,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557957,DTCT0024060,2791196,DTCC00514934,1588158,31586
CHEMBL510082,P08254,,MYTAFXBNPKBRNX-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17719700,IC50,>,300000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510905,DTCT0024060,2438472,DTCC00512742,1971363,30977
CHEMBL510694,P08254,,LCLWTUJSVDCASO-JLSHBGBKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18782669,IC50,=,3863,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 catalytic domain by spectrofluorimeter,,Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.,Bioorg. Med. Chem.,2008,16,18,"Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J",,557957,DTCT0024060,2791194,DTCC00514932,1716557,31586
CHEMBL512856,P08254,,WBXZBHWAMZPHQM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,IC50,=,3700,NM,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564427,DTCT0024060,2612862,DTCC00570505,1821575,33264
CHEMBL512856,P08254,,WBXZBHWAMZPHQM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,INHIBITION,=,94,%,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564424,DTCT0024060,2612809,DTCC00570505,1821575,33264
CHEMBL51407,P08254,,DVQPRCBYYWFDFC-WEYGHZABSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,55000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 by MCA peptide assay,,,Bioorg. Med. Chem. Lett.,1997,7,13,,,104713,DTCT0024060,666996,DTCC00194458,192915,2155
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,43,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1289476,DTCC00514693,1228441,14264
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,43,NM,,,,,,,,,,,,,,Inhibition of recombinant human stromelysin Matrix metalloprotease-3 (MMP-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104876,DTCT0024060,1289477,DTCC00514693,1228441,14264
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9733482,IC50,=,16.9,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,"Discovery of potent, achiral matrix metalloproteinase inhibitors.",J. Med. Chem.,1998,41,19,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Rydel T, Dunaway CM, Gu F, Mieling GE",,104724,DTCT0024060,1544202,DTCC00514693,1229057,14767
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9733482,KI,=,43,NM,,,,,,,,,,,,,,Inhibition of truncated stromelysin (Matrix metalloprotease-3),,"Discovery of potent, achiral matrix metalloproteinase inhibitors.",J. Med. Chem.,1998,41,19,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Rydel T, Dunaway CM, Gu F, Mieling GE",,104883,DTCT0024060,1544206,DTCC00514693,1229057,14767
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9888835,IC50,=,16.9,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,104722,DTCT0024060,1170608,DTCC00514693,1241881,15162
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9888835,KI,=,43,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,104870,DTCT0024060,1170609,DTCC00514693,1241881,15162
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10397503,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,"Picking the S1, S1' and S2' pockets of matrix metalloproteinases. A niche for potent acyclic sulfonamide inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,12,"Hanessian S, Bouzbouz S, Boudon A, Tucker GC, Peyroulan D",,101943,DTCT0024060,520524,DTCC00514693,1227848,3181
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10450979,KI,=,43,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease 3,,Synthesis of an array of potential matrix metalloproteinase inhibitors using a sequence of polymer-supported reagents.,Bioorg. Med. Chem. Lett.,1999,9,14,"Caldarelli M, Habermann J, Ley SV",,102101,DTCT0024060,1560599,DTCC00514693,1228109,3238
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,17,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1395522,DTCC00514693,1241292,15412
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,KI,=,43,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104743,DTCT0024060,1395523,DTCC00514693,1241292,15412
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669559,KI,=,43,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104750,DTCT0024060,1083290,DTCC00514693,1228978,16063
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327577,IC50,=,16.9,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104725,DTCT0024060,1321328,DTCC00514693,1242834,4760
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12217351,KI,=,43,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-3,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104742,DTCT0024060,1038239,DTCC00514693,1228546,5080
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,14,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,526001,DTCC00514693,1241045,13726
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15713379,IC50,=,22,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305734,DTCT0024060,1745782,DTCC00514693,1230128,18841
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19422229,IC50,=,19,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,2009,52,11,"Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW",,500583,DTCT0024060,2824174,DTCC00514693,1231748,33635
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19942433,KD,=,7,NM,,,,,,,,,,,,,,Binding affinity to stromelysin-1 catalytic domain expressed in Escherichia coli BL21 (DE3) by isothermal titration colorimetry,,A single step purification for autolytic zinc proteinases.,Bioorg. Med. Chem. Lett.,2010,20,1,"Wilfong EM, Locklear U, Toone EJ",,603252,DTCT0024060,3177041,DTCC00514693,1244615,36833
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19942433,KD,=,43,NM,,,,,,,,,,,,,,Binding affinity to stromelysin-1 catalytic domain,,A single step purification for autolytic zinc proteinases.,Bioorg. Med. Chem. Lett.,2010,20,1,"Wilfong EM, Locklear U, Toone EJ",,603251,DTCT0024060,3177037,DTCC00514693,1244615,36833
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21514700,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of human MMP3 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753768,DTCT0024060,6000259,DTCC00514693,1252235,44948
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22017477,IC50,=,16,NM,,,,,,,,,,,,,,Inhibition of MMP3 using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 4 hrs measured every 15 secs for 20 mins by fluorescence analysis,,"Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.",J. Med. Chem.,2011,54,24,"Marques SM, Tuccinardi T, Nuti E, Santamaria S, André V, Rossello A, Martinelli A, Santos MA",,799077,DTCT0024060,7595871,DTCC00514693,1234142,47023
CHEMBL514138,P08254,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23287054,KI,=,43,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944587,DTCT0024060,11835714,DTCC00514693,1255984,53820
CHEMBL514495,P08254,,PTRVCICYKILIEH-SQFISAMPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18358729,ACTIVITY,=,100,%,,,,,,,,,,,,,,Inhibition recombinant MMP3 at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518660,DTCT0024060,2708843,DTCC00515685,78922,32215
CHEMBL515980,P08254,,KBZNOZAJAJRTII-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22017477,IC50,=,6.7,NM,,,,,,,,,,,,,,Inhibition of MMP3 using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 4 hrs measured every 15 secs for 20 mins by fluorescence analysis,,"Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.",J. Med. Chem.,2011,54,24,"Marques SM, Tuccinardi T, Nuti E, Santamaria S, André V, Rossello A, Martinelli A, Santos MA",,799077,DTCT0024060,7595870,DTCC00562382,2006634,47023
CHEMBL518974,P08254,,ZAIPXKUDIXPSIL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,INHIBITION,<,1,%,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564424,DTCT0024060,2612847,DTCC00569555,2048582,33264
CHEMBL520785,P08254,,VALKNOMNTXYCBM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,KI,=,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457362,DTCC00115943,1535639,32556
CHEMBL521719,P08254,,ZFHJWQWVJPMAIW-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19457660,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of human MMP3,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523766,DTCT0024060,2828352,DTCC00554260,1427426,33677
CHEMBL52209,P08254,,QUKDWRYJPHUXQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,-3,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103920,DTCC00193427,1024887,43205
CHEMBL523034,P08254,,MKAIHDAGQJQAHA-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19278250,IC50,=,351,NM,,,,,,,,,,,,,,Inhibition of human MMP3,,"A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).",J. Med. Chem.,2009,52,7,"Li W, Li J, Wu Y, Wu J, Hotchandani R, Cunningham K, McFadyen I, Bard J, Morgan P, Schlerman F, Xu X, Tam S, Goldman SJ, Williams C, Sypek J, Mansour TS",,566460,DTCT0024060,2482788,DTCC00534180,682924,33018
CHEMBL523076,P08254,,JQTQTEMWCRRECT-LLQWEQGGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19457660,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of human MMP3,,Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.,Bioorg. Med. Chem. Lett.,2009,19,13,"Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W",,523766,DTCT0024060,2828353,DTCC00554323,1264840,33677
CHEMBL523915,P08254,,FBFLGERGLQVEPE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,IC50,=,13300,NM,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564427,DTCT0024060,2612865,DTCC00570591,985624,33264
CHEMBL523915,P08254,,FBFLGERGLQVEPE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,INHIBITION,=,91,%,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564424,DTCT0024060,2612808,DTCC00570591,985624,33264
CHEMBL523956,P08254,,YGNQFXKRHBOPDC-CZYKHXBRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,KI,>,4500,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457512,DTCC00546724,1243693,32556
CHEMBL52488,P08254,,XLTQUMHXLKQUTQ-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,>,200000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 by MCA peptide assay,,,Bioorg. Med. Chem. Lett.,1997,7,13,,,104713,DTCT0024060,656090,DTCC00194351,225260,2155
CHEMBL52555,P08254,,ZSOMEDSWCCPXER-OEQAEZTDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,81,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 by MCA peptide assay,,,Bioorg. Med. Chem. Lett.,1997,7,13,,,104713,DTCT0024060,665734,DTCC00194426,1967769,2155
CHEMBL525733,P08254,,SQICDVOXCYHCFG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19261472,INHIBITION,=,28,%,,,,,,,,,,,,,,Inhibition of human MMP3 catalytic domain at 50 uM after 1 hr by fluorescent substrate assay,,Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,Bioorg. Med. Chem. Lett.,2009,19,7,"Yan YL, Miller MT, Cao Y, Cohen SM",,564424,DTCT0024060,2612802,DTCC00570596,1050319,33264
CHEMBL539171,P08254,,PTSHMCCZVCAMNJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831904,KI,=,4.36,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP-3)(stromelysin-1).,,New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.,J. Med. Chem.,2002,45,4,"Sawa M, Kiyoi T, Kurokawa K, Kumihara H, Yamamoto M, Miyasaka T, Ito Y, Hirayama R, Inoue T, Kirii Y, Nishiwaki E, Ohmoto H, Maeda Y, Ishibushi E, Inoue Y, Yoshino K, Kondo H",,104748,DTCT0024060,1417576,DTCC00372443,531404,17147
CHEMBL539683,P08254,,WJFKRCVNGHZYFA-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10649971,IC50,=,17,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant human matrix metalloprotease-3 (MMP-3),,"Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.",J. Med. Chem.,2000,43,2,"O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H",,104706,DTCT0024060,904805,DTCC00186441,400504,15892
CHEMBL539930,P08254,,LNJYGNLGJFKFCM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17981034,IC50,=,62.9,NM,,,,,,,,,,,,,,Inhibition of MMP3,,1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.,Bioorg. Med. Chem. Lett.,2008,18,1,"Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF",,469431,DTCT0024060,2289323,DTCC00501228,1841595,25715
CHEMBL54049,P08254,,XGAYQDWZIPRBPF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,5,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103011,DTCC00200085,1445792,43205
CHEMBL540952,P08254,(CYCLOPROPYLAMINO)CARBONYLPHOSPHONIC ACID,XNEFJXZBPPJDHR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1298910,DTCC00261593,1305900,17838
CHEMBL541456,P08254,,YXFLQXXMKGQVQR-ZFJSRUIDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11229773,IC50,=,5350,NM,,,,,,,,,,,,,,Ability to inhibit the matrix metalloprotease-3 by method of Knight et al using the fluorogenic peptide substrate.,,Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.,Bioorg. Med. Chem. Lett.,2001,11,4,"Fray MJ, Burslem MF, Dickinson RP",,104575,DTCT0024060,1119574,DTCC00344053,1113146,4691
CHEMBL541456,P08254,,YXFLQXXMKGQVQR-ZFJSRUIDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,2818.38,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258399,DTCC00344053,1103037,24803
CHEMBL54170,P08254,ACETYLTRYPTOPHAN,DZTHIGRZJZPRDV-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,500000,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205500,DTCT0024060,745960,DTCC00201233,1934812,12439
CHEMBL542068,P08254,,KEHWHWRDWNFHCR-HWKASLJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10340614,KI,,,,,,,,,,,,,,,,,Inhibition of MMP-3 (human fibroblast stromelysin) (Not determined),Not Determined,Macrocyclic hydroxamate inhibitors of matrix metalloproteinases and TNF-alpha production.,Bioorg. Med. Chem. Lett.,1999,9,9,"Cherney RJ, Wang L, Meyer DT, Xue CB, Arner EC, Copeland RA, Covington MB, Hardman KD, Wasserman ZR, Jaffee BD, Decicco CP",,102087,DTCT0024060,933783,DTCC00573209,1308445,3648
CHEMBL542088,P08254,,YHLIANIUQRLCCV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11378378,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,104899,DTCT0024060,1042183,DTCC00573690,1099676,4214
CHEMBL54976,P08254,TRYPTOPHAN,QIVBCDIJIAJPQS-VIFPVBQESA-N,4,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,>,500000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,734629,DTCC00201298,356277,12439
CHEMBL550038,P08254,,FWPVXLYOKAOERT-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19725580,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of human MMP3,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579117,DTCT0024060,2894760,DTCC00589403,941987,34869
CHEMBL550081,P08254,,RPWGPXSVYLHGRZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19606871,IC50,=,1300,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571083,DTCT0024060,2859450,DTCC00590514,489960,34421
CHEMBL550148,P08254,,NKGRTRASISLCCZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19606871,IC50,=,320,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571083,DTCT0024060,2859449,DTCC00592085,1588878,34421
CHEMBL550350,P08254,,DKTYDWAJILHINP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19606871,IC50,=,1800,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571083,DTCT0024060,2859453,DTCC00592090,1653714,34421
CHEMBL550548,P08254,,UTCUOTDVVXFCLJ-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19606871,IC50,=,180,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571083,DTCT0024060,2859460,DTCC00592094,327760,34421
CHEMBL550628,P08254,,FRFSAUPOCJTACG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19606871,IC50,=,4300,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571083,DTCT0024060,2859456,DTCC00589012,1038878,34421
CHEMBL553109,P08254,,OQBQWDSSUDLMTA-RMTZWNOUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,78,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,539523,DTCC00135874,451627,14548
CHEMBL553109,P08254,,OQBQWDSSUDLMTA-RMTZWNOUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,37,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,539521,DTCC00135874,451627,14548
CHEMBL554269,P08254,,OBHHLEXVYGNCHI-INFYBVPRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19093877,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to MMP3 assessed as enzyme mediated cleavage of compound by measuring increase in fluorescence after 16 hrs by HPLC-MS,Not Active,Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers.,J. Med. Chem.,2009,52,2,"Lo PC, Chen J, Stefflova K, Warren MS, Navab R, Bandarchi B, Mullins S, Tsao M, Cheng JD, Zheng G",,495030,DTCT0024060,2594344,DTCC00582506,1049706,32091
CHEMBL560837,P08254,,LBKCSOUMADYGHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19606871,IC50,=,1800,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571083,DTCT0024060,2859451,DTCC00122971,1717205,34421
CHEMBL561036,P08254,,HZTQDRLCDGHQSA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19606871,IC50,=,1600,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571083,DTCT0024060,2859452,DTCC00122972,748051,34421
CHEMBL561038,P08254,,WVAIZSKMOMDPIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19606871,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571083,DTCT0024060,2859455,DTCC00122975,910381,34421
CHEMBL561039,P08254,,KJDPTHLLJDQIMT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19606871,IC50,=,4300,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571083,DTCT0024060,2859458,DTCC00122976,715703,34421
CHEMBL561625,P08254,,PZJJOMPTIHBGHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19606871,IC50,=,920,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571083,DTCT0024060,2859448,DTCC00587403,1492221,34421
CHEMBL561630,P08254,,JSQUVSOHRBZSNW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19606871,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571083,DTCT0024060,2859459,DTCC00587413,489961,34421
CHEMBL563026,P08254,,MRYXWLVKWYVRPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19606871,IC50,=,9100,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571083,DTCT0024060,2859457,DTCC00584342,327759,34421
CHEMBL563679,P08254,,ZQBRASLBYJYZLM-CMDGGOBGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19606871,IC50,=,710,NM,,,,,,,,,,,,,,Inhibition of MMP3,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571083,DTCT0024060,2859454,DTCC00587409,425709,34421
CHEMBL566233,P08254,,YLTJCMLZAIRVFF-FHWLQOOXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19635666,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP-3,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598557,DTCT0024060,3101255,DTCC00607716,1745918,36106
CHEMBL567893,P08254,GRASSYSTATIN A,JZYWSTGTBRHGTL-BIXXXADNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19715320,ACTIVITY,=,86,%,,,,,,,,,,,,,,Inhibition of MMP3 assessed as residual activity at 10 uM after 10 to 15 mins by fluorescence assay relative to control,,"Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.",J. Med. Chem.,2009,52,18,"Kwan JC, Eksioglu EA, Liu C, Paul VJ, Luesch H",,600015,DTCT0024060,3096283,DTCC00604795,1039098,36236
CHEMBL567893,P08254,GRASSYSTATIN A,JZYWSTGTBRHGTL-BIXXXADNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19715320,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of MMP3 after 10 to 15 mins by fluorescence assay,,"Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.",J. Med. Chem.,2009,52,18,"Kwan JC, Eksioglu EA, Liu C, Paul VJ, Luesch H",,600072,DTCT0024060,3096340,DTCC00604795,1039098,36236
CHEMBL567940,P08254,,VPNMZNYQFRFELQ-BZSNNMDCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19635666,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of MMP-3,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598557,DTCT0024060,3101261,DTCC00607747,1907035,36106
CHEMBL568346,P08254,,JRJYBZYDJRBFTK-FHWLQOOXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19635666,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP-3,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598557,DTCT0024060,3101256,DTCC00607719,780275,36106
CHEMBL56837,P08254,,WLWNRAWQDZRXMB-QBPKDAKJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15055993,KI,=,0.35,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease 3,,Azasugar-based MMP/ADAM inhibitors as antipsoriatic agents.,J. Med. Chem.,2004,47,8,"Moriyama H, Tsukida T, Inoue Y, Yokota K, Yoshino K, Kondo H, Miura N, Nishimura S",,104746,DTCT0024060,1382072,DTCC00205431,1163372,18075
CHEMBL569388,P08254,,YDJAXPJDHWQNLF-YPJRHXLCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19635666,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP-3,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598557,DTCT0024060,3101253,DTCC00607671,1524734,36106
CHEMBL569389,P08254,,JOTYZMGPCUSZKL-FHWLQOOXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19635666,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP-3,Not Determined,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598557,DTCT0024060,3101264,DTCC00607672,1104343,36106
CHEMBL572045,P08254,,MIUJFEWUCGLALV-VABKMULXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19635666,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of MMP-3,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598557,DTCT0024060,3101267,DTCC00607708,1363250,36106
CHEMBL572091,P08254,,FQSNZGGDFVIKEV-UFYCRDLUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19635666,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of MMP-3,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598557,DTCT0024060,3101263,DTCC00607644,490182,36106
CHEMBL572302,P08254,,PFMDDCHUGSRIJN-FKBYEOEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19635666,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of MMP-3,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598557,DTCT0024060,3101266,DTCC00607698,229826,36106
CHEMBL572780,P08254,,ZCRWOWSOWBMWGI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,=,1400,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044471,DTCC00597333,618949,35647
CHEMBL572982,P08254,,ILGSIIFHQGOKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19703773,IC50,>,98000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592275,DTCT0024060,3044567,DTCC00598166,824314,35947
CHEMBL572982,P08254,,ILGSIIFHQGOKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19703773,IC50,>,98000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592275,DTCT0024060,3044568,DTCC00598166,824315,35947
CHEMBL572982,P08254,,ILGSIIFHQGOKKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19703773,IC50,>,98000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2009,19,19,"Holmes IP, Gaines S, Watson SP, Lorthioir O, Walker A, Baddeley SJ, Herbert S, Egan D, Convery MA, Singh OM, Gross JW, Strelow JM, Smith RH, Amour AJ, Brown D, Martin SL",,592275,DTCT0024060,3044569,DTCC00598166,824313,35947
CHEMBL573714,P08254,,ITWGWXCEGHFMHT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,=,730,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044450,DTCC00597369,1427807,35647
CHEMBL573715,P08254,,YOMXWXIANUYIMH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,=,21,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044398,DTCC00597370,1297783,35647
CHEMBL573934,P08254,,OREDIHYKGISTDR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044485,DTCC00597353,327896,35647
CHEMBL573935,P08254,,HGICQEUHJFERNR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,=,74000,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044530,DTCC00597354,393223,35647
CHEMBL573936,P08254,,FIPYOKGRSDJCAR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,=,7500,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044497,DTCC00597355,1427806,35647
CHEMBL574,P08254,P-TOLUENESULFONAMIDE,LMYRWZFENFIFIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,-5,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103765,DTCC00146038,508352,43205
CHEMBL574370,P08254,,YYBFXMXFWMJGLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,=,23000,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044511,DTCC00597263,12430,35647
CHEMBL574589,P08254,,WQRJSSRVHCJAKB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,=,45000,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044521,DTCC00597341,1071501,35647
CHEMBL574605,P08254,,CPUBMGYGVNFLPZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,=,5600,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044491,DTCC00597298,327895,35647
CHEMBL575881,P08254,,ABXUEPSHNXWTBZ-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,=,54000,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044559,DTCC00597225,1653861,35647
CHEMBL575895,P08254,,QPFIKHZWPMXTRS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,>,50000,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044548,DTCC00597330,1427805,35647
CHEMBL575896,P08254,,MYZHQACPXTZCJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,=,27000,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044515,DTCC00597331,554423,35647
CHEMBL57644,P08254,,SSQXFNKOLMHXPO-DDHJBXDOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15055993,KI,=,2,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease 3,,Azasugar-based MMP/ADAM inhibitors as antipsoriatic agents.,J. Med. Chem.,2004,47,8,"Moriyama H, Tsukida T, Inoue Y, Yokota K, Yoshino K, Kondo H, Miura N, Nishimura S",,104746,DTCT0024060,1396889,DTCC00205510,1520468,18075
CHEMBL576762,P08254,,RPBGCJQDVJCGSK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,=,60000,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044526,DTCC00597340,1265255,35647
CHEMBL57725,P08254,,HRTBORRCNRXWRR-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1047275,DTCC00204860,1489535,15462
CHEMBL579067,P08254,,YMAXKJGQKQACFZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044540,DTCC00597343,812562,35647
CHEMBL579068,P08254,,HSMGGAWDRKACFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044546,DTCC00597380,1842555,35647
CHEMBL58235,P08254,,KFQYZMVFFVTGGQ-MOPGFXCFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,5000,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,663382,DTCC00105346,775995,2288
CHEMBL58361,P08254,,DGYOAFGUADSYMB-IFMALSPDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,4000,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,683291,DTCC00208220,1713530,2288
CHEMBL584116,P08254,,PDNKMRBXZXHUFT-ACRUOGEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19635666,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of MMP-3,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598557,DTCT0024060,3101265,DTCC00607673,360595,36106
CHEMBL584120,P08254,,XLCDJKIIBWOGQT-UFYCRDLUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19635666,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP-3,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598557,DTCT0024060,3101254,DTCC00607697,262112,36106
CHEMBL584122,P08254,,OAJUMLCSJOEUON-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,=,22000,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044510,DTCC00597332,715843,35647
CHEMBL584147,P08254,,XORCBTCEBZUVES-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,=,8000,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044499,DTCC00597381,2037631,35647
CHEMBL584334,P08254,,KSBCPHOBEZMZNM-FHWLQOOXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19635666,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of MMP-3,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598557,DTCT0024060,3101262,DTCC00607643,1686084,36106
CHEMBL584365,P08254,,DJZNIZCARKSSDE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,=,1600,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044473,DTCC00597271,165336,35647
CHEMBL585299,P08254,,YYMXPNNILUETLE-UFYCRDLUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19635666,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP-3,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598557,DTCT0024060,3101259,DTCC00607737,619058,36106
CHEMBL585376,P08254,,BZWDHUMJSSLVCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19775099,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of trypsin activated human pro-MMP3 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591601,DTCT0024060,3044544,DTCC00597342,100632,35647
CHEMBL58553,P08254,,WKYNDNVMBNENDU-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,2320,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1542343,DTCC00208405,1629045,4358
CHEMBL58577,P08254,,LQZDEWIIFWHTLX-BRSBDYLESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15055993,KI,=,2.1,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease 3,,Azasugar-based MMP/ADAM inhibitors as antipsoriatic agents.,J. Med. Chem.,2004,47,8,"Moriyama H, Tsukida T, Inoue Y, Yokota K, Yoshino K, Kondo H, Miura N, Nishimura S",,104746,DTCT0024060,1385967,DTCC00205932,743899,18075
CHEMBL585886,P08254,,KMMXFFDNBCQBEI-UFYCRDLUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19635666,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP-3,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598557,DTCT0024060,3101260,DTCC00607746,1842659,36106
CHEMBL586042,P08254,,QHTFXHUNNOAYME-BSOSBYQFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19635666,IC50,>,5000,NM,,,,,,,,,,,,,,Inhibition of MMP-3,,Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.,Bioorg. Med. Chem. Lett.,2009,19,17,"Li YL, Shi E, Burns D, Li Y, Covington MB, Pan M, Scherle P, Friedman S, Metcalf B, Yao W",,598557,DTCT0024060,3101258,DTCC00607731,1972305,36106
CHEMBL58834,P08254,,RMIHUCKIXBQQLS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,230,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1530491,DTCC00208196,1175034,4358
CHEMBL58945,P08254,,OPPSVVRCTWTXLK-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,80,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,659757,DTCC00105355,1293496,2288
CHEMBL58997,P08254,,GDWAEOPDOGIQAU-TZIWHRDSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,2000,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,691925,DTCC00208194,841133,2288
CHEMBL59023,P08254,,RRLGEVWMENCJGJ-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,14,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,512530,DTCC00208380,452901,13104
CHEMBL59023,P08254,,RRLGEVWMENCJGJ-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,14.13,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258513,DTCC00208380,455576,24803
CHEMBL59023,P08254,,RRLGEVWMENCJGJ-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,14,NM,,,,,,,,,,,,,,"Inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90641,DTCT0024060,656028,DTCC00208380,452428,2288
CHEMBL59023,P08254,,RRLGEVWMENCJGJ-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,<,100,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3 (potent inhibitor)",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102096,DTCT0024060,597367,DTCC00208380,465465,1496
CHEMBL59023,P08254,,RRLGEVWMENCJGJ-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,14,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102092,DTCT0024060,850840,DTCC00208380,465491,1497
CHEMBL59023,P08254,,RRLGEVWMENCJGJ-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,14,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102097,DTCT0024060,597366,DTCC00208380,465465,1496
CHEMBL590343,P08254,,LIKQSFURRNSUMR-UKKPGEIXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20022498,KI,=,17000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,3,"Rosner KE, Guo Z, Orth P, Shipps GW, Belanger DB, Chan TY, Curran PJ, Dai C, Deng Y, Girijavallabhan VM, Hong L, Lavey BJ, Lee JF, Li D, Liu Z, Popovici-Muller J, Ting PC, Vaccaro H, Wang L, Wang T, Yu W, Zhou G, Niu X, Sun J, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Arshad Siddiqui M, Strickland CO",,608476,DTCT0024060,3182377,DTCC00617046,100864,37349
CHEMBL59104,P08254,,HZWSSUJZEMEIID-YABDQXBESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,520,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1532804,DTCC00208267,819932,4358
CHEMBL591321,P08254,,AJPODVJJWNQXJU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19942433,KD,=,11000,NM,,,,,,,,,,,,,,Binding affinity to stromelysin-1 catalytic domain,,A single step purification for autolytic zinc proteinases.,Bioorg. Med. Chem. Lett.,2010,20,1,"Wilfong EM, Locklear U, Toone EJ",,603251,DTCT0024060,3177040,DTCC00609858,241434,36833
CHEMBL591321,P08254,,AJPODVJJWNQXJU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,19942433,KD,=,17000,NM,,,,,,,,,,,,,,Binding affinity to stromelysin-1 catalytic domain expressed in Escherichia coli BL21 (DE3) by isothermal titration colorimetry,,A single step purification for autolytic zinc proteinases.,Bioorg. Med. Chem. Lett.,2010,20,1,"Wilfong EM, Locklear U, Toone EJ",,603252,DTCT0024060,3177044,DTCC00609858,241434,36833
CHEMBL591774,P08254,,LRRAUDSVXJEODP-VTVVEXCCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20022498,KI,=,7700,NM,,,,,,,,,,,,,,Inhibition of MMP3,,The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,3,"Rosner KE, Guo Z, Orth P, Shipps GW, Belanger DB, Chan TY, Curran PJ, Dai C, Deng Y, Girijavallabhan VM, Hong L, Lavey BJ, Lee JF, Li D, Liu Z, Popovici-Muller J, Ting PC, Vaccaro H, Wang L, Wang T, Yu W, Zhou G, Niu X, Sun J, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Arshad Siddiqui M, Strickland CO",,608476,DTCT0024060,3182378,DTCC00617111,1330626,37349
CHEMBL59185,P08254,,MYFICVJSVBCBLS-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,70,%,,,,,,,,,,,,,,"Inhibition of human recombinant stromelysin (MMP-3, HFS) at 100000 nM",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90642,DTCT0024060,681924,DTCC00208609,775994,2288
CHEMBL59248,P08254,,VOHTXZWPKONFAR-ISKFKSNPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,90,NM,,,,,,,,,,,,,,"Inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90641,DTCT0024060,666939,DTCC00208352,937889,2288
CHEMBL59337,P08254,,KLFOAKCPAGOTNG-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,4700,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1541002,DTCC00208349,1753036,4358
CHEMBL59338,P08254,,AZODBPSQRNONKH-NVXWUHKLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,18,NM,,,,,,,,,,,,,,"Inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90641,DTCT0024060,685717,DTCC00208350,3213,2288
CHEMBL59361,P08254,,WGIKYFGWOYVGQU-ISKFKSNPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,10000,NM,,,,,,,,,,,,,,"Inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90641,DTCT0024060,669302,DTCC00208218,388791,2288
CHEMBL59472,P08254,,DHMHJSLNCAYKRH-QOMWVZHYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,320,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1554467,DTCC00208237,2044788,4358
CHEMBL596273,P08254,,SMHSNYHGGYVOMD-SAABIXHNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,26653735,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin) catalytic domain using Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552496,DTCT0024060,72567,DTCC00610562,2011708,65989
CHEMBL59684,P08254,,SMIPFSAKTAQFJC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,1610,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1526926,DTCC00208656,1175033,4358
CHEMBL59692,P08254,,KTCRMROJXXSPQJ-PDNQZYNLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12781187,KI,=,69.8,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-3,,Discovery of selective phosphonamide-based inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Sawa M, Kurokawa K, Inoue Y, Kondo H, Yoshino K",,104871,DTCT0024060,1068790,DTCC00212222,236996,5595
CHEMBL59722,P08254,,KCPCRNOCKZPKFZ-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,40,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,685712,DTCC00208604,582292,2288
CHEMBL60179,P08254,,HVGJVSYGPSRPHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,410,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1519822,DTCC00208217,1207239,4358
CHEMBL60196,P08254,,GJIKNAOMJVWUCN-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,80,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,663386,DTCC00208625,1741705,2288
CHEMBL603656,P08254,,KOTGODCEORJYIF-QAQDUYKDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20005097,KI,>,25000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605227,DTCT0024060,3176038,DTCC00610540,534004,36915
CHEMBL605201,P08254,,XDBOLPFDJWTESQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20005097,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605227,DTCT0024060,3176017,DTCC00610415,953811,36915
CHEMBL60536,P08254,,YFXAPTTTXDTWSV-QBPKDAKJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15055993,KI,=,50,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease 3,,Azasugar-based MMP/ADAM inhibitors as antipsoriatic agents.,J. Med. Chem.,2004,47,8,"Moriyama H, Tsukida T, Inoue Y, Yokota K, Yoshino K, Kondo H, Miura N, Nishimura S",,104746,DTCT0024060,1402046,DTCC00205931,1455567,18075
CHEMBL60546,P08254,,CNVCLEPNZAFTKK-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,1001,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,662091,DTCC00208623,1228054,2288
CHEMBL60567,P08254,,KVUZGLYOUHGFEF-SLXFGWRHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,600,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1557077,DTCC00208591,302724,4358
CHEMBL605764,P08254,,AZEKZZSSVLIPCQ-QZTJIDSGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20022498,KI,>,50000,NM,,,,,,,,,,,,,,Inhibition of MMP3,,The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,3,"Rosner KE, Guo Z, Orth P, Shipps GW, Belanger DB, Chan TY, Curran PJ, Dai C, Deng Y, Girijavallabhan VM, Hong L, Lavey BJ, Lee JF, Li D, Liu Z, Popovici-Muller J, Ting PC, Vaccaro H, Wang L, Wang T, Yu W, Zhou G, Niu X, Sun J, Kozlowski JA, Lundell DJ, Madison V, McKittrick B, Piwinski JJ, Shih NY, Arshad Siddiqui M, Strickland CO",,608476,DTCT0024060,3182376,DTCC00617773,1232601,37349
CHEMBL60624,P08254,,PPELJLBDXLMTEW-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,Inhibitory concentration against human matrix metalloprotease-3 (MMP-3),,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,104726,DTCT0024060,1044762,DTCC00204355,1936007,15462
CHEMBL60674,P08254,,MYJDKITWUNFHCY-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,70,%,,,,,,,,,,,,,,"Inhibition of human recombinant stromelysin (MMP-3, HFS) at 100000 nM",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90642,DTCT0024060,679423,DTCC00208705,518138,2288
CHEMBL61017,P08254,,KVNBSMBKXVJFRN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,630,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1530480,DTCC00105357,1046466,4358
CHEMBL61193,P08254,,WLWNRAWQDZRXMB-YLFCFFPRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12873504,KI,=,0.51,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,Structure--activity relationships of azasugar-based MMP/ADAM inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,16,"Moriyama H, Tsukida T, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104872,DTCT0024060,905720,DTCC00205699,1914636,5719
CHEMBL61193,P08254,,WLWNRAWQDZRXMB-YLFCFFPRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15055993,KI,=,0.51,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease 3,,Azasugar-based MMP/ADAM inhibitors as antipsoriatic agents.,J. Med. Chem.,2004,47,8,"Moriyama H, Tsukida T, Inoue Y, Yokota K, Yoshino K, Kondo H, Miura N, Nishimura S",,104746,DTCT0024060,1366761,DTCC00205699,1902686,18075
CHEMBL61354,P08254,,MALRHJHVJCYQHD-PUUKEUDRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,783,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1529260,DTCC00208378,107904,4358
CHEMBL61517,P08254,,CFKXSBQQOQUGFI-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,50,%,,,,,,,,,,,,,,"Inhibition of human recombinant stromelysin (MMP-3, HFS) at 100000 nM",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90642,DTCT0024060,659753,DTCC00105363,679551,2288
CHEMBL61538,P08254,,FLPUCLSORYCSPS-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,50000,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,673020,DTCC00208773,1326032,2288
CHEMBL61577,P08254,,CYDOQDKDFWIELG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,500,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1557083,DTCC00209511,787579,4358
CHEMBL61679,P08254,,PYYFTRAOBJSVDA-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873489,IC50,=,824,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,Design and synthesis of conformationally-constrained MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,16,"Natchus MG, Cheng M, Wahl CT, Pikul S, Almstead NG, Bradley RS, Taiwo YO, Mieling GE, Dunaway CM, Snider CE, McIver JM, Barnett BL, McPhail SJ, Anastasio MB, De B",,101941,DTCT0024060,763472,DTCC00214941,1693209,2711
CHEMBL61873,P08254,,VWVNHRHZTZJGIS-IFMALSPDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,70,NM,,,,,,,,,,,,,,"Inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90641,DTCT0024060,670579,DTCC00208702,1326033,2288
CHEMBL62007,P08254,,LBZOGBFXCHOCBC-ZCNNSNEGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873491,IC50,=,6.1,NM,,,,,,,,,,,,,,Inhibition of fibroblast stromelysin (MMP-3),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101938,DTCT0024060,1642449,DTCC00215441,75752,2712
CHEMBL62007,P08254,,LBZOGBFXCHOCBC-ZCNNSNEGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873712,IC50,=,2.6,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant matrix metalloprotease 3,,Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,22,"Sheppard GS, Florjancic AS, Giesler JR, Xu L, Guo Y, Davidsen SK, Marcotte PA, Elmore I, Albert DH, Magoc TJ, Bouska JJ, Goodfellow CL, Morgan DW, Summers JB",,102123,DTCT0024060,1403760,DTCC00215441,64880,2897
CHEMBL62056,P08254,,XTNDKIPXZCROEY-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,30,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,676964,DTCC00105359,1967947,2288
CHEMBL62089,P08254,,DVNVXZQJDUVWTB-RWWKDMOOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11454461,IC50,=,5660,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-3,,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,2001,11,15,"Tullis JS, Laufersweiler MJ, VanRens JC, Natchus MG, Bookland RG, Almstead NG, Pikul S, De B, Hsieh LC, Janusz MJ, Branch TM, Peng SX, Jin YY, Hudlicky T, Oppong K",,104714,DTCT0024060,1541007,DTCC00208658,1946674,4358
CHEMBL6216,P08254,,BAOZVZLVHANZCO-PYPSMOBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,15,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,524340,DTCC00135887,1292693,14548
CHEMBL6216,P08254,,BAOZVZLVHANZCO-PYPSMOBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,1400,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,524338,DTCC00135887,1292693,14548
CHEMBL62186,P08254,,GGPADGTYHCKBRV-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,INHIBITION,=,20,%,,,,,,,,,,,,,,"Inhibition of human recombinant stromelysin (MMP-3, HFS) at 100000 nM",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90642,DTCT0024060,660914,DTCC00208387,452429,2288
CHEMBL62245,P08254,,QICZKEXYEUFFTG-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,40,NM,,,,,,,,,,,,,,"50% inhibition of human recombinant stromelysin (MMP-3, HFS)",,,Bioorg. Med. Chem. Lett.,1997,7,2,,,90640,DTCT0024060,693234,DTCC00208645,452426,2288
CHEMBL62259,P08254,,RBLCSCFFNCADJO-CLYVBNDRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11831905,KI,=,5.2,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugs.,J. Med. Chem.,2002,45,4,"Sawa M, Tsukamoto T, Kiyoi T, Kurokawa K, Nakajima F, Nakada Y, Yokota K, Inoue Y, Kondo H, Yoshino K",,104744,DTCT0024060,573304,DTCC00211752,206431,17148
CHEMBL62259,P08254,,RBLCSCFFNCADJO-CLYVBNDRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11844676,KI,=,5.2,NM,,,,,,,,,,,,,,Inhibitory constant against recombinant human stromelysin-1 (Matrix metalloprotease-3),,Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.,Bioorg. Med. Chem. Lett.,2002,12,4,"Sawa M, Kondo H, Nishimura S",,104879,DTCT0024060,1409875,DTCC00211752,194682,5346
CHEMBL62259,P08254,,RBLCSCFFNCADJO-CLYVBNDRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12781187,KI,=,5.2,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-3,,Discovery of selective phosphonamide-based inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Sawa M, Kurokawa K, Inoue Y, Kondo H, Yoshino K",,104871,DTCT0024060,1080582,DTCC00211752,204533,5595
CHEMBL62436,P08254,,ZJGBNTKEURCATF-OAGGEKHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873489,IC50,=,58,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,Design and synthesis of conformationally-constrained MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,16,"Natchus MG, Cheng M, Wahl CT, Pikul S, Almstead NG, Bradley RS, Taiwo YO, Mieling GE, Dunaway CM, Snider CE, McIver JM, Barnett BL, McPhail SJ, Anastasio MB, De B",,101941,DTCT0024060,746971,DTCC00214475,1914171,2711
CHEMBL62709,P08254,,QHXGYXNTOKVMKC-OLZOCXBDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873489,IC50,=,2900,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,Design and synthesis of conformationally-constrained MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,16,"Natchus MG, Cheng M, Wahl CT, Pikul S, Almstead NG, Bradley RS, Taiwo YO, Mieling GE, Dunaway CM, Snider CE, McIver JM, Barnett BL, McPhail SJ, Anastasio MB, De B",,101941,DTCT0024060,744584,DTCC00214959,1144007,2711
CHEMBL63328,P08254,,BVDYWVVWERVABZ-WAVCKPEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,145000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,746024,DTCC00216040,161334,12439
CHEMBL63328,P08254,,BVDYWVVWERVABZ-WAVCKPEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,KI,=,120000,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205625,DTCT0024060,746025,DTCC00216040,161334,12439
CHEMBL63415,P08254,,IHXHBYFWSOYYTR-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,34000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,735942,DTCC00216041,1806054,12439
CHEMBL63415,P08254,,IHXHBYFWSOYYTR-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,KI,=,28000,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205625,DTCT0024060,735943,DTCC00216041,1806054,12439
CHEMBL63570,P08254,,GGRKLCWXRBTPLH-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,500000,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205500,DTCT0024060,747206,DTCC00216031,1681813,12439
CHEMBL63865,P08254,,RRONHWAVOYADJL-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,>,500000,NM,,,,,,,,,,,,,,Inhibition of recombinant full length stromelysin (FLS).,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205498,DTCT0024060,754699,DTCC00216127,1681812,12439
CHEMBL63865,P08254,,RRONHWAVOYADJL-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,>,500000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,754698,DTCC00216127,1681812,12439
CHEMBL64013,P08254,,YKYLOHCKSMYHPL-DSITVLBTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873491,IC50,=,9.1,NM,,,,,,,,,,,,,,Inhibition of fibroblast stromelysin (MMP-3),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101938,DTCT0024060,1673597,DTCC00216008,949443,2712
CHEMBL64571,P08254,,IPBVPRHDESNKFG-FTHRPBJHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12781187,KI,=,7.29,NM,,,,,,,,,,,,,,Inhibition of recombinant human Matrix metalloprotease-3,,Discovery of selective phosphonamide-based inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).,Bioorg. Med. Chem. Lett.,2003,13,12,"Sawa M, Kurokawa K, Inoue Y, Kondo H, Yoshino K",,104871,DTCT0024060,1061690,DTCC00211729,1629078,5595
CHEMBL64689,P08254,,SLHHOJZYTMNFRR-WTPASJBYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11844676,KI,>,650,NM,,,,,,,,,,,,,,Inhibitory constant against recombinant human stromelysin-1 (Matrix metalloprotease-3),,Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.,Bioorg. Med. Chem. Lett.,2002,12,4,"Sawa M, Kondo H, Nishimura S",,104879,DTCT0024060,1406540,DTCC00211726,1327684,5346
CHEMBL64912,P08254,,AWZZZYKHBJFDFK-MJGOQNOKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873489,IC50,=,518,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,Design and synthesis of conformationally-constrained MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,16,"Natchus MG, Cheng M, Wahl CT, Pikul S, Almstead NG, Bradley RS, Taiwo YO, Mieling GE, Dunaway CM, Snider CE, McIver JM, Barnett BL, McPhail SJ, Anastasio MB, De B",,101941,DTCT0024060,748194,DTCC00214838,2012573,2711
CHEMBL64981,P08254,,GNRZLXTVDQAZEM-MNOVXSKESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873489,IC50,=,11700,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,Design and synthesis of conformationally-constrained MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,16,"Natchus MG, Cheng M, Wahl CT, Pikul S, Almstead NG, Bradley RS, Taiwo YO, Mieling GE, Dunaway CM, Snider CE, McIver JM, Barnett BL, McPhail SJ, Anastasio MB, De B",,101941,DTCT0024060,731716,DTCC00214910,594041,2711
CHEMBL65017,P08254,,FKFFMEHZWLQPKM-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,63000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,733288,DTCC00216088,711709,12439
CHEMBL65017,P08254,,FKFFMEHZWLQPKM-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,KI,=,52000,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205625,DTCT0024060,733289,DTCC00216088,711709,12439
CHEMBL65048,P08254,,YRNMJERWBOKZEI-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,>,500000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,769935,DTCC00215932,1455684,12439
CHEMBL65134,P08254,,AHYFYYVVAXRMKB-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,86000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,734625,DTCC00214990,582370,12439
CHEMBL65134,P08254,,AHYFYYVVAXRMKB-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,287000,NM,,,,,,,,,,,,,,Inhibition of recombinant full length stromelysin (FLS).,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205498,DTCT0024060,734627,DTCC00214990,582370,12439
CHEMBL65134,P08254,,AHYFYYVVAXRMKB-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,KI,=,71000,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205625,DTCT0024060,734626,DTCC00214990,582370,12439
CHEMBL65134,P08254,,AHYFYYVVAXRMKB-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,KI,=,241000,NM,,,,,,,,,,,,,,Inhibition of recombinant full length stromelysin (FLS),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205624,DTCT0024060,734628,DTCC00214990,582370,12439
CHEMBL65159,P08254,,XEONYLBJVDXPRB-BDTNDASRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873491,IC50,=,2.6,NM,,,,,,,,,,,,,,Inhibition of fibroblast stromelysin (MMP-3),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101938,DTCT0024060,1643635,DTCC00215885,658870,2712
CHEMBL65234,P08254,,CPJXMXQYRHNIFU-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,102000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,734641,DTCC00216089,647508,12439
CHEMBL65234,P08254,,CPJXMXQYRHNIFU-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,KI,=,84000,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205625,DTCT0024060,734642,DTCC00216089,647508,12439
CHEMBL65386,P08254,,CNBUSIJNWNXLQQ-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,500000,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205500,DTCT0024060,744826,DTCC00216168,776057,12439
CHEMBL65439,P08254,,CEOGNMHWYSYXNX-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873489,IC50,=,250,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,Design and synthesis of conformationally-constrained MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,16,"Natchus MG, Cheng M, Wahl CT, Pikul S, Almstead NG, Bradley RS, Taiwo YO, Mieling GE, Dunaway CM, Snider CE, McIver JM, Barnett BL, McPhail SJ, Anastasio MB, De B",,101941,DTCT0024060,738278,DTCC00105494,2044854,2711
CHEMBL65493,P08254,,AHULRDCJAMYXHU-QUCCMNQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873489,IC50,=,1420,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,Design and synthesis of conformationally-constrained MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,16,"Natchus MG, Cheng M, Wahl CT, Pikul S, Almstead NG, Bradley RS, Taiwo YO, Mieling GE, Dunaway CM, Snider CE, McIver JM, Barnett BL, McPhail SJ, Anastasio MB, De B",,101941,DTCT0024060,762225,DTCC00214837,1979726,2711
CHEMBL65543,P08254,ACETYL TYROSINE,CAHKINHBCWCHCF-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,>,500000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,738542,DTCC00215400,937945,12439
CHEMBL65578,P08254,,TZBWHAVQMPRLJF-QRVBRYPASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873489,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,Design and synthesis of conformationally-constrained MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,16,"Natchus MG, Cheng M, Wahl CT, Pikul S, Almstead NG, Bradley RS, Taiwo YO, Mieling GE, Dunaway CM, Snider CE, McIver JM, Barnett BL, McPhail SJ, Anastasio MB, De B",,101941,DTCT0024060,736985,DTCC00214984,140438,2711
CHEMBL65579,P08254,,TZBWHAVQMPRLJF-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873489,IC50,=,108,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,Design and synthesis of conformationally-constrained MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,16,"Natchus MG, Cheng M, Wahl CT, Pikul S, Almstead NG, Bradley RS, Taiwo YO, Mieling GE, Dunaway CM, Snider CE, McIver JM, Barnett BL, McPhail SJ, Anastasio MB, De B",,101941,DTCT0024060,767434,DTCC00214985,1144006,2711
CHEMBL65670,P08254,,NFVNYBJCJGKVQK-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,500000,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205500,DTCT0024060,741284,DTCC00216096,647509,12439
CHEMBL65709,P08254,,NFVNYBJCJGKVQK-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,10000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,731942,DTCC00216425,64077,12439
CHEMBL65709,P08254,,NFVNYBJCJGKVQK-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,KI,=,8000,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205625,DTCT0024060,731943,DTCC00216425,64077,12439
CHEMBL6572,P08254,,QPEZTCMCOIDQRV-SMDDNHRTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327577,IC50,=,3.4,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104725,DTCT0024060,1316351,DTCC00133465,34547,4760
CHEMBL65770,P08254,,DJPCVJYIWLEUBO-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,>,500000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,763746,DTCC00216128,906180,12439
CHEMBL66098,P08254,,ZWYFAUSBUXUGKC-QJPTWQEYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11514157,KI,=,406,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution.,Bioorg. Med. Chem. Lett.,2001,11,16,"Musso DL, Andersen MW, Andrews RC, Austin R, Beaudet EJ, Becherer JD, Bubacz DG, Bickett DM, Chan JH, Conway JG, Cowan DJ, Gaul MD, Glennon KC, Hedeen KM, Lambert MH, Leesnitzer MA, McDougald DL, Mitchell JL, Moss ML, Rabinowitz MH, Rizzolio MC, Schaller LT, Stanford JB, Tippin T, Warner JR, Whitesell LG, Wiethe RW",,104569,DTCT0024060,900807,DTCC00220206,723370,4390
CHEMBL66134,P08254,,QPPXLNJKZJGLRN-HBMCJLEFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873491,IC50,=,4.2,NM,,,,,,,,,,,,,,Inhibition of fibroblast stromelysin (MMP-3),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101938,DTCT0024060,1649894,DTCC00215883,75751,2712
CHEMBL66143,P08254,,RRONHWAVOYADJL-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,40000,NM,,,,,,,,,,,,,,In vitro inhibition of recombinant stromelysin catalytic domain.,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205499,DTCT0024060,743544,DTCC00216162,808396,12439
CHEMBL66143,P08254,,RRONHWAVOYADJL-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,IC50,=,99000,NM,,,,,,,,,,,,,,Inhibition of recombinant full length stromelysin (FLS).,,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205498,DTCT0024060,743546,DTCC00216162,808396,12439
CHEMBL66143,P08254,,RRONHWAVOYADJL-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,KI,=,33000,NM,,,,,,,,,,,,,,Inhibition of recombinant stromelysin catalytic domain (SCD),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205625,DTCT0024060,743545,DTCC00216162,808396,12439
CHEMBL66143,P08254,,RRONHWAVOYADJL-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,8289198,KI,=,83000,NM,,,,,,,,,,,,,,Inhibition of recombinant full length stromelysin (FLS),,A recombinant human stromelysin catalytic domain identifying tryptophan derivatives as human stromelysin inhibitors.,J. Med. Chem.,1994,37,1,"Ye QZ, Johnson LL, Nordan I, Hupe D, Hupe L",,205624,DTCT0024060,743547,DTCC00216162,808396,12439
CHEMBL66181,P08254,,WEQCLTHHZZNFDV-ZNMIVQPWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11514157,KI,=,80,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution.,Bioorg. Med. Chem. Lett.,2001,11,16,"Musso DL, Andersen MW, Andrews RC, Austin R, Beaudet EJ, Becherer JD, Bubacz DG, Bickett DM, Chan JH, Conway JG, Cowan DJ, Gaul MD, Glennon KC, Hedeen KM, Lambert MH, Leesnitzer MA, McDougald DL, Mitchell JL, Moss ML, Rabinowitz MH, Rizzolio MC, Schaller LT, Stanford JB, Tippin T, Warner JR, Whitesell LG, Wiethe RW",,104569,DTCT0024060,909384,DTCC00219789,1882120,4390
CHEMBL66532,P08254,,ANFAAJVPGXQKBB-NXCFDTQHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873491,IC50,=,6.9,NM,,,,,,,,,,,,,,Inhibition of fibroblast stromelysin (MMP-3),,"The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.",Bioorg. Med. Chem. Lett.,1998,8,16,"Steinman DH, Curtin ML, Garland RB, Davidsen SK, Heyman HR, Holms JH, Albert DH, Magoc TJ, Nagy IB, Marcotte PA, Li J, Morgan DW, Hutchins C, Summers JB",,101938,DTCT0024060,1654873,DTCC00215598,29480,2712
CHEMBL66589,P08254,,JLEGVELHGVWFGG-ZACQAIPSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9873489,IC50,=,104,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3),,Design and synthesis of conformationally-constrained MMP inhibitors.,Bioorg. Med. Chem. Lett.,1998,8,16,"Natchus MG, Cheng M, Wahl CT, Pikul S, Almstead NG, Bradley RS, Taiwo YO, Mieling GE, Dunaway CM, Snider CE, McIver JM, Barnett BL, McPhail SJ, Anastasio MB, De B",,101941,DTCT0024060,743276,DTCC00214979,723315,2711
CHEMBL66970,P08254,,RGDBGIBFYROBCD-YNEHKIRRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11514157,KI,=,2323,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution.,Bioorg. Med. Chem. Lett.,2001,11,16,"Musso DL, Andersen MW, Andrews RC, Austin R, Beaudet EJ, Becherer JD, Bubacz DG, Bickett DM, Chan JH, Conway JG, Cowan DJ, Gaul MD, Glennon KC, Hedeen KM, Lambert MH, Leesnitzer MA, McDougald DL, Mitchell JL, Moss ML, Rabinowitz MH, Rizzolio MC, Schaller LT, Stanford JB, Tippin T, Warner JR, Whitesell LG, Wiethe RW",,104569,DTCT0024060,921864,DTCC00219913,1785265,4390
CHEMBL68553,P08254,,AHCJFAZGYUITPV-BFHYXJOUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11514157,KI,=,437,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution.,Bioorg. Med. Chem. Lett.,2001,11,16,"Musso DL, Andersen MW, Andrews RC, Austin R, Beaudet EJ, Becherer JD, Bubacz DG, Bickett DM, Chan JH, Conway JG, Cowan DJ, Gaul MD, Glennon KC, Hedeen KM, Lambert MH, Leesnitzer MA, McDougald DL, Mitchell JL, Moss ML, Rabinowitz MH, Rizzolio MC, Schaller LT, Stanford JB, Tippin T, Warner JR, Whitesell LG, Wiethe RW",,104569,DTCT0024060,900813,DTCC00220529,140487,4390
CHEMBL68667,P08254,,YPFZRQMUNBCBEG-YEBPUJJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11514157,KI,=,38,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP3),,N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution.,Bioorg. Med. Chem. Lett.,2001,11,16,"Musso DL, Andersen MW, Andrews RC, Austin R, Beaudet EJ, Becherer JD, Bubacz DG, Bickett DM, Chan JH, Conway JG, Cowan DJ, Gaul MD, Glennon KC, Hedeen KM, Lambert MH, Leesnitzer MA, McDougald DL, Mitchell JL, Moss ML, Rabinowitz MH, Rizzolio MC, Schaller LT, Stanford JB, Tippin T, Warner JR, Whitesell LG, Wiethe RW",,104570,DTCT0024060,928054,DTCC00220499,1144056,4390
CHEMBL68812,P08254,,VPADZEAGMFRILI-ZNMIVQPWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11514157,KI,=,354,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution.,Bioorg. Med. Chem. Lett.,2001,11,16,"Musso DL, Andersen MW, Andrews RC, Austin R, Beaudet EJ, Becherer JD, Bubacz DG, Bickett DM, Chan JH, Conway JG, Cowan DJ, Gaul MD, Glennon KC, Hedeen KM, Lambert MH, Leesnitzer MA, McDougald DL, Mitchell JL, Moss ML, Rabinowitz MH, Rizzolio MC, Schaller LT, Stanford JB, Tippin T, Warner JR, Whitesell LG, Wiethe RW",,104569,DTCT0024060,928048,DTCC00219778,1914232,4390
CHEMBL69194,P08254,,WGUQAEXNOBFCNK-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9632351,IC50,=,19000,NM,,,,,,,,,,,,,,Inhibition of Matrix Metalloprotease-3,,Rational design and combinatorial evaluation of enzyme inhibitor scaffolds: identification of novel inhibitors of matrix metalloproteinases.,J. Med. Chem.,1998,41,13,"Szardenings AK, Harris D, Lam S, Shi L, Tien D, Wang Y, Patel DV, Navre M, Campbell DA",,104888,DTCT0024060,823087,DTCC00222733,1359016,14688
CHEMBL69323,P08254,,SKDNVHHXHPMJHN-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9632351,IC50,=,2400,NM,,,,,,,,,,,,,,Inhibition of Matrix Metalloprotease-3,,Rational design and combinatorial evaluation of enzyme inhibitor scaffolds: identification of novel inhibitors of matrix metalloproteinases.,J. Med. Chem.,1998,41,13,"Szardenings AK, Harris D, Lam S, Shi L, Tien D, Wang Y, Patel DV, Navre M, Campbell DA",,104888,DTCT0024060,819275,DTCC00222906,550338,14688
CHEMBL69418,P08254,,UWHDYIJAXRNLQS-XQLPTFJDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11514157,KI,=,93,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution.,Bioorg. Med. Chem. Lett.,2001,11,16,"Musso DL, Andersen MW, Andrews RC, Austin R, Beaudet EJ, Becherer JD, Bubacz DG, Bickett DM, Chan JH, Conway JG, Cowan DJ, Gaul MD, Glennon KC, Hedeen KM, Lambert MH, Leesnitzer MA, McDougald DL, Mitchell JL, Moss ML, Rabinowitz MH, Rizzolio MC, Schaller LT, Stanford JB, Tippin T, Warner JR, Whitesell LG, Wiethe RW",,104569,DTCT0024060,915120,DTCC00219781,1532163,4390
CHEMBL69596,P08254,,IQHWFMFCBUDMAF-FZKCQIBNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11514157,KI,=,45,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP3),,N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution.,Bioorg. Med. Chem. Lett.,2001,11,16,"Musso DL, Andersen MW, Andrews RC, Austin R, Beaudet EJ, Becherer JD, Bubacz DG, Bickett DM, Chan JH, Conway JG, Cowan DJ, Gaul MD, Glennon KC, Hedeen KM, Lambert MH, Leesnitzer MA, McDougald DL, Mitchell JL, Moss ML, Rabinowitz MH, Rizzolio MC, Schaller LT, Stanford JB, Tippin T, Warner JR, Whitesell LG, Wiethe RW",,104570,DTCT0024060,913920,DTCC00220500,2076952,4390
CHEMBL69726,P08254,,NTWPNMLRTBRVIB-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9632351,IC50,>,40000,NM,,,,,,,,,,,,,,Inhibition of stromelysin (Matrix metalloprotease-3),,Rational design and combinatorial evaluation of enzyme inhibitor scaffolds: identification of novel inhibitors of matrix metalloproteinases.,J. Med. Chem.,1998,41,13,"Szardenings AK, Harris D, Lam S, Shi L, Tien D, Wang Y, Patel DV, Navre M, Campbell DA",,104577,DTCT0024060,828026,DTCC00223929,1870492,14688
CHEMBL6973,P08254,,DRWHINQPSIPRHF-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327577,IC50,=,404,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104578,DTCT0024060,1301008,DTCC00133507,110647,4760
CHEMBL70110,P08254,,LCWFIBYPSAWVLI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,-8,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103133,DTCC00224425,1349087,43205
CHEMBL7108,P08254,,VAQNHYAKIUNIKM-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327577,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104578,DTCT0024060,1286293,DTCC00133441,1209922,4760
CHEMBL71120,P08254,,NTWPNMLRTBRVIB-IAGOWNOFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9632351,IC50,>,40000,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1,,Rational design and combinatorial evaluation of enzyme inhibitor scaffolds: identification of novel inhibitors of matrix metalloproteinases.,J. Med. Chem.,1998,41,13,"Szardenings AK, Harris D, Lam S, Shi L, Tien D, Wang Y, Patel DV, Navre M, Campbell DA",,205493,DTCT0024060,845185,DTCC00223876,550337,14688
CHEMBL71573,P08254,,NTWPNMLRTBRVIB-DLBZAZTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9632351,IC50,>,40000,NM,,,,,,,,,,,,,,Inhibition of stromelysin-1,,Rational design and combinatorial evaluation of enzyme inhibitor scaffolds: identification of novel inhibitors of matrix metalloproteinases.,J. Med. Chem.,1998,41,13,"Szardenings AK, Harris D, Lam S, Shi L, Tien D, Wang Y, Patel DV, Navre M, Campbell DA",,205493,DTCT0024060,822976,DTCC00223905,1520641,14688
CHEMBL72457,P08254,,XIYFEESCIBNMIC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,9,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103202,DTCC00224003,1185922,43205
CHEMBL72511,P08254,PKF-242-484,IOLRUMINDIUCLJ-RRFJBIMHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12014967,KI,=,0.9,NM,,,,,,,,,,,,,,Inhibitory potency against Matrix metalloprotease-3 (MMP-3),,Beta-aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme.,J. Med. Chem.,2002,45,11,"Kottirsch G, Koch G, Feifel R, Neumann U",,104903,DTCT0024060,800971,DTCC01741036,853076,16740
CHEMBL72511,P08254,PKF-242-484,IOLRUMINDIUCLJ-RRFJBIMHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16516469,KI,=,0.9,NM,,,,,,,,,,,,,,Binding affinity to recombinant MMP3,,A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors.,Bioorg. Med. Chem. Lett.,2006,16,10,"Janser P, Neumann U, Miltz W, Feifel R, Buhl T",,354052,DTCT0024060,1926032,DTCC01741036,855239,20779
CHEMBL72628,P08254,2-PICOLINIC ACID,SIOXPEMLGUPBBT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,99,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5104023,DTCC00227813,1251244,43205
CHEMBL73173,P08254,2-CARBOXYPYRIDINE 1-OXIDE,FHYMLBVGNFVFBT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,18,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103195,DTCC01740992,1510695,43205
CHEMBL73380,P08254,4-PHENYLPHENOL,YXVFYQXJAXKLAK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15214773,KD,=,280000,NM,,,,,,,,,,,,,,Dissociation constant for Matrix Metalloprotease-3 (MMP-3),,Fragment-based drug discovery.,J. Med. Chem.,2004,47,14,"Erlanson DA, McDowell RS, O'Brien T",,104900,DTCT0024060,640543,DTCC01741012,1999739,17883
CHEMBL734,P08254,ACETOHYDROXAMIC ACID,RRUDCFGSUDOHDG-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,=,17000000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in place of acetohydroxamic acid.,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205633,DTCT0024060,1277066,DTCC00163357,624572,17092
CHEMBL734,P08254,ACETOHYDROXAMIC ACID,RRUDCFGSUDOHDG-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15214773,KD,=,17000000,NM,,,,,,,,,,,,,,Dissociation constant for Matrix Metalloprotease-3 (MMP-3),,Fragment-based drug discovery.,J. Med. Chem.,2004,47,14,"Erlanson DA, McDowell RS, O'Brien T",,104900,DTCT0024060,628268,DTCC00163357,627415,17883
CHEMBL734,P08254,ACETOHYDROXAMIC ACID,RRUDCFGSUDOHDG-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,5,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103374,DTCC00163357,637574,43205
CHEMBL73763,P08254,,OLEYZXUQGOKVKT-KFWWJZLASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,,,,,,,,,,,,,,,,,"Inhibition of human stromelysin-1, MMP3 (No data)",Not Determined,,Bioorg. Med. Chem. Lett.,1997,7,17,,,205640,DTCT0024060,1080529,DTCC00230328,1144162,2236
CHEMBL73803,P08254,,ZWZXXDZMSDNWNF-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,177,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,561306,DTCC00232109,1338270,16308
CHEMBL73803,P08254,,ZWZXXDZMSDNWNF-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,177,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,992462,DTCC00232109,1326608,1012
CHEMBL7390,P08254,,SUSMVCKSLVPRCL-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327577,IC50,=,3.1,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104725,DTCT0024060,1310677,DTCC00133540,693701,4760
CHEMBL74040,P08254,,RJDSAKRTODCGAU-DGPALRBDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,2.98,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,567366,DTCC00232410,335552,16308
CHEMBL74308,P08254,,ARCVMPXMLFTEBX-PXJZQJOASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,2.39,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,569692,DTCC00232232,1499898,16308
CHEMBL74670,P08254,,KYOFVPKPPTUVKK-KURKYZTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,9.1,NM,,,,,,,,,,,,,,"Inhibition of human stromelysin-1, MMP-3",,,Bioorg. Med. Chem. Lett.,1997,7,17,,,205639,DTCT0024060,1069941,DTCC00230314,335515,2236
CHEMBL74977,P08254,,OXBBHJALLZTSBF-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,701,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,579681,DTCC00232759,2077057,16308
CHEMBL74977,P08254,,OXBBHJALLZTSBF-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,701,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1693932,DTCC00232759,2077345,1013
CHEMBL75094,P08254,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,IC50,=,4.9,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3.,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104579,DTCT0024060,1369136,DTCC00231104,336627,15412
CHEMBL75094,P08254,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10579818,KI,=,0.27,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,104743,DTCT0024060,1369137,DTCC00231104,336627,15412
CHEMBL75094,P08254,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10669559,KI,=,0.27,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,104750,DTCT0024060,1072599,DTCC00231104,324460,16063
CHEMBL75094,P08254,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11212095,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,3,"Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P",,104720,DTCT0024060,628949,DTCC00231104,324195,4635
CHEMBL75094,P08254,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11754593,IC50,=,3.5,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3) in fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104893,DTCT0024060,1565053,DTCC00231104,323739,16699
CHEMBL75094,P08254,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12930146,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-3 (MMP3),,Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.,J. Med. Chem.,2003,46,18,"Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P",,104732,DTCT0024060,532646,DTCC00231104,336390,13726
CHEMBL75094,P08254,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15713379,IC50,=,0.23,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305734,DTCT0024060,1745891,DTCC00231104,325586,18841
CHEMBL75148,P08254,,GOFLUZCVSLWGBX-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,353,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,578435,DTCC00231346,433296,16308
CHEMBL75148,P08254,,GOFLUZCVSLWGBX-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,353,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1710779,DTCC00231346,433550,1013
CHEMBL75403,P08254,,FMRZZWFHPADOAW-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,8.3,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,556720,DTCC00231895,1914379,16308
CHEMBL75403,P08254,,FMRZZWFHPADOAW-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,8.3,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,1004548,DTCC00231895,1903268,1012
CHEMBL75403,P08254,,FMRZZWFHPADOAW-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,8.3,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1696341,DTCC00231895,1914647,1013
CHEMBL75419,P08254,,SXXYGGYNEUHILZ-ANYOKISRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,2200,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1997,7,18,,,104882,DTCT0024060,1569304,DTCC00232298,1240250,2242
CHEMBL76158,P08254,,JJZXSGSWLVQWHL-GGAORHGYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,0.8,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,575317,DTCC00232031,1403221,16308
CHEMBL76222,P08254,REBIMASTAT,GTXSRFUZSLTDFX-HRCADAONSA-N,2,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11754593,IC50,=,157,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3) in fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,104893,DTCT0024060,1562531,DTCC00231103,1326293,16699
CHEMBL76297,P08254,,GKLAUAGSCYZMQP-BFHYXJOUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12014967,KI,=,13.2,NM,,,,,,,,,,,,,,Inhibitory potency against Matrix metalloprotease-3 (MMP-3),,Beta-aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme.,J. Med. Chem.,2002,45,11,"Kottirsch G, Koch G, Feifel R, Neumann U",,104903,DTCT0024060,809399,DTCC00229222,981970,16740
CHEMBL76398,P08254,"4,4'-HYDROXYBIPHENYL",VCCBEIPGXKNHFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,=,150000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in the presence of 1-Napthohydroxamate,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205631,DTCT0024060,1275966,DTCC01741015,886602,17092
CHEMBL76398,P08254,"4,4'-HYDROXYBIPHENYL",VCCBEIPGXKNHFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12477346,KD,=,160000,NM,,,,,,,,,,,,,,Binding to stromelysin (MMP-3) in the presence of acetohydroxamic acid,,NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.,J. Med. Chem.,2002,45,26,"Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW",,205632,DTCT0024060,1275967,DTCC01741015,886602,17092
CHEMBL76519,P08254,,YGJCNDHMYMIUBJ-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,90.3,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,565129,DTCC00232260,659058,16308
CHEMBL76519,P08254,,YGJCNDHMYMIUBJ-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,90.3,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,991080,DTCC00232260,647971,1012
CHEMBL76869,P08254,,PNOAVGXEWQIVLB-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,277,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,555580,DTCC00232376,853104,16308
CHEMBL76869,P08254,,PNOAVGXEWQIVLB-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,277,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1705331,DTCC00232376,853377,1013
CHEMBL76869,P08254,,PNOAVGXEWQIVLB-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,21200,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1717668,DTCC00232376,853376,1013
CHEMBL77013,P08254,,IJQHRVZFTGGUJN-ZVAWYAOSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,4000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1997,7,18,,,104882,DTCT0024060,1581199,DTCC00232677,400993,2242
CHEMBL77057,P08254,,DKPQMSLWGNDZTO-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,5.87,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,578441,DTCC00232820,626727,16308
CHEMBL77163,P08254,,VAQVSMUJBPTVIS-ZBAATNBSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12824028,IC50,=,900,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,104894,DTCT0024060,1491830,DTCC00232704,1403218,5648
CHEMBL77461,P08254,,ZKISXIXLRWGPKA-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,834,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,571959,DTCC00231878,497734,16308
CHEMBL77461,P08254,,ZKISXIXLRWGPKA-SXOMAYOGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,834,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1700077,DTCC00231878,497988,1013
CHEMBL7756,P08254,,HTNLSTWGHBHDPS-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11327577,IC50,=,6.5,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,104725,DTCT0024060,1292486,DTCC00133590,207299,4760
CHEMBL77659,P08254,,QCHJWCBHICZTTP-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,22.2,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,580745,DTCC00232152,1661284,16308
CHEMBL77663,P08254,,RHQDIPUHXQNFIY-IHLOFXLRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,2.61,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,578438,DTCC00232153,1596726,16308
CHEMBL77754,P08254,,ABTPKZSVAHUDFA-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,25.3,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,562553,DTCC00231863,755644,16308
CHEMBL77754,P08254,,ABTPKZSVAHUDFA-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,25.3,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,989965,DTCC00231863,744425,1012
CHEMBL77808,P08254,,FCKWIYZMPDIGLV-FTJBHMTQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,77,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,554317,DTCC00232150,1946977,16308
CHEMBL77808,P08254,,FCKWIYZMPDIGLV-FTJBHMTQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,77,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,996269,DTCC00232150,1935248,1012
CHEMBL77956,P08254,,WVBSAEZXOPOUJB-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,1090,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,576405,DTCC00232618,497733,16308
CHEMBL77956,P08254,,WVBSAEZXOPOUJB-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,1060,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1679722,DTCC00232618,497987,1013
CHEMBL77995,P08254,,WFQFQAQNCYHBTC-FUJFQHJFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12824028,IC50,=,800,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,104894,DTCT0024060,1497635,DTCC00232836,820189,5648
CHEMBL78047,P08254,,VEAMBOBAFHZNKJ-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,1470,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,569698,DTCC00232544,2012756,16308
CHEMBL78047,P08254,,VEAMBOBAFHZNKJ-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,1470,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1706609,DTCC00232544,2013004,1013
CHEMBL78081,P08254,,ATHLMNGFZTVPSA-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,190.55,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258541,DTCC00238990,844217,24803
CHEMBL78081,P08254,,ATHLMNGFZTVPSA-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,190,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,852066,DTCC00238990,841463,1379
CHEMBL78233,P08254,,ROFAQOFULLWONA-FOIFJWKZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12824028,IC50,=,2700,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,104894,DTCT0024060,1501941,DTCC00232527,335546,5648
CHEMBL78335,P08254,,OUOSIGGTYBFYMF-IAPPQJPRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,384,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,568553,DTCC00232757,1273033,16308
CHEMBL78335,P08254,,OUOSIGGTYBFYMF-IAPPQJPRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,384,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1679726,DTCC00232757,1273287,1013
CHEMBL78598,P08254,,RRMMAIAIQQHWEX-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,820699,DTCC00238555,970296,1379
CHEMBL78826,P08254,,QCBWOUQUDIILOW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944582,DTCT0024060,11835670,DTCC00237661,868683,53820
CHEMBL78919,P08254,,OGYHNTDCEFBNGN-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,831367,DTCC00238554,2065532,1379
CHEMBL79267,P08254,,UYFGGWJRPCRSHW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,739,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1322793,DTCC00242002,1163761,16328
CHEMBL79433,P08254,,IMKDKHQDFFLOKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12773042,IC50,=,55,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,104890,DTCT0024060,494319,DTCC00235743,75938,17340
CHEMBL79712,P08254,,NNDUTDPDZHXRRE-QDSKXPNFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,845576,DTCC00239094,1585028,1379
CHEMBL79857,P08254,,VEYIMQVTPXPUHA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,35,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103054,DTCC00238936,701896,43205
CHEMBL79906,P08254,,QPSBVVFMTSFAJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,4840,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104715,DTCT0024060,1313202,DTCC00242125,1903109,16328
CHEMBL80102,P08254,,UVCYZCWBCCZIRY-LEOXJPRUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,4677.35,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258543,DTCC00238002,424708,24803
CHEMBL80102,P08254,,UVCYZCWBCCZIRY-LEOXJPRUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,4700,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,831370,DTCC00238002,421915,1379
CHEMBL81014,P08254,,IYAKGTQGDHUISZ-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,1778.28,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258542,DTCC00238976,164162,24803
CHEMBL81014,P08254,,IYAKGTQGDHUISZ-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,1800,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,843362,DTCC00238976,161583,1379
CHEMBL81113,P08254,,BDCJZZXWIQJYLP-FIWHBWSRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944582,DTCT0024060,11835671,DTCC00237078,1800998,53820
CHEMBL81264,P08254,,XXOYKWAQHGQSOT-YNJKOYDBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,177.83,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258533,DTCC00106070,972939,24803
CHEMBL81264,P08254,,XXOYKWAQHGQSOT-YNJKOYDBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,180,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,846961,DTCC00106070,970297,1379
CHEMBL81270,P08254,,XZCOTKRLQZVHTR-NYMACZPPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,42.66,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258531,DTCC00239051,1296589,24803
CHEMBL81270,P08254,,XZCOTKRLQZVHTR-NYMACZPPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,43,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,833846,DTCC00239051,1293829,1379
CHEMBL81398,P08254,,SNUSZUYTMHKCPM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,75,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103280,DTCC00239383,927980,43205
CHEMBL81672,P08254,,YCCKHBLGJUKATM-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,229.09,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258545,DTCC00238504,1684868,24803
CHEMBL81672,P08254,,YCCKHBLGJUKATM-WTNAPCKOSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,230,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,849689,DTCC00238504,1682060,1379
CHEMBL82047,P08254,,MEGRMEXCUOBMOZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,63,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1297848,DTCC00243231,1424137,14264
CHEMBL82047,P08254,,MEGRMEXCUOBMOZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,63.1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458936,DTCT0024060,2258814,DTCC00243231,1426643,24803
CHEMBL82113,P08254,,PYGZWPVJQNBFNS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,399,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1290350,DTCC00242452,1773868,16328
CHEMBL82169,P08254,,LFOGEPKUSWRLCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,56.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1298765,DTCC00241974,550551,16328
CHEMBL82203,P08254,,KIVYTNANTFIVKL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,943,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1306518,DTCC00243866,64401,14264
CHEMBL82203,P08254,,KIVYTNANTFIVKL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,933.25,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458936,DTCT0024060,2258526,DTCC00243866,67154,24803
CHEMBL82212,P08254,,NEQFZTMOZHEVSJ-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,28,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1293062,DTCC00243962,518537,14264
CHEMBL82232,P08254,,GATKQMPWFHNBFF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,78,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1302755,DTCC00243234,808698,14264
CHEMBL82232,P08254,,GATKQMPWFHNBFF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,77.62,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458936,DTCT0024060,2258815,DTCC00243234,811347,24803
CHEMBL82331,P08254,,HYKIXGPXDGBTKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,66,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1301600,DTCC00243600,938247,14264
CHEMBL82558,P08254,,XVGXNGSCQUTFFG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,3270,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1293068,DTCC00243449,518540,14264
CHEMBL82558,P08254,,XVGXNGSCQUTFFG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,3235.94,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458936,DTCT0024060,2258820,DTCC00243449,521153,24803
CHEMBL8256,P08254,,UXFNMUGVMKCZTP-NZJKTDFXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,68,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,351694,DTCC00135765,1099281,14548
CHEMBL8256,P08254,,UXFNMUGVMKCZTP-NZJKTDFXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,68,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,7,,,102093,DTCT0024060,614803,DTCC00135765,1101820,2023
CHEMBL82583,P08254,,CHQFHKHGXFPASX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,,,,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3) (Inactive),Not Active,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104741,DTCT0024060,1314625,DTCC00243285,1228442,14264
CHEMBL82597,P08254,,YHUAHVPZGNXPMS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,20,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5104056,DTCC00238679,1892887,43205
CHEMBL82759,P08254,,AZLPLQRRFWWDQE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,65,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1319374,DTCC00243184,1773881,14264
CHEMBL82783,P08254,,FVEJQZRUPDCJKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,104,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1296636,DTCC00243123,1132555,14264
CHEMBL8282,P08254,,RQBUQSJYJPOWOP-UODIDJSMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,13,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,530950,DTCC00135761,1869584,14548
CHEMBL8282,P08254,,RQBUQSJYJPOWOP-UODIDJSMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,690,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,530948,DTCC00135761,1869584,14548
CHEMBL82827,P08254,,OEQIQWOICMQOSX-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,104,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1286949,DTCC00243322,776386,14264
CHEMBL82855,P08254,,CFHYUBUDEMRKRQ-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,85,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1305432,DTCC00243613,1903122,14264
CHEMBL82868,P08254,,QCLOBJCDRHHNCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,70,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1321927,DTCC00243186,938248,14264
CHEMBL82869,P08254,,KPHZILOOIGLYMY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,1130,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1313496,DTCC00243625,906498,14264
CHEMBL82869,P08254,,KPHZILOOIGLYMY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,1122.02,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458936,DTCT0024060,2258525,DTCC00243625,909283,24803
CHEMBL83091,P08254,,YEHKZVNFGURGEX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,1130,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1296637,DTCC00243138,2033889,14264
CHEMBL83209,P08254,,URNFYSXQOHQAJN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,23287054,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP3 (unknown origin),Not Determined,Sulphonamides: Deserving class as MMP inhibitors?,Eur. J. Med. Chem.,2013,60,,"Jain P, Saravanan C, Singh SK",,944582,DTCT0024060,11835256,DTCC00240463,1995454,53820
CHEMBL83282,P08254,,ICFOTHUAZLHTNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,221,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1292787,DTCC00242039,1585074,16328
CHEMBL83368,P08254,,HGCZRPPCNXJXAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,41.8,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1287853,DTCC00242344,323868,16328
CHEMBL83508,P08254,,WLZISXXOYYGJNT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,4400,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1316991,DTCC00243572,225845,14264
CHEMBL83616,P08254,,JXAGDPXECXQWBC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,7950,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1310934,DTCC00242500,1773869,16328
CHEMBL83685,P08254,,VKUYLANQOAKALN-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,23,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1316993,DTCC00243418,258116,14264
CHEMBL83864,P08254,,AUQHYVHKEDXBCG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,58,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1315831,DTCC00243699,193514,14264
CHEMBL83864,P08254,,AUQHYVHKEDXBCG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,57.54,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458936,DTCT0024060,2258524,DTCC00243699,196124,24803
CHEMBL83865,P08254,,AXZZHNLXOYQTJZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,,,,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3) (Inactive),Not Active,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104741,DTCT0024060,1291977,DTCC00243700,1163781,14264
CHEMBL83955,P08254,,ILTCMGUVAAYHSE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,162,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1316682,DTCC00242203,1067615,16328
CHEMBL84031,P08254,,HQGDKMFOWKNNOV-OIBXWCBGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,829877,DTCC00239000,1742025,1379
CHEMBL84100,P08254,,NDRLUYJPDDYOBH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,,,,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3) (Inactive),Not Active,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104741,DTCT0024060,1304055,DTCC00243666,2065595,14264
CHEMBL84153,P08254,,RRQKNMDFRICFCC-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,31,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1296640,DTCC00243755,1100441,14264
CHEMBL84235,P08254,,HHNUCMCBLNOEAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,70,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1289481,DTCC00243137,64399,14264
CHEMBL84255,P08254,,QPQUTTGIKCBKTK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,305,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1288220,DTCC00243129,712017,14264
CHEMBL84408,P08254,,FPLZEJRPZZSIBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,700,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1300417,DTCC00243321,1742084,14264
CHEMBL8451,P08254,,XMKDGSRADZHPTC-MVERNJQCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,39,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,518241,DTCC00135663,224640,14548
CHEMBL8451,P08254,,XMKDGSRADZHPTC-MVERNJQCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,200,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,518239,DTCC00135663,224640,14548
CHEMBL84576,P08254,,HXQYFGDVXCVBKX-CJFMBICVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,<,2,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,493031,DTCC00247293,808731,13104
CHEMBL84594,P08254,,MICNEWMYBPETEW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,1820,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1315832,DTCC00243114,776387,14264
CHEMBL84598,P08254,,HQBHGTOYWBOXIB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,125,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1314626,DTCC00244026,1773882,14264
CHEMBL8474,P08254,,DFHTYEKEXQDADI-YNJKOYDBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,18,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,544212,DTCC00135731,1716,14548
CHEMBL8474,P08254,,DFHTYEKEXQDADI-YNJKOYDBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,18.2,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258534,DTCC00135731,8955,24803
CHEMBL8474,P08254,,DFHTYEKEXQDADI-YNJKOYDBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,18,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,825671,DTCC00135731,3815,1379
CHEMBL8474,P08254,,DFHTYEKEXQDADI-YNJKOYDBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,18,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,7,,,102093,DTCT0024060,360927,DTCC00135731,6489,2023
CHEMBL84814,P08254,,SFKKAERKHIUEOG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,38,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1301601,DTCC00243966,486302,14264
CHEMBL84918,P08254,,LJXAVTUOWRDMBX-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,29,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1296639,DTCC00243762,323888,14264
CHEMBL8494,P08254,L-696418,DLCYKLDSIUJNLE-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,310,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,528185,DTCC00135604,1162619,14548
CHEMBL8494,P08254,L-696418,DLCYKLDSIUJNLE-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,467.74,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258547,DTCC00135604,1166446,24803
CHEMBL8494,P08254,L-696418,DLCYKLDSIUJNLE-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,320,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-3,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,101940,DTCT0024060,1501830,DTCC00135604,1176117,1959
CHEMBL8494,P08254,L-696418,DLCYKLDSIUJNLE-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,310,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3 (MMP-3).,,,Bioorg. Med. Chem. Lett.,1996,6,7,,,102093,DTCT0024060,617195,DTCC00135604,1165200,2023
CHEMBL8494,P08254,L-696418,DLCYKLDSIUJNLE-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,470,NM,,,,,,,,,,,,,,Inhibitory activity against human stromelysin-3 (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,20,,,101950,DTCT0024060,840911,DTCC00135604,1163711,1379
CHEMBL8494,P08254,L-696418,DLCYKLDSIUJNLE-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,470,NM,,,,,,,,,,,,,,Inhibition of human fibroblast stromelysin (MMP-3),,,Bioorg. Med. Chem. Lett.,1995,5,6,,,102085,DTCT0024060,1008207,DTCC00135604,1164916,1529
CHEMBL8494,P08254,L-696418,DLCYKLDSIUJNLE-COPCDDAFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,470,NM,,,,,,,,,,,,,,Inhibition of MMP-3.,,,Bioorg. Med. Chem. Lett.,1996,6,3,,,102084,DTCT0024060,566864,DTCC00135604,1164280,1951
CHEMBL84969,P08254,BB-3554,AVDLWYHBABSSHC-ZGTCLIOFSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11551755,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-3,,Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.,Bioorg. Med. Chem. Lett.,2001,11,19,"Pratt LM, Beckett RP, Davies SJ, Launchbury SB, Miller A, Spavold ZM, Todd RS, Whittaker M",,104889,DTCT0024060,1077161,DTCC01741523,1617853,4468
CHEMBL85026,P08254,,IRVGVLJCCVMVAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,678,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1286650,DTCC00242319,421955,16328
CHEMBL85030,P08254,CGS-25966,ZGSTVUAZFACDLH-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,34,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1320655,DTCC01741458,518539,14264
CHEMBL85108,P08254,,JKXLPZUCXZNXTD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,236,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1285616,DTCC00243571,1035295,14264
CHEMBL85319,P08254,,MGXAKMSSIVSBNL-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,44,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1314624,DTCC00243775,356605,14264
CHEMBL85374,P08254,,BLYHHTXBRXLLOI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472202,IC50,=,86.1,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-3,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,104708,DTCT0024060,1320327,DTCC00242381,1455978,16328
CHEMBL8539,P08254,,VYRNNIARONKBRB-UODIDJSMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,1500,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,515083,DTCC00135734,1901970,14548
CHEMBL85427,P08254,,TUZPTIWMMRICKC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,2500,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1285615,DTCC00243113,1326440,14264
CHEMBL85620,P08254,,WMGKYBYVBSCKIZ-XCWJXAQQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,39,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1290711,DTCC00243964,486301,14264
CHEMBL85766,P08254,,JNFMXXAZBVSNRC-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,360,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,479950,DTCC00247454,1649994,13104
CHEMBL85766,P08254,,JNFMXXAZBVSNRC-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,363.08,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258521,DTCC00247454,1652640,24803
CHEMBL85766,P08254,,JNFMXXAZBVSNRC-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,360,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102097,DTCT0024060,605658,DTCC00247454,1661897,1496
CHEMBL8578,P08254,,JHLCBEICWMJALX-ULNYTKQRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,65,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,514086,DTCC00135683,1551747,14548
CHEMBL8580,P08254,,JJIIYULDEGYNEW-CMTIAEDTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,74,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,537719,DTCC00135771,1292694,14548
CHEMBL85806,P08254,,QSONFBZTWRVCKO-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,19,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,476406,DTCC00247106,615125,13104
CHEMBL85806,P08254,,QSONFBZTWRVCKO-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,19.05,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258515,DTCC00247106,617702,24803
CHEMBL85869,P08254,,VFQQYQDWXYLYBQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,134,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1293069,DTCC00243847,1196327,14264
CHEMBL85933,P08254,,NBDGYUOAVSOSOD-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,>,10000,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,499027,DTCC00247467,1067665,13104
CHEMBL85933,P08254,,NBDGYUOAVSOSOD-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102097,DTCT0024060,604511,DTCC00247467,1079879,1496
CHEMBL85987,P08254,,PJKBQUWSOBIDMI-VQIMIIECSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,54,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,477612,DTCC00247635,550594,13104
CHEMBL86113,P08254,,POWDSMHQGXHJER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,61,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1302756,DTCC00243200,1196329,14264
CHEMBL86113,P08254,,POWDSMHQGXHJER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,60.26,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458936,DTCT0024060,2258813,DTCC00243200,1198921,24803
CHEMBL86189,P08254,,YPCPCLGFXANQDQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9258358,KI,=,94,NM,,,,,,,,,,,,,,Inhibition activity against recombinant human stromelysin (Matrix metalloprotease-3),,"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.",J. Med. Chem.,1997,40,16,"MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT",,104740,DTCT0024060,1320654,DTCC00243996,1035296,14264
CHEMBL8634,P08254,,NFMRFQNSUWXJSA-XPWALMASSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,140,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,541397,DTCC00135606,937105,14548
CHEMBL86468,P08254,,URNQLXVLIBILTE-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,2200,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,478834,DTCC00247430,291411,13104
CHEMBL86468,P08254,,URNQLXVLIBILTE-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,2187.76,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258512,DTCC00247430,294024,24803
CHEMBL86468,P08254,,URNQLXVLIBILTE-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,2200,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102097,DTCT0024060,612500,DTCC00247430,303581,1496
CHEMBL86797,P08254,,WSGLDBYEABEDRD-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,6,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,477606,DTCC00247429,422017,13104
CHEMBL86797,P08254,,WSGLDBYEABEDRD-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,6.03,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258519,DTCC00247429,424707,24803
CHEMBL86797,P08254,,WSGLDBYEABEDRD-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,<,100,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3 (potent inhibitor)",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102096,DTCT0024060,590372,DTCC00247429,433910,1496
CHEMBL86797,P08254,,WSGLDBYEABEDRD-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,6,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102097,DTCT0024060,590371,DTCC00247429,433910,1496
CHEMBL87046,P08254,,HCELOWJRPJWTPO-CVEARBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,430,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,489186,DTCC00247443,874091,13104
CHEMBL87046,P08254,,HCELOWJRPJWTPO-CVEARBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,426.58,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258522,DTCC00247443,876666,24803
CHEMBL87046,P08254,,HCELOWJRPJWTPO-CVEARBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,430,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102097,DTCT0024060,604508,DTCC00247443,886020,1496
CHEMBL87113,P08254,,AJPFDJXQTUJCCW-NTKDMRAZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,6,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,475319,DTCC00247345,1520893,13104
CHEMBL8718,P08254,,HKGUEYWZKLSNKN-KWXIBIRDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,80,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,540339,DTCC00135639,1837647,14548
CHEMBL8718,P08254,,HKGUEYWZKLSNKN-KWXIBIRDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,9,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,540337,DTCC00135639,1837647,14548
CHEMBL87229,P08254,,IYJLBIPCLHKYKU-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,15,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,477609,DTCC00247084,582733,13104
CHEMBL87229,P08254,,IYJLBIPCLHKYKU-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,KI,=,15.14,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258516,DTCC00247084,585409,24803
CHEMBL87229,P08254,,IYJLBIPCLHKYKU-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,<,100,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3 (potent inhibitor)",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102096,DTCT0024060,593829,DTCC00247084,594887,1496
CHEMBL87229,P08254,,IYJLBIPCLHKYKU-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,15,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102092,DTCT0024060,819551,DTCC00247084,594918,1497
CHEMBL87229,P08254,,IYJLBIPCLHKYKU-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,15,NM,,,,,,,,,,,,,,"Inhibition of human fibroblast stromelysin, matrix metalloprotease-3",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102097,DTCT0024060,593828,DTCC00247084,594887,1496
CHEMBL8745,P08254,,IVVIGKFVPVPXEY-OZNIXHKMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,49,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,543139,DTCC00103481,95661,14548
CHEMBL87460,P08254,,BOCBQLXXKQDYBE-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,11,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,490379,DTCC00246902,938280,13104
CHEMBL8753,P08254,,VFGGQXYFBRUJJO-RMTZWNOUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,90,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,530956,DTCC00136027,1740945,14548
CHEMBL8753,P08254,,VFGGQXYFBRUJJO-RMTZWNOUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,11,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,530954,DTCC00136027,1740945,14548
CHEMBL8761,P08254,,QQSPWJZNPRUUJQ-CMTIAEDTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,37,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,543138,DTCC00135481,322699,14548
CHEMBL8761,P08254,,QQSPWJZNPRUUJQ-CMTIAEDTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,21,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,543136,DTCC00135481,322699,14548
CHEMBL87775,P08254,,RLERLGNKRGQTKW-AUSIDOKSSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,5,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,479953,DTCC00247358,1968376,13104
CHEMBL87990,P08254,,PJFWFMNFWQFLRK-WIYYLYMNSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,12,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,486824,DTCC00246328,486329,13104
CHEMBL8828,P08254,,RTPXKIITNMOTOD-RMTZWNOUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,525253,DTCC00135854,290150,14548
CHEMBL88302,P08254,,UIQVQDGRTFCYRY-DNVCBOLYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,7629797,KI,=,65,NM,,,,,,,,,,,,,,"Inhibitory potency against human stromelysin, MMP-3",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,205626,DTCT0024060,512533,DTCC00247216,1870767,13104
CHEMBL8833,P08254,,DKCIEOMWEADZSJ-MVERNJQCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,61,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,540336,DTCC00136055,646656,14548
CHEMBL8833,P08254,,DKCIEOMWEADZSJ-MVERNJQCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,19,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,540334,DTCC00136055,646656,14548
CHEMBL8847,P08254,,LGJQFTJRPHIEEF-UODIDJSMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,3,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,530953,DTCC00135967,549407,14548
CHEMBL8847,P08254,,LGJQFTJRPHIEEF-UODIDJSMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,24,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,530951,DTCC00135967,549407,14548
CHEMBL88520,P08254,,HFAGTNGCAZYYLZ-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472217,KI,=,14,NM,,,,,,,,,,,,,,Inhibition of human MMP-3.,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104875,DTCT0024060,1674081,DTCC00251150,291473,16346
CHEMBL8868,P08254,,MGIJXUJXJHNWQP-OZNIXHKMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,40,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,518238,DTCC00136056,1740946,14548
CHEMBL8868,P08254,,MGIJXUJXJHNWQP-OZNIXHKMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,40,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,518236,DTCC00136056,1740946,14548
CHEMBL88718,P08254,,URNHVXGRPYRYOM-DYXWJJEUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472217,KI,=,2.88,NM,,,,,,,,,,,,,,Inhibition of human MMP-3.,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104875,DTCT0024060,1646394,DTCC00250880,323988,16346
CHEMBL8888,P08254,,OGCXCGPUOHWTTK-KWXIBIRDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,31,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,518235,DTCC00135897,1325239,14548
CHEMBL88972,P08254,"PYRIDINE-2,5-DICARBOXYLIC ACID",LVPMIMZXDYBCDF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,91,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103944,DTCC00250420,2087684,43205
CHEMBL8914,P08254,,FWCQVBZMZSRSKB-HRHHFINDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,19,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,529074,DTCC00135633,937104,14548
CHEMBL8914,P08254,,FWCQVBZMZSRSKB-HRHHFINDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,2000,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,529072,DTCC00135633,937104,14548
CHEMBL8917,P08254,,SAJIBYZMJURFDN-TVZXLZGTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,0,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,544208,DTCC00135888,743214,14548
CHEMBL8917,P08254,,SAJIBYZMJURFDN-TVZXLZGTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,1500,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,544206,DTCC00135888,743214,14548
CHEMBL8930,P08254,,DZJGNVNCJWKZRX-KWXIBIRDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,7,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,514085,DTCC00136057,2064484,14548
CHEMBL8930,P08254,,DZJGNVNCJWKZRX-KWXIBIRDSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,49,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,514083,DTCC00136057,2064484,14548
CHEMBL8933,P08254,L-764004,WSHMSPGZDPZGRV-GZYXPWJKSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,2,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,538674,DTCC00135995,807584,14548
CHEMBL8961,P08254,,RZFXBBCSOPZCEJ-RMTZWNOUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,84,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,351693,DTCC00135756,1740947,14548
CHEMBL8961,P08254,,RZFXBBCSOPZCEJ-RMTZWNOUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,13,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,351691,DTCC00135756,1740947,14548
CHEMBL8984,P08254,,UZLLJEIQEDPUMV-UODIDJSMSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,350,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,517201,DTCC00135752,127844,14548
CHEMBL9028,P08254,,YQJZTTJHPABLHV-CMTIAEDTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,89,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,522318,DTCC00136040,1772721,14548
CHEMBL9028,P08254,,YQJZTTJHPABLHV-CMTIAEDTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,11,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,522316,DTCC00136040,1772721,14548
CHEMBL90321,P08254,,SSQXFNKOLMHXPO-IRCOFANPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12873504,KI,=,7.7,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,Structure--activity relationships of azasugar-based MMP/ADAM inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,16,"Moriyama H, Tsukida T, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104872,DTCT0024060,922973,DTCC00255629,1980200,5719
CHEMBL9074,P08254,,FAJSWDUTNDYTOS-CMTIAEDTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,90,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,544211,DTCC00135945,1837648,14548
CHEMBL9074,P08254,,FAJSWDUTNDYTOS-CMTIAEDTSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,13,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,544209,DTCC00135945,1837648,14548
CHEMBL90743,P08254,,YQELKCVHKSQHTN-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,8.15,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,1004554,DTCC00257144,1553043,1012
CHEMBL90806,P08254,,SSQXFNKOLMHXPO-WYUUTHIRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12873504,KI,=,85,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,Structure--activity relationships of azasugar-based MMP/ADAM inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,16,"Moriyama H, Tsukida T, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104872,DTCT0024060,912777,DTCC00255639,401254,5719
CHEMBL9102,P08254,,PMABCPFRGPPVJY-CKIYMEHHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,4,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,541396,DTCC00135904,1616679,14548
CHEMBL9102,P08254,,PMABCPFRGPPVJY-CKIYMEHHSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,27,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,541394,DTCC00135904,1616679,14548
CHEMBL9105,P08254,,GJWCMELEZPWLGX-RMTZWNOUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,INHIBITION,=,17,%,,,,,,,,,,,,,,Percent inhibition of MMP-3 mediated degradation of radiolabeled transferrin in the mouse pleural cavity (PLCAV) after 60 mpk oral dose of inhibitor.,,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,112616,DTCT0024060,542289,DTCC00135896,387990,14548
CHEMBL9105,P08254,,GJWCMELEZPWLGX-RMTZWNOUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,9083493,KI,=,1100,NM,,,,,,,,,,,,,,Inhibition of human stromelysin-1 (Matrix metalloprotease-3),,Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.,J. Med. Chem.,1997,40,6,"Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK",,104738,DTCT0024060,542287,DTCC00135896,387990,14548
CHEMBL91054,P08254,,NEPPMULRSZAPIH-JSOSNVBQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,>,10000,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1713423,DTCC00256413,1661532,1013
CHEMBL91055,P08254,,ZKISXIXLRWGPKA-SVBPBHIXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11428927,KI,=,20000,NM,,,,,,,,,,,,,,Inhibitory constant against matrix metalloprotease-3,,A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.,J. Med. Chem.,2001,44,14,"Terp GE, Johansen BN, Christensen IT, Jørgensen FS",,104874,DTCT0024060,548192,DTCC00256517,269931,16308
CHEMBL91055,P08254,,ZKISXIXLRWGPKA-SVBPBHIXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,20000,NM,,cell_based,,,,,,,,,,,NSO,Inhibition of the Stromelysin enzyme was determined from purified NSO cells.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102089,DTCT0024060,1697632,DTCC00256517,270192,1013
CHEMBL91636,P08254,,DONMTDNLNMLOIC-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472217,KI,=,7.8,NM,,,,,,,,,,,,,,Inhibition of human MMP-3.,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104875,DTCT0024060,1647507,DTCC00251443,1261581,16346
CHEMBL91649,P08254,,ULOTXPTWJAUGGE-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12217351,KI,=,19,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-3,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,104742,DTCT0024060,1027164,DTCC00252177,1682212,5080
CHEMBL91655,P08254,,RMDYHDHTWWNFHG-NOZRDPDXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,1.73,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,977167,DTCC00256713,1456109,1012
CHEMBL92385,P08254,,AMVCYHOEVISGQB-IPYPFGDCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,11472217,KI,=,3,NM,,,,,,,,,,,,,,Inhibition of human MMP-3.,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,104875,DTCT0024060,1660457,DTCC00250839,1903218,16346
CHEMBL92453,P08254,,WYEWOIOFHXNSNW-IAPPQJPRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,2.98,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,979477,DTCC00256945,324032,1012
CHEMBL92512,P08254,,RSWUWSKXIDLCIR-ULQDDVLXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,45,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, MMP-3",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,101947,DTCT0024060,1311589,DTCC00257798,518678,2323
CHEMBL92600,P08254,,NLAVZJASCRYXPN-SQHAQQRYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,6.35,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,1012028,DTCC00257096,1617949,1012
CHEMBL92767,P08254,,SSQXFNKOLMHXPO-QCNOEVLYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12873504,KI,=,1.7,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,Structure--activity relationships of azasugar-based MMP/ADAM inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,16,"Moriyama H, Tsukida T, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104872,DTCT0024060,918539,DTCC00255894,1914635,5719
CHEMBL92767,P08254,,SSQXFNKOLMHXPO-QCNOEVLYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12873505,KI,=,17,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,"Design, synthesis and evaluation of novel azasugar-based MMP/ADAM inhibitors.",Bioorg. Med. Chem. Lett.,2003,13,16,"Moriyama H, Tsukida T, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104873,DTCT0024060,968722,DTCC00255894,1914640,5720
CHEMBL92828,P08254,,IURHJAMYHLDNBR-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,0.96,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,988763,DTCC00256909,1935247,1012
CHEMBL92835,P08254,,SJEBBPDOLJCLQH-OJSMNCEXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,860,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, MMP-3",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,101947,DTCT0024060,1306828,DTCC00258294,1196484,2323
CHEMBL92970,P08254,,RSWUWSKXIDLCIR-YESZJQIVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,270,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, MMP-3",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,101947,DTCT0024060,1295705,DTCC00257891,356750,2323
CHEMBL93067,P08254,,FABJTKDLHAAFNV-DGAVXFQQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12873505,KI,=,44,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,"Design, synthesis and evaluation of novel azasugar-based MMP/ADAM inhibitors.",Bioorg. Med. Chem. Lett.,2003,13,16,"Moriyama H, Tsukida T, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104873,DTCT0024060,951749,DTCC00255808,917299,5720
CHEMBL93155,P08254,,DCCBWHQCASKYJR-NTZARQNWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,550,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, MMP-3",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,101947,DTCT0024060,1300777,DTCC00258060,1163956,2323
CHEMBL93235,P08254,,VQWLMWWSSYJPOW-NOZRDPDXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,1.38,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,996272,DTCC00256946,1870880,1012
CHEMBL93320,P08254,,CXNJLMYOAJTOHP-ADUPEVMXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,490,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, MMP-3",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,101947,DTCT0024060,1318617,DTCC00257892,1163955,2323
CHEMBL93357,P08254,,FYYNAVTYOZPHTC-JWDFLIAJSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,500,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, MMP-3",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,101947,DTCT0024060,1287264,DTCC00258033,2065748,2323
CHEMBL93395,P08254,,VGJHUMMWUOOYIO-CTNGQTDRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,0.8,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,989971,DTCC00257301,1520993,1012
CHEMBL93583,P08254,,CWNLQOSKBPEJOV-FTJBHMTQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,2.75,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,1008303,DTCC00257037,647972,1012
CHEMBL93620,P08254,,LQZDEWIIFWHTLX-BSDSXHPESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12873504,KI,=,2.6,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,Structure--activity relationships of azasugar-based MMP/ADAM inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,16,"Moriyama H, Tsukida T, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104872,DTCT0024060,901960,DTCC00255502,1144452,5719
CHEMBL93695,P08254,,MWWSEQIBKWJTDA-VPUSJEBWSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,2.39,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,1003464,DTCC00256937,64539,1012
CHEMBL93720,P08254,,SSQXFNKOLMHXPO-USZNOCQGSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,12873504,KI,=,490,NM,,,,,,,,,,,,,,Inhibition of recombinant human matrix metalloprotease-3,,Structure--activity relationships of azasugar-based MMP/ADAM inhibitors.,Bioorg. Med. Chem. Lett.,2003,13,16,"Moriyama H, Tsukida T, Inoue Y, Kondo H, Yoshino K, Nishimura S",,104872,DTCT0024060,922977,DTCC00255641,949872,5719
CHEMBL93791,P08254,,FWRANZUQAGPBMV-FTJBHMTQSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,5.87,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,992465,DTCC00256947,486431,1012
CHEMBL93890,P08254,,HLSQLCOADIMQBK-QYZOEREBSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,127,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,991083,DTCC00257036,96909,1012
CHEMBL94114,P08254,,UVOFCKSSQUNXIZ-IZLXSDGUSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,KI,=,2.61,NM,,,,,,,,,,,,,,Inhibition of the stromelysin enzyme.,,,Bioorg. Med. Chem. Lett.,1994,4,23,,,102088,DTCT0024060,987686,DTCC00256654,96910,1012
CHEMBL94256,P08254,,DKPAZQOKVRHHON-ADUPEVMXSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,550,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, MMP-3",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,101947,DTCT0024060,1322236,DTCC00257864,1035462,2323
CHEMBL94346,P08254,(PROPYLAMINO)CARBONYLPHOSPHONIC ACID,KMYNAIWKMORGAF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,=,50000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1288011,DTCC00260739,1850377,17838
CHEMBL94348,P08254,(ETHYLAMINO)CARBONYLPHOSPHONIC ACID,IZWWUWVUAGTWGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,=,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1319228,DTCC00260740,949944,17838
CHEMBL95068,P08254,PIPERIDIN-1-YLCARBONYLPHOSPHONIC ACID,LPCNDTNDDXIPDM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,=,90000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1290505,DTCC01741836,820511,17838
CHEMBL95237,P08254,,IHERVMJHCHNTKO-YJJOXIQCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,14611841,IC50,=,179,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-3,,MMPs inhibitors: new succinylhydroxamates with selective inhibition of MMP-2 over MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,17,"Marcq V, Mirand C, Decarme M, Emonard H, Hornebeck W",,104721,DTCT0024060,874027,DTCC00263307,518732,5741
CHEMBL95237,P08254,,IHERVMJHCHNTKO-YJJOXIQCSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17512742,IC50,=,179,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447906,DTCT0024060,2176040,DTCC00263307,520985,23716
CHEMBL95414,P08254,,FUYGKZYSHSZHFI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15125955,IC50,=,1500,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104895,DTCT0024060,1401123,DTCC00264967,1079590,6400
CHEMBL95483,P08254,,DYYRCQAVWNBEBP-MNOVXSKESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC60,=,100000,NM,,,,,,,,,,,,,,"Inhibition of Stromelysin-1, MMP-3",,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101948,DTCT0024060,1457843,DTCC00264377,917407,3373
CHEMBL95614,P08254,,QHRUJPVXLYJUEM-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1451870,DTCC00264573,205149,3373
CHEMBL95614,P08254,,QHRUJPVXLYJUEM-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,1995.26,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258352,DTCC00264573,196120,24803
CHEMBL95763,P08254,(CYCLOBUTYLAMINO)CARBONYLPHOSPHONIC ACID,UILNVWQPBYOCJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1286794,DTCC00261232,788164,17838
CHEMBL96438,P08254,(DIBUTYLAMINO)CARBONYLPHOSPHONIC ACID,NEQAQLUTBGWNLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,=,30000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1307518,DTCC00261385,465117,17838
CHEMBL96473,P08254,,LTRFXCQZLSSSPG-UBFHEZILSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,,IC50,=,4280,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-3, MMP-3",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,101947,DTCT0024060,1298176,DTCC00257913,129156,2323
CHEMBL97034,P08254,(ISOPROPYLAMINO)CARBONYLPHOSPHONIC ACID,ZBIIKTYRXGHZSP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1307510,DTCC00261507,335874,17838
CHEMBL97057,P08254,(DIETHYLAMINO)CARBONYLPHOSPHONIC ACID,DCJBWQGCBUBISK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,=,30000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1296411,DTCC00261591,1240575,17838
CHEMBL97382,P08254,,ZNTBEHZFMMNDRG-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1448189,DTCC00264485,433638,3373
CHEMBL97382,P08254,,ZNTBEHZFMMNDRG-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,1995.26,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258362,DTCC00264485,424706,24803
CHEMBL97388,P08254,(METHYLAMINO)CARBONYLPHOSPHONIC ACID,DKRGQDKOWKPDBY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,=,90000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1314463,DTCC00261329,659364,17838
CHEMBL97389,P08254,SODIUM HYDROGEN (BUTYLAMINO)CARBONYLPHOSPHONATE,XZWWCSRZYGUJCH-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1318099,DTCC00261330,368532,17838
CHEMBL97510,P08254,(SEC-BUTYLAMINO)CARBONYLPHOSPHONIC ACID,FRMUISNHCCQMGM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,=,80000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1305206,DTCC01741841,1273346,17838
CHEMBL97614,P08254,(CYCLOHEPTYLAMINO)CARBONYLPHOSPHONIC ACID,PZCAQCXIXVTXSS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1313341,DTCC00261524,1753576,17838
CHEMBL97709,P08254,(CYCLOOCTYLAMINO)CARBONYLPHOSPHONIC ACID,RDECIIJACWTCQB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1309955,DTCC00261479,917368,17838
CHEMBL97838,P08254,MORPHOLIN-4-YLCARBONYLPHOSPHONIC ACID,XUDXDIFMUCLQQH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,=,1000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1313350,DTCC01741839,1564617,17838
CHEMBL97936,P08254,,FCGVXISUYVDDPU-RPWUZVMVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1457848,DTCC00264930,401357,3373
CHEMBL97936,P08254,,FCGVXISUYVDDPU-RPWUZVMVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,50.12,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258355,DTCC00264930,391949,24803
CHEMBL97951,P08254,CYCLOHEXYLMETHYLCARBAMOYLPHOSPHONIC ACID,XBMRQHZMWARLEG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15139760,IC50,=,1000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-3 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,104892,DTCT0024060,1320468,DTCC00106572,1273345,17838
CHEMBL98017,P08254,,OEPLGUBYTRYCJX-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,800,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1451875,DTCC00264988,2013090,3373
CHEMBL98017,P08254,,OEPLGUBYTRYCJX-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,794.33,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258345,DTCC00264988,2003620,24803
CHEMBL98044,P08254,,MVRHXCGLUWVMKH-CVEARBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1474976,DTCC00264954,76259,3373
CHEMBL98044,P08254,,MVRHXCGLUWVMKH-CVEARBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,199.53,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258359,DTCC00264954,67153,24803
CHEMBL98044,P08254,,MVRHXCGLUWVMKH-CVEARBPZSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,18790648,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497404,DTCT0024060,2457481,DTCC00264954,79308,32556
CHEMBL98202,P08254,,KQXZHGMAVQYCLA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15125955,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104895,DTCT0024060,1386239,DTCC00265444,401371,6400
CHEMBL98390,P08254,,AYWKRESAZCSENH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15125955,IC50,=,1500,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104895,DTCT0024060,1403506,DTCC00265682,691581,6400
CHEMBL98852,P08254,,VDOSRWCTGZRCFD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15125955,IC50,=,6300,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104895,DTCT0024060,1364696,DTCC00265511,949990,6400
CHEMBL98917,P08254,,OVICMAJBKGLSNC-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1472417,DTCC00264408,755981,3373
CHEMBL98917,P08254,,OVICMAJBKGLSNC-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,3981.07,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258343,DTCC00264408,746928,24803
CHEMBL99045,P08254,,QSRYPQMSBYPAQC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15125955,IC50,=,5500,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104895,DTCT0024060,1382455,DTCC00264808,1403621,6400
CHEMBL99148,P08254,,ZVAKMIZOMSWYGQ-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1450625,DTCC00264513,788198,3373
CHEMBL99148,P08254,,ZVAKMIZOMSWYGQ-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,398.11,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258358,DTCC00264513,778988,24803
CHEMBL99189,P08254,,YLYMDJMYRSEUOA-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1466341,DTCC00265032,1532650,3373
CHEMBL99189,P08254,,YLYMDJMYRSEUOA-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,398.11,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258347,DTCC00265032,1523430,24803
CHEMBL99365,P08254,,YFYQFPIGOKJLFD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15125955,IC50,=,1300,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104895,DTCT0024060,1394861,DTCC00265479,562406,6400
CHEMBL99932,P08254,8-AMINOQUINOLINE,WREVVZMUNPAPOV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21189019,INHIBITION,=,56,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP3 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715232,DTCT0024060,5103288,DTCC00265364,540480,43205
CHEMBL99981,P08254,,ZBTKKYFIZQHNDQ-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,10522712,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of Strom-1 MMP-3,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,101945,DTCT0024060,1456612,DTCC00265035,173185,3373
CHEMBL99981,P08254,,ZBTKKYFIZQHNDQ-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,17275314,IC50,=,302,NM,,,,,,,,,,,,,,Inhibition of MMP3,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458939,DTCT0024060,2258350,DTCC00265035,164159,24803
CHEMBL99995,P08254,,CDDCBQKBUFNWAE-NTBLAEGASA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,15125955,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-3,,Reverse hydroxamate-based selective TACE inhibitors.,Bioorg. Med. Chem. Lett.,2004,14,11,"Kamei N, Tanaka T, Kawai K, Miyawaki K, Okuyama A, Murakami Y, Arakawa Y, Haino M, Harada T, Shimano M",,104895,DTCT0024060,1383851,DTCC00265558,853474,6400
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,=,574,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15031109,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,=,849,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15042921,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,=,887,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15042920,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,=,1065,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15042919,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,=,1770,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15054652,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,=,1878,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15054651,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,=,2845,NM,,cell_based,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15047493,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,=,3034,NM,,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14908137,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,=,3200,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15052444,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,=,4500,NM,,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14911318,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,=,4775,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15047494,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,=,6125,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15072988,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,=,13165,NM,,cell_based,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15072592,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,=,15342,NM,,cell_based,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15072590,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,=,99710,NM,,cell_based,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15072593,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,>,10000,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15072588,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,>,10000,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15072589,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,>,10000,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15072987,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,-1,IC50,>,100000,NM,,cell_based,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15072591,DTCC01744004,2113367,70044
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,27825552,IC50,=,1.5,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14934553,DTCC01744004,2113725,70170
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,27825552,IC50,=,2.5,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14940008,DTCC01744004,2113725,70170
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,27825552,IC50,=,2.6,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14940410,DTCC01744004,2113725,70170
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,27825552,IC50,=,23,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14973374,DTCC01744004,2113725,70170
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,27825552,IC50,=,30,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14996246,DTCC01744004,2113725,70170
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,27825552,IC50,=,370,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15031861,DTCC01744004,2113725,70170
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,27825552,IC50,=,2400,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15056955,DTCC01744004,2113725,70170
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,27825552,IC50,=,3300,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15056954,DTCC01744004,2113725,70170
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,27825552,IC50,=,4000,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15055521,DTCC01744004,2113725,70170
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,27825552,IC50,>,10000,NM,inhibition,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0024060,15072365,DTCC01744004,2113725,70170
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16220987,KI,=,23.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14745308,DTCC01744004,2108945,69259
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16220987,KI,=,158,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14754608,DTCC01744004,2108945,69259
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,20817735,KI,=,40,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14753292,DTCC01744004,2110394,69686
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21208635,IC50,=,10400,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14725124,DTCC01744004,2096616,67860
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21208635,IC50,=,36700,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14706804,DTCC01744004,2096616,67860
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21208635,IC50,=,44000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14724189,DTCC01744004,2096616,67860
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21208635,IC50,=,65000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14708391,DTCC01744004,2096616,67860
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21208635,IC50,=,65000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14726258,DTCC01744004,2096616,67860
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21827363,IC50,=,4750,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14723988,DTCC01744004,2096753,67989
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21827363,IC50,=,19500,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14723766,DTCC01744004,2096753,67989
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21827363,IC50,=,22500,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14723762,DTCC01744004,2096753,67989
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21827363,IC50,=,28000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14709363,DTCC01744004,2096753,67989
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,21827363,IC50,=,30000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14710280,DTCC01744004,2096753,67989
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22689580,IC50,=,300,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14725237,DTCC01744004,2098141,68703
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22689580,KI,=,40,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14753293,DTCC01744004,2098141,68703
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22689580,KI,=,103,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14751478,DTCC01744004,2098141,68703
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22689580,KI,=,329,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14749093,DTCC01744004,2098141,68703
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22689580,KI,=,2164,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14745585,DTCC01744004,2098141,68703
,P08254,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,22689580,KI,=,5819,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14746898,DTCC01744004,2098141,68703
,P08254,AGN-PC-00AW7I,ZBOSPOSQGJWURE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16220987,KI,=,18.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14746240,DTCC01746086,2109118,69259
,P08254,AGN-PC-00B1B8,QVHYJMPAZNGFHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16220987,KI,=,0.3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14753704,DTCC01745743,2103471,69259
,P08254,AGN-PC-00B1IZ,BEQXRWLSEUIFKP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16220987,KI,=,20,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14747798,DTCC01746160,2109488,69259
,P08254,AGN-PC-00BMEK,QYCUMAKSYBUWER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16220987,KI,=,12.6,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14753764,DTCC01746699,2110472,69259
,P08254,AGN-PC-00COJ9,WDPVPUZANMBBLA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16220987,KI,=,18.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14732733,DTCC01745926,2104739,69259
,P08254,AGN-PC-00D2VZ,NKHJMAWHLPBSOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16220987,KI,=,39.3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14752274,DTCC01746561,2110229,69259
,P08254,AGN-PC-00ERPQ,YLRBOIVJMWEGGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16220987,KI,=,0.3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14745121,DTCC01745987,2108904,69259
,P08254,ALPHA-SULFONE 27B,LFIZWBFUWVSLOR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16220987,KI,=,59,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14755208,DTCC01746809,2110669,69259
,P08254,ALPHA-SULFONE 35G,KLWUGXOQJJWEBZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16220987,KI,=,23,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14754582,DTCC01746770,2110582,69259
,P08254,ALPHA-SULFONE 35H,XJMDDZUUIUEEJH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 3,MMP3,Enzyme,,,16220987,KI,=,32,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024060,14746923,DTCC01746132,2109290,69259
